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Abstract
This epidemiological thesis explores the determinants of child asthma, focusing on the infant and 
child bedding environment. Three previous studies provided the datasets central to this thesis: (i) 
The 1988-1995 Tasmanian Infant Health Survey was a prospective birth cohort conducted to 
investigate the aetiology of sudden infant death syndrome; (ii) The 1997 Childhood Allergy and 
Respiratory Health Survey was a follow-up of children who as infants participated in the 
Tasmanian Infant Health Survey; and (iii) The 1995 cross-sectional Childhood Asthma Survey 
included all children turning 7 years of age in Tasmania.
In this thesis, bedding items used in infancy were found to be associated with adverse respiratory 
health in childhood. Infant sheepskin and plastic mattress covers were associated with 
subsequent house dust mite sensitization. Infants using cocoons were at a greater risk of 
wheeze in childhood. In the cross-sectional study, positive associations with increased wheeze 
were found between children either sleeping in the bottom bunk-bed or with their current use of 
an electric blanket. An adverse association was also found with synthetic quilt use on frequent 
wheeze and post-exercise lung function among children who slept supine but not among children 
who did not sleep supine. The main contribution to new knowledge from this thesis is the finding 
that wheeze risk in childhood at age 7 years increased linearly with increasing numbers of 
potentially high house dust mite-rich bedding items at one month of age. This composite bedding 
effect was further modified by the indoor environmental factors of bedroom heating, recent 
bedroom painting and absence of bedroom carpet. When two or more of these environmental 
factors were present the bedding-wheeze effect was markedly exacerbated with increasing 
composite bedding in infancy.
Bedding is an easily modifiable environmental factor. This thesis provides new knowledge on the 
role of bedding in early life in asthma. This has important implications for both future work and 
current public health recommendations regarding infant and child bedding and the prevention of 
asthma.
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Prologue
“I have no magic cure. Asthma has many aetiological aspects and should be treated 
according to the various causes that bring it about”. (1)
Moses Maimonides (1135-1204), one of the greatest physicians of Western Islam and court physician to 
the Sultan of Egypt and Syria.
THE CURRENT STATUS OF CHILD ASTHMA
At the end of the 20th century, the prevalence of asthma in children and young adults was 
reported to be increasing world-wide by 5% - 6% each year (2); although there is recent evidence 
that this may have leveled off or declined in some countries, including Australia (3-5). 
Notwithstanding, the prevalence of child asthma in Australia is amongst the highest in the world 
(6) and recent surveys conducted by the Australian Bureau of Statistics show that 14% -16% of 
Australian children have a diagnosis of asthma that remains a current problem (7).
The reported changes in the prevalence of asthma have occurred too rapidly to be in response to 
changes in genetic variants. Modifications in the pattern of exposure, and changes in 
susceptibility, to various environmental factors in large portions of the population may be 
important (6). Epidemiological studies have explored the putative role of environmental risk 
factors (for example, allergens, tobacco smoke, and air pollution) as well as the loss of possible 
protective factors over time, such as early infections and diet. These current putative risk factors 
cannot fully account for either the worldwide increase in prevalence or the international variations 
in asthma prevalence that have been observed (8). The aetiology of asthma is still unclear, and 
further research is required to better understand the environmental determinants of child asthma.
THE FOCUS OF THIS THESIS
To date, the infant bedding environment and its role in the aetiology of child asthma is not well
understood and research has focused on allergens, house dust mite (HDM) (9) and feather (10),
and, to a lesser extent, bacterial endotoxin (11) content in individual bedding items. Few
prospective studies have examined the associations between bedding and HDM sensitization and
wheeze (12,13). For infants and young children, a high proportion of indoor time is spent within
this one environment (14, 15) with close proximity to the bedding items. Thus, the bedding
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environment may be a key factor in child asthma. The aim of this thesis is to identify home 
environmental risk factors for HDM sensitization and child asthma, focusing on infant and child 
bedding and the bedding environment. My research provides the opportunity to identify factors 
that may play a causal role in child asthma, that can be modified in infancy, or in the early years 
of life, by exploring the relationship between the bedding environment with asthma development.
My analyses have been carried out on pre-existing data obtained from three studies previously 
undertaken by the Menzies Centre for Population Health Research in Tasmania, Australia: (i) The 
1988-1995 Tasmanian Infant Health Survey (TIHS) was a prospective birth cohort conducted to 
investigate the aetiology of sudden infant death syndrome (SIDS); (ii) The 1997 Childhood Allergy 
and Respiratory Health Survey (CARHS) was a follow-up of children who as infants participated 
in the TIHS; and (iii) The 1995 cross-sectional Childhood Asthma Survey included all children 
turning 7 years of age in Tasmania.
Although the datasets existed and some findings on the home environment and bedding had 
been reported, I was approached by my chief supervisor, Anne-Louise Ponsonby, to undertake 
further work because the studies were under-utilised. The detailed analyses of the bedding items 
and home environmental factors identified in this thesis, and their associations with HDM 
sensitization and asthma had not been previously undertaken. The relationship between 
composite bedding arrangements, their interactions with home environmental factors and 
respiratory health has not previously been assessed and is a major focus of the work for this 
thesis. In addition, this thesis undertakes comparisons of bedding-wheeze and bedding-HDM 
associations across each of the three datasets, assessing the consistency of the reported 
findings. A range of different methodological and statistical approaches have been applied in my 
analyses. Apart from Chapter 6 ,1 have provided the principle contribution to the design approach 
for the analyses, the analyses and the reporting of the findings of each Chapter in this thesis. In 
Chapter 6 ,1 principally undertook only sections of the analysis and reporting.
CHAPTER OUTLINE
Chapter 1 presents an overview of the history and definition of asthma, the genetic epidemiology 
of the disease and its immunopathogenesis. The evidence for potential environmental risk 
factors, and, their role in the development of asthma in the postnatal environment is overviewed 
in Chapter 2. The role of bedding and possible effect modifiers are discussed in detail in the
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introduction and discussion sections of each relevant Chapter. This approach was utilized 
because the findings in these Chapters are best interpreted and discussed with reference to 
previously reported findings.
Chapter 3 outlines the aim and hypotheses of this thesis, and describes the design features of the 
three Tasmanian studies and their applicability in asthma studies.
Chapters 4, 5, 6 and 7 focus on the analyses of the two cohort and one cross-sectional studies 
with the presentation, discussion and implications of the findings. Chapter 4 reports the results of 
associations between underbedding, mattress and bed types, and allergic sensitization and 
respiratory health. Chapter 5 presents the prospective associations between the use of cocoons 
and sleeping bags in infancy and the development of child wheeze and HDM sensitization. In 
Chapter 6, findings are reported of an association between child sleep position, bedding and 
respiratory health. Chapter 7 describes the relationships between composite bedding, bedding- 
environment interactions and chiid asthma.
The final chapter, Chapter 8, summarises the key findings of this thesis, and discusses their 
implications for public health policy and future research directions.
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Chapter 1
The biological and immunological basis of allergic sensitization 
and asthma
1.0 PREFACE
Epidemiological evidence suggests that the worldwide prevalence of asthma has increased 
significantly over the past 30 years with the greatest increase among children and adolescents 
(16). It now affects between 1% and 20% of the population, with the highest rates occurring in 
the USA, Australia, New Zealand and North-west Europe (17) Half of the cases present before 
the age of two years and more than 92% before the age of nine years (18). Public health 
programs are challenged to develop prevention programs based on an identification of the factors 
that have caused these increases. Critical to primary prevention programs, whereby the 
intervention precedes disease development, is an understanding of both the genetic and 
immunological basis of allergic sensitization and asthma. This Chapter will define asthma and 
discuss its pathogenesis.
1.1 THE HISTORY OF ASTHMA
The clinical manifestations of bronchial asthma have been known since antiquity; asthma-like 
symptoms were first recorded 3,500 years ago in an Egyptian manuscript called Ebers Papyrus 
(1300 BC). But almost 2,000 years elapsed between the first known description of the disease 
and its recognition as a distinct medical entity. The word “asthma” first appeared in Homer’s epic 
poem, the Iliad', and is derived from the Greek verb “azein” or “azo” meaning to pant or laboured 
breathing. Asthma was first described as a clinical entity 500 years following Homer’s Iliad, in the 
Hippocratic (460-370 B.C.) writings, “Corpus Hippocraticum” (19), where the word was used to 
denote all types of dyspnoea that became more common with increasing age. Hippocrates 
recognized the spasmodic nature of asthma and considered asthma had “its own nature” arising 
from external causes such as moisture, occupation and climate.
The first comprehensive book on asthma, “A Treatise of the Asthma” by Sir John Floyer (20) was 
published in 1698 where he considered the immediate cause of asthma was "straitness, 
compression, or constriction" of the bronchi. By observing the reactions of patients to both the
4
smoky London air and potent odors, Floyer was able to note that elements of the environment 
could trigger asthma attacks. In addition, he observed that exposure to airborne house dust plays 
an essential role in asthma (20), but it was only more recently that the Pyroglyphidae family (in 
particular the genus Dermatophagoides) were isolated by Voorhorst, in 1964, as the main source 
of allergen in house dust (21). By the late 19th century, physicians believed that asthma was a 
disease which had a specific set of causes, clinical consequences, and requirements for 
treatment, despite the diversity of individual experiences.
1.2 DEFINITION OF ASTHMA, ATOPY AND ALLERGY
The definition of asthma has become more complex as understanding of its pathophysiology has 
increased. However, despite this increased complexity, the basic characteristic feature of 
reversible airflow obstruction, by which one recognizes or diagnoses the disease, has changed 
little over recent years.
The 1959 CIBA Guest Symposium (22) was an important milestone in respiratory epidemiology. 
The definitions for a number of chronic lung diseases derive from this meeting. Asthma was 
defined as “...a widespread narrowing of the bronchial airways, which changes in severity over 
short periods of time either spontaneously or under treatment, and is not due to cardiovascular 
disease” (22). This definition still forms the basis of the current definition of asthma which 
remains based on pathology and its functional consequences: “Asthma is a chronic disorder of 
the airways that is characterized by reversible airflow obstruction and airway inflammation, 
persistent airway hyperreactivity (AHR), and airway remodeling” (23).
The term “atopy” was first introduced in the early 1920s (24) to designate some phenomena of 
hypersensitiveness in man and included the clinical characteristics of “bronchial asthma”. Today, 
atopy is defined as a personal or familial tendency to produce immunoglobulin (lg) E (IgE) 
antibodies directed to epitopes expressed on the molecules of common environmental allergens 
such as domestic mites, animal proteins, pollens and fungi (25), and to develop related disorders 
such as asthma, rhinoconjunctivitis, or eczema/dermatitis (26). Allergy is a hypersensitivity 
reaction initiated by immunological mechanisms. It can be antibody, (IgE-mediated allergy or 
humoral), or cell-mediated (non IgE-mediated allergy). The term “atopy” is used if the allergy is 
IgE-mediated (26).
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In accordance with a recent joint statement (27), high-risk infants are defined as “infants with a 
well-defined increased risk of developing allergic disease: that is, infants with at least one first 
degree relative (parent or sibling) with a documented allergic disease”. However, in some studies 
“high-risk” has been defined as double parental heredity or single heredity (parents or sibling) 
combined with elevated cord blood IgE (28).
1.3 THE GENETIC EPIDEMIOLOGY OF ASTHMA AND ASSOCIATED 
TRAITS
The genetic aetiology of asthma has been increasingly emphasized as a means of better 
understanding its pathogenesis with the ultimate goal of improving preventive strategies, 
diagnostic tools and therapies. However, the significant increase in the prevalence of atopy- 
related disorders over the past decades cannot be explained by changes in gene frequencies. It 
is probable that various pre-existing genetic factors interacting with a dramatically changing 
environment (decline of infectious diseases, change in diet, immunizations, and others) have 
rendered a large percentage of the population susceptible to asthma and atopy (29).
Asthma, eczema and the atopic state are familial (30) with multiple twin and family analyses 
strongly implicating a genetic basis for atopy-related traits (31). Studies of twins have reported 
that concordance rates for asthma are significantly higher in monozygotic twins than in dizygotic 
twins (32-35), whether reared apart or together (36). The estimated heritability for twins, under 
the multifactorial threshold model, ranges from 36% (33) to 75% (32). As the sum of population 
attributable fractions can exceed 100% (37), these findings do not indicate environmental 
influences to be insignificant. Furthermore, epidemiological studies suggest that maternal 
phenotype, more than paternal phenotype (38), influences the development of atopic disease in 
childhood (39). The inheritance of asthma, however, does not follow the classical Mendelian 
patterns that are characteristic of single-gene disorders (31, 40). Complex genetic disorders, 
such as asthma, exhibit multifactorial traits, the dissection of which is hampered by phenocopy, 
incomplete penetrance, and genetic heterogeneity (41). The genetics of asthma and other atopy- 
associated phenotypes is complex and is reflected by an increasingly large number of 
chromosomal regions showing (weak to moderate (41)) evidence for linkage, as well as various 
genetic variations in multiple candidate genes that are associated with asthma and associated 
phenotypes (29).
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Linkage studies (genome-wide searches and candidate gene region analyses) have identified 
multiple chromosomal regions related to asthma and atopy (29), with markers in 19 chromosomal 
regions having shown some evidence of linkage to asthma, atopy or related phenotypes in 
multiple independent genome-wide searches (42). Thus, it has been clearly established that no 
single gene or even a small number of genes exert a decisive influence in determining 
susceptibility to asthma (43). Asthma appears to be essentially a polygenic disease in which 
many genetic variants determine small changes in immune responses or in the manner in which 
the airway responds to the environment (44).
1.3.1 Gene-environment interactions
Environmental factors, therefore, play a key role in the pathogenesis of atopic asthma (45) and it 
is postulated that onset of disease and its clinical course are determined by gene-environment 
interactions. Those persons, in whom asthma develops, are both genetically susceptible and 
receive an appropriate environmental stimulus (46). Across the range of asthmatics in the 
population, the relative influence of genes and environmental factors probably varies (46), 
generating the hypothesis that individuals with different asthma-related genotypes will have 
different sensitivities to environmental exposures (47). Chapter 2 provides a review of 
epidemiological studies, and discusses the environmental exposures that may play a role in the 
development of asthma.
1.3.2 Asthma phenotypes
The current definition of asthma describes its pathophysiologic basis and a single uniform 
phenotypic definition of asthma does not exist. There is no quantitative marker specific for 
asthma and no gold standard against which to validate the diagnostic usefulness of physiologic 
measures, such as bronchial hyperreactivity (48). This is in contrast with other complex diseases 
in which quantitative traits, or a series of measurable “biomarkers” have assisted in identifying 
susceptibility genes, for example prostate-specific-antigen in prostate cancer.
Asthma is, however, associated with a number of quantitative “intermediate” phenotypes (49), 
such as elevation of the total serum IgE and nonspecific airway responsiveness to inhaled 
spasmogens such as histamine or methacholine. Bronchial hyperresponsiveness (BHR) is
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associated with asthma and atopy, as observed by the close association of serum IgE levels, 
BHR and asthma in asymptomatic children (46). As the atopic state underlies a considerable 
portion of childhood asthma (46, 50) other measures of the allergic phenotype, such as total 
serum eosinophil counts, skin prick test (SPT) responses to common allergens and specific IgE 
measures, are also studied as intermediate phenotypes (46). The asthma-associated 
quantitative phenotypes of atopy, elevated blood eosinophil counts, and increased airways 
responsiveness are also highly heritable (50). Asthma and all of its associated quantitative 
phenotypes are characterized by heterogeneity. Although the evidence suggests that the 
commonly measured asthma-associated pathophysiological factors are under some genetic 
control, the degree of genetic control and the extent to which most of these traits are genetically 
distinct from each other and from asthma is still unclear (50).
The pathogenesis of asthma is extremely complex, and it is conceivable that alterations in the 
regulation of many different immune and non-immune pathways may give rise to the same 
common finai pathway: namely recurrent, reversible bronchial obstruction associated with chronic 
airway inflammation and BHR (43). Evidence suggests some of the intermediate phenotypes 
associated with asthma (in particular serum IgE) are caused by an oligogenic background 
modified by strong environmental factors (50). Clinical severity is one means of delineating sub­
groups of asthma (51). The classic distinction between extrinsic (atopic) and intrinsic (non-atopic) 
asthma considers measurements of atopy. Other clinical sub-phenotypes may be defined 
clinically as nocturnal asthma, aspirin-induced asthma, or based on inclusion criteria such as age 
of onset or smoking (51).
1.3.2.1 Paediatric asthma phenotypes
Epidemiological studies suggest that, at least in the case of childhood asthma, the disease may 
have different phenotypic expressions at different ages, as assessed by their risk factors and 
prognosis (52). There are at least three distinct paediatric phenotypes which may each have a 
different aetiology and this has to be considered when searching for causes of asthma. These 
different phenotypes have been described as follows:
(i) Transient early wheezing, characteristically resolving by age 3 years, and not associated 
with a family history of asthma or allergic sensitization (53). The primary risk factor is 
reduced pulmonary function (for example, from congenitally smaller airways) (53, 54).
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Other risk factors include prematurity (55), maternal smoking during pregnancy and 
postnatal exposure to tobacco smoke (56), and exposure to siblings and other children at 
day care centres (57).
(ii) Non-atopic wheezing associated with a viral infection-induced bronchial obstruction 
during ages 2 - 3 years and resolving in most children by 13 years of age (58). This is 
most frequently caused by the respiratory syncytial virus (RSV), and is not associated 
with an increased risk for allergic sensitization (58). Early age (under 2 years) of onset of 
wheeze is a poor predictor of continuing asthma in later childhood (59-61).
(iii) Atopic wheezing/asthma. More than half of all cases of persistent asthma start before 
age 3 years, and 80% begin before age 6 years (58). Among school-aged children with 
persistent asthma, the onset of symptoms before age 3 years is associated with 
increased severity of the disease and increased BHR and is frequently associated with 
atopy (58).
1.4 ATOPIC AND NON-ATOPIC ASTHMA
Although asthma is multifactorial in origin, atopy is the strongest identifiable predisposing factor 
for the development of asthma, and there is considerable information regarding both its genetic 
and environmental risk factors. In comparison little is known, however, about the genetic basis 
for non-atopic asthma, though some data are available on environmental risk factors (smoking is 
of prime importance; but, viral infection, exercise, chronic sinusitis and gastro-oesophageal reflux 
may all be relevant) (62). Non-atopic asthma may also constitute around 50% of adult asthma 
(62) and is often severe. Although the aetiology is less well defined, similar inflammation is 
present in the lungs of non-atopics and atopies and the same drugs treat both diseases (62). 
Non-atopic asthmatics show negative SPTs to allergen provocation and there is no clinical or 
family history of allergy. Previous studies have shown that serum IgE concentrations are within 
the normal range and there is no evidence of specific IgE antibodies directed against common 
allergens (63). There is a preponderance of females with onset of symptoms in later life, and the 
association of nasal polyps and aspirin sensitivity occurs more frequently in the non-atopic form 
of the disease (63).
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1.5 PATHOGENESIS OF ASTHMA
The current concept of asthma pathogenesis (64) is that a characteristic chronic inflammatory 
process involving the airway wall causes the development of airflow limitation and increased 
responsiveness, thereby predisposing the airways to narrow  in response to a variety of stimuli. In 
addition, characteristic features of the airway inflammation are an increased number of activated 
eosinophils, mast cells and T lymphocytes in the airway mucosa and lumen, and an increased 
thickness of the reticular layer of the basement membrane (sub-epithelial fibrosis). These 
changes may be present even when asthma is asymptomatic.
The majority of the data regarding the pathogenesis of asthma concentrates on atopic asthma 
and the imbalance between the Th1 (cell-mediated immunity) and Th2 (humorally-mediated 
immunity) phenotypes, and is the pathogenesis presented here. However, asthma may also 
occur through non-allergic mechanisms of inflammation (65), which as stated in Section 1.4 is 
similar to the inflammation found in atopic asthma.
The response of the airway to inhaled allergen provides insights into immunological mechanisms 
that contribute to the pathogenesis of atopic asthma. In patients with asthma, inhaled allergen 
may precipitate acute obstruction of the airway by initiating the release from mast cells of 
histamine and leukotrienes, which cause constriction of smooth muscles. This early-phase 
reaction usually resolves within an hour. Four to six hours later, a prolonged late-phase reaction 
with obstruction of airflow may develop as a result of cytokines and chemokines generated by 
resident inflammatory cells (for example, mast cells, macrophages, and epithelial cells) and 
recruited inflammatory cells (lymphocytes and eosinophils) (66) (see Figure 1.1).
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Figure 1.1 Early and late pathophysiological respiratory airway responses to 
allergen
Inhaled Allergen
Histamine release
Physiological effects in airway 
Early Response
(bronchospasm, oedema, airflow obstruction)
Late response
(airway inflammation, airflow obstruction 
and remodelling, airway hyperresponsiveness)
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1.5.1 Immunopathogenesis of Asthma
Central to an understanding of how susceptible (atopic) individuals develop IgE against certain 
environmental factors is a knowledge of how the immune system recognizes and responds to the 
offending agents (67). This involves uptake and processing of allergens, usually at a mucosal 
surface of the airway by the antigen-presenting dendritic cells, and subsequent presentation of a 
small peptide to naive T lymphocytes (68) inititating a primary immune response. Terminally 
differentiated T helper cells 1 and 2 (Th1 and Th2 cells) derive from a common naive T precursor 
cell depending on the signals received at the time of antigen recognition (69). Th1 responses 
drive protective, cell-mediated immunity and also inhibit Th2 responses by their release and 
production of interleukin (IL)-2 (IL-2), tumour necrosis factor (TNF-ß), and the cytokine interferon 
gamma (IFN-y) (67, 69). In contrast, in those destined to develop an allergic response, the naive 
T cells differentiate to Th2 cells, Th2 cells produce IL-4, IL-13, IL-5, IL-9, IL-6 (69) and IL-10, and 
are important in the stimulation of IgE production, mucosa! mastocytosis, and eosinophilia (66). A 
possible immunopathogenic role for Th2 cells in asthma has been postulated on the role that 
these cytokines play in IgE synthesis and eosinophil regulation (66). The process of polarization 
of the immune system from a Th2 (allergic) to a Th1 (non-allergic) response (70-72) is called 
immune deviation (70). This process is presented diagrammatically in Figure 1.2. Flowever, this 
concept of immune deviation is continuing to be refined (see Section 1.5.4), and, new 
epidemiologic findings may assist this process of refinement.
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Figure 1.2 The development of the immune response
* Based on Holgate, 2000 (67)
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1.5.2 Timing for the development of the immune response
The introduction of avoidance measures or other interventions to influence these immune 
responses requires an understanding of the timing of the immune response. In the first years of 
life, the immune system of children is relatively immature compared to that of adults (73-76). This 
creates a “window period” between birth and 5 years of age during which there is an enhanced 
risk of allergic sensitization and subsequent atopic disease (72), and therefore a period for 
prevention.
Early exposure to ‘high’ levels of inhalant allergens, particularly during the first 3 months of life, 
and in some cases possibly in utero, maximizes the risk in genetically susceptible individuals for 
development of T-cell sensitization and atopic disease (77, 78) (see Section 2.2.1.1). Being born 
during the pollen season has been associated with a significantly increased risk of developing 
pollen allergy in later life (77), indicating that early postnatal exposure to ‘high’ levels of allergens 
during this “window period” for sensitization maximizes the risk for subsequent expression of 
allergic reactivity to that allergen in adult life. The response of the T-cells to initial encounters 
with an individual allergen may determine sensitivity to that allergen later in life. As initial 
exposure to ubiquitous inhalant allergens such as HDM and pollens invariably occurs during the 
first year of life, the capacity of the infant immune system to deal with such environmental 
challenges assumes major importance in relation to the aetiology of respiratory allergy (77). 
Permanent immune responses to common environmental allergens are usually established 
during these first few years of life (79). The type of immune response to a specific allergen is 
influenced not only by individual atopic propensity but also by environmental factors during the 
initial encounters with the allergen (78). Sensitization to aeroallergens occurring at an early age 
is more strongly associated with asthma risk than late allergic sensitization (43).
1.5.3 Immunologic mechanisms for the influence of microbial agents 
on the prevention of allergic disease
Initial priming of T-cells to environmental allergens occurs in utero or soon after birth. Initial T-cell 
priming commonly occurs across the placenta (80, 81), particularly to allergens encountered by 
the mother in the last trimester of pregnancy (82). The cytokine phenotype of these T-cells is 
typically Th2-po!arised (83, 84). Thus, after birth, priming occurs in an immunological
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environment polarized to a Th2 phenotype. T-cell memory is driven by the environmental 
selection of Th1 or Th2 T-cells. For example, bacterial and viral infections stimulate Th1 cells 
and parasitic infections induce a Th2 response (see Figure 1.2). Compartmentalisation of 
allergen-specific T-cell immunity into adult-equivalent Th1 patterns rather than Th2 patterns has 
been shown to occur in most children before the age of 5 years (72), and it has been reported to 
be as early as before 2 years (85). Thus, in normal individuals, initial low-level Th2 immunity is 
converted to Th1 by 5 years of age, whereas the process fails in atopies, leading instead to the 
consolidation of Th2-polarized inhalant allergen-specific immunological memory involving the 
production of IL-4, 5, 9,10 and 13 (72, 86). In children with “established” atopic disease, a 
disturbed balance in Th-cell subsets (Th1 versus Th2) toward a polarized Th2 phenotype is 
generally accepted (87-90). The failure of atopic children to develop a long-term, Th1-dependent 
memory has been proposed to be due to a reduced IFN- y production (83,91, 92).
The capacity to produce IFN-y is much lower in foetal T cells than in adults, and production of 
IFN-y increases progressively from birth to age 5 years (93). There is evidence that at-birth IFN- 
y-producing capacity is lowest in children with a genetic background of atopy, and remains so 
throughout infancy (92, 94-97), suggesting that slow postnatal development of Th1-associated 
functions is a primary risk factor for atopy (97). The transient reduction in Th1 function is much 
greater in individuals genetically at risk of atopy (97). This IFN-y production deficiency is 
reflected in the slower postnatal up-regulation of allergen-specific Th1 responses, particularly 
during early infancy. Low capacity to produce IFN-y during initial extrauterine exposure to 
environmental allergens may compromise the immune-deviation process, given that the 
underlying process involves IFN-y-mediated inhibition of Th2 cell growth.
Recent studies (98) have shown that a number of allergens, in addition to acting as immunogens, 
have enzymatic activity that may subvert the immune response toward the Th2 phenotype. In 
response to the Group I allergen from the HDM Dermatophagoides pteronyssinus (Der p 1), 
peripheral blood T cells show markedly diminished proliferation and IFN-y secretion. These 
findings indicate that Der p 1 could upset the balance of Th1/Th2 subset distribution by 
decreasing growth and expansion of the Th1 subset, and, as a consequence, augmenting 
expansion of the Th2 subset that favours a pro-allergic response. Der p 1 may also contribute to 
the allergic phenotype by cleaving CD23 on B-cells that would normally serve to inhibit IgE 
synthesis and thereby disrupt the IgE regulatory mechanism, resulting in an up-regulation of IgE 
synthesis (98). And, through its ability to disrupt epithelial architecture, Der p 1 may also facilitate 
its own passage across the epithelium, thus enhancing its (own) access to immune cells (98).
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Although allergens such as Der p 1 can potentially create a microenvironment conducive to Th2 
cell expansion, normal individuals do not mount Th2 responses to these allergens, which 
suggests that despite the nature of these antigens, other factors also contribute to the allergic 
outcome following inhalation of aeroallergens in susceptible individuals. Subsequent allergen 
exposure in a sensitized individual would cause mediator release, bronchoconstriction and 
cellular infiltration resulting in histological changes: allergen stimulation being the driving force 
behind the inflammatory changes (99)
The shift toward a polarized Th2 phenotype during the process of allergic sensitization in children 
that develop atopy is not completely understood. However, allergen challenge in an atopic 
patient results in the selective activation, recruitment, and accumulation of specific Th2 cells in 
the target organs, such as skin and lungs. A prospective study by Prescott et al., 1999 (100), 
showed an age-dependent decline in Th2 responses to inhalant allergens in non-atopic children, 
and a reciprocal pattern in those who developed atopy by the age of 2 years. These results 
support the conclusions of earlier cross-sectional studies (72, 84,101) that the atopic phenotype 
is defined by the postnatal boosting of foetal allergen-specific Th2 immunity to inhalants, as 
opposed to a re-direction (immune deviation) of these responses towards the Th1-cytokine 
phenotype (100). Thus, the development of atopy appears to be associated with postnatal 
consolidation of the weakly foetally primed allergen-specific Th2 responses.
1.5.4 Immune deviation or immune modulation
Although the Th1/Th2 paradigm suggests that Th1 and Th2 cells counterbalance each other and 
that Th1 cells protect or prevent Th2-mediated allergic disease and asthma, and, in addition, 
provides a framework within which to understand the immune event that promote airway 
inflammation and bronchial hyperreactivity, this construct may be oversimplified (65). Th1 
responses alone have been shown in murine models to fail to counterbalance Th2 cell-induced 
airway hyperreactivity but induce reversible airway inflammation (102). Furthermore, the 
evidence that allergen-induced Th1 cytokine production is down-regulated is now less clear with 
recent studies finding decreased, no difference or increased IFN-y responses to allergens in 
atopic subjects (103), suggesting that multiple mechanisms, which have yet to be defined, may 
be involved in defining the nature of T-cells which mediate allergic and tolerant responses (104). 
The findings from a recent study (105) that investigated atopic allergy in Estonian children, led the 
authors to conclude that instead of immune deviation with decreased Th1 and increased Th2
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responses leading to atopic disease, there is a mechanism of immune modulation throughout life 
whereby Th1 and Th2 responses are increased in atopic subjects. Thus, the influence of 
microbial exposure on the immune system may not yet be completely defined. Critical to any 
effect will be (i) the timing in relation to the dose and route of allergen exposure, and (ii) the 
interaction between microbial exposure and other non-infective environmental and lifestyle factors 
(106).
1.6 CONCLUSION
Asthma is a multifactorial disease, with a polygenic profile, and characterized by different 
phenotypic groups influenced by a range of environmental factors. Primary prevention strategies 
directed at adjusting the environment of those at risk of developing asthma are more feasible than 
altering genetic components, perhaps presenting the best potential for significant decrease in 
disease prevalence in the future. The age and length of time that an at-risk infant is particularly 
vulnerable is important. There is a “window of opportunity” in early life where a variety of 
environmental factors, for example microbial agents, may be important in initiating the 
development of asthma and atopy. Environmental modification will be important beginning at (or 
very possibly even before) birth in an effort to control the immune system’s balanced response to 
those environmental risk factors involved in the development of atopic disease.
1.7 POST-SCRIPT
Chapter 2 will discuss the epidemiological evidence for potential environmental risk factors and 
their role in the development of child asthma with an emphasis on the postnatal environment.
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Chapter 2
Epidemiological review of child asthma
2.0 PREFACE
This Chapter discusses the epidemiological evidence relating to the prevalence of asthma in 
children and the potential environmental factors that may play a role in the aetiology of child 
asthma. The evidence presented considers primarily the strongest epidemiological studies 
addressing child asthma that are available, recognizing the limitations arising from a particular 
study type. Longitudinal studies (cohort studies or intervention studies) may provide a high level 
of evidence of primary causation. Randomized controlled trials (RCTs) provide the highest 
quality of evidence and are traditionally considered the gold standard however, observational 
studies have several advantages over RCTs including lower cost, greater timeliness and a 
broader range of participants (107). Observational studies are primarily used to identify risk 
factors and in situations where RCTs are not feasible or unethical (107): the association between 
exposure early in life to differing environmental factors with the subsequent development of 
asthma can be considered in these study types. Moreover, prospective non-interventional 
studies can be used to generate hypotheses on the relationship between cause and effect in the 
development of a specific disease such as asthma, with confirmation of a possible cause-effect 
relationship through RCTs. These studies are not always available thus making it necessary to 
consider other population-based studies of asthma. Retrospective case-control studies, however, 
due to recall bias and selection bias, reduce their strength regarding the evaluation of 
predictive/risk factors for the development of allergic diseases. Moreover, cross-sectional studies 
are not suitable for assessment of cause-effect relationships between exposure to factors and 
development of allergic diseases.
2.1 PREVALENCE OF ASTHMA
At the end of the 20th century, the prevalence of asthma in children and young adults was 
reported to be increasing worldwide by 5%-6% each year (2); although there is recent evidence 
that this has leveled off or declined (see Section 2.1.3 and Section 8.2.3). Until recently, 
however, methods for assessing changes in the prevalence of asthma over time were not 
standardized, making comparisons both within countries and between countries difficult,
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prompting concerns that the increases in reported prevalence are largely due to increased 
awareness (information bias), labeling and differential diagnosis of symptoms (108). 
Questionnaires are the main methodological tool used in prevalence studies but if supplemented 
with biological markers, such as lung function tests, they are less prone to diagnosis 
misclassification. The cross-sectional design of these studies gives no direct information about 
the incidence of asthma and, prevalence can also be influenced by a variety of factors such as 
remission, exacerbation and treatment. A difficulty encountered in the interpretation of such 
studies is that asthma prevalence in a population reflects both asthma incidence and the average 
duration of the condition. A factor that prolongs or exacerbates asthma symptoms may thereby 
increase asthma prevalence even if it has no effect at all on the incidence of asthma (109). 
However, the difficulties in studying true incidence or variations in incidence, such as competing 
risks which may cause an underestimation of the incidence proportion, support the use of 
measurement of prevalence changes.
Repeated cross-sectionai studies which have determined the prevalence of asthma symptoms 
using the same methodology, in the same population, and at different time periods, consistently 
reported an increase in asthma prevalence in recent decades until 1999. These studies are 
presented in Table 2.1 and have included prevalence studies undertaken in Australia.
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Table 2.1 Worldwide changes in asthma prevalence in children and young adults until 
1999*
C o u n try P e r io d  A s th m a  p re v a le n c e  %
1st s tu d y  2 nd s tu d y
R e fe re n c e
Australia 1964-90 19.1 46.0 Robertson et al. (110)
1982-92 12.9 19.3 Peat e ta l. (111)
1987-92 5.6 9.3 Campbell et al. (112)
Canada 1992-95 9.3 11.4 Adam s et al. (113)
1980-89 3.8 6.5 Infante-Rivarde et al. (114)
1980-90 1.4 2.6a M anfreda et al. (115)
1.3 2.5b
England 1956-75 1.8 6.3 Morrison Smith (116)
1966-90 18.3 21.8 W hincup et al. (117)
1973-86 2.4 3.6 Burney et al. (118)
1978-91 11.1 12.8 Anderson (119)
England + W ales 1970-81 11.6 20.5a Fleming and Crombie (120)
8.8 15.9b
Finland 1961-86 0.1 1.8 Haahtela et al. (121)
France 1968-82 3.3 5.4 Perdrizet et al. (122)
Germany 1991/2-95/6 3.7 4.1 Von Mutius et al. (123)
Israel 1986-90 7.9 9.6 Auerbach et al. (124)
Italy 1983-93/5 2.9 4.4 C iprandi e ta l.  (125)
Japan 1982-92 3.3 4.6 Nishima (126)
New Zealand 1969-82 7.1 13.5 Mitchell (127)
1975-89 26.2 34.0 Shaw et al. (128)
Papua New Guinea 1973-84 0.0 0.6 Dowse et al. (129)
Scotland 1964-89 10.4 19.8 Ninan and Russell (130)
1989-94 19.8 25.4 Omran and Russell (131)
Sweden 1971-81 1.9 2.8 Aberg (132)
1979-99 2.5 5.7 Aberg et al. (133)
Tahiti 1979-84 11.5 14.3 Liard et al. (134)
Taiwan 1974-85 1.3 5.1 Hsieh and Shen (135)
U.K. 1978-91 11.1 12.9 Butland et al. (136)
USA 1964-83c 1.8 2.8 Yunginger et al. (137)
1971-76 4.8 7.6 Gergen et al. (138)
1981-88 3.1 4.3 W eitzm an et al. (139)
1983-92 9.2 15.9 Färber et al. (140)
W ales 1973-88 4.0 9.0 Burr et al. (141)
aMen. bWomen. incidence rates per 1000 person-years. 
*Data adapted from Pearce et al 2000 (142).
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2.1.1 Asthma prevalence studies in Australia in the 20th century
Peat et al., 1994 (111), in serial cross-sectional studies of 8-10 year old children in Wagga 
Wagga and Belmont, New South Wales, in 1982 and in 1992, found that the prevalence of 
wheeze in the previous 12 months increased in Belmont from 10.4% to 27.6% (p<0.001) in 1992 
and in Wagga Wagga from 15.5% to 23.1% (pcO.001). In Wagga Wagga, parent-reported 
wheeze in the past 12 months increased by 6.6% and asthma diagnosis by 17.6%. Objective 
measures of atopy (SPTs to common allergens) and of BHR (histamine inhalation challenge and 
forced expiratory volume in one second (FEVJ) were collected in the years 1982 and 1992. The 
prevalence of airway hyperresponsiveness in atopic children increased by 10.7% (95% Cl 7.3, 
14.1) (2-fold) to 19.8% in Belmont, and by 6.4% (95% Cl 2.9, 9.9) (1.5-fold) to 18.1% in Wagga 
Wagga. The prevalence of airway hyperresponsiveness increased mainly in atopic children only 
(with a non-significant increase in non-atopics), but the prevalence of atopy was unchanged 
(about 28.5% in Belmont and 32.5% in Wagga Wagga).
A further cross-sectional survey (143), with a similar design, was undertaken in Wagga Wagga to 
compare asthma prevalence from 1992 to 1997 with the previous study. Between 1992 and 
1997, the prevalence of wheeze in the past 12 months increased by 5.1% (95% Cl 1.2, 9.0), from 
22.1% in 1992 to 27.2% in 1997 and asthma diagnosis increased by 8.1% (95% Cl 3.8, 12.4). 
Objective measures of atopy by SPTs to common allergens were also undertaken. There was 
significant increase in prevalence of atopy by 6.7% (95% Cl 2.2,11.2), between 1992 and 1997, 
although the increase between 1982 and 1992 was not significant.
2.1.2 International comparisons of asthma prevalence in the 20th 
century
The International Study of Asthma and Allergies in Childhood Study (ISAAC) (144) has enabled 
international comparisons of asthma prevalence. Phase 1 of the ISAAC used standardized, and 
validated, written questionnaires and a video asthma questionnaire to measure the prevalence of 
self-reported, or parentally reported, symptoms and clinical signs of allergic disease (6,145,146). 
The ISAAC compared the prevalence rates of asthma, allergic rhinoconjunctivitis and atopic 
eczema over a period of one year in 155 centres in 56 countries with a study population of 
257,800 schoolchildren 6-7 years of age and 463,801 schoolchildren 13-14 years of age (6). The 
ISAAC, the first truly global study of asthma prevalence in children, found that asthma symptom
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prevalence varied from 1.6% to 27.2% in the 6-7 year old age group, and 1.9% to 35.3% in the 
13-14 year old children. Highest prevalences (>17% prevalence) were reported from the United 
Kingdom (UK), New Zealand, Australia, Republic of Ireland, North America, Canada and Peru. 
And, the lowest prevalences (<3% prevalence) in Indonesia, Greece, China, Taiwan, Uzbekistan, 
India and Ethiopia (6).
In 1993-94, Australia ranked second-highest in prevalence of current wheeze for 6-7 year olds 
and third-highest for 13-14 year olds (6). As part of the ISAAC, the prevalence of “wheeze in the 
past 12 months” in children was measured in four Australian cities from 1993-94 by Robertson et 
al., 1998 (147). The prevalence in 10,914 children aged 6-7 years and 12,280 children aged 13- 
14 years in Melbourne, Sydney, Adelaide and Perth was 24.6% (95% Cl 23.8, 25.5) and 29.4% 
(95% Cl 28.6, 30.2) respectively. These results are similar to the prevalence of wheeze of 27.2% 
found in Wagga Wagga in 1997 by Downs et al., 2001 (143). In the ISAAC, prevalences of 
current eczema and allergic rhinitis were 10.9% and 12.0% respectively for the 6-7 year olds, and 
9.7% and 19.6% respectively for the 13-14 year olds. The prevalence of asthma, eczema and 
rhinitis in the four Australian cities (1993-94) are shown in Figure 2.1. Asthma, eczema and 
rhinitis co-existed in 1.8% of 6-7 year olds and 2.8% of 13-14 year olds. The interrelation 
between wheeze, eczema and rhinitis in the previous 12 months in Australian schoolchildren 
(1993-94) is shown in Figure 2.2, with a lower than anticipated correlation found between the 
three atopic diseases (147). Any association between atopy and asthma appeared to differ in 
differing locations, suggesting that the relative balance of atopic versus non-atopic asthma may 
differ by location (148).
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Figure 2.1 Prevalence of wheeze, eczema and rhinitis in the previous 12 months* among 
Australian schoolchildren (1993-94)**
*12 months preceding winter-spring, 1993, in Melbourne, Sydney, Adelaide and winter-spring, 1994 in Perth.
“ Data sourced from Robertson CF, Dalton MF, Peat JK, Haby MM, Bauman A, Kennedy JD, Landau LI. Asthma and other atopic 
diseases in Australian children. MJA, 1998; 168:434-8.
23
Figure 2.2 Venn diagrams showing the interrelation between wheeze, eczema and rhinitis in the 
previous 12 months* in Australian schoolchildren (1993-94)**
6-7 years o,d
Asthma
15.0%
Rhinoconjunctivitis
Eczema Rhinoconjunctivitis
‘ 12 months preceding winter-spring, 1993, in Melbourne, Sydney, Adelaide and winter-spring, 1994 in Perth.
“ Data sourced from Robertson CF, Dalton MF, Peat JK, Haby MM, Bauman A, Kennedy JD, Landau LI. Asthma and other atopic 
diseases in Australian children. MJA, 1998; 168:434-8.
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Based on the ISAAC Phase I findings and other studies of asthma prevalence, Beasley et al., 
2000 (8), concluded that the international patterns of asthma prevalence demonstrated five key 
features: (i) asthma prevalence is increasing worldwide; (ii) asthma is generally more common in 
western countries and less common in developing countries; (iii) asthma is more common in 
English-speaking countries; (iv) asthma prevalence is increasing in developing countries as they 
become more westernized or communities become more urbanized; and (v) the prevalence of 
other allergic disorders, allergic rhinitis and atopic eczema, may also be increasing worldwide. 
This final feature has been supported by results from the three UK national birth cohorts of 1946, 
1958 and 1970, which have shown a marked increase (5.1%, 7.3%, and 12.2% respectively) in 
the prevalence of eczema in children aged under 5 years (149).
2.1.3 Asthma prevalence studies in the 21st century
The results of recent studies question the continuing increase in asthma prevalence. Several 
published papers report either a decline (3, 4, 150-153) or a plateauing (5, 154-156) of child 
asthma prevalence in the British Isles, Singapore, Hong Kong, Australia, Switzerland and Italy. 
Two Australian studies have recently reported a decrease in prevalence of child asthma (3, 4). 
Robertson et al., 2003 (3), using the ISAAC protocol, surveyed 6-7 year old school children in 
Melbourne between 1993 and 2002 and found the prevalence of reported current wheeze fell by 
26% over 9 years, from 27.2% in 1993 to 20.0% in 2002. In that study, however, the prevalence 
of eczema and allergic rhinitis continued to increase. The 12-month period prevalence of 
reported eczema increased from 11.1% in 1993 to 17.2% in 2002, and rhinitis increased from 
9.7% to 12.7%. The authors were unable to explain the decrease in the prevalence of current 
wheeze, suggesting that it may have been influenced by the level of symptom complex 
awareness in the community or the increase in attendance at child care facilities (148) (see 
Section 2.3.2). Whereas, Toelle et al., 2004 (4), using the same questionnaire as in 1992 (111), 
found the prevalence of recent wheeze decreased significantly (-4.9%; 95% Cl -9.1%, -0.7%) 
b e tw e e n  1992 and 2002 in schoolchildren from Belmont, New South Wales.
The reported changes in the prevalence of asthma, discussed above, have occurred too rapidly 
to be in response to changes in genetic variants. Modifications in the pattern of exposure, and 
changes in susceptibility, to various environmental factors in large portions of the population may 
be important (6). Epidemiological studies have explored the putative role of environmental risk 
factors (for example, allergens, tobacco smoke, and air pollution) as well as the loss of possible
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protective factors over time, such as early infections and diet. These current putative risk 
factors, however, cannot fully account for either the worldwide increase in prevalence or the 
international variations in asthma prevalence that have been observed (8). The major 
environmental and lifestyle factors that are considered to contribute to the aetiology of child 
asthma are discussed in the following sections of this Chapter.
2.2 PUTATIVE RISK FACTORS FOR ASTHMA 
2.2.1 HDM Allergens
Indoor allergens, notably from HDM, have received considerable attention as a possible major 
cause of asthma and of the global increase in prevalence (99, 157). In westernized countries, 
lifestyle changes have resulted in more time spent indoors, potentially increasing exposure to 
indoor allergens. In addition, alterations to the domestic environment such as fitted carpets, 
increased temperatures, tighter insulation, and cold water washing, have increased the 
opportunity for HDM to grow by making a more conducive environment (158). Peat et al., 1994 
(111), showed a 5.5-fold increase in the number of HDM in domestic dwellings in Belmont and a 
4.5 increase in Wagga Wagga over a period of 10 years from 1982 to 1992. Dust mite faecal 
particle allergen becomes airborne, and exposure of the immune system to these foreign proteins 
in household dust will be directly influenced by the number of particles, their size (and 
aerodynamic properties) and the solubility of the proteins (159).
The term “house dust mites” applies to all mites of the family Pyroglyphidae, of which the genus 
Dermatophagoides predominates. Four species currently dominate all others: Dermatophagoides 
(D.) pteronnysinus, D. farinae, D. microceras, and Euroglyphus maynei (160). The main 
determinants for survival are high humidity, moderate temperatures and an adequate food source 
(human skin scales are a primary source). Two main groups of allergens appear important: 
Group I allergens (Der p 1, Der f 1 and Der m 1) found in mite faecal pellets; and, Group II 
allergens (Der p II, Der f II) found in both faecal pellets and mite bodies (99). Many studies 
discussed in this thesis have not differentiated the specific Group allergen of D. pteronyssinus, 
reporting the allergen as Der p. The possible mechanism of action within the human body of the 
allergens from these HDMs has been discussed in Section 1.5.3.
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2.2.1.1 HDM allergen and sensitization
For an allergen to have a major clinical effect, prior sensitization must have occurred. An 
individual’s degree of susceptibility to allergens, the immunogenic properties of the allergen, and 
the degree of exposure (99) are all determinants of an allergen-specific immune response. In any 
population there is a gradient in the ability to respond to allergens: from individuals who do not 
become sensitized regardless of exposure to others who show extensive sensitization to many 
different allergens (99). And, even among individuals with a tendency to respond, the 
development of sensitization to an allergen is dependent on exposure, as other environmental 
factors operating in early life may modify the incidence of sensitization (161). The ability to 
respond to an allergen is partially genetically determined.
Provisional standards for both sensitization to mites and also mite-allergen exposure have been 
recommended by a World Health Organizarion (WHO) workshop in 1987 (162). It was proposed 
that a level of 2 pg of Der p 1 per gram of dust (equivalent to 100 mites per gram or 0.6 mg of 
guanine per gram of dust) should be regarded as a risk factor for sensitization and the 
development of asthma. The higher level of 10 pg of Der p 1 per gram of dust (or 500 mites per 
gram of dust) was proposed as a major risk factor for the development of acute asthma in mite- 
allergic individuals. However, Strachan, 2000 (10), recently stated that a threshold level below 
which sensitization does not occur, as had been suggested, is now considered unlikely. The 
HDM allergen is especially immunogenic such that in areas with high mite exposure, such as 
Australia, New Zealand, UK and the United States of America (USA), the level of mite exposure 
appears sufficient to sensitize ‘all’ potentially atopic children (99).
Both skin testing and measurements of IgE antibodies are used to determine sensitization to 
HDM allergen. Sensitization to an allergen can occur at any age however the predisposed infant 
is more susceptible to allergen sensitization (see Section 1.5.1). Sensitization to mite allergens 
commonly starts to be measurable by serum antibodies or by SPT early in childhood. Birth 
cohort studies (159, 163) and longitudinal studies (164) have shown that positive SPTs to 
inhalant allergens are unusual before 2 years of age. A prospective study (163) of children born 
to at least one allergic parent showed that IgG and IgE antibody responses to mite allergen 
developed in the second and third years of life. Household exposure above threshold levels of 
Der p 1 (>5,000 ng/g fine dust) in infancy was positively associated with the prevalence of skin 
test positivity and increased levels of specific IgE to mites (163).
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2.2.1.2 Mite Allergen Exposure as a risk factor for sensitization
A clear dose-response relationship between dust mite allergen exposure and sensitization is 
supported by studies of different communities and climates. Both prospective (161, 165, 166) 
and cross-sectional studies (167-169) have now shown a dose-response relationship between 
the level of exposure to HDM allergens and allergic sensitization. The incidence of sensitization 
to D. pteronyssinus in 1,812 children in Germany with a mean initial age of 7.3 years over a two- 
year period was examined (166). The study identified an increased risk for initial sensitization 
(odds ratio (OR) 2.2; 95% Cl 1.2, 4.1) for increasing levels of Der p 1 in the child’s mattress dust 
(>10 pg/g). The German Multicenter Atopy Study (165) with a prospective cohort of 1,314 
newborns followed for three years, using mixed floor dust from the child’s bedroom, parent’s 
bedroom and living room, found that in homes with low (<25th percentile) dust concentrations, the 
risk of sensitization to HDM for these children was substantially lower, 1.6% compared to 6.5%, 
with domestic exposure to the HDM allergen than if dust concentrations were above the 75th 
percentile. Children sensitized to HDM were exposed to significantly higher HDM (median 868 
ng/gm versus 210 ng/gm; p=0.001) allergen concentrations in carpet dust compared to the group 
without sensitization. Children with a positive family history of atopy were especially susceptible 
to even very low levels of exposure. In children with a positive family history of asthma, a mite 
allergen exposure below 750 ng/gm is sufficient to result in a sensitization rate of 3% whereas, an 
exposure up to 25,000 ng/gm is necessary to achieve the same sensitization rate in children with 
a negative family history (165).
Allergen exposure in early infancy appears critical for primary sensitization. Exposure to mite 
allergen has been measured in the homes of infants studied prospectively (170). When skin prick 
tested at age 10 years, none of the children exposed to <2 ug Der p 1/g fine dust in infancy 
developed sensitization to mites or asthma. Conversely, in those exposed to >10 ug/g in infancy, 
50% were sensitized to mites. Repeated challenge with an allergen can cause a secondary 
response with an increase in allergen specific IgE levels.
2.2.1.3 Mite allergen sensitization as a risk factor for asthma
Clincial studies have shown that the proportion of sensitized asthma patients, as reflected by 
either positive SPTs or presence of specific IgE antibodies to HDM, is significantly higher than for 
those without asthma (129, 171), with up to 85% of patients with asthma reported as being skin
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prick sensitive to HDM, as compared with only 5-30% of the general population. HDM 
sensitization is a significant risk factor for asthma in areas with high levels of HDM allergens in 
homes (157). The development of early sensitization, that is before the age of six to eight years, 
was found to be a stronger predictor for asthma than sensitization being only detectable at a later 
age (172, 173). Furthermore, sensitized individuals are likely to have more severe asthma if 
exposed to high allergen levels than if their level of exposure is low (158).
Epidemiological studies assessing atopy with SPT responses or IgE can reduce measurement 
bias attributable to awareness of asthma and differences in diagnostic labeling. Several studies 
using these objective measures have demonstrated that mite sensitization is a strong 
independent risk factor for asthma (174-180) and that the risk of asthma increased with the extent 
of allergic sensitization (174,179,181). A large random population sample (176) of children in 7 
climatic regions of New South Wales found HDM sensitization to be the most important risk factor 
for asthma in coastal regions. A longitudinal birth cohort (175) in New Zealand children up to age 
13 years, found a strong independent risk of HDM sensitization on the development of asihma 
(adjusted relative risk (aRR) 6.71; 95% Cl 1.21,13.38). The association was found in only 2% of 
non-atopic children compared with 33% of HDM sensitive children. A recent study, a birth cohort 
(174) of 1,456 children from the Isle of Wight, reported that at age 4 years, atopy was closely 
associated with asthma with a direct and linear relationship, and that HDM sensitization was the 
most important risk factor for asthma (OR 8.07; 95% Cl 4.60, 14.14). However, it should be 
remembered that a substantial proportion of child asthma is non-atopic. The proportion of cases 
with allergic disease attributable to atopy is less than 50% (109) (see Section 2.2.3).
2.2.1.4 HDM allergen exposure as a cause for asthma
Evidence for a direct association between indoor allergen exposure and asthma is less clear (see 
Figure 2.3). In most studies the prevalence of sensitization is higher than the prevalence of 
asthma, suggesting that a higher level of exposure is required for the development of symptoms. 
In experimental studies, the inhalation of HDM allergen has repeatedly been shown to cause 
bronchoconstriction and wheeze in sensitized children and adults in a dose dependent manner, 
inducing both immediate and late responses (99).
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Figure 2.3 Relation between sensitization, exposure to allergens, and development of 
asthma*
Sensitization
Asthma
— -  not confirmed
established
Exposure to 
allergens
‘ Adapted from Grad R, Lancet 2000; 356:1396-70.
A key finding linking allergen exposure in infancy to the subsequent development of asthma came 
from the Poole birth cohort (170) in England. In 67 children, selected at being at risk because of 
family history of asthma, 35 were atopic (positive SPT) and 32 were non-atopic. Of the 17 
children with active asthma, 16 were atopic (p<0.005), all of whom were sensitized to the HDM 
(measured by SPT and IgE levels). The relative risk (RR) of active asthma in any child was 4.8 
times greater if he or she had been exposed to more than 10 pg/g of Der p 1 per gram in infancy 
(p=0.05). The study reported that the age at which the first episode of wheezing occurred was 
inversely related to the level of exposure to HDM allergen at the age of 1 for all children (p=0.015) 
but especially for the atopic children (r=0.66, p=0.001) (170).
The German Multicentre Allergy Study (178) also reported a strong association of HDM allergen 
sensitization with respiratory symptoms and BHR during the first 7 years of life. However, a 
consistent relationship between HDM allergen exposure and respiratory allergic manifestation 
was not found. Reports of no association between allergen exposure and asthma could partially 
reflect the high level of misclassification of exposure (for example, bedroom floor mite allergen 
level as a proxy measure of inhalational allergen dose) and outcome (through disease 
misclassification of the asthma sub-types, for example, asthma ever rather than severe wheeze 
as an indicator of allergen-induced airway disease) (see Section 2.2.1.6). Further studies that 
use severe symptom as the outcome measure should reduce the level of disease 
misclassification as this will identify the sub-group that is more likely to reflect allergen-induced
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airway disease rather than airway disturbance due to viral infection or other non-atopic factors. 
Intervention studies will have the greatest weight to show causal effects.
2.2.1.5 Allergen exposure and the clinical severity of asthma
Precise dose-response relationships between exposure to indoor allergen and asthma severity 
are difficult to estimate. The level of exposure to indoor allergens necessary to induce and 
maintain airway inflammation, BHR, and symptoms varies over a wide range (182). The 
relationship between exposure to indoor allergens and symptoms of asthma is complex. Many 
studies have observed that approximately 50% of allergic children who are exposed to relevant 
allergens in their homes do not wheeze (167, 183,184). Platts-Mills et al., 1997 (183), reported 
that factors influencing the relationship between exposure and symptoms include: (i) interaction 
between the effects of exposure to several different allergens; (ii) the influence of multiple factors 
that can enhance the inflammatory response to allergens; (iii) the lack of a simple objective test 
that characterizes asthma or inflammation of the lungs; and (iv) the triggers and enhancers that 
can influence narrowing of the airways or the perceived severity of symptoms, for example 
exercise, cold air, histamine, viruses and air pollution. Moreover, studies have shown in both 
children and adults that the severity of asthma symptoms will vary with the level of exposure in 
persons sensitive to indoor allergens (185,186).
Several cross-sectional (167, 187, 188) and longitudinal (189-191) studies provide evidence to 
support a direct relationship between the level of exposure to mite allergens in the home and 
asthma symptom severity. These studies reported that associations between HDM allergen 
exposure and clinical severity of asthma were either greater or only detected in HDM sensitized 
children. The importance of the bed and bedroom as a source of mites is suggested by several 
of these studies.
A cross-sectional study (167), revealed a dose-response relationship between exposure to Der p 
1 and increased risk of current asthma in mite-sensitized children. In mite-sensitized children 
from six regions of New South Wales, Australia, each with different levels of humidity and 
concentrations of HDM, current asthma prevalence increased progressively with the level of mite 
exposure (r2=0.82, p=0.013). Going from the lowest to highest HDM-infested areas was 
associated with an increased prevalence of HDM-positive SPT, ranging from 13% at the low end
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to 29% at the high end. In children with positive SPT for HDM, the risk of current asthma doubled 
with every doubling of Der p 1 level, after adjusting for sensitization to other allergens.
These results have been extended with a small longitudinal study (190) in Sydney, Australia, 
which showed a significant association between minimum morning peak flow rate and bed Der p 
1 (a composite sample from mattress and upper bedding), in mite-sensitized children (aged 8 to 
12 years). An association was not found in children without HDM atopy. Results suggested that 
an increase of one natural log concentration of Der p 1 would lead to an approximately 15 litres 
(L)/min decrease in peak expiratory flow rate (PEFR), equivalent to about a 6% fall from baseline.
Furthermore, these results show some similarity to a longitudinal study (187) over 12 months in 
Canada with 52 asthmatic children and 68 adults with asthma. It was reported that the level of 
HDM allergens was an important determinant of asthma severity in children with HDM 
allergy/sensitization. Moreover, the study identified mite allergen levels in the mattress to be a 
more important determinant of asthma severity in children with HDM allergy, than levels in floor 
samples. After controlling for seasonality, a significant negative relationship between mean 
PEFR (percent predicted) and HDM allergen concentration (sum of Der p 1 and Der f 1 for 
mattress and floor) for children allergic to mites only was found. In HDM allergic children, there 
was about a 5% decrease in mean PEFR (percent predicted) for every 1 log (microgram per gram 
of dust) increase in HDM allergen concentration (187).
An Australian study (192), using the data from a RCT of mite allergen avoidance to measure the 
association between changes in Der p I exposure and changes in the severity of asthma, showed 
that in mite-sensitive subjects (from 13-54 years of age) with asthma, changes in mite allergen 
levels were significantly positively correlated with changes in the severity of airway reactivity. 
Changes in allergen concentration in the bed were significantly correlated with changes in BHR 
(p=0.003) and symptom score (p=0.04). Changes in allergen concentration in the living room 
floor were only significantly correlated with changes in symptom scores (p=0.01).
Thus, these studies have shown that in mite sensitive patients, the level of exposure to mite 
allergens has a major influence on severity and clinical activity of asthma, using measures of 
disease severity such as PEFR variability, BHR and pulmonary function.
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2.2.1.6 Disease misclassification and the role of HDM allergen in 
asthma severity
Disease misclassification and the relatively small number of prospective studies available still 
remain a considerable issue for asthma epidemiology. Asthma is a clinical syndrome reflecting 
airway inflammation and obstruction (193) (see Section 1.2). The heterogeneity of clinical sub­
groups within asthma patients (193) is likely to partially reflect mixed aetiologic components. The 
relative contribution of allergen-induced, irritant-induced and infection-induced wheeze within the 
broad spectrum of asthma has not yet been clearly identified. The dominant theoretical paradigm 
for childhood asthma is that of a largely allergic aetiology; however this assumption has been 
challenged (194) (see Section 2.2.3).
A small number of studies have looked at a sub-group of those children with asthma in an effort 
to address disease misclassification within the asthma spectrum. Atopic individuals are over­
represented at the severe end of the asthma spectrum (181, 195-197). The findings in these 
studies suggest that symptoms such as frequent wheeze may be better markers of HDM- 
allergen-related airway disease than a history of asthma or milder symptoms, and, is also 
consistent with past work that found increasing Der p exposure is associated with increasing 
wheeze frequency (167).
A population based case-control study (197) in Sheffield, UK, found the most powerful risk 
factors for severe asthma (defined as 12 or more wheezy episodes or speech limiting wheeze 
over the previous 12 months) were pet ownership (which indicates high exposure to pet allergens 
(198)) and the use of non-feather bedding (which may be a marker for high exposure to mite 
allergens (198)), with little or no effect of parental smoking, gas cooking and mould growth.
In the Australian Capital Territory, Australia, a cross-sectional asthma survey (195) of a 
population sample of 758, 8-10 year old children and a hospital-based sample of 78 children 
attending the hospital for asthma, found the clinical features of frequent wheeze or hospital 
asthma attendance are largely attributable to atopy, but infrequent wheeze or a history of asthma 
ever are not. Atopic children are over-represented in the severe range of the asthma spectrum. 
The association between atopy and wheeze by wheeze frequency episodes over the past year 
was as follows: no episodes (OR 1.00 (reference); 1-3 episodes (OR 3.27; 95% Cl 2.15,4.97); 4- 
12 episodes (OR 3.44; 95% Cl 1.75, 6.75); and >12 episodes (OR 8.70; 95% Cl 3.07, 24.55),
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with a higher population attributable fraction (PAF) for > 12 episodes (75%) than 1 to 3 episodes 
(49%). Atopy was moderately related to asthma ever (OR 2.09; 95% Cl 1.52, 2.85; PAF 33%) 
but was strongly related to 1999 hospital attendance for asthma (OR 16.5; 95% Cl 6.76, 42.48; 
PAF 89%).
In the Tasmanian birth cohort, (TIHS) (196), HDM sensitization was associated with increased 
wheeze frequency in the past year compared with no wheeze (1-3 episodes: RR 1.49; 95% Cl 
1.05, 2.13; 4-12 episodes: RR 6.48; 95% Cl 3.23, 12.63; >12 episodes: RR 12.75; 95% Cl 4.25, 
38.24; Test for linear trend, p<0.001). HDM sensitization was only moderately associated with 
childhood asthma (asthma ever) (unadjusted RR 1.65; 95% Cl 1.32, 2.06), suggesting that this 
outcome measure was less likely to reflect HDM-related airway disease than frequent wheeze. 
The authors thus concluded that a focus on severe symptoms such as frequent wheeze should 
reduce disease misclassification in population-based studies examining HDM-induced airway 
disease (196).
There are multiple other factors such as virus infection, endotoxin exposure, and air pollution that 
can contribute to the severity of symptoms in allergic individuals (199). These would all tend to 
interfere with the quantitative correlation between current allergen exposure and symptoms. 
However the choice of frequent wheeze (>12 episodes) as the outcome measure should reduce 
the level of disease misclassification by identifying a sub-group that is more likely to reflect 
allergen-induced airway disease rather than airway disturbance due to viral infection or other non- 
atopic factors (195).
2.2.1.7 Improvement in asthma with reduction of allergen exposure
Further evidence for the role of HDM allergen as a putative risk factor in asthma has been 
provided by studies that examine the effect of reducing allergen exposure on improving asthma 
symptoms. Several studies in children and young adults have shown short-term improvement in 
asthma symptoms and BHR with prolonged HDM allergen avoidance away from their residence, 
and a recurrence of symptoms when the children return to areas with higher HDM levels (200- 
202). A small number of controlled trials of allergen avoidance have also reported a prolonged 
decrease in mite allergen exposure with significant improvements in BHR (203-207). However, a 
recent Cochrane review (208) found that the current chemical and physical methods to reduce
34
exposure to HDM allergens seem to be ineffective, recommending that other methods of mite 
control be evaluated.
2.2.1.8 Primary prevention of allergen exposure
There are few studies of primary prevention. In a prenatally RCT of infants genetically at high- 
risk of atopy followed until age 4 years in the UK (209), a significant reduction in atopy and 
allergic symptoms was found in the prophylactic group at ages 1 year, 2 years and was 
maintained at age 4 years. The prophylactic group (n=58) was either breastfed with their mothers 
excluding foods regarded as highly antigenic from their diets, or given an extensively hydrolysed 
formula and, in addition, HDM exposure was reduced through the use of an acaricide to 
upholstered furniture, bedroom and living room carpets. All the children have now been reviewed 
at the age of 4 years, and SPTs to a wide range of dietary allergens and aeroallergens have been 
performed. The control group (n=62), fed on breastmilk or on formula, with no specific 
environmental measures taken, continues to show more total allergy (OR 2.73; 95% Cl 1.21, 
6.13), definite allergy (allergic symptoms plus positive SPT) (OR 5.6; 95% Cl 1.8, 17.9), and 
eczema (OR 3.4; 95% Cl 1.2,10.1). More control children have positive SPTs (OR 3.7; 95% Cl 
1.3, 10.0). The authors concluded that a dual approach to the prevention of allergic disease, 
avoiding as far as possible sensitization to food and aeroallergens, significantly reduces the risk 
of atopic disease.
Other prospective studies of primary prevention of asthma and allergies are currently being 
undertaken (210-212) with early results available. A prospective prenatally randomized cohort 
study (211) in the UK, The Manchester Asthma and Allergy Study, has reported that 
environmental manipulation (reduction of . exposure to allergens) reduces some respiratory 
symptoms in the first year of life in high-risk infants (RR 0.44; 95% Cl 0.20, 1.00). A second 
prospective prenatally randomized controlled study (210) in Canada with follow-up through the 
age of 1 year, found that the mulitfaceted intervention program (including avoidance of HDM and 
pet allergens and tobacco smoke) resulted in a reduction (aRR 0.66; 95% Cl 0.44, 0.98) in the 
risk of possible or probable asthma. While encouraging, the authors did conclude that there is no 
validated definition of asthma at 12 months of age and further follow-up is needed to determine 
the effectiveness of the intervention program in the primary prevention of asthma when the 
participants can have their allergic and asthmatic status measured more reliably. The Childhood 
Asthma Prevention Study (212, 213) is a RCT in Sydney, Australia, where 616 pregnant women
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were randomized to an HDM avoidance intervention, comprising the use of impermeable 
mattress covers and an acaricide or control, and the use of an oil supplement, margarines, and 
cooking oils containing high levels of omega-3 fatty acids or control. In the children at 18 months 
of age, the maternal diet resulted in a 9.8% absolute reduction (95% Cl 1.5, 18.1) in the 
prevalence of wheeze ever and a 7.8% absolute reduction (95% Cl 0.5,15.1) in the prevalence of 
wheeze for >1 week, but there was no effect on serum IgE, atopy or doctors’ diagnosis of 
asthma. Over the 18-month study period, bedding HDM allergen levels in the active HDM 
intervention group were more than 3-fold lower than levels in the bedding of the control HDM 
group. However, the HDM avoidance intervention did not influence the development of 
sensitization and wheeze symptoms (213).
2.2.2 Other allergens
There is clear evidence of communities in which a high prevalence of asthma is associated with 
indoor allergens other than HDM (183), most commonly cat, dog, alternaria (176, 214) and 
cockroach (215) allergens, supporting the view that it is specific sensitization to indoor allergens 
rather than generalized IgE hyperresponsiveness that is associated with perennial asthma. Thus, 
individuals susceptible to developing atopic disease will become sensitized to the allergens 
prevalent in the environment.
A systematic review (216) of the literature up to the end of 1999, concluded that exposure to pets 
appeared to slightly increase the risk of asthma and wheezing in older children over the age of 6 
years (OR 1.19; 95% Cl 1.02,1.40). Selection bias may be a major source of error in examining 
the association between exposure to pets and the risk of asthma as parents of asthmatic children 
are more likely to selectively avoid or remove pets from the. home, biasing the results of 
prevalence studies (217). However, more recent longitudinal studies (218-222), including large 
birth cohorts, have observed an inverse relationship between pet keeping in early life and the 
development of atopic sensitization, hay fever and asthma. Using the Oslo birth cohort (219) of 
2,531 children, it was reported that exposure to cats in early life was associated with a reduced 
risk of developing asthma (aOR 0.7; 95% Cl 0.5,1.1) and allergic rhinitis (aOR 0.6; 95% Cl 0.4, 
1.0) at age 4 years. Whereas in the Tucson Children’s Respiratory Study (221), a birth cohort of 
1,246 children, it was found that children living in households with one or more indoor dogs at 
birth were less likely to develop frequent wheeze than those not having indoor dogs (p=0.004). 
This inverse association was confined to children without parental asthma (adjusted hazard ratio
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0.53; 95% Cl 0.34, 0.81) and was not evident for children with parental asthma (adjusted hazard 
ratio 1.19; 95% Cl 0.76, 1.88). A prospective birth cohort (220) in Michigan, recently reported 
exposure to two or more dogs or cats in the first year of life was associated with a significantly 
lower risk of atopy (measured by SPT) (aOR, 0.23; 95% Cl, 0.09,0.60) and seroatopy (measured 
by serum IgE) (aOR, 0.33; 95% Cl, 0.13-0.83) at age 6-7 years to HDM, cat, dog and grass 
allergens. The protective effect of exposure to dogs and cats may not be entirely related to 
allergen exposure, but possibly confounding lifestyle factors or increased exposure to bacterial 
endotoxin associated with household pets (223, 224) may also be responsible. The role of 
endotoxin and atopic disease is discussed in Section 2.3.6.
In addition, other inhalant aeroallergens may play a significant role in the aetiology of asthma. 
For example, exposure to soybean dust (225-227) can result in a steep increase in acute 
exacerbation of asthma symptoms, but, overall not causing an increase in prevalence, whereas, 
allergens such as pollen allergens (grasses, weeds and trees) are associated with hay fever or 
seasonal and episodic asthma (228, 229) rather than persistent asthma (175, 230).
2.2.3 Atopy
Atopy is a clearly established risk factor for asthma. There has been a long held misconception 
that the majority, if not all, child asthma is allergic however, Pearce et al., 1999 (194), examined 
population-based studies, each with at least 600 child subjects, and determined the overall 
proportion of population-based childhood asthma attributable to atopy is only approximately 38%. 
The same group assessed the available evidence on the association between allergen exposure 
and the subsequent risk of asthma at the population level. They concluded that aeroallergen 
exposure is not a major risk factor for the primary causation of asthma in children (109). .
Moreover, atopy cannot be regarded as an environmental exposure (142) as, for example indoor 
allergen exposure, smoking, and air pollution, which could by itself explain the increases in 
asthma prevalence. Atopy is a biological response to various exposures (for example, the 
production of specific IgE antibodies to environmental allergen exposure) which is modified by 
susceptibility factors (genetic or environmental) and as such should not be considered as a 
primary causal exposure (109), that is, it is an intermediate on the pathway by which an 
environmental exposure causes asthma. In addition, standardized comparisons across 
populations or time periods show only weak and inconsistent associations between the
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prevalence of asthma and the prevalence of atopy (194), thereby indicating that the changes in 
prevalence of asthma are unlikely to be directly linked to changes in atopy. The work of Pearce 
et al., 1999 (194), is highly important and, if only 38% of child asthma is due to atopy, then the 
long held misconception that the majority, if not all, child asthma is allergic has probably 
hampered asthma research. Thus future studies will need to investigate both (i) other 
mechanisms that may lead to the development of asthma, and (ii) the factors that are responsible 
for atopic individuals becoming asthmatic.
2.2.4 Air Pollution
2.2.4.1 Outdoor air pollution
The increase in allergic respiratory diseases, which is observed more in urban than in rural areas, 
is paralleled by increasing atmospheric concentration of traffic-related air pollutants such as 
gases, for example sulphur dioxide and ozone, and respirable particulate matter, in particular 
diesel exhaust emissions (231). A correlation has also been found between increased 
atmospheric levels of air pollution and increased frequency of mortality for respiratory and 
cardiovascular diseases (232). These pollutants, besides acting as irritants, increasing airways 
hyperreactivity and exacerbating symptoms in already allergic subjects (233-236), are thought to 
be possible causal factors which act to modulate the immune response, with an adjuvant activity 
on IgE synthesis (231,237, 238).
The effects of air pollutants on lung function will depend largely on the type and environmental 
concentration of pollutant, the duration and timing of pollutant exposure and the exposed 
subjects’ predisposition to develop airway hyperresponsiveness. A cross-sectional study in 
Germany reported that high rates of road traffic diminish forced expiratory flow and increase 
respiratory symptoms in children (239). Other cross-sectional studies have, however, not 
reported an increase in the prevalence of asthma in relation to air pollution (176, 240). A case- 
control study (241) of patients aged 2-64 years, from two general practices in London, UK, 
showed no increase in risk of asthma needing treatment with living close to busy roads. In 
children under 16 years of age, the adjusted OR for being treated for asthma when living 150 
metres or less from busy roads compared with more than 150 metres from them was 0.96 (95% 
Cl 0.78, 1.22). This study may have failed to demonstrate a causal relationship between 
exposure to air pollutants and the development of asthma as it reviewed only the place of current
residence, and did not consider lifetime residence, particularly during birth and the early infancy
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postnatal period. Prospective birth cohorts are still required to fully examine the effect of air 
pollution.
2.2A.2 Indoor air pollution
The effect of different types of indoor air pollutants remains to be fully determined. An 
association between exposure to household nitrogen dioxide (NO2), from heating and/or cooking 
appliances, and increased respiratory symptoms has been reported in several studies (242-244). 
In the Tasmanian birth cohort, living room gas heater use in infancy was associated with 
subsequent child asthma (aRR 1.92; 95% Cl 1.33, 2.76) and indoor pollutants from gas 
combustion were found to increase the risk for HDM sensitization (aRR 1.98; 95% Cl 1.04, 3.79) 
at age 7 years (245). In an earlier prospective study of 6-11 year old Australian schoolchildren, 
Pilotto et al., 1997 (244), reported significant dose-response relationships between exposure to 
NO2 and mean rates for respiratory symptoms such as cough with phlegm (p=0.04).
2.2.5 Environmental Tobacco Smoke
The extent to which parental cigarette smoking, either before or after birth, influences the 
development of atopy has been extensively discussed and it appears to have little, if any, impact 
(246). A review of observational studies (247) up to 1999, that reported IgE, skin prick positivity, 
hay fever or eczema (considered separately from asthma), failed to find a positive association of 
exposure to environmental tobacco smoke (ETS) on allergic sensitization. A subsequent study 
(248), in the Isle of Wight supported the review’s conclusions: in a birth cohort of 1,218 children 
neither maternal smoking during pregnancy or after birth increased aeroallergen sensitization or 
the development of respiratory allergic disease at age 4 years (248).
However, there is now substantial evidence from studies in both human infants and animal 
models, to suggest that foetal exposure to active maternal smoking during pregnancy adversely 
affects infant lung function (249). Maternal smoking during pregnancy results in structural and 
hence functional changes to the developing lung, such that exposed infants have small airways at 
birth (249). A number of studies have documented that exposing the foetus to tobacco smoke 
during gestation leads to reduced lung and airway function (250-252), airway obstruction (250, 
252), and airways hyperresponsiveness (253) in the newborn period. Together these alterations
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in lung and airway function, and their persistence throughout infancy, suggest that exposure to 
products of tobacco smoke during foetal life and early postnatal life, a time of extremely rapid 
lung development, may have long lasting consequences for airway and lung structure and 
function (249), with suggestion that forced expiratory flows are reduced on average by 
approximately 20% in infants whose mothers smoke (249).
A systematic quantitative review (254) up to April 1997, of the evidence relating parental smoking 
to the prevalence of respiratory symptoms in school-age children concluded that there was a 
causal relationship between parental smoking and asthma (pooled OR 1.21; 95% Cl 1.10,1.34, 
for either parent smoking). Moreover, several more recent cross-sectional studies (136,255-258) 
have consistently reported an association between parental smoking and increased prevalence of 
asthma and wheezing in childhood. Studies using objective measures of lung function have also 
showed, in children exposed to ETS, an association with decrease in airway calibre and an 
increase in airway responsiveness (259). A meta-analysis (260), up to April 1997, of the 
relationship between BHR as assessed by challenge test, and exposure to ETS (largely maternal 
smoking) in 10 population samples suggests a small but real increase in BHR amongst the 
children of smoking mothers (OR 1.29; 95% Cl 1.10,1.50).
There are accepted difficulties using epidemiological studies (247) in separating the effects of pre 
and postnatal smoke exposure as most parents who smoke during pregnancy continue to do so 
thereafter (249). It has been estimated that 90% of mothers who smoke during pregnancy still do 
so 5 years later (261). However, several cross-sectional (262, 263), longitudinal (264) and 
prospective birth cohort (56, 245, 265) studies have reported a positive association between 
maternal smoking during pregnancy or very early infancy and child asthma. The Southern 
California Children’s Health Study (263) investigated the exposure of maternal smoking during 
pregnancy on asthma in 5,762 school-age children. In utero exposure to maternal smoking 
without subsequent postnatal ETS exposure was associated with increased prevalence of 
physician-diagnosed asthma (OR 1.8; 95% Cl 1.1, 2.9). Current ETS exposure was associated 
with wheezing, but not physician-diagnosed asthma. It was concluded that ETS operates as a 
co-factor with other environmental factors, such as intercurrent infections, as a trigger of 
wheezing attacks, rather than as a factor that induces asthma; whereas in utero exposure acts to 
increase physician-diagnosed asthma (263).
In 15,712 children who were part of a British birth cohort (56), maternal smoking during 
pregnancy was an independent determinant of wheeze (OR 1.39; 95% Cl 1.22, 1.58) at age 5
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years. The effects of either exposure to smoking during pregnancy or at 5 years of age were 
similar, both exhibiting a dose-related association with cumulative wheeze, but in mothers for 
whom both of these smoking measures were known, smoking during pregnancy was slightly 
more strongly related (56). In the Tasmanian birth cohort, early infant exposure to ETS at one 
month of age was shown to be positively associated with child asthma (245). In smoking 
households, infant exposure to smoking in the same room was associated with increased asthma 
at age 7 years (aRR 1.52; 95% Cl 1.01, 2.29). However, for infants living in non-smoking 
households, exposure to any smoking in the same room did not predict asthma (56).
Thus, observational studies have provided considerable evidence for the adverse role of parental 
smoking and child asthma. RCTs will be able to address the effects of reducing exposure to 
ETS. In addition, future studies distinguishing the role of prenatal versus postnatal exposure in 
the aetiology of asthma are required to inform public health prevention programs.
2.2.6 Heredity
A history of asthma in the immediate family is the best recognized risk factor for asthma and has 
been reported in a large number of epidemiological studies (266, 267). A recent study (266) in 
306 children (median age 3.5 years) from 217 Boston families with at least one parent with 
physician-diagnosed “asthma, hay fever or allergies”, found that the multivariable OR for 
childhood asthma when the mother had asthma was 4.1 (95% Cl 1.7,10.1); for paternal asthma, 
2.7 (95% Cl 1.0, 7.2). However, as discussed in Section 1.3, there is strong evidence suggesting 
that asthma is a polygenic trait, where maternal phenotype may have a greater influence than 
paternal phenotype on child atopic disease, and recognition of the different phenotypes will assist 
the gene hunt.
2.3 THE HYGIENE HYPOTHESIS
It is evident that the putative risk factors, discussed in Section 2.2, for the development of asthma 
probably cannot fully account for either the worldwide increase in prevalence or the international 
variations in prevalence that have been observed. Epidemiological studies have identified 
additional environmental and lifestyle factors that may be either a risk or protective factor for the 
development of asthma. In an endeavour to explain the rise in the inverse association between
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family size and hay fever, the “Hygiene hypothesis” was proposed by Strachan in 1989 (268). 
The Hygiene hypothesis postulates that infection, bacterial and viral, protects against atopy. In 
summary, this stated:
“These observations ...could be explained if allergic diseases were prevented by infection in early 
childhood, transmitted by unhygienic contact with older siblings, or acquired prenatally ...Over the past 
century declining family size, improved household amenities and higher standards of personal cleanliness 
have reduced opportunities for cross-infection in young families. This may have resulted in more 
widespread clinical expression of atopic disease.” (268)
Bacterial and viral infections are known to influence cytokine levels, potentially suppressing the 
Th2 immune responses involved in IgE mediated allergy and probably determining the phenotype 
of the subsequent specific Th1 response (269) (see Section 1.5.1). Early life environmental 
exposure to such infections is hypothesized to cause an infant’s immune system to shift away 
from its Th2 profile thereby diminishing the likelihood of the development of a clinical allergic 
diathesis. As a corollary, it was hypothesized that changes to infant diets, early use of antibiotics, 
and reduced exposure to bacterial products predispose to the persistence of Th2 responses in 
childhood (270). The decline in cross-infections within young families caused by decrease in 
family size and improvement in hygienic standards is, among the set of characteristics of the 
western lifestyle, possibly responsible for the increase of atopy prevalence (271). Many 
epidemiological studies have consistently demonstrated that factors that are surrogates or 
indirectly related to early childhood infections are associated with the prevalence of atopy and 
asthma. These factors are discussed in the following sections and include family size, use of day 
care centres, use of antibiotics, immunizations, endotoxins, and a rural lifestyle.
2.3.1. Large family size; sibship; and birth order
Strachan, 1989 (268), hypothesized that the sibling effect could be explained as a protective 
effect of childhood infections on the development of atopy. The Hygiene hypothesis interprets the 
variation in allergy risk with family size as a reflection of differential exposure to infection acquired 
in childhood from contact with siblings. The negative association between the number of siblings 
(older siblings being more influential (272)) and the development of atopic disorders was first 
demonstrated by Strachan: children who come from large families are at a decreased risk of 
having hay fever (268). The British National Child Development Study, a birth cohort, found that
at age 11 and 23 years, hay fever was inversely related to the number of children in the
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household at age 11 years. The number of older siblings had a more powerful independent effect 
on the prevalence of atopy than did the number of younger siblings. Strachan reported that the 
negative association of the number of older siblings (birth order) with atopic disease was more 
important than the negative association of the number of younger siblings with atopic disease, 
and postulated that high rates of infection in those exposed to other children, particularly those 
exposed to older children, may confer some protection against hay fever and eczema (268).
Many studies have shown an inverse association of family size with objective measures of 
allergic sensitization such as SPTs or circulating levels of aeroallergen-specific IgE (273). 
Children of large families have an increased risk of early respiratory infection (274). Firstborn 
children are often exposed to common infections after their enrollment in kindergarten or school, 
whereas children born subsequently are often exposed much earlier, through their siblings. Thus, 
having more siblings may be associated with an increased exposure to viral infections early in life 
(275). The Tasmanian birth cohort (276) reported that a history of upper respiratory tract infection 
(URTI) in infancy was associated with family size (aOR 1.17; 95% C! 1.05,1.31).
Many other population studies have also identified a sibling effect on atopy using objective 
measures such as SPTs (272, 277, 278) and/or specific IgE levels to aeroallergens (279-281). 
Moreover, studies have identified a sibling effect on asthma and wheeze (57, 276, 282, 283). A 
cross-sectional survey (278) among school children aged 9-11 years in Germany, found that the 
prevalence of atopic sensitization (as measured by SPT) decreased linearly with increasing 
number of siblings (OR 0.96 for one sibling, OR 0.67 for five or more siblings; p=0.005). And, 
recently, the Detroit Childhood Allergy Study, a birth cohort (280), reported that first-born children 
were at a higher risk of allergen-specific IgE (OR 1.92; 95% Cl 1.16, 3.18) and positive SPT at 6 
years of age (OR 1.68; 95% Cl 1.02, 2.75). A population-based study (279) in the Netherlands, 
also reported that in families with a parent with asthma, children with more siblings (both older 
and younger) were less likely to have positive specific IgE to common aeroallergens (aOR 0.73; 
95% Cl 0.56, 0.97).
Two cross-sectional studies, one in the UK and one in Australia, have reported an association 
between siblings and asthma. A large UK study (282) of 11,924 family sets, found in children 
aged 5-11 years that three or more siblings compared with no siblings was highly inversely 
associated with a child’s asthma or wheezing (OR 0.5; 95% Cl 0.4, 0.6). And, in children aged 3- 
5 years from Wagga Wagga and Lismore, New South Wales, having three or more older siblings
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decreased the risk of recent asthma (aOR 0.16; 95% Cl 0.04, 0.71), but no effect was found for 
having less than 3 older siblings (283).
Birth cohorts have reported similar findings. The Tasmanian birth cohort (276) found family size 
at birth showed a per sibling association (aOR 0.86; 95% Cl 0.74, 0.99) with hay fever but not 
with asthma. However, in contrast, family size at age 7 years was inversely associated with 
asthma (aOR 0.82; 95% Cl 0.72, 0.92) and hay fever (aOR 0.82; 95% Cl 0.71, 0.96). Increased 
household density was also associated with a higher risk of early URTIs (aOR 1.77; 95%% Cl 
1.07, 2.94) but not for lower respiratory tract infections (LRTIs). The apparent protective effect of 
large household size and asthma could not be explained by an increase in reported early 
respiratory illness. A history of early respiratory illness, although prospective, was based on 
parental interviewing and the possibility of selection bias must be considered. The first year of life 
may not be the most critical time for the protective effect of large household size to be mediated 
in relation to asthma, but this effect had occurred by the 7th year of life (276). A dose-response 
trend for asthma was reported for children aged 6-13 years followed since birth in the Tucson 
Children’s Respiratory Study (57). The presence of one or more older siblings at home protected 
against the development of asthma (aRR for each additional older sibling 0.8; 95% Cl 0.7,1.0).
These studies have demonstrated that family size plays an important role in the development of 
atopic disease. However, the importance of the number of older siblings versus overall family 
size, the critical period for effect of family size on atopy and the biological basis for the effect 
remain unclear. A recent review (273) in 2002, of 53 studies from 1965, strongly supported the 
“protective” effects of having a higher number of siblings for the risk of atopic eczema, asthma, 
hay fever and allergic sensitization. For eczema, 10 of 11 studies reported an inverse association 
with number of siblings (weighted OR = 0.66), 22 of 31 studies on asthma (weighted OR = 0.93), 
all 17 studies on hay fever (weighted OR = 0.56), and 14 of 16 studies on allergic sensitization 
(weighted OR = 0.62). The authors concluded however, that despite epidemiological support, 
there was no comprehensive biological explanation for this “protective” effect of a higher number 
of siblings and that the causal nature of the effect was not adequately explained by the “Hygiene 
hypothesis”; other alternative explanations may include in utero programming or endocrine effects 
(273).
44
2.3.2 Day Care Centres
A similar effect to sibship may be expected from exposure to children outside the home. Family 
and sibship size have decreased in many westernized countries (57, 284) where the percentage 
of older children may be far greater than for infants (57). Increased child-to-child contact occurs 
in day care centres and in western countries, the number of working mothers has increased and 
more children are attending day care outside of the home (285) with exposure from early in life. 
Moreover, there is evidence that attendance at day care centres during the first 3 years of life 
increases the risk of respiratory infections when compared with those children who remain at 
home (285-291). In a retrospective cohort study of 1-7 year old children in Finland, attendance at 
day care centres increased the risk of respiratory infections (common cold aRR 1.69; 95% Cl 
1.43,2.01) in children under 2 years of age (290).
Attendance at day care before age 2 years has been shown in cross-sectional (292, 293) and 
longitudinal studies (280) to be inversely associated with atopy, as defined by a positive SPT. In 
addition, in children from large families (more than 3 members), age of entry to day care had no 
effect on atopy (292). In a cross-sectional study (292), 2,471 children were examined in three 
age-groups (5-7,8-10, and 11-14 years) from 3 towns in eastern Germany. In children from small 
families (up to three people), the prevalence of atopy (measured by SPTs and IgE) was higher 
among children who started to attend day nursery at an older age than in those who started to 
attend at a younger age (p<0.05). Compared with children who first attended day nursery at age 
6-11 months, the adjusted ORs for a positive SPT were 1.99 (95% Cl 1.08, 3.66) for children who 
attended at age 12-23 months and 2.72 (95% Cl 1.37, 5.40) for those who attended at age 24 
months and older. In children from large families (more than three people), age of entry to day 
nursery had no effect on atopy. These findings accord with the hypothesis that early infection 
may protect against allergies in later life (292). The Detroit Childhood Allergy Study (280) 
similarly found that early day care use (before 1 year of age) was associated with a decreased 
risk of seroatopy (OR 0.57; 95% Cl 0.34, 0.96).
In a prospective birth cohort (285) of 1,268 Minnesotan children followed up to 2 years of age, 
day care centre attendance was found to be an important risk factor for LRTI in young children 
(rate ratio 2.0; 95% Cl 1.7, 2.2) and was associated with a 3-fold risk of having recurrent 
wheezing illnesses. The results in this study may have identified early transient wheeze in this
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young age group. Other studies have found an inverse relationship between attendance at day 
care centres and child asthma (57).
The Tucson Children’s Respiratory Study (57), distinguished between prevalence of wheezing 
disorders, which may be the sub-group of children born with smaller airways in whom wheezing 
does not persist, or those whose wheezing illnesses appear to represent the early onset of 
asthma (52, 294) (see Section 1.3.2.1) and incident diagnoses. The attendance at day care 
during the first six months of life protected against the development of asthma (aRR 0.4; 95% Cl 
0.2,1.0). Children with more exposure to other children at home or at day care were more likely 
to have frequent wheezing at the age of 2 years than children with little or no exposure (aRR 1.4; 
95% Cl 1.1,1.8) but were less likely to have frequent wheezing from the age of 6 years (aRR 0.8; 
95% Cl 0.6,1.0) through the age of 13 years (aRR 0.3; 95% Cl 0.2,0.5).
Thus, attendance at day care centres during infancy is a risk factor for wheezing associated with 
LRTI early in life, but it appears to protect against wheezing associated with atopy later in 
childhood. These findings show the importance again of considering asthma phenotype with 
increased precision in that the association with wheeze differed by age of onset.
2.3.3 Early respiratory infections and subsequent atopic disease
The early epidemiologic studies in Papua New Guinea (295) reported that respiratory infections 
were more common among young children in the Highlands, where asthma prevalence was 
exceedingly low, than in the coastal regions of the country, where asthma occurred more 
frequently. However, such ecologic findings do not provide strong evidence. Since that time, 
several cross-sectional and prospective studies have reported that early respiratory infections 
may be associated with atopic disease, including asthma (276, 296-298). The Oslo Birth Cohort 
Study (299) found a positive association between children with LRTIs during infancy and asthma 
at 4 years of age (aOR 3.4; 95% Cl 2.3, 7.0). The risk of current asthma was, however, inversely 
related to older siblings after controlling for early respiratory infections. LRTIs in the first year of 
life were associated with an increased risk of current asthma (aOR 3.84; 95% Cl 2.82, 5.24 for 
two or more illnesses) but not atopy in the Western Australia Pregnancy Cohort Study. This 
association was evident for both non-atopic and atopic asthmatics (300).
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Episodes of rhinitis early in life may also protect against the development of asthma. In the 
German Multicenter Allergy Study (301), compared with children with one or less episode of 
runny nose before the age of 1 year, those with 2 or more episodes were less likely to have a 
doctor’s diagnosis of asthma at age 7 years (OR 0.52; 95% Cl 0.29, 0.92) or to have wheeze at 
age 7 years (OR 0.60; 95% Cl 0.38, 0.94), and were less likely to be atopic, determined by IgE 
concentrations to various allergens, before the age of 5 years. Similarly, having one or more viral 
infection of the herpes type in the first 3 years of life was inversely associated with asthma at age 
7 years (OR 0.48; 95% Cl 0.26, 0.89). However, repeated LRTIs in the first 3 years of life 
showed a positive association with wheeze up to the age of 7 years (OR 3.37; 95% Cl 1.92, 5.92 
for 4 or more infections vs 3 or less infections) (301). The authors concluded that repeated viral 
infections other than LRTIs early in life may reduce the risk of developing asthma up to school 
age (301). A random sample of more than 15,000 school children in Germany, using the ISAAC 
protocol, found asthmatic children with recurrent early childhood infections as assessed 
retrospectively by parental questionnaires, were at a lower risk of being symptomatic at school 
age (302). When considering atopic and non-atopic asthmatic children separately, the highest 
risk of asthma with repeated early childhood infections was found for non-atopic asthma (OR 
24.29; 95% Cl 11.86, 49.76). The authors concluded that a sub-group of children with a 
triggering or inducing of asthmatic symptoms through repeated early childhood infections may 
exist within the "asthma syndrome" which has a better prognosis and is less related to the atopic 
phenotype (302).
In summary, these studies have provided conflicting results on the relationship between early 
infections and asthma. However, the relationship between early respiratory infections and atopy 
depends on a number of factors including timing, anatomical site, dose, protractedness, exposure 
to other infections, and host characteristics (303), including genetic predisposition (302), as well 
as the stage of immunological development and type of infection.
2.3.4 Intestinal flora and antibiotics
Recent retrospective and cross-sectional studies have reported an increased risk of asthma and 
atopic disease associated with the use of antibiotics in infancy (302, 304-308). There is, 
however, the possibility of disease misclassification in the determined prevalence of current 
asthma and also misclassification with parent recall of their child’s wheeze and antibiotic use. 
Both the frequency and age at the time of antibiotic use may be important in the subsequent
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development of asthma. A retrospective study (305) in Oxfordshire, UK, found that oral antibiotic 
treatment for any clinical indication in the first two years of life was the strongest predictor of 
subsequent atopic disorders (asthma, hay fever or eczema), (aOR 2.07; 95% Cl 1.64, 2.60). In 
some studies (305, 308), this association was dose-dependent with atopic disorders increasing 
with the number of antibiotic courses received in the first two years of life. A cross-sectional 
study (306) in 5-10 year old children at Rudolf Steiner1 schools in New Zealand, found a strong 
association for asthma (OR 4.05; 95% Cl 1.55,10.59) if antibiotics were used in the first year of 
life and a lesser association (OR 1.64; 95% Cl 0.60, 4.46) if antibiotics had been used only after 
the first year of life when compared with children who had never used antibiotics.
The bacterial flora of the gastro-intestinal tract (GIT) plays an important role in maintaining the 
integrity of the enterocyte, modulating metabolic and immunologic processes, and protecting 
against colonization by invasive pathogens (309, 310). Confrontation with microbial pathogens 
through stimulation via indigenous microflora colonizing the infant GIT drives the postnatal 
maturation of the mammalian immune system (310-312). It is hypothesized that exposure to 
commensal microflora of the gut, that promote normal immunity in early life, is disrupted or 
diminished by antibiotic use (313), which alter the stable gut flora by promoting the colonization of 
pathogenic bacteria (309). Oyama et al., 2001 (314), using a mouse model, showed that 
neonatal antibiotic use induced a Th2-skewed response with increased serum levels of total lgG1 
and IgE, enhanced in-vitro IL-4 secretion and reduced in vitro IFN-y secretion. These results 
suggested that antibiotic use during infancy may disturb the intestinal microflora and thereby 
prevent postnatal Th1 cell maturation, thus resulting in a Th2-polarized immune deviation (314). 
This same group of researchers subsequently showed, again using murine models, that adequate 
probiotic intervention after antibiotic treatment may improve the intestinal ecosystem and thereby 
prevent the Th2-shifted immunity induced by neonatal antibiotic use (315).
In retrospective studies, these findings of an association between antibiotic use in early life and 
asthma may be due to recall bias and/or reverse causation, that is, the use of antibiotics may be 
the consequence of an increased occurrence of respiratory infections in children having asthma. 
To explore this, a cross-sectional study (304) in Belgium, reported that children who received 
antibiotics in their first year of life are at risk of subsequently developing asthma (aOR 1.7; 95% 
Cl 1.0, 3.1) and allergic diseases at age 7 and 8 years, but this increased risk was only found in 
children who are genetically predisposed to atopic immune responses. These results suggested
1 Steiner schools follow an anthroposophic lifestyle: use antibiotics restrictively, have few vaccinations, 
and their diet usually contains live lactobacilli, which may affect the intestinal microflora.
48
that the use of antibiotics in early childhood may affect the immune system in the presence of a 
genetically determined tendency towards atopic (Th2-like) responses. However, the Tasmanian 
birth cohort (276) and a prospective birth cohort (316) in Boston, USA, have subsequently 
reported that among children with a familial history of atopy, the use of oral antibiotics in the first 
year of life was not associated with recurrent wheezing, asthma, allergic rhinitis, or eczema at 
age 5 years (316), supporting possible reverse causation as an explanation of the previously 
reported link.
2.3.5 Immunizations
Epidemiologically, several of the common infectious diseases of childhood provide the 
opportunity to explore the temporality of the exposure-response relationship. The proportion of 
children contracting pertussis, measles and mumps has reduced substantially in the developed 
world as a result of the introduction of vaccines. With the exception of mumps, this reduction in 
these infectious diseases occurred prior to the earliest reports of increases in the prevalence of 
allergic disease (317). Immunization could possibly have either positive or negative effects on 
the incidence of allergic disease. Three theoretical reasons for a possible association of asthma 
with vaccination have been recently proposed by DeStefano et ai., 2002 (318) : (i) vaccines or 
their adjuvants may have direct IgE-potentiating effects; (ii) vaccination may directly stimulate Thi 
immunity; and (iii) vaccination may reduce the burden of infection in early childhood.
Positive associations with pertussis vaccination and atopic diseases have been reported in a 
small number of studies (305, 319-321). In the Christchurch Health and Development Study, a 
birth cohort, none of the non-immunized children developed asthma by the age of 10 years 
compared with nearly one quarter of the immunized children (321). There were limitations to the 
study however, as the number of non-immunized children was small (23 of 1,265 subjects) and 
the differential use of health services, leading to different rates of asthma detection, could not be 
excluded (321). A retrospective birth cohort in Oxfordshire (305) reported a statistically significant 
association between pertussis immunization and asthma (OR 1.44; 95% Cl 1.17, 1.85). 
However, the possibility of confounding effects and reverse causation could not be excluded 
(305). Two other studies, one in the UK (319) and one using the USA Third National Health and 
Nutrition Examination Survey (320), also reported an association but these were cross-sectional 
surveys and may be subject to recall bias.
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Methodologically stronger studies have not shown any association between pertussis 
immunization and atopic disease. In a RCT in Sweden (322), 669 children were evaluated for the 
development of atopic disease, including asthma, from age 2 months to 2.5 years. The incidence 
of asthma, and other atopic diseases, was similar in the groups of children who received whole­
cell pertussis vaccine, acellular pertussis vaccines and placebo (dipheria-tetanus only). The 
Avon Longitudinal Study of Parents and Children cohort in the UK, found no increased risk for 
wheezing illnesses associated with pertussis immunization in young children from birth to 42 
months of age (323). The most recent study (318) evaluated the suggested association between 
childhood vaccinations and risk of asthma in a birth cohort to 6 years of 167,240 children enrolled 
in four health maintenance organizations in the USA. In this study 11% (18,407) children 
developed asthma. The relative risks of asthma were: 0.92 (95% Cl 0.83, 1.02) for diphtheria, 
tetanus and whole cell pertussis vaccine; 1.09 (95% Cl 0.9, 1.23) for oral polio vaccine; 0.97 
(95% Cl 0.91, 1.04) for measles, mumps and rubella (MMR) vaccine; 1.18 (1.02, 1.36) for 
Haemophilis influenzae type b (Hib); and 1.20 (95% Cl 1.13,1.27) for hepatitis B vaccine. These 
weak associations observed for Hib and hepatitis B vaccines seemed to be explained by health 
care utilization or information bias (318).
The immune responses to measles and measles vaccine are complex, involving both Th1 and 
Th2 responses (318) and studies have provided conflicting results. Shaheen et ai., 1996 (324), in 
a historical cohort study of 262 young adults from Guinea-Bissau found that children with a 
documented history of measles infection, before 6 years of age, were less atopic, as measured 
by positive allergen-specific skin test (OR 0.36; 95% Cl 0.17, 0.78) than children who did not 
contract measles (usually because they have been immunized). However, in a very large cross- 
sectional nationwide study (325) in Finland of 547,910 individuals, a statistically significant 
association between measles infection and atopy at all ages was found. The age-adjusted 
prevalence ratio among those who had had measles compared with those who had not was 1.67 
(95% Cl 1.54, 1.79) for asthma (325). Whereas a retrospective birth cohort in the UK (305) and 
the birth cohort from the four US health maintenance organizations (318) did not find that children 
immunized for measles were at an increased risk of developing asthma compared with non- 
immunized children.
Shirakawa et al., 1997 (303), reported an inverse association between positive tuberculin 
responses and atopic disorders among Japanese children, suggesting that BCG immunization 
may influence the Th lymphocyte balance, resulting in decreased atopy. This inverse relation, 
however, has not been confirmed by three other studies (326-328). Significant inverse correlation
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between national tuberculosis notification rates, from the World Health Organization, and the 
prevalence of asthma symptoms in subjects from the ISAAC have been reported (329). An 
increase in tuberculosis notification rates of 25 per 100,000 population was associated with an 
absolute reduction in the prevalence of wheeze ever of 4.7%. However, a major limitation of this 
ecologic analysis (where the analyses has been based on countries rather than individuals) for 
making causal inference is ecological bias (330), which is the failure of expected ecologic effect 
estimates to reflect the biologic effect at the individual level.
2.3.6 Endotoxins: a rural versus urban lifestyle
Endotoxin, a component of the cell wall of gram-negative bacteria, is a potent pro-inflammatory 
agent and causes reversible airway obstruction in subjects with established asthma (331). 
However, bacterial endotoxins are also potent inducers of the Th1 cytokines IFN-y and IL-12 
which inhibit the proliferation of Th2, thereby having the potential to decrease allergen 
sensitization in cells (224, 332). It has been postulated that exposure to endotoxin at a critical 
time might shift the developing immune system to a predominantly Th1 -type responsiveness, thus 
protecting against asthma and allergies (270, 333) (see Section 1.5.1).
Endotoxins are ubiquitous in nature, being found abundantly in stables where pigs, cattle and 
poultry are kept, and they are also present in normal urban indoor environments as a constituent 
of house dust with significant positive associations found between house dust endotoxin levels 
and household pets (cats and dogs) (334-337). In comparison to children from non-farming 
families, farmer’s children are exposed to higher concentrations of endotoxin both in stables and 
in dust from kitchen floors and mattress (338-342) and several studies have examined the 
possible protective effects of a farming environment against asthma in children. Children from 
farm environments, where endotoxin levels are higher (340), are reported to have a significantly 
decreased risk of developing atopy and asthma (341-348) than children from a non-farming 
environment. However, this protective effect has also been observed in children from non­
farming households where there are high mattress endotoxin levels (342).
Endotoxin has been considered as a potential marker for a lower hygienic level (335) and as such 
several studies have supported the Hygiene hypothesis by reporting that exposure to high 
concentrations of endotoxin very early in life is related to an increased prevalence of non-specific 
respiratory diseases. A German prospective cohort (337) of infants at high risk for developing
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asthma found that during the first six months of life, the risk for non-specific respiratory infections 
was increased (OR 1.69; 95% Cl 1.25, 2.28) by exposure to high concentrations of endotoxin in 
dust from the mother’s and child’s mattresses.
A study in the USA, measuring allergen sensitization by SPT in 61 infants at risk for asthma 
(aged 9-24 months) reported that allergen-sensitized infants had significantly lower house dust 
endotoxin levels than non-sensitised infants (mean 468 vs 1035 EU/ml, respectively; p=0.01) 
(224). A recent cross-sectional study (342), found that endotoxin levels in a child’s current 
mattress were inversely related to the occurrence of hay fever, atopic asthma and atopic 
sensitization in 6-13 year old children in rural Germany, Austria as well as Switzerland. Non- 
atopic wheeze and asthma was not significantly associated with the endotoxin level. Atopic 
asthma was inversely associated (OR 0.42; 95% Cl 0.18, 0.96) with exposure to farming during 
the first year of life and also current endotoxin exposure (OR 0.52; 95% Cl 0.30, 0.90) (342). 
Litonjua et al., 2002 (218), undertook a longitudinal analysis of childhood wheezing in a birth 
cohort in Boston, USA, in children from allergic or asthmatic parents. In that study, 226 children 
(<5 years of age) were followed over a 4-year period and an increased risk for wheeze was 
associated with high levels of house dust endotoxin early in life which rapidly decreased over time 
(Test for trend, p=0.005), suggesting that exposure to endotoxin might protect against further 
episodes of wheezing as the children get older (218). Wheezing episodes of older children are 
more often associated with an atopic phenotype and the results of these two studies may be 
interpreted as a possible protective effect of endotoxin on atopic wheeze.
The epidemiological associations of environmental endotoxin exposure in early life reported in 
these studies are consistent with the Hygiene hypothesis associations of other microbial 
exposures or infections with a lower incidence of atopic disease. Endotoxin may be a factor in 
both atopic and non-atopic asthma. However, the timing of endotoxin exposure may be 
important. Douwes et al., 2002 (349), recently reviewed studies of endotoxin exposure and 
atopy; endotoxin and asthma; and, farming and asthma; concluding that exposure to 
environmental endotoxin might prevent the primary causation of allergic asthma, but it may be 
both a primary and secondary cause of non-allergic asthma, in particular in the aetiology of 
occupational asthma caused by organic dust exposure. Moreover, farming per se is not always 
linked to a reduced risk of allergy, and exposure of farmers to storage mites, pesticides, 
herbicides and disinfectants have all been implicated either directly or indirectly as potential 
causes of asthma (350).
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2.4 RISK AND PROTECTIVE ENVIRONMENTAL FACTORS NOT 
WITHIN THE HYGIENE HYPOTHESIS
In addition to factors that are explained solely by the Hygiene hypothesis, there are several other 
risk and protective factors that have been associated with the development of asthma. These are 
discussed briefly in the following Sections.
2.4.1 Breastfeeding
The literature regarding the relationship between infant breastfeeding and the development of 
childhood asthma is conflicting. In 1988, Kramer (351) suggested that previous studies 
assessing the relation between breastfeeding and the development of atopy and asthma were 
methodologically flawed. Several more recent birth cohort studies (352-357), with follow-up 
periods ranging from 2-17 years, have shown protective relationship between breastfeeding and 
the development of allergy, allergic symptoms, wheezing illness and asthma; though other 
studies (358, 359) have failed to confirm this, reporting that breastfeeding increases the risk of 
childhood asthma. The longitudinal Dunedin Multidisciplinary Health and Research Study (359) 
assessed respiratory history, function and SPTs in 1,037 children every 2-5 years from ages 9 to 
26 years; each child’s history of breastfeeding had been independently recorded in early 
childhood. Children who were breastfed were more likely than those who were not breastfed to 
have current asthma with AHR or current wheeze with AHR at all ages up to 21 years with one 
exception (at age 15 years). Generalised estimating equations, allowing for repeated measures 
analysis, showed that children (aged 9-21 years) who were breastfed were more than twice as 
likely as those who were not breastfed to have wheeze or current asthma (OR 2.09; 95% Cl 1.42, 
3.08) (359). Whereas, the Western Australian Pregnancy Cohort Study (352) found exclusive 
breastfeeding for at least 4 months was associated with a significant reduction in the risk of 
physician-diagnosed childhood asthma at age 6 years (OR 1.31; 95% Cl 1.05,1.64). In Sweden, 
a birth cohort (357) of children up to 2 years of age reported that exclusive breastfeeding for 4 or 
more months reduces the risk of asthma (OR 0.66; 95% Cl 0.51, 0.87). In that study, the group 
of children that benefited the most from breastfeeding were those with a parental history of atopic 
disease independently of maternal asthma.
The issue regarding whether infants of asthmatic mothers should be breastfed has created further 
controversy. The Tucson Children’s Respiratory Study (360) found the relationship between
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breastfeeding and asthma or recurrent wheeze varies with the age of the child and the presence 
or absence of maternal asthma and atopy in the child. Exclusive breastfeeding for >4 months 
within the first 2 years of life was associated with significantly lower rates of recurrent wheeze 
(OR 0.45; 95% Cl 0.2, 0.9), irrespective of maternal asthma or atopy in the child. Whereas 
breastfeeding was associated with an increased risk of asthma beginning at the age of 6 years, 
but only for atopic children with asthmatic mothers (360). But, the Western Australian Pregnancy 
Cohort Study (361) found a consistent protection conferred by exclusive breastfeeding against 
current asthma in children aged 6 years with asthmatic mothers. Breastfeeding was associated 
with lower rates of asthma in children of asthmatic mothers and in both atopic and nonatopic 
children. Exclusive breastfeeding for less than 4 months, compared to children exclusively 
breastfed >4 months, was a significant risk factor for current asthma (aOR 1.35; 95% Cl 1.00,
1.82), and this risk was not altered by atopy or maternal asthma status.
Unlike a RCT, these observational studies have been hampered by difficulties in classifying 
breastfeeding, notably between exclusive breastfeeding and being breastfed, confounding and 
other biases. The first randomized trial (362), conducted in Belarus as part of PROBIT, the 
Promotion of Breastfeeding Intervention Trial, was able to assess the role of breastfeeding 
duration and exclusivity on atopic eczema, gastrointestinal and respiratory infections. Infants 
from the intervention sites were significantly more likely to be breastfed and had a significant 
reduction of atopic eczema in the first 12 months (aOR 0.54; 95% Cl 0.31, 0.95). The study did 
not report on any associations with asthma or atopy.
Breastfed and formula fed infants differ in the development of the intestinal flora considered of 
importance for protection against harmful microorganisms and for the maturation of the intestinal 
immune system. Thus, a possible mechanism related to the Hygiene hypothesis through which 
the protective effect of breastfeeding may operate is the establishment of normal intestinal flora. 
Harmsen et al., 2000 (363) found that the components of the faecal samples from breastfed 
infants were mainly lactobacilli and streptococci while samples from formula-fed infants often 
contained staphylococci, Escherichia coli and Clostridia. Any effect of breastmilk to protect from 
atopic disorders could be the result of a reduced exposure to alimentary allergens in early life. 
Breastmilk contains immunodulatory and anti-inflammatory factors that protect against allergic 
sensitization and influence the development and maturation of the infant’s immune system after 
birth (364, 365). These immunological properties of breastmilk neutralize foreign proteins to 
prevent catching infections, to produce a favourable intestinal flora, and to induce tolerance (366).
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2.4.2 Diet
Temporal patterns indicate that changes in diet may be associated with the increase in asthma
(367) . Westernization has resulted in a change in diet for many population groups with an 
increase in the amount of polyunsaturated fat and a fall in saturated fat, a decrease in fresh 
vegetables and fruits, containing antioxidants and magnesium, and an increase in vegetable oils 
and margarine, containing omega-6 polyunsaturated fatty acids. There is also evidence for a 
decrease in the consumption of oily fish which contains omega-3 polyunsaturated fatty acids
(368) .
Increased intake of unsaturated fatty acids may increase the risk of the development of atopic 
diseases. The consumption of polyunsaturated margarine and oils, containing omega-6 fatty 
acids, may promote the formation of IgE from T-cells (369). A small number of epidemiological 
studies have demonstrated a positive association between polyunsaturated fat intake on atopic 
disorders in children (123, 283, 369). In Australia, a cross-sectionai study of 535 preschooi 
children, reported high intakes of polyunsaturated fats was associated with an increased risk of 
recent asthma (OR 2.03; 95% Cl 1.15, 3.60) (283). Two observational studies (123, 369) 
reported that butter intake was inversely associated with the development of atopy, suggesting 
that the relative quantities of saturated fats in the diet may be of importance. Validation of the 
questionnaire was reported in only one (283) of these three studies. However, even though this 
type of measurement error will result in a lack of precision, the effect on the results would bias the 
reported effects toward the null for the dichotomous exposure (330). An ecological study (370) 
compared the intake of trans fatty acids in 14 European countries to asthma atopy and 
prevalence from the ISAAC study. A positive association was found between per capita 
consumption of trans fatty acids and the prevalence of asthma (ß=20.9), allergic 
rhinoconjunctivitis (ß=8.2) and atopic dermatitis (ß=12.40) (Test for trend, p<0.001) (370). One of 
the strongest relationships in the ISAAC study was reportedly the “McDonalds Index”: the more 
McDonalds outlets in a country, the higher is the prevalence of symptoms (371).
Fish consumption (in the form of omega-3 fatty acids) has demonstrated a protective effect on 
atopic disorders in a small number of studies (368, 369, 372). In Australia, a population based 
study of 7-14 year old children (372) found a significant inverse association between regular fish 
intake (>once a week) and BHR (defined as >20% fall in FEVi measured by bronchial challenge), 
with an aOR=0.35 (95% Cl 0.10, 0.90) (372). This same research group subsequently reported 
in a stratified case control study using this same population, that only oily fish (>2% fat)
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consumption was associated with a reduced risk of current asthma (aOR 0.26; 95% Cl 0.09, 
0.72) (368). No other food groups or nutrients were associated with a positive or negative risk of 
current asthma. A recent retrospective case control study in Finland reported that children who 
develop atopic disease had consumed statistically significantly less fish compared to non-atopic 
controls (p<0.001) (369). Moreover, a recent RCT, the Childhood Asthma Prevention Study (212, 
213) (see Section 2.2.1.8), reported that with a diet intervention containing high levels of omega-3 
fatty acids by the mother during her pregnancy, there was a 9.8% absolute reduction (95% Cl 1.5, 
18.1) in the prevalence of wheeze ever and a 7.8% absolute reduction (95% Cl 0.5,15.1) in the 
prevalence of wheeze for >1 week in the children at 18 months of age whose mothers had the 
intervention diet compared with children of the control group of mothers (213). Thien at al., 2004 
(373) conducted a Cochrane review of dietary marine n-3 fatty acids (fish oil) supplementation 
and placebo in 9 RCTs undertaken between 1986 and 2001. No consistent effect on FEVi, peak 
flow rate, asthma symptoms, asthma medication use or BHR was found. Two of the studies were 
conducted in children. In Australia, Hodge et al., 1998 (374), reported that fish oil 
supplementation and a diet that increases omega-3 and reduces omega-6 fatty acids in 39 
asthmatic children aged 8-12 years over a 6-month period, had no effect on the clinical severity of 
asthma in these children.
A recent review of epidemiological studies (375) considered the effects of dietary nutrients on 
asthma. The review concluded there is relatively persuasive evidence that reduced magnesium 
and vitamin C intake, and increased sodium consumption, may be involved in the aetiology of 
asthma, though these hypotheses remain unproven (375). However, Cochrane reviews, based 
on currently available evidence, were not able to conclude whether dietary salt reduction (376) or 
vitamin C (377) have a specific role in the treatment or management of asthma.
2.4.3 Socioeconomic variations
British birth cohort studies have reported an increased prevalence of atopic disease with higher 
social classes (378, 379). Socioeconomic variations in the prevalence of allergy are evident not 
only in western countries such as Britain and the USA (271), but also in the German Democratic 
Republic before German unification (380) and in urban Ghana (381) where the prevalence of 
atopy and exercise induced bronchospasm in urban rich in Ghana was significantly higher than in 
the urban poor or rural children aged 9-16 years, p<0.005 and p<0.01 respectively. The variation 
with parental socioeconomic status is independent of, and more powerful than, the effect of the
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child’s own socioeconomic status as an adult, and is also independent of family size and birth 
order (271).
These epidemiological findings add support to the hypothesis that a higher prevalence of early 
infections, being more common in lower social gradients, could protect against the development 
of allergic diseases (382). However, the Hygiene hypothesis offers only a partial explanation for 
the socioeconomic gradient, with a higher prevalence of atopic diseases among children from 
more affluent families. Correlates of educational status, such as positive health-related behaviour 
with early presentation to medical care and thus detection of the disease, may cause selection 
bias towards higher asthma diagnosis in the higher social classes. Socioeconomic status should 
not be considered as directly causal, but it encompasses environmental influences which may 
also impact on the risk of an atopic disease and which need to be considered.
2.4.3.1 Australian indigenous population
A cross-sectional population study of four remote Australian indigenous communities in 
Queensland, the Northern Territory and South Australia (383) in 1990/91 found recent wheeze to 
be low in rural indigenous children: 3.5% (95% Cl 0.1%, 6.8%) in children aged 5-7 years and, 
1.9% (95% Cl 0.1%, 3.7%) among 8-12 year olds. More recent studies, however, have reported 
a higher prevalence of recent wheeze in indigenous communities. In 1993, a cross-sectional 
study (384) in an isolated community in northern Western Australia reported a higher prevalence 
of current wheeze in indigenous female children (<18 years) than in non-indigenous children 
(24.4% versus 20.4% respectively). Though, the prevalence of recent wheeze in indigenous 
male children (<18 years) was lower than in non-indigenous males (13.5% versus 30.9% 
respectively) (384).
Two reported studies which retrospectively reviewed hospitalization for asthma among 
indigenous and non-indigenous children also provide conflicting results. Williams et al., 1997 
(385), comparing Aboriginal and non-Aboriginal hospitalization patterns from 1988 to 1993 in 
Western Australia, found consistently higher rates of admission for asthma for indigenous than 
non-indigenous children (1-4 years: RR 2.1 (95% Cl 2.0, 2.2); 5-14 years: RR 1.4 (95% Cl 1.3, 
1.5)). Also, the rates were higher in non-metropolitan than metropolitan areas. Whereas, 
Whybourne et al.,1999 (386), reviewed the separation data from the Royal Darwin Hospital, 
Northern Territory, between 1991 and 1997 for children aged 1-9 years, and found that the
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hospitalization rate for asthma for indigenous children was significantly lower than for non- 
indigenous children (rate ratio 0.72; 95% Cl 0.59, 0.86). The hospitalization rates were not 
significantly different between rural and urban indigenous children or between urban indigenous 
and non-indigenous children. However, hospitalization rates are not a good proxy for prevalence 
and, as many indigenous communities are remote, a factor that restricts their access to 
metropolitan facilities, the true accuracy may not be reflected in these results (387).
Moreover, several other studies have reported asthma prevalence rates similar or higher for 
indigenous populations in non-remote communities. The 1995 National Health Survey (388) 
collected information from more than 54,000 people of whom almost 1,800 were Aboriginal or 
Torres Strait Islander (indigenous) descent. Indigenous Australians who live in non-remote areas 
showed a trend for higher prevalence rates of asthma compared to non-indigenous Australians 
also living in non-remote regions. Both ethnic groups had a similar age distribution pattern of 
illness, with a higher prevalence in childhood (388). A cross-sectional study in two non-remote 
towns in rurai New South Wales in 1997, Downs et al., 2001 (389), found that recent wheeze and 
asthma compared to 27.3% for non-indigenous children (difference 3.7%; 95% Cl -4.0%, 11.3%). 
For asthma, the prevalence was 39.4% versus 39.3% (difference 0.1%; 95% Cl -8.0%, 8.2%) for 
indigenous versus non-indigenous respectively.
Some of the observed differences between these studies may be explained by a lack of 
standardized methods, such as different questionnaires and different age groups, across these 
studies. Valery et al., 2001 (387), used the standardized and validated ISAAC questions to 
address some of these methodological differences in a more recent study of five randomly 
selected remote communities in the Torres Strait and Cape York Peninsula. This cross-sectional 
study of 1,650 children aged 0-15 years concluded that the prevalence of asthma in these remote 
indigenous communities is much higher than previously reported and is comparable to non- 
indigenous urban centers. Overall, the prevalence of self-reported ever wheezing was 20.6% 
(95% Cl 18.6, 22.6); recent wheeze in the past 12 months 12.4% (95% Cl 10.8,14.0); and ever 
having asthma 15.8% (95% Cl 14.0,17.6). The authors also reported significant intercommunity 
differences in prevalence of asthma symptoms even in neighbouring communities; some of these 
being partially explained by socioeconomic factors such as education and employment status.
A two-stage questionnaire survey conducted in 1999 through 2001 in the Australian Capital 
Territory, Australia, is the first to examine the prevalence of respiratory symptoms among 
indigenous children living in major metropolitan environments. Glasgow et al., 2003 (390), using
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ISAAC questions, found that urban indigenous primary school children (4-6 years old) had more 
recent wheeze (21%, OR 1.4: 95% Cl 1.0, 2.0) and parent-reported asthma (24%, OR 1.8; 95% 
Cl 1.3, 2.5) than non-indigenous children (both 15%). This higher respiratory morbidity in 
indigenous children did not appear to be due to factors closely related to the atopic diseases of 
hayfever or eczema. In addition, rates of ETS exposure were much higher for indigenous 
children compared to non-indigenous children among the sub-group of children with respiratory 
symptoms (OR 3.5; 95% Cl 2.1,5.9) (390).
Thus, the majority of these reported studies have demonstrated a high prevalence of recent 
wheeze in indigenous communities. Peat & Veale, 2001 (391), recently reviewed the burden of 
respiratory illness in remote and non-remote Australian indigenous communities. They reported 
that the aetiology of asthma in indigenous communities is not clear, however indigenous 
communities continue to be exposed to the environmental factors of low immunization rates, low 
rates of breastfeeding and high rates of cigarette smoking; all factors that may increase the 
prevalence of asthma (see Sections 2.3.5,2.4.1 and 2.2.5).
2.4.3.2 USA urban minority population
Among African-American children, asthma is more prevalent and more severe than among non 
African-American children (392, 393). Yet, Kay, 2001 (394), considered that the Hygiene 
hypothesis is not easily reconciled with the increased prevalence of atopic asthma among poor 
black children reported in the Second National Health and Nutrition Examination Survey (395) in 
the USA, as the living conditions of this population may be expected to be more comparable to 
those of other economically disadvantaged populations, and which, under the Hygiene 
hypothesis, would predict a lower burden of atopic disease. However, using the 1988 Child 
Health Supplement to the USA National Health Interview Survey (393), it was found that the 
higher prevalence of asthma among black children is not due to race or to low income per se, and 
that all children living in an urban setting are at increased risk for asthma. Compared with non- 
urban white children, urban children, both black and white, were at significantly increased risk of 
asthma: urban and black (aOR 1.45; 95% Cl 1.14, 1.86), urban and white (aOR 1.22; 95% Cl 
1.01,1.48), whereas non-urban black children were not. African-American children are, however, 
more likely to live in cities. In the Childhood Allergy Study in Detroit (396), the prevalence of 
physician-diagnosed asthma was 10% for both African-American and European-American 
groups, but non-urban middle class African-American children were found to be more reactive to
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methacholine (p=0.001) and had significantly higher total IgE (p=0.001) than European-American 
children, supporting the hypothesis that African-American children may be predisposed to more 
severe asthma. The Yale cohort (397) found that African-American children are more likely to 
receive an asthma diagnosis, after adjustment for symptom frequency and medication use in the 
first two years of life, than non African-American children.
Thus, the difference in the observed and expected asthma prevalence among African-American 
children may be related to a number of factors that these children are exposed: premature birth, 
passive smoking, substandard housing, increased time indoors, decline in physical activity, air 
pollution, increase in obesity, poor diet, decreased access to health care, exposure to some 
allergens, less pet keeping, diagnostic bias, and genetic or biologic characteristics (392, 393, 
396). Many of these factors may influence asthma severity, possibly resuiting in an increased 
prevalence in this particular group, despite a similar incidence of disease (398).
2.4.4 International variations and westernization
The unification of Germany provided a unique opportunity to study the impact of East and West 
European living conditions on the prevalence of respiratory and allergic disorders in two ethnically 
similar populations over time. In 1991-92, von Mutius et al., 1994 (399), found that atopic 
sensitization to common aeroallergens, assessed by SPT, was considerably more frequent in 
West German 9-11 year old children than in their peers in East Germany (36.7% vs 18.2%, OR 
2.6; 95% Cl 2.3, 2.9). In 1995-96, 5-6 years after the unification, von Mutius et al., 1998 (123), 
undertook a second similar study in Liepzig, (East Germany) in 9-11 year olds. These children 
spent their first 3 years of life under eastern German living conditions and were then 
subsequently exposed to a western lifestyle. The prevalence of hay fever (2.3% vs 5.1%, OR 
2.2; 95% Cl 1.5, 3.3) and atopic sensitization (19.3% vs 26.7%, OR 1.5; 95% Cl 1.3, 1.8) 
increased significantly between 1992-92 and 1995-96. There was no significant change in the 
prevalence of asthma, asthma-related symptoms, or BHR. Thus, factors operating very early in 
life may be particularly important for the acquisition of childhood asthma, whereas the 
development of atopic sensitization and hay fever may also be affected by environmental factors 
beyond infancy. This rapid increase in the prevalence of hay fever and atopic sensitization points 
towards the importance of lifestyle factors.
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2.4.4.1 Migrants
Studies in migrants from developing to developed countries support the aetiological 
environmental changes associated with westernization. The nature of these environmental 
changes is obscure, but speculation has focused on increased air pollution or other toxins in the 
environment, inhalant allergens, increased indoor exposure to HDM allergens in less well 
ventilated modern homes, dietary changes, high residential density and the use of woollen 
blankets (400). One factor temporally associated with the rise of atopic diseases is the decline of 
many infectious diseases in developed countries as the result of improved living standards and 
immunization programs: childhood respiratory infections that might strongly modify the developing 
immune system, both systemically and within the lung, include measles, whooping cough and 
tuberculosis (401).
Children of immigrants have been found in some countries to be at greater risk for developing 
allergic manifestations than the population in general (400, 402). The prevalence of asthma was 
studied in Tokelauan children aged 0-14 years (402). Migrant Tokelauan children in New 
Zealand were found to have a significant increase in the prevalence of asthma, eczema and 
rhinitis compared to their non-migrant peers living in Tokelau (25.3% versus 11.0%, respectively). 
For those children examined in New Zealand there was no significant difference in the prevalence 
of asthma between those children who were born in New Zealand and those who were born in 
Tokelau.
Immigrants arriving from south-east Asian countries with a low prevalence of asthma, and now 
living in countries with a high asthma prevalence, such as Australia, reportedly demonstrate an 
increased risk of asthma and allergic disease (403). The prevalence of atopic disease, including 
asthma, in Asian immigrants, increased significantly with the length of stay in Australia, 
independent of age at arrival, sex and atopic status (Test for trend, p=0.05 for asthma; pcO.001 
for hay fever) (404).
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2.4.5 Pre and perinatal risk factors
The association of perinatal factors with the risk of asthma and atopic diseses has been 
measured through parental or patient reporting, medical record review or study documentation at 
birth. Several factors have been identified and are discussed in the following Sections.
2.4.5.1 Gestational age, low birth weight and premature birth
Many studies have suggested that a history of preterm birth is associated with decreased lung 
function in childhood (78,405). In addition, a number of studies have shown that low birth weight 
and premature birth are important risk factors for subsequent asthma. In a cross-sectional study 
of 9-11 year old German school children, premature girls (<37 weeks gestation) with a birth 
weight of 2,500 gm or less, had significantly more current asthma (OR 2.6; 95% Cl 1.4, 4.7) and 
recurrent wheezing (OR 1.7; 95% Cl 1.1, 2.7) than term girls (405). These differences were not 
shown in boys. In a population of 4,795 male conscripts born between 1973 and 1975 in 
Denmark (406), the prevalence of asthma in male conscripts with a birthweight below 2,501 gm 
was significantly greater compared with conscripts with a birth weight of 3,001-3,500 gm (aOR 
1.5; 95% Cl 0.7, 3.1) (406). In the largest study to date, data on 149,398 Swedish male military 
conscripts (age 17-20 years) was record-linked to the Swedish Medical Birth Register (407). This 
historical cohort study reported the prevalence rates of allergic rhinitis among those with term 
birth (>36 weeks), moderately preterm birth (33-36 weeks) and very preterm birth (<33 weeks) as 
15.2%, 13.1% and 11.6%, respectively. For those born at less than 33 weeks gestation versus 
those born between 37 and 41 weeks gestation, the aOR was 0.82 (95% Cl 0.68, 0.98) for hay 
fever. Lower birth weight, less than 2,500 gm (aOR 1.26; (95% Cl 1.09,1.46); and 2,500-3,000 
gm ( aOR 1.19; 95% Cl 1.10, 1.30), and younger maternal age were both independent risk 
determinants of asthma, which remained even in the sub-set of asthmatics with hay fever (407).
The prevalence of atopy, however, was not increased in children of preterm birth (405, 408). 
Therefore, these finding suggest that factors other than atopic sensitization, such as functional 
airway abnormalities, may increase the risk that wheezing and asthma will develop in prematurely 
born children. In premature and very low birthweight babies, the aetiology for reversible airway 
obstruction may be more a function of smooth muscle hypertrophy than atopy (405) (see Section 
1.3.2).
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Increased gestational age has been reportedly associated with the later development of atopy, 
but the relationship with subsequent asthma is not well defined. A record linkage study (409) of 
birth records of 7,862 infants born in a Danish municipality found that children born at 41 weeks 
gestation had an increased risk of atopic dermatitis compared with children born at 39-40 weeks 
(aOR 1.32; 95% Cl 1.06, 1.63). In a prospective birth cohort of 31 years in Finland (410), an 
apparent linear association was found between longer gestation and atopy. Children born at 41 
weeks or more gestational age were at the highest risk (aOR 1.65; 1.16-2.34). Values were for 
39-40 weeks: aOR 1.42 (95% Cl 1.02, 1.98); 36-38 weeks: aOR 1.22 (95% Cl 0.87, 1.70); and 
<35 weeks: 1.00 (referent). No associations with gestational age were observed for doctor- 
diagnosed asthma (410).
The linkage of data from nationwide and population-based registries, as used in some of these 
studies above, avoids a disease-dependent bias resulting from recall bias in retrospective 
interviews. However, the analysis is restricted to variables included in the registers and many 
potential confounding variables, which may perhaps explain the observed effects in the statistical 
analysis, are often not included.
2.4.5.2 Head circumference at birth
A large head circumference at birth may be a marker for enhanced risk of atopic sensitization 
(411) but currently there is limited epidemiological evidence regarding head circumference and 
asthma risk. Several studies have reported a significant positive association between large head 
circumference at birth and atopy (412-414). A New Zealand longitudinal birth cohort (414), the 
Dunedin Multidisciplinary Child Development Study, found that infants with a head circumference 
of 37 cm or more at birth had a greatly increased risk of increased total IgE at 11 years of age 
(aOR 3.4; 95% Cl 1.4,7.9). The relationship was non-linear with a step-up in prevalence in those 
with a head circumference of more than 37 cm. Recent asthma symptoms were not associated 
with head circumference (414). However, only one study to date has reported an association 
between a large head circumference at birth and asthma in childhood. A longitudinal study of a 
birth cohort (415) in New Zealand, found that children with head circumference at birth of 37 cm 
or greater had odds of asthma that were 1.8 (p<0.01) to 3.0 (p<0.0001) times higher than the 
odds for children of lesser head circumference.
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2.4.5.3 Sex differences
Epidemiological data on asthma prevalence support a sex difference that varies with age in the 
risk of having asthma (416). Asthma and wheezing is more prevalent in boys than in girls prior to 
puberty; during puberty the male disadvantage disappears and women older than 20 years 
appear to have higher prevalence and morbidity rates of asthma than do males (416).
2.4.5.4 Parental ages at birth
Young mothers have been reported to have an increased risk of having a child with asthma 
compared with mothers over 30 years of age (417). In over 1,200 infants born in Arizona, USA, 
infants of mothers less than 21 years of age, when compared with infants of mothers aged over 
30 years, were at a significantly greater risk of wheezing lower respiratory tract illnesses during 
the first year of life (aOR 2.4; 95% Cl 1.8, 3.1) (275). A retrospective cohort study (407) of 
Swedish conscripts similarly found that lower maternal age (less than 20 years) was significantly 
associated with an increased risk for asthma in infants (aOR 1.28; 95% Cl 1.16, 1.42). Both 
biological and environmental factors, such as socioeconomic status, may be a possible 
explanation for these findings.
2.4.6 Obesity and physical activity
The potential contribution of obesity and physical inactivity to the observed worldwide asthma 
epidemic has been recently debated (418). There is evidence of a positive association between 
asthma and obesity in children (419-424). A case-control study of urban minority children aged 4- 
16 years (419) in the USA, reported a significant difference in asthma status between those 
children with a body mass index (BMI) at or above 85th percentile (p<0.04). Children with asthma 
were also significantly more overweight than controls (mean+/-SD, 22.5%+/-28.3% vs 12.0%+/- 
19.6% overweight, p=0.004). The difference in obesity between children with asthma and 
controls was significant for both sexes and across the 4.5 to 10.9 years and 11 to 16 years age 
groups. Asthma severity was not related to obesity. Similar results were reported from the British 
National Study of Health and Growth (422), in a cross-sectional analysis of 18,218 children 4-11 
years old, where BMI and asthma were associated (OR for the comparison of the 10th and 90th 
centiles of BMI 1.28; 95% Cl 1.11,1.48). Furthermore, a recently reported cross-sectional study
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(424) of 12,388 children aged 2 months to 16 years from the Third National Health and Nutrition 
Examination Survey in the USA found that children with a BMI >85lh percentile had significantly 
greater doctor-diagnosed asthma (OR 1.94; 95% Cl 1.09, 3.46). In a prospective study (425), the 
Odense schoolchild study in Denmark, of asymptomatic children followed from 9.7 to 10.5 years 
of age, physical fitness was inversely related to the new development of physician-diagnosed 
asthma (OR 0.93; 95% Cl 0.87, 0.99). However, it should be remembered that early 
undiagnosed asthma may prevent physical activity and asthma may lead to obesity, thus disease- 
related changes in behaviour may have contributed to these associations.
2.5 ENVIRONMENTAL FACTORS INCONSISTENT WITH THE 
HYGIENE HYPOTHESIS
2.5.1 Respiratory syncytial virus
There is evidence to suggest that respiratory tract infections, particularly respiratory syncytial 
virus (RSV) infections, increase the risk of asthma in later life (see Section 2.3.3). The Tucson 
Children’s Respiratory Study (426) found RSV LRTIs before the age of 3 years are associated 
with a significant increase in the risk of subsequent frequent wheeze OR 4.3 (95% Cl 2.2, 8.7) 
compared with children who had no LRTIs. A recent review (298), of retrospective and 
prospective studies from 1978 until 2000, confirmed an association between RSV bronchiolitis in 
infancy and subsequent development of reactive airway disease or allergic sensitization in 
childhood. This association was strongest for children who experience severe RSV illness that 
required hospitalization. A family history of atopy or asthma did not explain the association. One 
possible explanation is that severe respiratory tract infections either damage lung tissue or impair 
the development of the lung in such a way as to promote asthma. The timing of the infection may 
also be relevant and have specific affects on immune system ontogeny, lung development or both 
(298).
2.5.2 Parasites
Helminth infections are highly prevalent in large parts of the developing world, where allergy is 
uncommon. Ecological data support an inverse relationship between countries with a high 
prevalence of parasitic infection having very low asthma rates and countries with high asthma 
rates having very low rates of parasitic infection (427). Infestation of children with helminth
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parasites, which are potent stimuli for allergen-associated Th2 immunity (high levels of total and 
parasite specific IgE), is paradoxically associated with reduced susceptibility to atopy (428). This 
challenges the Th1/Th2 paradigm and the Hygiene hypothesis for atopy. Moreover, the notion 
that a reduction in the overall microbial burden will result in weak Th1 imprinting and unrestrained 
Th2 responses that allow an increase in allergy, is contradicted by observations that the 
prevalence of Th1 autoimmune disease, such as Type I diabetes, is also increasing and that Th2- 
skewed parasitic worm (helminth) infections are not associated with allergy (429). Worldwide 
helminth infections and allergic diseases do not overlap despite both conditions being 
accompanied by strong Th2 immune response, suggesting an alternate immunological framework 
for the Hygiene hypothesis than simple Th1/Th2 imbalance. While helminths may stimulate Th2- 
mediated immune responses, they additionally trigger anti-inflammatory mechanisms which limit 
the magnitude of ensuing in vivo responses to allergen (430)
As stated above, there has also been an increase of the autoimmune diseases (in which the 
immune response is dominated by Thl cells) such as Type 1 diabetes, Crohn’s disease, and 
multiple sclerosis (431). In addition, the geographic distribution of both these allergic and 
autoimmune diseases follows a north-south gradient (431), and genetic-environmental factors are 
believed to influence susceptibility to these diseases. There is also a trend toward an association 
between allergic and autoimmune diseases in individual patients: the frequency of atopic disease 
is increased in patients with Type 1 diabetes and rheumatoid arthritis (431, 432). A strong 
positive association has been reported between a history of Th2-mediated allergic disorders and 
Th1 -mediated autoimmune disorders, such as asthma and diabetes, coeliac disease and 
rheumatoid arthritis, using cross-sectional survey and register data in children (433) and adults 
(432). At a population level a strong positive association has been shown between the 
occurrence of Type 1 diabetes and symptoms of asthma (434), further supporting the co­
existence of Th1/Th2 diseases.
These studies demonstrate that the existence of Th1 type disease does not reduce the risk of 
asthma. Co-existence of Th1 and Th2 diseases may suggest a common environmental factor or 
factors*underlying these conditions (433). These finding have led some authors to consider 
additional processes for the development of atopic disease. Sheik et al., 2003 (432), suggest that 
reduced exposure to infectious agents in early childhood might adversely effect the developing 
immune system, leading to the generation of inappropriate immunologic responses to 
autoantigens (manifesting as autoimmune disease), allergens (manifesting as atopic disease) or 
both. Whereas Kemp & Bjorksten, 2003 (106), report that early life immune deviation may not be
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a critical factor in preventing the development of atopic disease but a mechanism of immune 
modulation throughout life whereby both Th1 and Th2 responses are enhanced or suppressed in 
concert, and any effect will depend critically on the timing in relation to the dose and route of 
allergen exposure, and that the interaction between microbial exposure and other non-infective 
environmental and lifestyle factors are of critical importance (see Section 1.5.4).
2.6 CONCLUSION
There is compelling evidence that the prevalence of child asthma has increased in recent 
decades, though, this increase may have now plateaued in some countries (see Section 2.1.3). 
This Chapter has discussed both putative and protective factors that may contribute to the risk of 
development of asthma, but their relative importance in terms of the attributable fraction of atopic 
disease is difficult to determine. The identification of environmental risk factors for child asthma 
will provide the basis from which to develop strategies for prevention. And, it is therefore 
important to consider all possible changes in the environment and lifestyle that correlate with the 
time course of the increase in asthma prevalence. The role of bedding and possible effect 
modifiers in the development of child asthma has not been overviewed in this Chapter, but is 
discussed in detail in the introduction and discussion sections of each subsequent relevant 
Chapter enabling the findings in these Chapters to be interpreted and discussed with reference to 
the previously reported findings.
Several authors have suggested that changes in exposures within the indoor environment have 
been responsible for the trends in the prevalence of asthma (170, 435). Yet, very few studies 
have compared the increase in asthma prevalence over time with changes in the identified 
potential risk factors for asthma and atopy development. An overall increase in atopic diseases 
has accompanied the decline in infectious diseases. However, despite the strong inverse 
associations that have been reported between family size (number of siblings) and atopy and/or 
asthma, the role that family size plays in explaining increases in asthma prevalence is relatively 
minor. The progressive reduction in family size between 1961 and 1991 (2- to 3-fold reduction in 
the proportion of families with 4 or more children) may have led to only a 1% to 5% relative 
increase in the prevalence of asthma in childhood in the UK and New Zealand (284).
Two population based case-control studies in the UK also investigated the association between 
childhood wheeze and characteristics of the home environment to assess whether changes in
67
these characteristics between 1978 and 1991 may have contributed to an increase in the 
population prevalence of wheeze of 20% (Prevalence OR 1.20; 95% Cl 1.04,1.39) among school 
children (136). Over that time period, compared with the controls, cases were found to have 
experienced: (i) increases in the proportion of children living in accommodation with central 
heating in the bedroom (50% to 79%) and in the living room (57% to 81%); (ii) increases in the 
proportion of children using non-feather pillows (44% to 67%); and (iii) little change in proportion 
using gas for cooking (75% versus 77%) or the proportion owning furry pets (58% versus 52%). 
Interestingly, the rise in the use of non-feather pillows was large enough to explain 57% (95% Cl 
18%, 96%) of the 20% increase in wheeze prevalence; whereas the rise in the use of gas for 
cooking was only large enough to explain 4% of the 20% increase. When all the risk factors, 
including non-feather pillows, were investigated in the multifactorial analysis they appeared to 
explain 52% of the increase in the population prevalence odds of wheeze. The type of pillow was 
one factor for which changes in exposure over time were conducive to an increase in prevalence. 
Further studies are required to assess the relative importance of other risk factors (for example, 
women smoking, dietary factors, and antibiotic use) that may have changed over time and may 
contribute to an increasing prevalence of atopic disease.
Objective evidence suggests that the primary immune response to inhalant allergens is a Th2 
response, which occurs during the first 5 years of life and is unusual before the age of 2 years. 
Although wheezing is common before the age of 2 years, the majority of cases are transient and 
do not go on to develop into persistent asthma. In regards to HDM, there is a proven association 
between allergen exposure and allergen sensitization. There is also a strong association 
between indoor allergen sensitization and asthma. However, despite very strong evidence for a 
role for HDM allergens in asthma, there is ongoing controversy as to whether allergens play a 
causal role in the development of the disease. The effects of sensitization, prolonged time 
course, and difficulty measuring allergen inhaled may all obscure the dose-response relationship 
(159).
Increased exposure to indoor allergens over time because of changes in houses and increased 
time spent indoors may be a contributing factor to the increase in asthma prevalence. In 
Australia, from 1982 to 1992, in the towns of Belmont and Wagga Wagga, the prevalence of 
recent wheeze in children aged 8-10 years, increased 1.5-fold to about 25% and the prevalence 
of BHR increased 2-fold to almost 20%. The populations of HDM increased 5-fold during the 
study period, but similar evidence has not been reported from other places (367). HDM allergens 
have been shown to play a major role in child asthma but this role may be underestimated due to
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measurement error. Moreover, this Chapter has outlined several of the possible factors which 
may be linked to a modern lifestyle and that may decrease the threshold for wheezing among 
allergic individuals (159).
2.7 POST-SCRIPT
This thesis will explore further the association of environmental factors and HDM sensitization 
and child asthma. My study will consider the role infant and child bedding, and in addition 
possible pollutants that may potentiate the role of HDM allergens, play in the development of 
HDM sensitization and child asthma. Chapter 3 will describe the design and the methodological 
approach undertaken for each study that has been analysed in this thesis.
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Chapter 3
Thesis study design and methodology
3.0 PREFACE
This thesis explores the associations between the home bedding environment and HDM 
sensitization and child asthma. My analyses have been carried out on pre-existing data obtained 
from three studies previously undertaken by the Menzies Centre for Population Health Research 
in Tasmania, Australia: (i) The 1988-1995 Tasmanian Infant Health Survey (TIHS) was a 
prospective birth cohort conducted to investigate the aetiology of SIDS; (ii) The 1997 Childhood 
Allergy and Respiratory Health Survey (CARHS) was a follow-up of children who as infants 
participated in the TIHS; and (iii) The cross-sectional 1995 Childhood Asthma Survey included all 
children turning 7 years of age in Tasmania. This Chapter presents the aim and hypotheses of 
my thesis. The design features of each of the three Tasmanian studies are also described. In 
addition, this Chapter discusses the strengths and limitations of the two main study types used, 
prospective cohort and cross-sectional studies, and their applicability in asthma studies.
3.1 THESIS AIM AND HYPOTHESES
The aim of this thesis is to identify home environmental risk factors for HDM sensitization and 
child asthma, focusing on infant and child bedding and the bedding environment. The study 
includes detailed analyses of infant and child bedding, and also other environmental factors, and 
their associations with HDM sensitization and childhood asthma. The specific hypotheses of this 
thesis are:
(i) the type of underbedding or mattress an infant at one month of age, or a child, at 7 years of 
age, sleeps on is related to child HDM sensitization and/ or the respiratory symptoms of wheeze 
(Chapter 4);
(ii) the use of, predominantly synthetic, cocoon/baby nests or sleeping bags in infancy is 
associated with the respiratory symptoms of wheeze in childhood and/or HDM sensitization 
(Chapter 5);
70
(iii) the association between synthetic quilt use and frequent wheeze is significantly stronger 
among children who slept supine compared with children who slept non-supine (Chapter 6);
(iv) the association between bedding items and child wheeze is of a greater magnitude for 
composite bedding than for individual bedding items (Chapter 7); and
(v) other home environmental factors interact with bedding items to influence the bedding-wheeze 
association (Chapter 7).
3.2 THE STUDY DATASETS
3.2.1 The Tasmanian infant Health Survey
The Tasmanian Infant Health Survey (TIHS) was an 8-year birth cohort study of children born 
during the period from 1988 to 1995 in Tasmania (436). This study operated from six obstetric 
hospitals where approximately 93% of births in Tasmania occurred, and it consisted of infants 
born at higher risk of SIDS. Infants born within these hospitals were scored to assess the risk of 
SIDS using a iocal perinatal score model (437). The composite score (437) was based on 
maternal age (years), birth weight (gm)* infant sex, breastfeeding, season of birth and duration of 
second stage of labour (minutes). Infants that exceeded a scoring cutoff (>532) were eligible for 
inclusion and the sample of eligible infants represented approximately one-fifth of livebirths in the 
State from 1988 through 1995 (437). The scoring system is outlined in Table 3.1.
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Table 3.1 Component scores for model predicting infants at high risk of SIDS in Tasmania
Risk fa c to r C a tegory C o m p o n e n t sco re *
Age Age in years (-1 0 .3  x age)
Sex Fem ales 200
M ales 261
B irthw e igh t U nder 2 ,000gm 200
2,000-2 ,499gm 82
2 ,500-2 ,749gm 49
2 ,750-3 ,499gm -68
3,500+gm -28
M onth o f b irth M arch, April 200
M ay to  Ju ly 146
O the r m onths 114
B reastfeed ing B reastfed 200
N ot b reastfed 280
D uration  2nd s tage  o f labour <5 m ins 200
5*14 m ins 235
>14 m ins 185
C aesarian 207
Born be fore  a rr iva l a t hosp ita l 235
‘ Included in study if score > 532.
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Compared with all live births, there was a relative overrepresentation of low-birth weight infants 
(<2,500 g), 21.9% (2,155/9,826); male infants, 69.0% (6,781/9,826); infants born in March/April, 
32.9% (3,230/9,826), or May through July, 26.5% (2,601/9,826); and infants born to younger 
mothers; and, there was an under-representation of infants whose mothers intended, at hospital 
interview, to fully breastfeed (245). Singletons with a score over the cut-off were eligible to join 
the survey; multiple births were automatically eligible. Infants with severe neonatal disease or a 
major congenital anomaly, infants for adoption and infants who would not be resident in 
Tasmania at one month of age were excluded from the study (n=15 of 1988 cohort data) (436). 
From 1 January 1988 until 31 December 1995,11,070 live-born infants in Tasmania were eligible 
for inclusion in the survey, of these eligible infants 9,826 (89%) participated in both the hospital 
and home interviews. Of 13,592 live born infants in Tasmania in 1988 and 1989, 2,791 were 
eligible for the TIHS. The eligibility criteria and study methods are reported in more detail 
elsewhere [26]. Standard study measurements were collected by trained research nurses in 
three stages.
3.2.1.1 Study measurements (438)
The hospital interview. The first interview was conducted with the mother in hospital on the fourth 
day of the infant’s life. Sociodemographic, obstetric and perinatal data were included in the data 
collected. It involved four major areas:
(i) The early postnatal questionnaire: including sociodemographic characteristics, education, 
family history, prenatal medical history and clinical contact, smoking, alcohol and drug history, 
and expected feeding practice. At this time, information was collected on whether the infant had 
any siblings, parents, or grandparents with asthma;
(ii) The Maternal Nutrition Survey: the CSIRO Division of Human Nutrition food frequency 
questionnaire “Freqpan” 1987, Adelaide, Australia was used to assess dietary intake during the 
third trimester of pregnancy;
(iii) The obstetric and perinatal data sheet: detailing type and progress of delivery, Apgar 
score, gestation, neonatal disease, placental weight and state, maternal blood group and rhesus 
status; and
(iv) The physical infant measurements: including weight, length, head circumference, tricep 
and subscapular skinfold measurements and mid-upper arm circumference.
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The home interview. A home visit and interview was conducted during the fifth postnatal week. 
For premature infants (<36 week’s gestation) this visit was done at 40 weeks post conceptional 
age. For babies kept in hospital because of complications, the home visit was delayed until the 
infant had been at home for at least two weeks. In 1988,1,111 of 1,307 eligible infants (85% of 
eligible) participated in a TIHS home interview at 1 month of age. The median postnatal age at 
home interview was 33 days (inter-quartile range 30-40 days). At this interview, a comprehensive 
structured verbal questionnaire was administered on a large number of parental, infant, 
environmental and child-care factors.
Data from the home interview included infant illness, health service attendance and family health 
history over the preceding month, pattern and type of infant feeding, parental smoking practice, 
child care patterns, home heating, ventilation and housing details, pets (dogs and/or cats) and 
other characteristics of the infant and of parental care. The room where the baby usually slept at 
night was defined as the infant bedroom. The infant’s usual sleep position, infant 24-hour 
sleeping patterns and features of the infant’s sleeping environment, including type of pillow, 
mattress liner, mattress and bed, type of overnight clothing and bedding used during the previous 
night and also the number and types of upper bedding items that would be used in cold weather 
were recorded.
Anthropometric and temperature measurements were made on the one-month old infant. A 
developmental assessment was conducted and included:
■ weight, length, head circumference, tricep and subscapular skinfold measurements and 
mid-upper arm circumference;
■ temperature measurements -  skin temperature, per axilla temperature, core temperature; 
and
■ a clinical assessment of infant development.
Physical features of the infant’s home and bedroom were also documented by the interviewer and 
included:
■ 24-hour maximum-minimum temperature on day of home visit for infant’s room, external 
southern aspect of house, geographical area;
■ humidity in infant’s room, external southern aspect of house, geographical area; and
■ physical features of the house, in particular, the infant’s room.
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The telephone interview. A third interview was conducted by telephone usually with the same 
parent respondent as for the home visit, when the infant was approximately 10 weeks postnatal 
age to review infant progress, medical attention, illness history, feeding and immunization. It 
included a review of infant progress, infant illness history, immunization status, reaction to needle 
prick of immunization, medical care, child health clinic attendance, infant weight at last weighing 
and infant feeding pattern. The median postnatal age at interview was 80 days (inter-quartile 
range 73-93 days).
3.2.2 The 1995 Childhood Asthma Survey
In 1995, a cross-sectional survey was conducted on all children who turned seven years of age in 
Tasmania. In March 1995, parental questionnaires were distributed through all primary schools, 
home learning, and distance education organizations in the State to the parents of children 
reaching the age of 7 years in 1995. The questionnaire included questions from the 1968 
Tasmanian Asthma Survey (439) and the ISAAC (6). A total of 6,911 children born in 1988 were 
identified as being resident in Tasmania in 1995. By December 31, 1995, questionnaires had 
been completed for 92% (6,378/6,911) of eligible children. The 71-item questionnaire (see 
Appendix 1) included questions from the ISAAC (6). The questionnaire contained, in sequence: 
identification; questions from the 1968 Tasmanian Asthma Survey (439); the eight core questions 
on asthma and wheeze from the ISAAC protocol (6, 144) (see Section 3.2.2.1); asthma 
medication use; hospitalization for respiratory illness; attendance at regular child care; history of 
respiratory illness (bronchitis, pneumonia); family history (siblings, parents and grandparents) of 
atopic and other disease; maternal/paternal history of asthma, wheezy breathing, or hay fever; 
maternal and paternal education, occupation, and employment; parental and other smoking; 
whether mother or others smoke in same room as child; duration of breastfeeding; age of 
introduction to solids; some aspects of current diet; history of a cat as family pet; and details of 
the current home environment. Regular child care was defined as the child attending a child care 
arrangement with more than two other children at least once a week for three hours or more. The 
term “asthma” refers to any history of asthma (ISAAC question 6), and “current asthma” is defined 
as a positive history of asthma (ISAAC question 6). The child’s age (in completed years) at onset 
of wheezy breathing or asthma was obtained. In addition, exercise challenge lung function 
testing was additionally conducted on 414 children (92% of eligible children) at 23 randomly 
selected schools in southern Tasmania.
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In 1996, the data from this study were record linked to the pre-existing database from the TIHS. 
Of the 1,111 children who participated in the 1988 TIHS home interview, 863 (78%) also 
participated in the 1995 Childhood Asthma Survey, provided data on asthma status, and agreed 
to record linkage. The relation between the TIHS, the 1995 Childhood Asthma Survey and the 
Infant cohort study (TIHS) with 1995 follow-up is shown in Figure 3.1.
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3.2.2.1 Study measurements
(i) The Questionnaire. As there is no gold standard for the definition of asthma, the risk of 
misclassification of outcome is significant. The use of the term current wheeze (usually defined 
as wheeze in the past 12 months) has the advantage of freedom from any bias arising from the 
diagnostic label of asthma (48). The validity of the ISAAC questions has been previously 
examined. A positive history of wheeze or whistling in the chest over the past 12 months had a 
sensitivity, the probability that the question correctly classifies those with asthma as having the 
disease, of 0.85, and a specificity, the probability the question correctly classifies those without 
asthma as non-diseased of 0.81, for respiratory physician-diagnosis of asthma (440).
The 8 core questions from the ISAAC on asthma and wheeze included in the 1995 Childhood 
Asthma Survey were:
Has your child ever had wheezing or whistling in the chest at any time in the past?
Has your child had wheezing or whistling in the chest in the last 12 months?
How many attacks of wheezing has your child had in the last 12 months?
In the iast 12 months, how often, on average, has your child’s sieep been disturbed due to 
wheezing?
y
In the last 12 months, has wheezing ever been severe enough to limit your child’s speech to only 
one or two words at a time between breaths?
Has your child ever had asthma?
In the last 12 months, has your child’s chest sounded wheezy during or after exercise?
In the last 12 months, has your child had a dry cough at night, apart from a cough associated with 
a cold or chest infection?
(ii) Exercise challenge lung function testing. The exercise protocol used in the 1995 
Childhood Asthma Survey was based on the work of Haby et al., 1994, (441) who reported that 
exercise challenge is a practical epidemiological tool for objective measurements of bronchial 
responsiveness in children. In this study, the children were instructed to take a maximal breath in 
and then blow out as hard and fast as they could in the standing position without a nose clip. 
After instruction and two practice attempts, each child performed sets of three forced expiratory 
manoeuvres (FEV, measurements) until two readings within 100 ml of one another were obtained 
in a set. The highest FEV, overall, excluding the two practice attempts, was taken as the
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baseline measurement of FEV,. The child then ran for six minutes on a 100 metres track with a 
nose clip and heart rate monitor (442). Following exercise, FEV, measurements were made at 
three, five and 10 minutes. At each point, three expiratory manoeuvres were performed. The 
minimum of the maximal values recorded at three, five, and 10 minutes was defined as the 
postexercise FEV,.
A population-based sample of 199 seven year old children in Tasmania reported that the 
probability a child will demonstrate BHR after exercise is related to the responses to the ISAAC 
questions, “Has your child ever had asthma?” and “Has your child had wheeze or whistling in the 
chest in the past 12 months?” (442). In addition, it was found that the respiratory response to 
exercise was consistent with parental responses to the ISAAC questionnaire. The median 
percentage fall in FEV, was significantly higher in children whose parents responded positively to 
ISAAC questions on a history of wheeze (p=0.003) or asthma (p=0.0005), recent wheeze 
(p=0.0005) or sleep disturbance due to wheeze (p=0.0005) (442).
3.2.3 The 1997 Childhood Allergy and Respiratory Health Survey
In 1997, a follow-up study of the TIHS study participants born in 1988 to 1989 was conducted in 
Northern Tasmania through school records. This follow-up study was called the 1997 Childhood 
Allergy and Respiratory Health Survey (CARHS). Eligible children and their parents were invited 
to attend the Launceston General Hospital for a parental interview and child assessment. The 74- 
item parental questionnaire (see Appendix 2) included the eight childhood questions on asthma 
and wheeze from the ISAAC (6) (see Section 3.2.2.1) and also questions on the home 
environment such as child bedding and other factors. In Northern Tasmania in 1997, 499 (84%) 
of the 596 children identified as participants in the 1988-89 TIHS at birth agreed to participate in 
the CARHS study. SPT data were not obtained on one autistic child. For 456 of these children, 
TIHS home visit data as well as the initial TIHS hospital interview data were also available. 
Satisfactory lung function recordings were achieved for 495 children.
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3.2.3.1 Study measurements
(i) Skin prick testing. In epidemiologic studies, both skin testing and measurements of IgE 
antibodies are used to determine sensitization to HDM allergen. The relationship between serum 
IgE antibodies and specific skin responses to the same protein produced by HDMs of the genus 
Dermatophagoides, is close (r values 0.7-0.8) (443). In the CARHS, SPT was used to assess the 
cutaneous reaction to exposure to the HDMs D. pteronyssinus and D. farinae, cat, dog, alternaria, 
ryegrass, cow’s milk, egg, and peanut (Hollister-Stier purified allergen extracts supplied by Bayer, 
Sydney, Australia) and positive (histamine 10mg/ml and 1 mg/ml) and negative (glycerine) 
controls. Wheal size was determined at 15 minutes. Der p and Der f extracts were both used 
because both mites have been found in Tasmanian homes (444). Skin wheal allergen reactions 
of 2 mm or greater at 15 minutes were classified as positive, but analyses in this thesis were also 
conducted with regard to the wheal size of mite allergens using both a 3 mm cut-off and wheal 
size as a continuous variable. Children with a positive SPT to any of the allergens tested for were 
classified as atopic. Children with a positive SPT to either D. pteronyssinus or D. farinae were 
classified as sensitized to HDM (445).
2. Lung function tests. Baseline lung function measures were obtained for each child. Trained 
research nurses performed the testing. The children were asked to perform forced expiratory 
manoeuvres standing without a nose clip following a standard protocol (446) using a Fleisch type 
electronic spirometer (Model AL 0642; Vitalograph, Buckingham, UK), which was calibrated to 
within 1% of calibration volume at the beginning of every session and checked hourly thereafter. 
FEV1 (in litres) and forced vital capacity (FVC), the total volume of air that can be expelled from 
the lungs in litres, were measured for each subject. A ratio of FEV/FVC, the percentage of lung 
volume that could be expelled in one second, was used as a measure of airway obstruction (447).
3. Statistical hypothesis testing. For this thesis, the level of statistical significance is a p value of 
0.05. That is, results are considered “significant” when the p value is less than 0.05; and “not 
significant” when the p value is greater than 0.05 (448).
80
3.2.4 Type I and Type II errors
3.2.4.1 Type I error
A Type I error (or alpha error) refers to the rejection of the null hypothesis when it is in fact true. 
In this thesis, the alpha (a) level of 5% is selected as the criterion to judge the p value. Thus, an 
hypothesis testing procedure is valid if, whenever the null hypothesis is true, the probability of 
rejection (that is, the probability that p < a) does not exceed the alpha level (provided there is no 
bias and all test assumptions are satisfied) (330). An alpha level of 0.5% would indicate that the 
likelihood of erroneously rejecting the null hypothesis is 5% and p=0.05 (449). When multiple 
comparisons are evaluated for any associations, chance guarantees a certain proportion of such 
associations. And, many false positives are possible when many associations are studied (448). 
The analyses of the hypothesised associations in this thesis however, were on a relatively small 
and finite number of exposures -  underbedding, mattress and bed type, and composite bedding -  
and I have reported positive and negative associations. These exposures pertain to the specific a 
priori hypotheses outlined in Section 3.1. There was also a considerably larger number of 
confounders. In addition, I have assessed the consistency of findings between the three studies. 
More weight has been placed on findings replicable in each of the three data sets. And, in 
accordance with Rothman, 1986 (448) all associations assessed have been reported as if each 
one alone was the sole focus of the study. For those findings, consistent across the studies, the 
likelihood of Type 1 error is reduced.
3.2.4.2 Type II error
A Type II error (or beta error) occurs when the null hypothesis is false, but it is not rejected and 
there is a real difference between the study groups. The probability of a Type II error is related to 
the power of a study by the equation (330): Probability (Type II error) = 1 -  Power. The power of 
a study is defined as the probability of rejecting the null hypothesis and concluding that there is a 
statistically significant difference between the study groups if one truly exists (449). Type II errors 
result when the magnitude of an effect, biases, and random variability combine to give results 
insufficiently inconsistent with the null hypothesis to reject it (330). This failure to reject the null 
hypothesis can occur either because the effect is small, the observations are too few, or both, as 
well as from biases (330). Although the cross-sectional 1995 Child Asthma Survey is large, the 
two cohorts are of smaller sample size. For rare exposures, the statistical power of the study to
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detect an effect may be inadequate. I have considered the issue of Type II error within the 
Chapters of this thesis where this issue is pertinent to interpretation, particularly in Chapter 5 (see 
Section 5.7).
3.2.5 Ethics
These studies were approved by the Ethics Committee (Human Experimentation) of the 
University of Tasmania and parents provided informed written consent, including consent for data 
linkage between the TIHS and the 1995 Tasmanian Asthma Survey, and for the TIHS and 1997 
CARHS.
3.3 THEORETICAL STUDY DESIGN ISSUES
The Tasmanian studies comprised two main study types: a prospective cohort and a cross- 
sectional study. The strengths and limitations of these two study designs are discussed in the 
following sections, and further methodological issues are discussed throughout the thesis. As it is 
not feasible here to sample on disease status, a nested case-control analysis within the already 
collected cross-sectional data was also used in Chapter 6 (see Section 6.3.2) in order to match 
on confounder status to increase efficiency. RCTs do provide the highest level of evidence 
regarding causation (28) and the potential for selection bias is reduced in comparison to both 
cohort and cross-sectional studies. However, for child asthma studies, RCTs may raise ethical 
concerns when the study would require the infant to be exposed to a potential cause of disease 
such as some of the bedding items discussed in this thesis. Moreover, the paediatric phenotypes 
of asthma are distinguished by their age of onset (see Section 1.3.2.1) thus requiring studies to 
be undertaken over several years (80% of atopic asthma will begin by age 6 years). An RCT 
over this same period of time would realistically experience issues of lack of compliance by the 
study participants. In addition, there would be ethical issues pertaining to the administration of 
potentially harmful forms of bedding (for example, sheepskin) which require evaluation. In regard 
to an “hierarchy of evidence” (28), a prospective cohort study is considered to provide the next 
level below a RCT. Host & Halken, 2002 (28), identify several study criteria for the evaluation of 
possible risk factors in allergic disease: truly prospective; well-defined inclusion criteria; sufficient 
duration of follow-up; and, a proper sample size for adequate statistical evaluation. This 
Tasmanian birth cohort, which has been followed for 7 years, meets these study criteria and does
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provide an appropriate study to explore infant exposures that may be associated with child 
asthma.
3.3.1 Design aspects of a prospective cohort study
A cohort is a particular “closed” set of individuals, an enumerable set of persons, all experiencing 
an admissibility-defining event in a domain that is restrictive in both place and time (450).
By recording disease occurrence in a defined group, absolute and relative risks measures can be 
obtained from a cohort study, providing measures of disease incidence, or mortality rates, and it 
is these rates that provide the basic measures of disease risk. Cohort studies have an extended 
period of observation relating to disease experience, and sometimes to exposure experience as 
well, and, the individual is the unit of observation. These two features contrast with those of 
cross-sectional studies in which populations are compared on both exposure and disease 
occurrence at the same time (450) and incidence rates cannot be calculated.
In a prospective cohort study, exposure measurement occurs before disease status is known. 
The study samples on a population group or by exposure status and then follows up study 
subjects over time with regard to disease occurrence. As participants are free from the disease 
at the time their exposure status is defined, the temporal sequence between exposure and 
disease can be more clearly established (449). Therefore, the cohort design is advantageous for 
studying the temporal relationship between exposure (such as bedding items) and outcome (child 
sensitization or asthma-wheezing). Cohort studies also allow examination of several effects or 
outcomes after a single exposure as well as the development of wheezing or asthma subsequent 
to exposure (or no exposure) to bedding. One difficulty in using a childhood cohort to examine 
the occurrence of asthma or sensitization is that neither outcome occurs uniformly over time, 
asthma symptoms may be intermittent and the development of either might be protracted (451).
In prospective cohort studies, recall bias can usually be eliminated (452) and selection bias 
reduced. Recall bias is a form of measurement bias (see Section 5.7.2 and Section 6.5.1) where 
bias in evaluating an effect arises from errors in obtaining the needed information, and can occur 
whenever there are differential errors in the classification of subjects either on exposure or 
outcome (448). Recall bias where recalled exposure information is misclassified differentially for 
those with and without the disease (37), should not occur. Selection bias (see Section 5.7.1) in
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cohort studies can occur when the selection of exposed and non-exposed subjects is related to 
the disease outcome (449). For cohort studies with a high participation rate and then good 
follow-up, problems of selection bias should also not arise (452), provided that the follow-up does 
not favour particular exposure groups. This can be checked by examining the data, then 
comparison of the disease experience among different sub-groups of the study cohort should be 
unbiased. Losses to follow up, both in exposed and non-exposed subjects, represents the 
greatest potential bias of a cohort study (451). Failure to collect outcome data on the greater 
proportion of subjects can render a study “uninterpretable” (449). Thus, in all cohort studies, the 
level of selection bias and how it may influence results should be assessed.
As cohort studies require a commitment over many years, another disadvantage is expense. The 
follow-up period will be influenced by natural history of the disease as well as sample size 
considerations. Repeated measures of current exposure can be obtained allowing a better 
understanding of diseases with different time effects, however, this more frequent monitoring may 
also prove expensive.
Three principal multiplicative measures of effect are used in cohort studies (453): (i) the rate ratio 
(incidence rate ratio); (ii) the risk ratio (cumulative incidence ratio), and, (iii) the (incidence) odds 
ratio. The first two measures are sometimes referred under the generic term of relative risk, and 
the odds ratio is often interpreted as an estimate of relative risk. They are all approximately equal 
when the disease is rare during the follow-up period (for example, cumulative incidence of less 
than 10%) (453). However, when the incidence of an outcome of interest is common in the study 
population (>10%), the OR can no longer approximate the risk ratio (454). The more frequent the 
outcome, the more the OR overestimates the risk ratio when it is more than 1 or underestimates it 
when the OR is less than 1 (454, 455). Measures of effect are discussed below in Section 3.4.3. 
Relative risk guides inferences of cause and effect when an association is observed between an 
exposure and disease occurrence in epidemiological studies (456). Relative effect measures are 
based on the ratio of an absolute effect measure to a baseline measure of occurrence (330). 
Where possible, both relative and absolute measures of risk should be considered. Cohort 
studies allow the determination of absolute risk. The risk difference quantifies the potential 
importance of this association in absolute terms, that is the absolute risk.
The full picture of the long-term health effects of a given exposure can be provided only by the 
cohort approach. In this regard, cohort studies have several distinct advantages over cross- 
sectional observations (457). The most important of these are that the predictive power of early
84
factors can be assessed and age effects clarified (457). Studies operating over a sufficient time- 
period to be able to provide data relevant to children’s asthma are now able to examine the 
association between long-term outcomes, through childhood and factors measured both during 
pregnancy and in early life. These studies have provided unique and important contributions to 
the understanding of respiratory disease in childhood (457). However, where ethical and 
feasible, RCTs provide more rigorous evidence on the role of bedding in asthma.
3.3.2 Design aspects of a cross-sectional study
In a cross-sectional study all information collected refers to the same point in time, providing 
information of the population status with respect to disease or exposure variables, or both (37). 
As both exposure and health outcome are determined simultaneously, the risk measure is that of 
disease prevalence rather than incidence. Cross-sectional studies are commonly used to learn 
about risk factors for diseases of long duration. Diseases of short duration are not suitable for 
this type of study as too few people would have the disease at any given point in time (458). A 
major advantage over cohort studies is reduced costs, as they can be undertaken over a 
relatively short time frame. A cross-sectional study may also be used rather than longitudinal 
data when current exposure is likely to be a reliable proxy for past exposure, and where reliable 
recall of past exposure is difficult to ascertain (37).
However, although an association can be shown between exposure and outcome, cross-sectional 
studies are limited in their ability to establish causality (459). A further limitation is that cross- 
sectional studies are biased toward sampling diseases of long duration; a series of prevalent 
cases will have a higher proportion of cases with disease of long duration than a series of incident 
cases. There is a potential for selection bias when there is a difference in exposure status 
between subjects in whom the disease is short or fatal, and those who live with the disease for a 
long time (330). People who either recover or die from a disease quickly have less chance of 
being included in the disease group (458). In cross-sectional studies, where intermittent diseases 
with remissions periods, such as asthma, are being studied, it is critical that disease 
measurement involve questions about past symptoms in order to avoid disease misclassification.
There are two effect measures that can be ascertained from cross-sectional data with a 
dichotomous variable, the prevalence rate ratio (PRR) and prevalence odds ratio (POR) (460). 
The relationship between a variable and the disease can be examined (i) in terms of the
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prevalence of disease in different population sub-groups defined according to the presence or 
absence or level of the exposure variables, and (ii) in terms of the presence or absence (or level) 
of the variables in the diseased versus the non-diseased (461).
3.3.3 Measures of effect or association
In epidemiology, summary parameters are used to estimate the association between an exposure 
and an outcome, in a defined population. These measures of association are frequently based 
on incidence rates and on risks of developing disease.
3.3.3.1 Cohort studies
Assuming that the exposed and non-exposed groups are otherwise comparable with regard to 
risk for disease, measures of disease occurrence can be compared to assess the effect of 
exposure.
In cohort studies, the measure of primary interest is often the rate ratio (incidence density ratio) 
where the measure of association is based directly on incidence rates over a defined time period. 
The incidence rate ratio is defined as the ratio of rates for two groups differing in their exposure to 
a possible risk factor for the disease under study and is shown by the equation:
incidence rate of disease for exposed
Incidence rate ratio (incidence density ratio) = ------------------------------------------------------------ (458)
incidence rate of disease for unexposed
A second effect measure is the risk ratio (cumulative incidence ratio) which is the ratio of the 
cumulative incidence in the exposed group to that in the non-exposed group. The cumulative 
incidence (incidence proportion) is the proportion of study subjects who experience the outcome 
of interest at any time during the following period (450). When the outcome is rare over the 
follow-up period the risk ratio is approximately equal to the rate ratio (453). The risk ratio is 
based on a comparison of probabilities of developing the disease. It is defined as
Ri (risk among exposed)
Risk ratio = -----------------------------------------------
Ro (risk in unexposed)
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These relative measures of effect, the risk ratio and incidence rate ratio, range from zero to 
infinity.
A third possible measure is the (incidence) odds ratio which is the ratio of the incidence odds in 
the exposed group (a/c) to that in the non-exposed group (b/d) (see below). Again, when the 
outcome is rare over the study period (454) the incidence odds ratio is approximately equal to the 
incidence rate ratio (453).
The risk difference is the difference in cumulative incidence between the exposed and non- 
exposed groups and is represented by R i - Ro. Risk difference (values from -1 to +1) and 
incidence rate difference (values from -  infinity to + infinity) are measures of absolute effect. 
Relative risk is used to refer to either an incidence rate raiio or a risk ratio. Relative risk is non­
linear and takes on values between zero and infinity. Although relative measures of effect are 
useful, they do not incorporate the issue that risks of similar magnitudes will be more important 
for common rather than uncommon exposures at the population level. The population attributable 
fraction is discussed in Section 4.3.3.4.
Each of these relative effect measures involves the ratio of a measure of disease occurrence in 
the exposed group to that in the non-exposed group. These three measures of disease 
occurrence all involve the same numerator (for example, HDM sensitization or asthma) but differ 
in whether their denominators are based on person-time at risk, persons at risk, or survivors. 
They are all approximately equal when the disease is rare during the follow-up period (see 
Section 3.3.1). The odds ratio is readily biologically interpretable only in so far as it estimates the 
incidence proportion or incidence density ratio (462).
The odds ratio relates to the odds of having the disease and is defined by (449)
a /c  _ ad 
b /d  be
Where
a = the number of individuals who are exposed and have the disease 
b = the number who are exposed and do not have the disease 
c = the number who are not exposed and have the disease 
d = the number who are both non-exposed and non-diseased
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3.3.3.2 Cross-sectional studies
In cross-sectional studies, since the time dimension is not available, the measures of association 
are: (i) the prevalence rate ratio (PRR), the proportion of the population with the disease, and (ii) 
the prevalence odds ratio (POR), the ratio of affected to non-affected individuals (463).
Based on the measures above (449),
(i)
(ii)
PRR =
POR -
a/(c + b) 
c /(c  + d)
a /c
bTd
The POR and the PRR estimate true parameters using different scales. PRR is a probability 
measured on a linear scale from zero to one, whereas (prevalence) OR is non-linear and takes 
on values between zero and infinity.
Only under certain conditions does the odds ratio approximate the risk ratio: when the incidence 
of an outcome of interest in the study population is low (<10%) the OR is close to the risk ratio 
(see Section 3.3.1). However, the more frequent the outcome becomes, the more the OR will 
overestimate the risk ratio when it is more than 1 or underestimate the risk ratio when it is less 
than 1 (454). As an estimate of relative risk, the OR is biased away from one. This issue should 
be particularly kept in mind for studies on child asthma, a disease of high prevalence. When the 
duration of disease is similar among the exposed and non-exposed subjects and when the risk of 
disease is sufficiently small, the rate ratio, risk ratio and the OR give nearly identical values (458), 
that is POR = incidence rate ratio.
3.3.4 Confounding
Confounding is a systematic error that is key to control in epidemiological studies (see Section 
5.7.3). It is defined as the distortion of a disease-exposure association brought about by the 
association of other factors with both disease and exposure, the latter associations with disease 
being causal (464). Thus, a confounding factor is a factor that, in addition to being causally
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related to the disease or outcome of interest (for example, asthma) is also correlated with, but is 
not a consequence of, the exposure being investigated. During analysis of a study, confounding 
can be seen to have occurred if the estimate of exposure effect (risk ratio, odds ratio, or rate 
difference) is altered after adjustments for another factor, which has been referred to as the 
change-in-estimate criterion (465) in which variables are selected based on relative or absolute 
changes in the estimated exposure effects (466). Confounders may cause an overestimate, 
underestimate, or may even change the direction of a true association between exposure and 
disease (449). Factors that might potentially confound, either positively (strengthening the 
magnitude of effect) or negatively (reducing the magnitude of effect), any association between 
bedding and wheeze, may include, for example, the family history of asthma.
For observational studies, potential confounders can be controlled for in the study design through 
matching cases and controls on confounder status, and restriction. Flowever, controlling for 
confounding in the analysis is a more common approach. Control of confounding is achieved 
either by stratification, which reduces or eliminates confounding by evaluating the effect of an 
exposure across strata of the confounding variable, or by multivariate analysis (330) which 
adjusts for confounding through mathematic modeling.
3.3.5 Multivariate analysis
Multivariate analysis is able to describe simultaneously the effect of exposure on outcome and 
the effect of other factors that may be confounding or modifying the effect of exposure. 
Multivariate models can also be used for other factors operating in other ways, for example 
intermediates. The types of multivariate models most frequently used in child asthma are multiple 
logistic regression and multiple linear regression.
3.3.5.1 Multiple logistic regression
The appropriate multiple logistic regression predicts the proportion of subjects with the feature of 
interest (or, equivalently, the probability of an individual having that characteristic) for any 
combination of the explanatory variables in the model (467). A logistic regression model enables 
us to predict the probability of a particular outcome in relation to several prognostic variables by 
providing an odds ratio. When the outcome of interest is a binary factor, such as disease or no
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disease, logistic regression can be used to estimate odds ratios of disease adjusted for relevant 
confounding factors.
The logistic regression model is based on the equation (467)
In
V i - pj
=  CC +  ß X j
Where p is the probability of the outcome being present with a range from 0 to 1, and (1-p) is the 
probability of the outcome not being present. The ratio p/1-p is referred to as odds p and has a 
range of zero to infinity. The logarithm of the odds (In [p/1 -p]) will have a range from -  infinity to + 
infinity. The ratio of In (p/1-p) estimates the log odds ratio of the outcome being present and is 
referred to as the logit, a represents the intercept term and ß is the regression coefficient. The 
regression coefficient ß is a basic measure of the strength of relationship between the exposure 
and the outcome.
If the data have been collected for several exposures (which could also be potential confounders) 
then this model (468) becomes;
f_P_̂
l 1-Py
= a  + ß1x1+ ß 2x2 + .... +  ßKx l<
where X2 .... xr are the additional exposures or confounders (covariates) and ß2 .... ßk are their 
corresponding regression coefficients (468). The ß parameter provides a log-form estimate of the 
odds ratio associated with that particular term, adjusted for all the other terms in the model. The 
antilogarithm of the ß parameter will provide the point estimate of the odds ratio for that term and 
the standard error of the term can be used to calculate the confidence interval for that point 
estimate (469).
3.3.5.2 Multiple linear regression
Multiple linear regression analysis yields a regression model in which the dependent (or outcome) 
variable is expressed as a combination of the explanatory variables (predictor variables or 
covariates) (467). Multiple linear regression is used when the outcome of interest is a
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continuously distributed variable, such as lung volume. If Y denotes the dependent variable, then 
its relationship to the predictor variables is described by (458):
Y = a  + ß1x1 + 3 2 X2 + ....+ ßKxK
As for logistic regression, a, ßi, ..., ßkare coefficients estimated from the data, and xi, ...Xk are 
the set of values for the regressor variables. The coefficients indicate the magnitude of the 
increase (or, if negative, the decrease) in the value of the dependent variable resulting from an 
increase of one unit for the relevant predictor variable, while holding constant all other predictor 
variables in the model (458).
3.3.5.3 Generalized linear models
Logistic regression is used for the analysis of cross-sectional studies to obtain prevalence odds 
and odds ratios, and is suitable when the dependent variable in the logistic regression equation is 
the log odds of having the disease at the time the study is conducted, rather than of developing 
new disease (458). Logistic regression yields an OR rather than a risk ratio even in a cohort 
study (37). In cohort studies, logistic regression does not account for possible different durations 
of follow up for cohort members or for change in values of variables over time (459). Cox 
proportional hazard models (see Section 4.3.3.1) and generalized linear models (463, 470) can 
be used to estimate the risk ratio and risk difference multivariately for prospective binomial data. 
By choosing different link functions of transformations of prospective binomial or binary data, risk 
ratio and risk differences can be estimated in the generalized linear model framework. Risk ratio 
and risk difference parameters can be related to regression coefficients for fitting binomial data by 
assuming a functional relationship between disease probabilities and a linear combination of the 
covariates. In generalized linear models, the linear predictor (%LP) when there are k covariates 
is defined as the sum of the products of unknown regression coefficients and the values of the 
covariate ßk for the Ah proportion (470):
%LP = ß0 + ß1x1 + ß2x2 +.... + ßKxK
A monotonic link function relates the covariates for each proportion to its respective probability 
through the linear predictor. The regression coefficient ßk represents the difference in the 
probability, transformed by the appropriate link function, associated with a unit change in the
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value of the covariate Xk when the other k -1  covariates remain constant (470). The “log” link 
function and binomial error structure can be used to obtain relative risk ratio estimates (470). 
However, due to the complex nature of the generalized linear model framework, computing is 
intensive and the model may not always converge (455).
3.4 POSTSCRIPT
The TIHS was undertaken to explore the possible risk factors for SIDS. It has provided detailed 
information regarding an extremely large number of factors such as infant characteristics and the 
home environment, including infant bedding and sleeping practices, parental history and care, 
and sociodemographic variables. Thus, this prospective birth cohort has provided a wealth of 
infant information that has been followed up through the 1995 Child Asthma Survey and the 1997 
CARHS. Both these latter two studies have specifically addressed the respiratory health of 
children aged 7 and 9 years respectively in Tasmania. These three data sets have been 
analysed to determine associations between the home bedding environment and HDM 
sensitization and child ashtma. Chapter 4 will discuss the relationship between underbeddding, 
mattress and bed type and HDM sensitization and respiratory health.
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Chapter 4
The association between underbedding, mattress and bed, and 
allergic sensitization and respiratory health
4.0 PREFACE
This Chapter explores the associations between underbedding, mattress and bed type with child 
HDM sensitization and asthma. The two prospective studies, the 1997 CARHS and the Infant 
cohort study with 1995 follow-up, and the cross-sectional 1995 Childhood Asthma Survey have 
been analysed and the findings are described in this Chapter. The findings from the 1997 
CARHS, reported in this Chapter, have been recently published (see Appendix 3):
Trevillian LF, Ponsonby AL, Dwyer T, Lim LL, Kemp A, Cochrane J, Carmichael A. An association 
between plastic mattress covers and sheepskin underbedding use in infancy and house dust mite 
sensitization in childhood: a prospective study. Clin Exp Allergy 2003; 33(4):483-9.
4.1 INTRODUCTION
Early infancy has been identified as a critical period for primary sensitization (165, 471) to indoor 
inhalant allergens such as HDM (see Section 1.5.2). The bedding environment during infancy 
may play an important role in increasing an infant’s likelihood of HDM sensitization (14, 170). 
Infants spend prolonged periods in bed with close proximity to bedding items, enhanced further 
by their sleep position, and there is increasing evidence that the bedroom is the major site of mite 
exposure (472). Air sampling has identified the bedroom as the major site of exposure to HDM 
allergens (473), with airborne mite allergen levels during sleep about 10-fold higher than during 
usual domestic life in the living rooms of the same houses. The use of new upper bedding 
appears to be an effective measure for reducing airborne mite allergen exposure (474). After 
changing to new bedding, the geometric mean level of exposure to airborne Der p 1 was reduced 
from 102 pg/m3 to 19.9 pg/m3. Encasing pillows, quilts and mattresses in allergen occlusive 
covers also reduced airborne Der p 1 levels by approximately 6-fold (102.1; 95% Cl 54.6, 228.6 
to 17.5; 95% Cl 7.2,42.7) pre and post intervention respectively (475).
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Several cross-sectional studies have shown that later sensitization to mites is strongly associated 
with HDM mattress level in childhood (168, 169, 476, 477). Lau et al., 1989 (168), in a cross- 
sectional study determined the concentrations of HDM in 183 dust samples of mattresses of 133 
atopic and 50 non-atopic children, (mean age 9.3 years), in Germany. The authors reported a 
strong correlation between HDM allergen exposure (Der p 1 or Der f 1) and specific IgE 
sensitization. Atopic children with significant (>+2,000-10,000 ng/gm) or high (>=10,000 ng/g) 
amounts of HDM in their mattresses were found to have significantly higher serum IgE antibodies 
to D. pteronyssinus or D. farinae than patients with very low (<400 ng/g) concentrations of D. 
pteronyssinus or D. farinae. The relative risk for sensitization in the highly exposed group versus 
the group with very low exposure was 7-fold to 32-fold increased. Furthermore, the use of foam 
mattress was found to be associated with sensitization to D. pteronyssinus at age 5 years or older 
in a cross-sectional study in Ethiopia (OR 1.97; 95% Cl 1.16, 3.33) (478).
Prospective data on infant underbedding and subsequent HDM sensitization and respiratory 
symptoms has not been previously examined. This is iikely to be an important area because 
different bedding items differ with regard to HDM allergen levels. The concentrations of HDM 
have been found in previous studies to vary between the underbedding items as a result of their 
different material composition (9) as well as the capacity of the individual item to provide a 
microclimate conducive to the proliferation of HDM. Infant sheepskins because of their frequent 
use, dampness and warmth can contain very high populations of mites (14, 479). In addition, 
mattress type has been the determinant for differing Der p 1 levels of beds in some studies. 
Innerspring mattresses were found to have a greater mite allergen concentration than foam in 
Australian and New Zealand studies (9, 480) yet other studies have shown either no difference 
between the two mattress types (477) or even foam mattress harbouring higher levels of HDM 
than innerspring mattresses (14, 481, 482). Both sheepskins and mattresses have been shown 
to accumulate allergen rapidly (483, 484), whereas, mattress covers have been shown to be 
effective in reducing the amount of HDM allergen (485, 486) but data on their role in asthma is 
less clear. However, the use of mattress covers which provide a barrier effect to HDM, may alter 
the concentration of HDM found in beds (485-487).
A Swedish study (486) using the bedding of 7 atopic children sensitive to HDM, reported that 
following a six-month period of mattress and pillow encasement in semi-permeable polyurethane 
covers, there was an average difference of 98% (p<0.001) between the vacuumed amount of 
mite allergen on top of the covers. Furthermore, the Melbourne House Dust Mite study (485) 
assessed the long-term effectiveness of mite avoidance measures in the homes of 85 asthmatic
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children in Melbourne, Australia, on 10 home visits over a 16-month period. The use of semi- 
permeable polyethylene mattress encasements substantially lowered the concentration of Der p 1 
recovered: 4.2 ug/gm (95% Cl 2.5, 6.5 ug/gm) at the fourth visit compared with 28.4 ug/gm (95% 
Cl 22.0, 36.6 ug/gm) at the third visit. When the mattress encasements were then removed, the 
Der p 1 concentration in dust obtained from the mattress itself had fallen relative to the levels 12 
months previously: 13.8ug/mg (95% Cl 10.5, 18.1) compared with 28.4 (95% Cl 22.0, 36.6); 
p<0.0001. However, a recent Cochrane meta-analysis (488) reported that the use of mite control 
measures, including mattress barrier covers, did not result in a statistically significant 
improvement of asthma (see Section 4.7.2).
Furthermore, mattress and bedding are two of the main reservoirs of HDM (489, 490) and also a 
potential source of pulmonary irritants in the form of volatile organic compounds (VOCs) (491, 
492) (see Section 4.7.2). Thus, an effect of bedding type on allergen sensitization may not only 
be due to allergen levels (493). Waterproof infant cot mattress covers release VOCs (494) that 
may be associated with airway inflammation (either atopic or non-atopic) in humans (491, 495) 
and animals (492), and the promotion of sensitization to allergens (496). Moreover, inhalant 
HDM allergen sensitization is an important determinant of childhood asthma (167,170,175) (see 
Section 2.2.1.3).
Previous studies have reported conflicting results regarding associations between mattress type 
and wheeze. A case-control study in New Zealand of 233 children found no association between 
asthma and current mattress characteristics: kapok versus foam mattress (OR 0.35; 95% Cl 0.09, 
1.33); and, innerspring versus foam (OR 0.87; 95% Cl 0.57,1.33) (179). A retrospective analysis 
of a birth cohort, also in New Zealand, similarly found no significant associations between 
mattress type used in the first three years of life, or at any time to age 9 years, and asthma or 
wheeze at age 9, or at any subsequent age up to 15 years (497). Whereas, the large population- 
based survey in Ethiopia reported a positive association of synthetic foam mattress and current 
wheeze (OR 1.48; 95% Cl 1.14,1.91) (478). Also, a retrospective case-control study of 7-9 year 
old children in New Zealand reported an increased risk of asthma with the parental recalled use 
of sheepskin bedding in their first year of life (aOR 1.91; 95%C11.11,3.33) (179).
This Chapter examines the prospective relationship between an infant’s underbedding, mattress 
or bed and HDM sensitization and asthma in childhood. Personal HDM allergen load could be 
affected by proximity. Therefore, the infant’s usual sleep position and its association with 
subsequent HDM sensitization is also examined. In addition, the association between current
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use of underbedding and respiratory symptoms is described. The aim of this Chapter is to test 
the hypotheses that the type of underbedding and mattress an infant at one month of age, or a 
child, at 7 years of age, sleeps on is related to child HDM sensitization and/ or the respiratory 
symptoms of wheeze.
4.2 METHODS
At the home interview conducted as part of the TIHS, data were collected on the type of 
underbedding, mattress, cot or bassinet used by the infant. Underbedding is defined as any form 
of bedding lying underneath the infant or child’s body. In this study, it refers to undersheets, 
sheepskins and mattress liners (fitted or not). Mattresses are considered as a separate bedding 
item. Pillows are not classified as underbedding items, and have been reported elsewhere (13), 
and are considered in Chapter 7. Sheepskin is a common form of underbedding for infants in 
Australia and comprises the animal hide with the natural wool fibres attached. Infants are 
typically placed directly on the sheepskin. The use of a sheepskin as underbedding at the time of 
interview or intention to use sheepskin in cold weather was recorded in order to avoid the effect of 
current season when questioned. Responses of plastic to the type of mattress lining used were 
classified as having plastic mattress covers. A plastic mattress cover is used mostly as a 
mattress protector from wetting. The material structure of the infant’s cot or bassinet was also 
recorded at the home interview. In addition, the usual sleeping position of the infant was 
recorded. To examine the influence of bedding on HDM sensitization, SPTs were classified as 
described in Section 3.2.3.1. The prospective association between the particular type of infant 
underbedding, mattress or cots and subsequent HDM sensitization (as determined by the child’s 
SPT in 1997) and/or respiratory symptoms in childhood are examined using (i) the 1997 CARHS, 
and (ii) the children who participated in both the 1995 Childhood Asthma Survey and in the TIHS 
as infants, that is, the Infant cohort study with 1995 follow-up.
For the 1995 Childhood Asthma Survey, the child’s current mattress type and coverings were 
recorded in addition to the current bed type. Allergy covers are recommended (183,498, 499) to 
reduce HDM levels within the bedding and comprise fabric impermeable to HDM antigen. The 
use of an electric blanket or intention to use an electric blanket in cold weather was recorded. 
The full cross-sectional data of the 1995 Childhood Asthma Survey is analysed to provide 
associations between the current childhood underbedding and bed type, and respiratory 
symptoms.
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4.3 STATISTICAL METHODS: THE 1997 CARHS
4.3.1 Exposure variables
The main bedding exposure variables of interest are the use in infancy of sheepskin 
underbedding, plastic mattress cover, cotton undersheet, and foam mattress. The majority of 
other mattresses were ti-tree. Ti-tree is native to Australasia and the bark is used for mattress 
filling. Cot types were either plasticaine or wood/steel frames. Plasticaine is plastic covered 
cane. Composite bedding is considered in Chapter 7. Two additional variables were 
constructed: one variable for the use of both a sheepskin and a plastic mattress cover; and the 
other variable for the use of neither a sheepskin nor a plastic mattress cover. In this Chapter, all 
six variables were dichotomous for exposure or no exposure to the bedding variable. The sleep 
position was recorded as the infant’s usual sleep position and the variables were (i) side versus 
prone and (ii) supine versus, prone. Infants with no usual sleep position recorded or missing data 
were excluded.
4.3.2 Outcome variables
HDM sensitization refers to a positive SPT to either D. pteronyssinus or D. farinae. Sensitization 
to the other indoor aeroallergens, cat and alternaria, and the outdoor aeroallergen ryegrass, were 
also outcome variables, (see Section 3.2.3.1). In accordance with the ISAAC terminology, 
Recent wheeze, refers to one or more wheeze episodes over the past 12 months (6). Night 
wheeze is defined as the child’s sleep being disturbed one or more nights per week in the past 12 
months due to wheezing. A history of asthma (Asthma ever) refers to a positive response to the 
question, “Has your child ever had asthma?” (6). Wheeze frequency over the past year was also 
examined. Wheeze over the past year was defined as 1-3 episodes; 4-12 episodes; or greater 
than 12 wheeze episodes (frequent wheeze). Each wheeze outcome was compared to a 
baseline group of no wheeze.
The continuous outcome variables of lung function were: FEVi in litres; FVC in litres; and the lung 
volume ratio (FEVi/FVC) as a percentage (447).
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4.3.3 Statistical methods to examine HDM sensitization 
4.3.3.1 The Cox proportional hazards model
The Cox proportional hazards model [29] was applied as the main method of analysis for the risk 
of subsequent HDM sensitization. The hazard or risk ratio (RR), as a measure of relative risk, 
was used as the measure of effect to report any risk associations, firstly for exposure to outcome 
associations without any potential confounders, and secondly, for the multivariate analysis that 
included potential confounders. ‘Time to event” was defined as the period in days from birth to 
the date of assessment. Children not HDM sensitized at the time of follow-up assessment were 
considered censored.
The regression model proposed by Cox (500) is a multiple regression model for analysis of 
censored survival data and it may be used to study and utilize the pattern of covariation of many 
variables with the hazard (501). Cox proportional hazards model uses a mathematical modei to 
adjust for multiple covariables, and not stratification as does the Mantel-Haenzel procedure (502).
The Cox proportional hazards model is based on the instantaneous hazard designated h(t), which 
is the risk that the event will occur for a subject in a small time interval (At) at time t, given the 
subject did not have the event before that time (501). The risk function (for instantaneous risk it is 
called a hazard function) applicable to the general population is labeled hot. The hazard function 
for a specific individual is h,(t). And the ratio of the hazard functions, comparing that for an 
individual with that for the general population [hi(t)/ hot] can be considered constant. The value of 
this constant depends on the characteristics (that is, explanatory variables) of the individual (502).
Cox (500) suggested that the fixed ratio of the two hazard functions be considered as an 
exponential function of the explanatory variables:
M j)
h0t
— S ß ^ j + ß2X2j + ß 3 ̂  3 j +  ••••
Where xij is the value of explanatory variable 1 for the jth individual, X2j and xy are the values of 
the second and ith variables for the jth individual (502).
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By taking the logarithm of each side and recognizing that the hazard function ratio expresses 
relative risk, the equation becomes:
In relative risk = + ß2x 2j + ß3x3j +....
From this equation it can be seen that the model assumes that the explanatory variables are 
linearly related to In RR (503). The equation provides relative risks for each subject, since 
although ho(t) is unknown, it is the same for each subject (502). When interest is in determining 
the relative risk of morbidity or mortality of two groups, adjusted for potentially confounding 
variables, one of the variables (say xi) can be an indicator variable so that xij = 1 if the jth 
individual is in the specified group (perhaps being exposed to a bedding item) and xij = 0 if not in 
that group. Under these conditions, the In RR of an event comparing exposed to non-exposed, 
and adjusted for various confounding variables (X2 and X3....), is Bi. If X2 were also a dichotomous 
variable, the In RR comparing exposed persons with X2 present to those non-exposed with X2 
absent would be ßij + 62 (502). The methods are analogous to those used for multiple regression 
and the results may be similarly interpreted. Thus ßj represents the estimated change in In RR 
for each unit change in Xj after removing from both Xj and In RR their linear relationship with the 
other explanatory variables included in the analysis (502).
4.3.3.2 Confounder identification
To identify potential confounders, the association between a large number of factors and HDM 
sensitization were examined (Table 4.2). I further examined how these factors related to the 
bedding exposures of interest. More than 80 potential confounders were examined to see how 
they each related separately to use of the individual exposure variables and HDM sensitization in 
terms of magnitude and statistical significance. Several factors, early introduction of solid food, 
home gas heating and private health insurance at birth, are associated with sensitization to HDM 
and have been previously reported (504). Moreover, it has been previously shown in this 
population in a cross-sectional analysis that feather bedding is inversely associated with HDM 
sensitization (196).
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4.3.3.3 Proportional hazards model
A proportional hazards model was then constructed as follows. For each exposure, potential 
confounders (330) were added to the model as covariates if the variables were associated with 
HDM sensitization in the exposure to outcome analysis, or were reported to be related to HDM 
sensitization or asthma in the literature. I examined the confounding effect of these factors on 
each exposure-disease association using change-in estimate methods (466). Those factors that 
altered the point estimate for the exposure-HDM association by 10 percent or more were included 
as potential confounders. To confirm that the final confounder sets used were the most 
appropriate, I then added in the remaining variables in Table 4.2 as individual factors into the final 
model. None of these factors altered the adjusted risk ratios reported in Table 4.3. Family history 
was defined as asthma in any of the infant’s siblings, parents or grandparents. A positive family 
history at birth may result from shared bedding practices within the family (505), thus the possible 
contribution of family history of asthma to the association between bedding and HDM 
sensitization was explored and not merely treated as a routine confounder.
4.3.3A Population attributable fraction
The aetiologic fraction of HDM sensitization in childhood attributable to either plastic mattress 
cover or sheepskin use in infancy was calculated as p (aRR-1 )/aRR, where p = the proportion of 
children with either plastic mattress cover or sheepskin use in infancy among those with the 
outcome of HDM sensitization and aRR = the relative risk estimate for either plastic mattress 
cover or sheepskin use and HDM sensitization, after adjustment for the confounders listed in 
Table 4.2 (330). In a population in which there are exposed and unexposed individuals, as in this 
birth cohort, the incidence due to a given exposure is calculated as It -  l0, where It = total 
incidence in the population and l0 = incidence in non-exposed (456). The population attributable 
fraction (PAF) assumes causality, that is, that the exposure causes the outcome and gives the 
proportion of the occurrence of the disease in exposed individuals that was due to the exposure.
4.3.4 Statistical methods to assess respiratory symptoms
A generalized linear model (see Section 3.1.5.3) with a log link function and binomial error 
structure was used to control simultaneously for multiple confounders and to obtain confidence
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intervals for RR estimates (452). Confounders were selected using the change-in estimate 
methods (466). Those factors that altered the point estimate for the exposure-wheeze 
association by 10 percent or more were included in the final model. It is not appropriate to use 
Cox proportional hazards model for the analysis of wheeze. Unlike HDM sensitization where a 
child was determined as having the “event”, either a positive or negative SPT by the time of 
assessment, the date of wheeze occurrences have not been ascertained. Only the first event 
contributes to the analysis in Cox’s regression. Repeated episodes in the same individual are not 
statistically independent and cannot be considered as separate timed events in proportional 
hazards regression (506). Further, unlike sensitization, wheeze is intermittent throughout the 
course of the illness - some non-wheezing children will have had wheeze but not in the last 12 
months. Thus, wheeze does not fit a cumulative incidence pattern.
4.3.4.1 Lung function tests
Multiple linear regression models (see Section 3.1.5.2) were used to examine continuous 
outcomes, such as FEVi, FVC and FEVi/FVC. The ratio of FEVi to FVC was taken as a 
measure of airway obstruction (196, 504).
4.4 RESULTS: THE 1997 CARHS
4.4.1 Characteristics of the study population
In Northern Tasmania in 1997, parents of 499 (84%) of the 596 children identified as participants 
in the 1988-89 TIHS at birth agreed for their children to participate in the CARHS study. SPT 
data were available on 498 as one autistic child did not undergo the SPT. Data on the use of 
underbedding was available on 460, for mattresses on 457, for cots on 459 children. Overall, 
23.3% of the children were sensitized to mite allergen, D pteronyssinus or D. farinae. Respiratory 
symptoms were common: 30.8% of the children reporting recent wheeze, 20.7% night wheeze 
and 37.8% wheeze ever. The characteristics of the study sample are shown in Table 4.1.
Plastic mattress covers (55%, 254/460) were used more commonly than sheepskin underbedding 
(23%, 106/460) in early infancy. Other types of mattress covers used included cotton, wool or 
synthetic material. Undersheets were predominantly cotton (91.4%). The use of foam 
mattresses (52%, 237/457) was also common. Non-foam mattresses were predominantly ti-tree
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(40%) or other (8%). Cots were mostly either plasticaine (41.0%) or comprised a wood or steel 
frame (47.1%). The complete time period of use for each particular bedding item was not 
available. Infants more commonly slept on their side (57.2%) than on their back (7.9%) as 
reported by their parents.
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Table 4.1 Characteristics of the Study Population in the 1997 CARHS
C a te g o r ic a l m e a s u re s % n /to ta l N *
M ale 71 .5 3 5 7 /499
D. p te ro n yss in u s  sens itiza tion** 22.5 112 /498
D. fa rinae  se n s itiza tio n ** 11.9 59 /498
H D M  se n s itiza tio n ** 23 .3 116 /498
R yegrass se n s itiza tio n *** 17.1 85 /498
O the r indoor a e roa lle rgen  sens itiza tion**** 7 .0 35 /498
C at sens itiza tion 2.8 14/498
A lte rn a ria  sens itiza tion 4.0 20 /498
D og sens itiza tion 0 .2 1/498
R e s p ira to ry  s y m p to m s
R ecen t w heeze 30 .8 153/497
W heeze  ep iso d es  in past 12 m on ths
N o w h e e ze 67.0 321 /479
1-3 23.0 110/479
4-12 6.7 32 /479
>12 3.3 16/479
N igh t w heeze 20.7 101/487
A sthm a  ever 37 .8 188/497
U n d e rb e d d in g
N eithe r sh eepsk in  no r p las tic  co ve r use 30.2 139/460
O n ly sheepsk in  use  in in fancy 14.6 67 /460
O n ly  p lastic  m a ttre ss  cover 46.7 2 1 5 /460
Both sheepsk in  and  p lastic  cove r 8.5 39 /460
C otton  un d e rsh e e t use 91.4 3 8 0 /416
O ther
♦
8.6 36 /416
M a ttre s s  ty p e
Foam  m attress 51.9 2 3 7 /457
N atura l fib re  m a ttress***** 40.7 186/457
O ther 7.4 34 /457
Table 4.1 continued
C ateg orica l m easu res % n /to ta l N t
C o t type
P lastica ine 41 .0 188/459
W ood /s tee l fram e 47.1 2 1 6 /459
O the r 12.0 55 /459
S leep  position
Prone 40 .6 187/461
Side 54 .0 249/461
B ack 3.5 16/461
O ther 2.0 9/461
C o n tin u o u s  variab les M ean S tan d ard
d ev ia tio n
A ge (in years) 8.7 0.6
M axim um  F orced E xp ira to ry  V o lum e  (F E V i) (in litres) 1.70 0 .28
M axim um  Forced V ita l C apac ity  (FVC ) (in litres) 1.88 0 .36
F E V i/F V C  ratio  (%) 0.91 0.07
'Small N for some characteristics: bedding items (N=416).
"A n y  skin prick reaction of greater than or equal to 3 mm to mite allergen, D. pteronyssinus or D. farinae. 
‘ "A ny  skin prick reaction of greater than or equal to 3 mm to ryegrass.
" " A n y  skin prick reaction of greater than or equal to 3 mm to altemaria, cat or dog.
" ‘ "Natural fibre comprises ti-tree or kapok mattresses.
4.4.2 Potential predictors of HDM sensitization
Table 4.2 shows the unadjusted risk ratios for the bedding variables and potential confounders 
and the associations with HDM sensitization. The unadjusted RR showed that sheepskin only 
use, without a plastic mattress cover, in infancy was significantly associated with sensitization to 
HDM in childhood (unadjusted RR 2.12; 95% Cl 1.12, 4.04). The use of only plastic mattress 
covers was also associated with a significant increase in the risk ratio of HDM sensitization 
(unadjusted RR 1.96; 95% Cl 1.18, 3.25). The use of both a sheepskin and a plastic mattress 
cover was significantly associated with HDM sensitization (unadjusted RR 2.97; 95% Cl 1.51, 
5.86). A cotton undersheet was not associated with HDM sensitization in childhood (p=0.948). 
Foam mattress use in infancy was not significantly more likely to be associated with HDM 
sensitization in childhood (unadjusted RR 1.01; 95% Cl 0.69,1.48). Plasticaine infant cots were 
not associated with HDM sensitization in childhood (p=0.296). Individual adjustment for the 
factors, listed in Table 4.2, considered as potential predictors of subsequent HDM sensitization 
did not alter the point estimate for the exposure-HDM association by 10 percent or more.
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Table 4.2 Unadjusted risk ratio for infant underbedding, mattress and potential predictors 
of HDM sensitization* in the 1997 CARHS
HDM  se n s itiza tio n
U n ad ju s ted  RR (95 %  Cl) p va lue
In fan t b ed d in g  variab les
Sleep en v iro n m e n t (re fe rence  g roup)**
U n derb edd ing
N either sheepsk in  nor p las tic  cove r 1.00 (re fe rence)
O n ly sheepsk in 2 .1 2 (1 .1 2 ,4 .0 4 ) 0 .022
O nly p lastic  m attress  cover 1.96 (1.18, 3 .25) 0 .009
Both sheepsk in  and p lastic  cove r 2 .97 (1 .5 1 ,5 .8 6 ) 0 .022
C otton  u ndershee t (no co tton  undersheet) 0 .98  (0 .5 1 ,1 .8 8 ) 0 .948
M attress typ e
Foam  m attress  (o ther m attress)*** 1.01 (0 .6 9 ,1 .4 8 ) 0 .945
C ot typ e
P lastica ine  (w ood, stee l o r o ther) 0 .83  (0 .5 9 ,1 .1 8 ) 0 .296
P o ten tia l con fou nd in g  in fant variab les
M aternal fac tors
M other sm ok ing  du ring  p regnancy 0 .89  (0 .6 2 ,1 .3 0 ) 0 .566
T eenage  m othe rhood 0 .75  (0 .4 3 ,1 .3 2 ) 0 .323
A t-b irth  fa m ily  h is to ry  o f as thm a 1.30 (0 .9 0 ,1 .8 9 ) 0 .168
In fan t fac tors
In fant on ly  ch ild 0 .29  (0 .0 7 ,1 .1 9 ) 0 .087
In fant firs t born 0 .7 8  (0 .5 4 ,1 .1 4 ) 0 .203
Low  b irth  w e igh t 1 .1 5 (0 .7 3 ,1 .8 2 ) 0 .550
Infant bo ttle  fed  a t one  m onth 1.03 (0 .6 9 ,1 .5 4 ) 0 .883
Solid  food  in troduced  by phone  in te rv iew  a t 10 w eeks 1.26 (0 .8 5 ,1 .8 5 ) 0 .247
Infant exc lus ive ly  b reast fed by phone in te rv iew  at 10 w eeks 0 .74  (0 .4 8 ,1 .1 5 ) 0 .183
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Table 4.2 continued
HDM sensitization
Unadjusted RR (95% Cl) p value
Infant sleep position
Usual sleep position in infancy = supine 1.00 (reference) —
Usual sleep position in infancy = prone 1.33 (0.47,3.73) 0.591
Usual sleep position in infancy = side 1.33 (0.48,3.71) 0.582
Household factors
Private health insurance at birth 1.86 (1.29,2.70) 0.001
Home gas appliance use 1.83(0.89,3.77) 0.101
No-one smoking in same room as infant 1.18 (0.80,1.72) 0.402
More than six residents in household at birth 1.23 (0.76,2.00) 0.404
Cat as pet during infancy 1.42 (0.97,2.08) 0.069
Bedroom factors
Use of foam pillow at one month age 0.62 (0.27,1.41) 0.251
Infant sleeping in bedroom alone 0.75 (0.50,1.13) 0.176
Carpet in infant’s bedroom 1.13(0.59,2.17) 0.716
Humidity in infant’s bedroom>75% 1.44 (0.70,2.98) 0.321
Window in infant’s bedroom open at night 1.06 (0.70,1.60) 0.774
Use of feather quilt as child 0.65 (0.45,0.95) 0.025
‘ Skin prick reaction of greater than or equal to 3 mm to either mite allergen, D. pteronyssinus or D. farinae. 
"Reference group properties not listed for brevity.
"*T i-tree mattresses comprised the majority of other mattresses (see Table 4.1).
4.4.3 Prospective association between underbedding and HDM 
sensitization
Table 4.3 reports the association between underbedding and mattress type and HDM 
sensitization after adjustment for confounders. The adjusted risk ratios for subsequent HDM 
sensitization remained significant when the different bedding combinations of sheepskin use 
and/or plastic mattress cover use were compared against a reference variable of neither 
sheepskin nor plastic mattress cover use. There was very little additional effect with exposure to 
both sheepskin and plastic mattress cover in infancy. Both sheepskin use and plastic mattress 
cover use in combination were significantly associated with HDM sensitization (Table 4.3). The
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population attributable fractions for HDM sensitization associated with sheepskin or plastic 
mattress cover use in infancy, if causal, were as follows: 8.8% for sheepskin; and, 26.2% for 
plastic mattress cover. The use of a foam mattress in infancy was not prospectively associated 
with an increased risk of sensitization to HDM. The results in Table 4.3 were not altered when 
the SPT cut off for positivity was 2mm wheal diameter. Similar patterns to Table 4.3 were also 
found using D. pteronyssinus or D. farinae as individual species-specific outcomes, both as 
dichotomous or continuous variables.
For children exposed only to plastic mattress covers in infancy, there was no significant 
association with childhood sensitization to the other primarily indoor aeroallergens, cat 
(unadjusted RR 0.60; 95% Cl 0.18,1.90) or alternaria (unadjusted RR 1.46; 95% Cl 0.55, 3.90). 
Moreover, there was no association with exposure to sheepskin (unadjusted RR 1.51; 95% Cl 
0.76, 3.02), plastic mattress (unadjusted RR 1.28; 95%CI 0.76, 2.18) or both covers together 
(unadjusted RR 1.43; 95% Cl 0.61, 3.35) as an infant and subsequent ryegrass sensitization. 
Use in infancy of sheepskin alone or piastic mattress cover alone were significantly associated 
with hayfever (aRR 2.26; 95% Cl 1.19, 4.32) and aRR 1.78; 95% Cl 1.09, 2.90), respectively. 
The use in infancy of both these underbedding items was not significantly associated with 
hayfever in childhood (adjusted RR 1.91; 95% Cl 0.89,4.07).
Usual infant sleep position was not associated with HDM sensitization. The association between 
sheepskin and HDM sensitization or plastic cover and HDM sensitization did not vary by whether 
the infant slept prone or not.
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Table 4.3 The prospective association between sheepskin, plastic mattress cover and 
foam mattress use in infancy and child sensitization to house dust mite in the 1997 
CARHS
% HDM  s e n s itized **  
am ong exp o sed
A d ju s ted *** RR  (9 5 %  Cl) 
fo r b ed d in g  vs  none
p va lue
B e d d in g  (re fe re n c e  group)*
Neither sheepskin nor plastic cover 15.8% (22/139) 1.00 (reference)
Only plastic mattress cover 25.6%  (55/215) 2 .06(1 .22 , 3.51) 0.007
Only sheepskin 25.4%  (17/67) 2 .27(1 .14 , 4.55) 0.020
Both sheepskin and plastic cover 35.9%  (14/39) 2 .2 5 (1 .05 ,4 .83 ) 0.038
Foam mattress (other)**** 23.6%  (56/237) 1.09 (0 .72 ,1 .67) 0.676
S leep  p o s itio n
Sleep side vs prone 22.9 (57/249) 0.99 (0 .64 ,1 .52) 0.949
Sleep back vs prone 31.3 (5/16) 0.94 (0.30, 2.89) 0.908
‘ Reference group properties not listed for brevity.
“ Skin prick reaction of greater than or equal to 3 mm to either mite allergen, D. pteronyssinus or D. farinae.
“ ‘ The risk ratio has been adjusted for parents with private health insurance at time of child’s birth, at-birth family history of 
asthma, being an only child, whether child was exclusively breastfed by ten weeks of age, home gas heater use in infancy, and 
use of a feather quilt as a child.
**"Ti-tree mattresses comprised the majority of other mattresses (see Table 4.1).
4.4.4 Prospective association between underbedding and asthma
Prospective associations between the underbedding variables and respiratory symptoms are 
presented in Table 4.4. There is no association between sheepskin, plastic mattress cover or 
cotton undersheet use in infancy and asthma symptoms in childhood. The type of infant cot is 
also not associated with childhood respiratory symptoms of asthma. HDM sensitization was 
significantly associated with child asthma ever (unadjusted RR 1.65; 95% Cl 1.32, 2.06) and 
hayfever (unadjusted RR 2.57; 95% Cl 1.78, 3.72).
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Table 4.4 The prospective association between underbedding and cot type and respiratory 
symptoms in the 1997 CARHS
R e s p ira to ry  s y m p to m  in 
c h ild h o o d
In fan t b e d d in g  (re fe re n ce  g ro u p )*
n /to ta l N
%  C h ild re n  w ith  in fa n t  
b e d d in g  c o m b in a t io n  
w ith  w h e e z e
R is k  ra tio 9 5 %  Cl p v a lu e
R e c e n t W h e e z e
U nderbedd ing
N eithe r sheepsk in  no r p las tic  cove r 125/419 29.8 1.00 (re fe rence)
O n ly  p las tic  m attress  co ve r 64 /215 29.8 1.02 0 .7 7 ,1 .3 6 0 .875
O n ly  sheepsk in 15/66 22.7 0 .74 0 .4 7 ,1 .1 9 0 .217
Both sheepsk in  and p las tic  co ve r 10/40 25.0 0 .84 0 .4 8 ,1 .4 6 0 .534
C otton 112/380 29.5 1.72 0.82, 3 .62 0 .154
C ot type
P lastica ine  (w ood, s tee l o r o the r) 58 /187 31.0 1.09 0 .8 2 ,1 .4 5 0 .564
N ig h t W h e e z e
U nderbedd ing
N eithe r sheepsk in  nor p la s tic  cove r 81 /409 19.8 1.00 (re fe rence)
O n ly p las tic  m attress  co ve r 43 /209 20.6 1 .10 0 .7 5 ,1 .6 0 0 .627
O n ly  sheepsk in 9 /65 13.9 0 .67 0 .3 6 ,1 .2 7 0 .2 23
Both sheepsk in  and p la s tic  co ve r 7 /40 17.5 0 .8 8 0 .4 4 ,1 .7 8 0 .729
C otton 70 /370 18.9 0 .32 0 .57 , 3 .05 0 .515
C ot type
P lastica ine  (w ood, s tee l o r o the r) 35 /182 19.2 0 .9 6 0 .6 6 ,1 .4 1 0.841
A s th m a  E v e r
U nderbedd ing
»
N eithe r sheepsk in  nor p la s tic  co ve r 155/419 36.7 1.14 0 .57, 2 .28 0 .714
O n ly  p las tic  m attress  co ve r 82 /214 38.3 1.10 0 .8 7 ,1 .4 1 0 .4 20 .
O n ly  sheepsk in 25/67 37.3 1 .03 0 .7 4 ,1 .4 4 0 .863
Both sheepsk in  and p las tic  co ve r 12/40 30.0 0.81 0 .5 0 ,1 .3 2 0 .402
C otton 140/378 37.0 1.21 0 .73, 2 .02
C ot type
P lastica ine  (w ood, s tee l o r o the r) 76 /188 40.4 1.19 0 .9 4 ,1 .5 2 0 .147
‘ Reference group properties not listed for brevity.
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4.4.4.1 The prospective association between mattress type and 
wheeze
The prospective associations between foam mattress and wheeze are shown in Table 4.5. The 
positive association between foam mattress use in infancy and subsequent respiratory symptoms 
found in the unadjusted analysis was reduced following the adjustment for potential confounders, 
including other infant bedding factors such as sheepskin, plastic mattress cover and synthetic 
quilt. There was no association between foam mattress and frequent wheeze.
Table 4.5 Prospective association between foam mattress use in infancy and childhood 
respiratory symptoms in the 1997 CARHS
R e s p ira to ry  sym p to m  
in c h ild h o o d
Infant m attress 
(reference group)*
n /to ta l N
%  C h ild ren  w ith  
in fan t bedding  
c o m b in a tio n  w ith  
w heeze
U n ad ju s te d  RR p v a lu e A d ju s ted  RR** p va lue
R e c e n t w h e e ze
Foam m attress (other)*“ 81/235 34.5 1.41 (1.05, 1.89) 0.021 1.35 (0.98,1.83) 0.063
N ig h t w h e e ze
Foam m attress (other)*“ 54/230 23.5 1 .4 9 (1 .01 ,2 .20 ) 0.043 1.28 (0.83,1.88) 0.289
A s th m a  e v e r
Foam m attress (other)*** 96/236 40.7 1.26 (0 .99 ,1 .61) 0.065 1.13 (0 .87 ,1 .46 ) 0.364
‘ Reference group properties not listed for brevity.
“ The risk ratio has been adjusted for parents with private health insurance at time of child’s birth, at-birth family history of asthma, 
being an only child, whether child was exclusively breastfed by ten weeks of age, home gas heater use in infancy, use of a 
sheepskin in infancy, use of a plastic mattress cover in infancy, and use of a synthetic quilt as a child.
“ *Ti-tree mattresses comprised the majority of other mattresses (see Table 4.1).
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4.4.4.2 Infant underbedding and child lung function
In this sample of 499 children, lung function data were available on 495. The mean FEVi was 
1.70 litres, (standard deviation 0.28), and the mean FVC was 1.88 litres, (standard deviation 
0.36). The FEVi and FVC volumes were close to volumes predicted for healthy Australian 
children of a similar height and gender using a previously published normogram (441). The 
previous study had calculated predicted values of FEVi and FVC, based on height and sex, and 
from normal values obtained for 1,280 Australian children without asthma, not using asthma 
medications, with no recent respiratory infection, and who were not treated for bronchitis before 
the age of 2 years (441). The regression equation for normal FVC was calculated as follows 
(441):
FVC = 0.000123xheighf -  0.261 (-0.147 for females)
And for FEVi:
FEVi = 0.000106xheighf -  0.155 (-0.09 for females).
Applying these equations to the 1997 CARHS study population, the mean percentage of 
predicted was 98% for FEVi and 97% for FVC. The mean FEVi/FVC ratio was 91% (standard 
deviation 7). Only 6.9% (34/495) children had a FEVi/FVC ratio of less than 80%.
I undertook an analysis of the Spirometrie values to allow an assessment to be made of the 
clinical importance of a change in respiratory function. I did not demonstrate any significant 
differences in the mean Spirometrie values between children with exposure to the different 
underbedding and mattress types in infancy. These results are shown in Table 4.6 and Table 
4.7. Children who were exposed to the listed underbedding items in infancy did not demonstrate 
a greater reduction in their adjusted difference in mean FEVi/FVC ratio when compared to 
children with either recent or frequent wheeze.
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4.4.5 Family history
I further examined the role of family history and HDM sensitization and asthma. An at-birth family 
history of asthma was not significantly associated with subsequent HDM sensitization (unadjusted 
RR 1.30; 95% Cl 0.90, 1.89). There was no evidence that parents of infants with an at-birth 
family history of asthma were selectively avoiding sheepskins (37.1% use versus 37.0% non-use, 
p=0.953) as part of a bed allergen reduction strategy, nor were they selectively using a plastic 
mattress cover (38.8% use versus 34.8% non-use, p=0.376). Exposures to sheepskin 
(unadjusted RR 2.12; 95% Cl 0.94, 4.80) or plastic mattress cover (unadjusted RR 1.89; 95% Cl 
1.01, 3.55) tended to be positively associated with HDM sensitization even among the subgroup 
of those with no at-birth family history of asthma. The positive association with either sheepskin 
use or plastic mattress cover use in infancy and subsequent HDM sensitization remained 
significant after adjustment for the child’s history of eczema, hay fever and asthma, and also the 
family history of asthma in 1997. Further adjustment for at-birth family history of asthma did not 
alter the results in Table 4.3.
4.5 STATISTICAL METHODS: THE 1995 CHILDHOOD ASTHMA 
SURVEY
4.5.1 The Infant cohort study with 1995 follow-up
For the children who as infants were part of the TIHS birth cohort and also participated in the 
1995 Childhood Asthma Survey, the identical underbedding exposure variables and coding were 
constructed as for the 1997 CARHS (see Section 4.3.1). The outcomes variables were recent 
wheeze, night wheeze or asthma ever (see Section 4.3.2). For this prospective data, a 
generalized linear model with a log link function and binomial error structure was used to control 
simultaneously for multiple confounders and to obtain confidence intervals for RR estimates (452) 
as described in Section 4.3.4.
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4.5.2 The cross-sectional 1995 Childhood Asthma Survey
The main underbedding exposure variables of interest were the use in childhood at age 7 years 
of cotton quilted cover, sheepskin, plastic mattress cover, electric blanket, foam mattress and 
innerspring mattress. Bed types were single, double, top bunk-bed and bottom bunk-bed. All ten 
variables were dichotomous for exposure or no exposure to the bedding variable. The outcome 
variables were recent wheeze, night wheeze or asthma ever (see Section 4.3.1).
ORs were estimated by logistic regression analysis (502) (see Section 3.1.5.1). To examine the 
possible contribution of confounders, multiple logistic regression models that included terms for 
the exposure and potential confounding variables were used following the procedures described 
in Section 4.3.4.
4.6 RESULTS: THE 1995 CHILDHOOD ASTHMA SURVEY
4.6.1 The Infant cohort study with 1995 follow-up
4.6.1.1 Characteristics of the study population
Among the 863 children in the 1995 Childhood Asthma Survey who were also included in the 
cohort study, the mean age was 6.9 years (standard deviation 0.3 years). Table 4.8 describes 
the characteristics of this study population. Similar to the children from the TIHS who were seen 
in 1997, wheeze was also common. There were 27.0% (222/823) of the children with recent 
wheeze, 19.2% (160/834) with night wheeze and 32.4% (280/863). The most common type of 
cots was either plasticaine 39.1% or cots with either wood or steel frames 44.6%. Other cot types 
included carry cot (1.5%) and other (14.9%).
116
Table 4.8 Characteristics of the study population in the Infant cohort study with 1995 
follow-up
C a teg o ric a l m easu res % n /to ta l N
Male sex 71.3 615/863
R e s p ira to ry  sy m p to m s
Recent wheeze 27.0 222/823
W heeze episodes in past 12 months
1-3 17.2 125/726
4-12 10.0 67/668
>12 4.8 30/631
N ight wheeze 19.2 160/834
Asthm a ever 32.4 280/863
U n d erb ed d in g
Neither sheepskin nor plastic cover use 35.7 307/859
O nly sheepskin use in infancy 34.5 296/859
O nly plastic mattress cover 23.3 200/859
Both sheepskin and plastic cover 6.5 56/859
Cotton undersheet use 81.4 699/859
M attre s s  type
Foam mattress 62.8 536/854
Natural fibre mattress* 32.4 277/854
Other 4.8 41/854
C o t typ e
Plasticaine 39.1 334/855
W ood/steel frame 44.6 381/855
Other 16.4 140/855
C o n tin u o u s  variab les M ean S tand ard
dev ia tion
Age 6.9 0.3
‘ Natural fibre comprises ti-tree or kapok mattresses.
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4.6.1.2 Prospective associations between underbedding and asthma
Prospective associations between the underbedding variables and respiratory symptoms are 
presented in Table 4.9. There is no association between sheepskin, plastic mattress cover or 
cotton undersheet use in infancy and asthma symptoms in childhood. No prospective association 
was found between cot type in infancy and subsequent development of wheeze or HDM. Further 
analysis of wheeze by sub-group of frequency did not provide different results from Table 4.9.
4.6.2 The cross-sectional 1995 Childhood Asthma Survey 
4.6.2.1 Characteristics of the study population
The 1995 cross-sectional Childhood Asthma Survey was similar to the Infant cohort study with 
1995 follow-up with regard to child age, but the proportion of children experiencing respiratory 
symptoms was lower. Cotton quilted covers (42.1%), electric blanket (21.4%) and sheepskin 
(21.1%) were the most common underbedding items. The majority of children in 1995 slept in a 
single bed (73.4%) whereas 10.8% slept in either the top or bottom bunk-bed. The study 
characteristics are presented in Table 4.10.
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Table 4.9 The prospective association between underbedding and cot type and respiratory 
symptoms in the Infant Cohort Study with 1995 follow-up
C h ild h o o d  resp ira to ry  sym p to m s
I n fa n t  b e d d in g  ( r e fe r e n c e  g r o u p ) *
%  C hild ren  w ith  
in fan t bedding  
com b in a tio n  w ith  
w heeze
n /to ta l N R isk  ratio 95%  Cl p va lue
R ecent W h eeze
U n d e r b e d d in g
N eithe r sheepsk in  nor p las tic  cove r 27.1 2 0 7 /764 1.00 (re fe rence )
O n ly p las tic  m attress  cover 27 .3 77 /282 1.03 0 .8 1 ,1 .3 0 0 .836
O n ly  sheepsk in 27.7 52 /18 8 1.04 0 .8 0 ,1 .3 5 0 .778
Both sh eepsk in  and p lastic  cove r 23 .6 13/55 0 .87 0 .5 3 ,1 .4 2 0 .584
M a t t r e s s  ty p e  
Foam  m attress  (o ther)** 27.1 138 /509 1.05 0 .8 3 ,1 .3 3 0 .706
C o t  ty p e
P lastica ine  (vs w ood, s tee l o r o ther) 29 .6 93 /314 1.19 0 .9 4 ,1 .4 9 0.141
N ig ht W h eeze
U n d e r b e d d in g
N eithe r sheepsk in  nor p lastic  cove r 19.2 149 /776 1.00 (re fe rence )
O n ly  p las tic  m attress  cover 18.0 52 /28 9 0.92 0 .6 8 ,1 .2 4 0 .577
O n ly  sheepsk in 18.7 36 /19 3 0.97 0 .7 0 ,1 .3 6 0 .877
Both sheepsk in  and p las tic  cove r 16.7 9 /54 0.87 0 .4 7 ,1 .6 0 0.651
M a t t r e s s  ty p e  
Foam  m attress  (other)** 19.0 98 /517 1.01 0 .7 5 ,1 .3 5 0 .965
C o t  ty p e
P lastica ine  (vs w ood, s tee l o r o ther) 21 .9 70 /320 1.24 0 .9 6 ,1 .6 9 0.091
A sth m a E ver
U n d e r b e d d in g
N eithe r sheepsk in  nor p las tic  cove r 32 .3 2 5 9 /803 1.00 (re fe rence )
O n ly p las tic  m a ttress  cover 31 .8 94 /296 0.97 0 .7 9 ,1 .1 9 0 .783
O n ly  sheepsk in 29 .5 5 9 /200 0.89 0 .7 0 ,1 .1 3 0.331
Both sheepsk in  and  p las tic  co ve r 33 .9 19/56 1.05 0 .7 2 ,1 .5 4 0 .794
M a t t r e s s  ty p e  
Foam  m attress  (o ther)** 33 .8 181 /536 1.12 0 .9 1 ,1 .3 7 0 .284
C o t  t y p e
P lastica ine  (vs w ood, s tee l o r o ther) 33 .2 111/334 1.04 0 .8 5 ,1 .2 6 0 .719
'Reference group properties not listed for brevity.
**Ti-tree mattresses comprised the majority of other mattresses (see Table 4.8).
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Table 4.10 Characteristics of the study population in the cross-sectional 1995 Childhood
Asthma Survey
C o ntinu ou s  m easu res M ean S tand ard  d ev ia tio n
Mean age (years) 6.9 0.3
C ateg orica l m easu res % n /to ta l N
Recent wheeze 22.9 1400/6107
Wheeze episodes in past 12 months
1-3 15.8 880/5587
4-12 7.5 384/5091
>12 2.8 136/4834
Night wheeze 14.4 889/6172
Severe wheeze 3.9 249/6317
Asthma ever 27.1 1710/6307
Type of m attress
Foam 32.0 2038/6364
Innerspring 66.3 4218/6364
Other 1.7 108/6364
M attress liners
No covering 8.3 524/6307
Cotton covered quilted 42.1 2653/6307
Plastic/PVC 12.8 809/6307
Sheepskin 21.1 1331/6307
Electric blanket 21.4 1347/6307
Allergy cover 0.9 54/6307
Other (for example, rugs) 1.1 71/6306
T yp e of bed
Single 73.4 4662/6354
Double 2.0 129/6354
Top bunk 10.8 687/6354
Bottom bunk- 10.8 686/6354
Other 3.0 190/6354
Bed on the floor 1.4 90/6329
Bed supported by legs or frame 98.6 6239/6329
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4.6.2.2 Current underbedding and mattress type and respiratory 
symptoms
Associations between the current use of different underbedding and types of mattress are shown 
in Table 4.11. Current electric blanket use is positively associated with both recent wheeze (OR 
1.18; 95% Cl 1.02, 1.3) and night wheeze (OR 1.27; 95% Cl 1.08, 1.50). The current use of 
sheepskin is negatively associated with respiratory symptoms. This inverse association was 
greater for children with frequent wheeze: OR 0.84 (95% Cl 0.70, 1.01) for 1-3 episodes; OR 
0.75 (95% Cl 0.57, 0.98) for 4-12 episodes; and, OR 0.54 (95% Cl 0.33, 0.90) for more than 12 
episodes of wheeze in the past year (Test for trend, p=0.002).
4.G.2.3 Current electric blanket and sheepskin use and respiratory 
symptoms
The associations between current electric blanket use and various wheeze outcomes remained 
significant after the adjustment for potential confounders: recent wheeze (aOR 1.26; 95% Cl 1.08, 
1.46), night wheeze (aOR 1.35; 95% Cl 1.13, 1.61) and asthma ever (aOR 1.17; 95% Cl 1.01, 
1.35). Compared to no wheeze the association was stronger for children with frequent wheeze: 
aOR 1.08 (95% Cl 0.90,1.30) for 1-3 episodes; aOR 1.53 (95% Cl 1.19,1.96) for 4-12 episodes; 
and, aOR 1.79 (95% Cl 1.21, 2.65) for more than 12 episodes of wheeze in the past year (Test 
for trend p=0.003). The inverse association between current use of sheepskin as underbedding 
and wheeze remained greater for more than 12 episodes of wheeze than less episodes of 
wheeze in the past year after the adjustment for potential confounders. The Test for trend, 
p=0.083, was of borderline significance. These results are shown in Table 4.12.
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Table 4.11 Association between underbedding and mattress use in childhood and 
respiratory symptoms in the cross-sectional 1995 Childhood Asthma Survey
C hild  resp ira to ry  sym p to m
Child bedding (reference group)*
%  C hild ren  w ith  
b ed d in g  com bin atio n  
w ith  resp ira to ry  
sym p to m s
n /to ta l N O dd s ratio 95%  Cl p va lue
R ecen t W h eeze
Underbedding at age 7 (more than
one type was recorded)
No cover (any cover) 23.0 116/505 1.00 0 .81 ,1 .24 0.997
Cotton quilted (other) 23.3 589/2533 1.03 0 .91 ,1 .16 0.649
Plastic (other) 23.3 182/780 1.02 0 .86 ,1 .22 0.792
Sheepskin (other) 19.7 252/1278 0.78 0.67, 0.91 0.002
Electric blanket (other) 25.3 325/1284 1.18 1.02,1 .36 0.024
Mattress type a t age 7
Foam mattress (vs other*) 24.3 475/1953 1.12 0 .99 ,1 .28 0.071
N ig ht W h eeze
Underbedding at age 7
No cover (any cover) 16.3 83/510 1.17 0 .91 ,1 .50 0.210
Cotton quilted (other) 14.4 368/2564 0.99 0 .86 ,1 .15 0.917
Plastic (other) 13.2 104/788 0.89 0.71,1.11 0.300
Sheepskin (other) 12.4 161/1297 0.81 0.67, 0.97 0.021
Electric blanket (other) 16.9 220/1305 1.27 1.08,1.50 0.005
Mattress type at age 7
Foam mattress (vs other)** 15.2 299/1966 1.10 0 .95 ,1 .28 0.208
A sth m a Ever
Underbedding at age 7
No cover (any cover) 29.0 150/517 1.11 0 .91 ,1 .36 0.290
Cotton quilted (other) 26.9 706/2625 0.99 0.88,1.11 0.835
Plastic (other) 27.5 219/796 1.03 0.87,1.21 0.744
Sheepskin (other) 23.9 314/1316 0.81 0.70, 0.93 0.004
Electric blanket (other) 28.3 378/1339 1.08 0 .94 ,1 .24 0.266
Mattress type at age 7
Foam mattress(vs other)** 28.3 570/2011 1.09 0 .97 ,1 .23 0.140
* Reference group properties not listed for brevity.
"Innerspring mattresses comprised the majority of other mattresses (see Table 4 .10 ).
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Table 4.12 Association between electric blanket and sheepskin use in childhood and 
respiratory symptoms in the cross-sectional 1995 Childhood Asthma Survey
C hild  B edd ing  
(re fe re n c e  g ro up )*
Child respiratory 
symptom
%  C h ild ren  
w ith  bed item  
w ith  
resp ira to ry  
sym p to m s
n / to ta l N
U n ad ju s ted  
O dd s ratio  
(95%  Cl)
P
v a lu e
A d ju s ted  O dds  
ra tio ** (95% C I)
P
va lue
E lec tric  b lan ke t
Wheeze frequency over 
past year
None (0 episodes) 1.00 (reference) 1.00 (reference)
1-3 episodes 16.3 187/1146 1.05 (0.88,1.25) 0.599 1.08 (0.90,1.30) 0.390
4-12 episodes 9.4 99/1058 1.37 (1.08,1.74) 0.011 1.53 (1.19,1.96) 0.001
>12 episodes 3.9 39/998 1.56(1.07, 2.29) 0.021 1.79(1.21,2.65) 0.004
p value for test for trend 0.024 0.003
S h eep sk in
Wheeze frequency over 
past year
None (0 episodes) 1.00 (reference) 1.00 (reference)
1-3 episodes 14.1 168/1194 0.84 (0.70,1.01) 0.063 0.89 (0.74,1.08) 0.229
4-12 episodes 6.0 66/1092 0.75 (0.57, 0.98) 0.038 0.89 (0.67,1.19) 0.433
>12 episodes 1.7 18/1044 0.54 (0.33, 0.90) 0.017 0.65 (0.39,1.08) 0.096
p value for test for trend 0.002 0.083
* Reference group properties not listed for brevity.
“ Adjusted for family history of asthma as a child, use of a synthetic quilt as a child, male sex, exposure to cigarette smoke as a 
child, carpet in the child’s bedroom.
4.6.2.4 Bed type and respiratory symptoms
In the univariate analysis, there was no relationship between the child’s current use of a single 
bed, double bed or the top bunk-bed and recent wheeze, night wheeze and asthma ever (see 
Table 4.13). Table 4.14 shows that when frequency of recent wheeze was examined, for those 
children sleeping in the bottom bunk-bed, there was an increased risk of greater than 12 episodes 
of wheeze (aOR 1.63; 95% Cl 1.01,2.65). Sleeping on the top bunk-bed was not associated with 
respiratory symptoms.
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Table 4.13 Association between bed type in childhood and respiratory symptoms in the 
cross-sectional 1995 Childhood Asthma Survey
Child  resp ira to ry  sym p to m
Child Bedding (reference 
group)*
%  C h ild ren  w ith  
b ed d in g  
c o m b in a tio n  w ith  
w h eeze
n /to ta l N
U n ad ju s ted  
O d d s  ratio
9 5%  Cl p va lue
R ecent W h eeze
Single bed 22.6 1011/4473 1.00 (reference)
Double bed 21.3 26/122 0.91 0.59,1.41 0.677
Top bunk 23.4 153/653 1.04 0 .85 ,1 .25 0.723
Bottom bunk 23.8 156/655 1.06 0 .8 8 ,1 .28 0.546
Supporting frame 22.3 1370/5976 1.49 0.84, 2.65 0.178
N ight W h eeze
Single bed 14.2 639/4517 1.00 (reference)
Double bed 12.3 15/122 0.83 0 .48 ,1 .44 0.515
Top bunk 14.3 95/666 0.99 0 .79 ,1 .25 0.951
Bottom bunk 16.7 110/660 1.22 0 .98 ,1 .52 0.072
Supporting frame 14.4 867/6043 0.90 0 .50 ,1 .64 0.734
A sthm a E ver
Single bed 27.0 1247/4612 1.00 (reference)
Double bed 23.0 29/126 0.80 0 .53 ,1 .22 0.297
Top bunk 27.8 189/679 1.04 0 .87 ,1 .24 0.656
Bottom bunk 27.3 185/678 1.01 0.84,1.21 0.916
Supporting frame 27.2 1679/6174 1.27 0.77, 2.10 0.350
‘ Reference group properties not listed for brevity.
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Table 4.14 Association between bunk-bed use in childhood and respiratory symptoms in 
the cross-sectional 1995 Childhood Asthma Survey
B u nk-bed  (re feren ce  
g roup)*
Child respiratory 
symptom
%  C hild ren  
w ith  bed  
item  with  
resp ira to ry  
sym p to m s
n / to ta l N
U n ad ju s ted  
O d d s  ratio  
(9 5 %  Cl)
p v a lu e
A d justed  O dds  
ra tio ** (95% C I)
p va lue
B ottom  b u n k-b ed  (vs  
top  b un k  b ed)
Recent wheeze 
Wheeze frequency 
over past year
23.8 156/655 1.06 (0 .88 ,1 .28) 0.546 1.09 (0.89,1.33) 0.413
None (0 episodes) 
1-3 episodes 15.3 90/589 0.96 (0 .76 ,1 .22) 0.750 1.03 (0.80,1.31) 0.838
4-12 episodes 8.1 44/543 1.10 (0 .79 ,1 .52) 0.579 1.06 (0.75,1.50) 0.743
>12 episodes 4.2 22/521 1.64(1.03, 2.61) 0.038 1.63 (1 .01 ,2 .65 ) 0.046
p  value for test for 
trend
0.546 0.413
Night wheeze over 
past year
16.7 110/660 1.22 (0.98, 1.52) 0.072 1 .26 (1 .00 ,1 .59 ) 0.048
Asthma ever 27.3 185/678 1.01 (0 .84 ,1 .21) 0.916 1.00 (0.82,1.21) 0.968
‘ Reference group properties not listed for brevity.
“ Adjusted for family history of asthma as a child, use of a synthetic quilt as a child, cat as a pet as a child, number of household 
residents as a child, carpet in the child’s bedroom.
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4.7 DISCUSSION
In the 1997 birth cohort, the use of sheepskin or the use of plastic mattress covers in infancy 
were associated with an increased risk of HDM sensitization in childhood. There was no 
evidence of a synergistic multiplicative interaction when both sheepskin and plastic mattress 
cover were together with an aRR 2.25 (95% Cl 1.05, 4.83). This aRR was not multiplicative of the 
two individual risk ratios, that is aRR 2.06 (95% Cl 1.22, 3.51) for plastic mattress cover and aRR 
2.27 (95% Cl 1.14, 4.55) for sheepskin. This may be demonstrating the importance of closer 
proximity to the airways of one item over another. No association was found between the other 
types of underbedding nor with foam mattress use and HDM sensitization. The type of infant cot 
was not associated with HDM sensitization in childhood.
The strengths of this study include prospective infant bedding measures, the ability to examine 
many potential confounders and the availability of a biological parameter to HDM sensitization 
among the child sample. The study sample was not representative of all live births in the 
geographical area, it consisted of infants born at higher risk of SIDS (436) (see Section 3.2.1). 
However, none of the cohort entry criteria predicted HDM sensitization. After controlling for the 
factors listed in Table 4.3, additional individual adjustment for any scoring system components did 
not alter the results. The results are not likely to be influenced by differential follow-up as the 
proportion of TIHS children followed up from infancy did not differ by the type of bedding to which 
they were exposed. In addition, I was able to control for other bedding variables that are 
associated with underbedding plus a large number of potential confounding factors operating in 
either infancy or childhood. Confounding, including that due to family history of asthma, could not 
explain the identified associations. In fact, the risk ratio increased in magnitude after adjustment 
for significant confounders, showing the importance of being able to take these into account.
There was a good follow-up rate and the children in this study should not differ from other 
children to any large extent with regard to the development of allergic sensitization. Furthermore, 
there was no recall bias or disease related choice in bedding because the bedding exposure was 
measured prospectively and was independent of disease awareness. At the time of assessment 
for HDM sensitization, the research nurse was also unaware of the infant bedding status. The 
findings of similar results in children with no family history of asthma also argue against a 
spurious association caused by the non-selection of sheepskin and/or the selection of plastic 
mattress liners by parents in asthmatic families. However, these findings cannot be conclusive in
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an observational study. The generalizability of the results from this cohort is discussed in 
Chapter 5 (see Section 5.7.6).
Personal exposure measures to HDM allergen levels were not available. However, recent 
studies have also not used intra nasal sampling to directly measure the inhaled HDM dose. 
Furthermore, there is uncertainty concerning the most appropriate measures of personal 
exposure thus, further studies which measure (i) inhaled HDM dose (507), (ii) HDM allergen 
levels both on the mattress surface (168) and in the bedding (167), and (iii) bedding composition 
arrangements during early infancy, may be needed to assess to what extent the reported positive 
association between bedding (for example, sheepskins or bottom bunks) and HDM sensitization 
is mediated by higher exposure to inhaled HDM allergens.
The 1995 Childhood Asthma Survey relied on parental report of exposures. Thus, reporting bias, 
which could result in bias of results away form the null value, may be an issue in this study. In 
addition, due to the cross-sectional nature of the study, the associations demonstrated here may 
reflect wheeze-induced bedding alterations.
4.7.1 Exposure to sheepskin
As stated above, in the 1997 CARHS, sheepskin use in infancy was positively associated with 
subsequent HDM sensitization. Previous work indicates that underbedding may increase the risk 
of HDM sensitization by allergen loading and/or a potentiation of bedding allergenicity (505) (see 
Section 1.5.3). Earlier studies have reported a clear biological plausibility for HDM’s role in 
sensitization as the proteolytic activity of their enzymes can actively damage the airway 
epithelium (508). Infant sheepskins, may harbour very high levels of mites and potentially serve 
as an important source of exposure for infants. Sheepskins have also been found to have higher 
HDM levels than mattresses (483). Moreover, it has been shown that the high levels of airborne 
HDM allergens experienced during sleep are generated from the bedding and not from the floor 
(473). In the absence of experimental or household disturbance, most investigators have been 
unable to detect airborne mite (183). Thus, most exposure is likely to occur when the individual 
contacts and disturbs the dust on the surfaces and in the materials where the mites breed (509), 
such as bedding items. In this study, the exposure to sheepskin in infancy tended to be positively 
associated with HDM sensitization even among the sub-group of those with no at-birth family
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history of asthma, suggesting that the avoidance of sheepskin should not be guided by only a 
family history of atopic disease.
As previously discussed, inhalant allergen sensitization is an important determinant of childhood 
asthma (167,170,175) (see Section 2.2.1.3). The 1997 CARHS and the Infant cohort study with 
1995 follow-up did not demonstrate an association between sheepskin use in infancy and 
subsequent asthma. However, an earlier case-control study of children from the New Zealand 
arm of the ISAAC, found an increased risk of asthma associated with the recalled use of 
sheepskin bedding in infancy (aOR 1.91; 95% Cl 1.11, 3.33) (179). In the 1995 cross-sectional 
Childhood Asthma Survey, there was an inverse association between current use of sheepskin as 
underbedding and wheeze. There was a significant dose-response trend for increasing wheeze 
frequency for the unadjusted analysis which remained greater for more than 12 episodes of 
wheeze compared with less episodes of wheeze in the past year after the adjustment for potential 
confounders. This result may be considered to be most likely due to reverse causality. By age 7 
years, as in this Survey, children with asthma may be avoiding sheepskins in agreement with 
current recommendations (498,499). The inverse association was greater for those children with 
frequent wheeze possibly because those with severe disease would be most likely to make 
disease-related changes to their bedding.
4.7.2 Exposure to plastic mattress liner
The increased risk of sensitization to HDM associated with plastic mattress covers in infancy 
demonstrated in this study is unexpected. No other study has previously reported an association 
between plastic mattress liner and HDM sensitization. Previous studies have shown mattress 
covers to be effective in reducing the amount of HDM allergen in the bed (487,510) of asthmatics 
who were already sensitized to HDMs. However, the threshold level of HDM required to cause 
sensitization in susceptible persons is much lower than the level needed to trigger an asthma 
attack (see Section 2.2.1.2). Occlusive bedding covers are advocated as an important avoidance 
measure to mite allergens (183,485,486). Far fewer mites have been collected from the surface 
of cot mattresses which were either vinyl topped or covered with a plastic coverslip than were 
collected from a cot mattress with a cotton top alone (479). Yet, despite allergen levels being 
dramatically reduced in the weeks after the introduction of such covers (487), long-term 
effectiveness is unknown.
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A recent Cochrane meta-analysis (488) of 29 RCTs from 1980 until 1996, found that bedding 
changes aimed at reducing exposure to allergens from HDMs seem to be ineffective in improving 
the symptoms of asthma in asthmatic people known to be sensitive to HDMs. Overall, the 
Cochrane review found there was no statistically significant difference in improvement of asthma 
(RR 1.04; 95% Cl 0.83, 1.31), asthma symptom scores (standardized mean difference -0.07; 
95% Cl -0.35,0.22), medication usage (standardized mean difference -0.14; 95% Cl -0.43,0.15), 
or peak flow in the morning (standardized mean difference 0.04; 95% Cl -0.13, 0.21), even 
among the sub-group on whom effective allergen reduction was documented (488). The findings 
of two subsequent randomized, double-blind, placebo controlled studies of allergen-impermeable 
bed covers are in accordance with the meta-analysis. The mite-proof bedding covers did reduce 
the level of exposure to mite allergens but did not lead to a significant improvement of clinical 
symptoms in 1,122 aduit patients with asthma (511) or 279 adult patients with allergic rhinitis 
(512). This could be because even though beneficial in relation to HDM allergen reduction (513), 
if the trials did not specifically assess the effect in the sub-group of mite-sensitive asthmatics 
sensitized to HDM, but assessed across all asthmatics, there would be a dilution of the ability to 
detect the mattress cover effect if other causes of non-HDM sensitized asthma were operating. 
Also, these two trials were in adults. An earlier study (15) has reported that when mite avoidance 
measures are taken in the bedroom, mite-sensitive asthmatics appear to improve more quickly, 
and to a greater degree, if they are children than if they are adults: bronchial responsiveness to 
histamine improves 4-fold within 2-4 months in children, but in adults there is only a 2-fold 
improvement after 12 months. These authors postulated that the magnitude of the response may 
be greater in children because they spend more time in bed, than adults, in contact with the high 
concentration of mite allergen that is found in bedding. In addition, HDMs are not the only agent 
that can influence lung function. The home environment, apart from the mattress, is an important 
source of non-specific irritants as well as other allergens. For example, endotoxin and cat 
allergen have been demonstrated to affect nasal and bronchial symptoms (514) (see Section 
2.3.6 and Section 2.2.2).
The use of plastic mattress liner in infancy was not associated with sensitization to other indoor or 
outdoor allergens. The number of children with sensitization to other indoor allergens was very 
small in this study, but in addition, an allergen-specific interaction may be responsible for the 
results reported here. The lack of an association between exposure to infant bedding and 
subsequent ryegrass sensitization is consistent with an exposure effect acting principally on 
inhalant allergens present in the bedding environment. There was no association of infant 
bedding with ryegrass, which demonstrated a prevalence of sensitization similar to HDM (see
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Table 4.1). Furthermore, bedding is known to contain high concentrations of HDM allergen, with 
HDM allergen thus being in larger amounts close to the nasal passages of infants than other 
aeroallergens. One interpretation of this is that the concomitant exposure of the infant to both 
allergen and, for example, VOCs from bedding in early life could be critical, and exposure to 
ryegrass being outdoors and not necessarily occurring in the early months of life might not be 
expected to be influenced by indoor VOCs. Also, the age of sensitization is generally younger for 
HDM than for ryegrass (515), hence infant bedding may be more important for the former. 
Sensitization to other indoor allergens is less prevalent in this study and therefore numbers are 
decreased, with reduced statistical power to detect any effect. In addition, similar considerations 
to variability in early infant exposure could apply.
There may be other adverse effects from the barrier method used. Plastic mattress covers 
release VOCs close to an infants breathing zone. Therefore, the finding that exposure to plastic 
mattress covers is not associated with other indoor allergen sensitization, only HDM, does not 
mean that HDM loading is the only possible mechanism. Plastic mattress covers release VOCs 
which in animal models produce airway inflammation and airflow limitation after a brief one-hour 
exposure (492). Furthermore the presence of these compounds in the bedroom has been 
associated with Th2 deviation and increased allergen sensitization in children (496). This could 
specifically affect HDMs. One possibility is that VOC and HDM interaction at the bedding site is 
greater than at other locations. Sleeping infants whose airway is in close proximity to such 
covers may be exposed to high concentrations of these compounds for considerable periods of 
time (492). Sensitization to inhaled allergens such as HDM could thus be enhanced either by 
airway inflammation resulting in increased airway permeability and enhanced allergen 
presentation to the immune system (491, 492, 516-519), by VOC-induced Th2 deviation (238, 
496,520) or a combination of both.
There is a growing body of work to support the proposition that organic or other components 
affecting infant air quality may induce sensitization to allergens (521). In this Tasmanian birth 
cohort, recently published work reported an increased risk for home gas appliance use at one 
month of age and HDM sensitization (RR 1.98; 95% Cl 1.04, 3.79) with confounder matching 
(504). And, also in this cohort, it was previously demonstrated that infant exposure to indoor gas 
cooking, gas heating and frequent hairspray use in the bedroom were all significantly associated 
with subsequent childhood asthma (245), again implicating organic compounds in the air as a 
factor to be considered.
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Furthermore, in a matched pair case-control study based on the Oslo Birth Cohort, the risk of 
bronchial obstruction during the first two years of life was related to the presence of plasticizer 
(VOC)-emitting (491) surface materials: PVC flooring (aOR 1.89; 95% Cl 1.14, 3.14) and textile 
wall materials (aOR 1.58; 95% Cl 0.98, 2.54) (522). This relation was modified by household 
ventilation. The relation of bronchial obstruction to plasticizer-emission was considerably 
stronger when there was low air exchange (aOR 12.6; 95% Cl 1.00,1.59) than when it was high 
(aOR 2.6; 95% Cl 1.02, 6.58) (523). A subsequent population-based cross-sectional study (524) 
of 2,568 Finnish children aged 1 to 7 years, found that persistent wheezing was strongly related 
to the presence of plastic wall materials (aOR 3.42; 95% Cl 1.13, 10.36). And, Jaakkola et al., 
2004, recently reported in a cross-sectional study of Russian 8-12 year old schoolchildren, that 
risks of current wheeze were associated with recent renovation and the installation of materials 
with potential chemical emissions, such as PVCs: aOR 1.36 (95% Cl 1.00, 1.86) with new 
linoleum flooring; and aOR 1.70 (95% Cl 1.21, 2.40) with new synthetic carpet. Overall, the 
findings reported here support the proposition that chemical emissions may play a role in the 
development of sensitization to allergens and child asthma, and indicate that it would be 
appropriate to consider the type of materials present in bedding items and their potential to emit 
organic chemicals.
4.7.3 Exposure to different mattress type
In the 1997 CARHS, infant mattress type was not associated with HDM sensitization or with 
wheeze in childhood. As discussed earlier, the evidence regarding one mattress type reducing 
allergen exposure over another type is inconclusive, as previous studies report conflicting levels 
of HDM allergen when mattress types are compared (see Section 4.1). Further, the age of the 
mattress may be important and data on mattress age has not been collected here. Custovic et 
al., 1996 (484), however, reported that new mattresses can become a significant source of 
exposure to mite allergens after a short period of time (<4 months). Moreover, some earlier 
studies have reported findings as mattress samples, which were in fact composite samples that 
included dust from pillows, mattresses, quilts and underbedding (480, 525), therefore making it 
difficult to attribute HDM levels to any one particular bedding item. Notwithstanding, a number of 
studies have demonstrated a strong correlation between the current level of HDMs in children’s 
mattresses (type not specified) and specific IgE sensitization (168, 169). Also, in a large 
population survey (478) in Ethiopia, foam mattress use was positively associated with sensitivity 
to D. pteronyssinus (OR 2.09; 95% Cl 1.22, 3.57). In regions of New South Wales, Australia,
131
where mattress Der p I levels were high, in a cross-sectional study (167), more children were 
sensitized to HDMs, and these children had significantly more AHR and recent wheeze. The risk 
of HDM-sensitized children having current asthma doubled with every doubling of Der p I level. 
There was a modest correlation between Der p I exposure in individuals and AHR (r = 0.23, p < 
0.03) (167). Even so, the results reported in this Chapter are in agreement with those from other 
studies that have not found an association with mattress type and HDM sensitization or 
respiratory symptoms. A cross-sectional study in Spain found no significant difference in mite 
sensitization levels related to the type of mattress (foam or innersprings) in 94 subjects (526). 
Also, when data from a New Zealand birth cohort of 677 children was examined retrospectively, 
there was only a slight tendency for the prevalence of any atopy to common allergens to differ by 
different mattress types: 48.2% of children who had an innerspring mattress were atopic 
compared to 34.7% of the children who had not used an innerspring mattress (p=0.09) (497). 
And, the case-control study of children from the New Zealand arm of the ISAAC found no 
association between asthma and current mattress characteristics: kapok versus foam mattress 
(OR 0.35; 95% C! 0.09,1.33); and innerspring versus foam OR 0.87; 95% C! 0.57,1.33) (179).
Furthermore, it has been reported that the recording of mattress type is not a good surrogate for 
measuring actual exposure to HDM allergens as the mattress itself is not a direct source of 
allergen exposure, as mattress dust contains allergens which have filtered down from the upper 
bedding (527). And, as such, it is argued, mattresses are only a proxy for the measurement of 
other allergen sources closer to the subject (527), suggesting that proximity of the bedding to the 
infant’s airways may play a major role in allergen inhalation. The results reported in this Chapter 
may in part support this proposal as I was unable to demonstrate any association, after adjusting 
for confounders, between exposure to certain mattress types in infancy and HDM or wheeze. It 
can be postulated that mattresses contain larger reservoirs than underbedding items yet the 
effect on sensitization to HDM is stronger for the latter. This may indicate that not only is the 
HDM reservoir important but other factors, for example proximity to the airway, may play a 
significant role. In this study, the potential confounders adjusted for included other bedding items 
known to harbour HDM and/or be associated with HDM sensitization in this cohort.
4.7.4 Exposure to different bed type
In the 1997 CARHS, no difference in childhood HDM sensitization or respiratory symptoms by 
bed type in infancy was found. However, in the 1995 cross-sectional Childhood Asthma Survey,
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those children sleeping in the bottom bunk-bed were found to have an increased risk of frequent 
wheeze (aOR 1.63; 95%CI 1.01, 2.65) compared with children sleeping in the top bunk-bed. 
Categorizing bottom bunk-bed versus top bunk-bed in the analysis, ensured there was no “bunk” 
effect and restricted the variability of other potential confounders such as the number of residents 
and sibling effect, as both resident and sibling numbers were considered to be high if families 
were using bunk-beds.
This finding is consistent with results from a cross-sectional study (526) in Spain, of 94 
consecutive bunk-sleeping subjects (47 pairs of siblings). In that study, asthma was found to be 
more prevalent in subjects sleeping on the bottom bunk-bed than those sleeping on the top bunk- 
bed (p<0.05). 60% of subjects showed mite sensitization, but differences between bottom bunk- 
bed and top bunk-bed subjects were not found. A tendency was found towards higher Der p 1 
levels in the bottom bunk-bed compared with the top bunk-bed 11.9 (95% Cl 0.4, 562.29) pg/g 
versus 7.84 (95% Cl 0.27, 140.59) pg/g respectively), although the difference did not reach 
statistical significance (526). As previously stated, measurement of mattress mite levels do not 
necessarily encompass all the mattress reservoirs within the bedding environment (513) and, in 
addition, measurement at a particular moment does not reflect the dynamics of exposure during 
sleep, when movements of the top bunk-bed sleeper may cause particles of top-mattress house 
dust to be released over the bottom bunk-bed sleeper who is also being exposed to allergens 
within his/her own bedding items. Also, sleeping in the bottom bunk-bed may expose the child to 
greater allergen exposure than if sleeping in the top bunk-bed owing to the “sandwich” position 
between two mite infested sets of mattresses and beddings (526).
4.7.5 Exposure to electric blanket
In the cross-sectional 1995 Childhood Asthma Survey, a positive association was found between 
the current use of electric blanket and wheeze. This association was stronger for children with 
more frequent wheeze, particularly for more than 12 episodes of wheeze in the past year, though 
I was unable to demonstrate a significant test for trend for wheeze frequency, possibly reflecting 
inadequate statistical power. At first, these results appear contrary to our understanding of 
conditions favourable for HDM microclimates. A combination of high temperatures (above 30 deg 
C) and a low relative humidity is known to be detrimental to the survival of HDM (528), and such 
conditions may be reached in beds by heating the mattress with the aid of electric blankets at 
times that they are not being slept on (528, 529). An earlier study (529) observed a median
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reduction in concentration to 60% of the initial value concentration of HDMs on mattress surfaces 
in the beds with electric heating blankets compared to an increase to 119% in the beds without 
the blankets (p>0.05) after one year (529). However, another study (528) has reported that 
despite a reduction of between 19% to 84% of the HDM populations in the part of the mattress 
that was covered by the electric blanket, HDMs in the non-heated portions of the mattress were 
much more abundant than in the treated areas (528). Moreover, both these two studies 
concluded that complete elimination of HDMs from already infested mattresses does not seem 
possible with electric blankets. And, from a clinical point of view, it was considered that a 
reduction in the concentration of mites or mite allergen of about 40% such as one of the studies 
had achieved, would probably not be sufficient to benefit HDM-allergic patients (529).
Also, in normal household use, electric blankets are not left on for a period of up to 12 hours 
when not being slept on as occurred in these two studies (528, 529). Normal usage would further 
reduce the time when the heat from the blanket could influence the microclimate of the mattress 
underneath. It has subsequently been reported that the presence of an electric blanket on the 
bed did not influence bed Der p 1 levels in 467 beds of children participating in the New Zealand 
arm of the ISAAC (525). Thus, even with the use of electric blankets, the HDM level may be high 
enough to trigger wheeze in HDM sensitized children. Moreover, higher levels of HDM in other 
parts of the mattress not underlying the electric blanket may migrate to the overlying pillows or 
quilts thereby increasing the HDM allergen load close to the child’s airways. The density of mite 
populations is the highest near the surface (528) and laboratory studies have reported mites tend 
to move towards areas of high humidity and low temperature, finding the best locations within 
their microenvironment (530).
There have been no previous cross-sectional or prospective studies reporting an association 
between electric blanket use and either HDM sensitization or wheeze. Moreover, there are no 
current recommendations regarding the use of electric blankets for children at risk of, or suffering 
from, atopic diseases. The results presented in this Chapter are, to my knowledge, the first to 
identify an association between current use of an electric blanket and wheeze in children. This 
study has found a dose-response trend between electric blanket use and increasing wheeze 
frequency. This may be reflecting HDM sensitization as it has been suggested that symptoms 
such as frequent wheeze may be better markers of HDM-allergen related airway disease than a 
history of asthma or milder symptoms (196) (see Section 2.2.1.6) and, in addition, atopic 
individuals are over-represented at the severe end of the asthma spectrum (181, 195, 196). 
However, this does not mean that a casual relationship must be present. One or more factors
134
might be strongly associated with both exposure and disease to give rise to the pattern found 
here without there being any causal connection between them (456). As electric blankets are not 
used in infancy, it is not possible to exclude reverse causality: the dose-response trend may be 
as a result of children with frequent wheeze being given electric blankets, whereas children with 
no or lesser wheeze were not.
4.8 CONCLUSION
In the cross-sectional 1995 Childhood Asthma Survey, the current use in childhood of an electric 
blanket or sleeping in a bottom bunk-bed are associated with frequent wheeze. A proposed role 
of HDMs contributing to the increased association of frequent wheeze and the use of electric 
blankets or sleeping on a bottom bunk-bed is speculative. The reporting of wheeze episodes as 
outcome measures should reduce the level of disease misclassification by identifying sub-groups 
of children with more frequent episodes of wheeze in the past year that are more likely to reflect 
allergen-induced airway disease rather than airway disturbance due to viral infection or other non- 
atopic factors (195) (see Section 2.2.1.6). Thus, these findings may be related to HDM 
sensitization and as such suggest new areas which might be the subject of further consideration 
and study. In future work, prospective study designs which exclude disease-related changes in 
bedding are required.
This Chapter has reported that an infant’s underbedding in the form of sheepskins and the use of 
plastic mattress covers are associated with the development of HDM sensitization in childhood. 
Infants spend a significant proportion of their time in bed (15) with consequent opportunity for 
prolonged exposure to adverse environmental influences. Furthermore, bedding is a readily 
modifiable environmental factor. Sheepskins are commonly used in infant bedding in Australia 
and New Zealand, although they may have a more restricted use worldwide. However, due to 
their high content of HDM allergen (479, 483), they indicate a likelihood of a high infant exposure 
to HDM allergen when in the bed. The results in this Chapter support current recommendations 
(183, 498, 499) that the use of sheepskins as infant bedding in atopic families is inappropriate 
because they are responsible for significantly greater exposures to HDM allergens. A novel 
finding in this study also included that exposure to sheepskin in infancy tended to be positively 
associated with HDM sensitization even among the sub-group of those children with no at-birth 
family history of asthma. Thus indicating that it may be appropriate to review the current
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recommendation, with a view to extension for all infants, and not only those infants at high-risk of 
acquiring asthma, to avoid the use of sheepskins in infancy.
The results reported here also suggest that greater attention and further study should be given to 
other potentially adverse environmental factors related to the bedding environment such as 
VOCs. Plastic mattress covers are used throughout the world as part of infant bedding, largely 
for the protection against bedwetting. Current New South Wales Health recommendations to 
minimize exposure to HDM state “consideration should be given to encasing children’s 
mattresses and pillows with high quality impermeable mattress covers” (498), and the National 
Asthma Council, Australia recommends encasing of mattresses in mite-proof covers (499). 
However, there is no specific recommendation regarding the actual material composition of the 
mattress cover. Moreover, as demonstrated by the Cochrane review, there is conflicting 
evidence regarding the efficacy of using mattress covers in the prevention of asthma symptoms 
despite a reduction in HDM levels. The results presented in this Chapter are not consistent with 
the use of plastic/vinyl mattress covers to be recommended for infants at high-risk of atopic 
disease, and in addition, further studies should be undertaken considering potential factors other 
than HDM, for example VOCs, that may initiate and/or trigger asthma in those individuals 
exposed to plastic mattress covers.
The role of bedding manipulation in primary prevention of atopy and wheeze may not yet have 
been fully assessed and future RCTs addressing these issues could prove worthwhile. 
Observational studies of bedding are potentially complicated by selection bias: children with 
asthma may preferentially use one type of bedding rather than another. Selection bias cannot be 
fully excluded in this observational study: it is unlikely, but children at risk of atopy may have been 
given bedding items such as sheepskin. Bedding is a feasible intervention for a RCT to confirm 
the causal nature of these findings. And, identification of modifiable factors contributing to the 
burden of asthmatic disease would have considerable public health benefit.
4.9 POST-SCRIPT
This Chapter provides new information which will increase the evidence base for 
recommendations on bedding and asthma prevention. Current recommendations may not be 
addressing all environmental factors that are associated with the development and/or triggering of 
asthma. Consideration needs to now be given to other bedding items, in addition to the proximity
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of these materials to the nasal passages. The following Chapter 5 will consider both the 
composition of bedding materials and the bedding item’s relative proximity to the airways as it 
examines the role of infant cocoon and sleeping bags in allergic sensitization and respiratory 
health.
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Chapter 5
Infant cocoons and sleeping bags: allergic sensitization and 
respiratory health
5.0 PREFACE
This Chapter examines the relationship between two specific bedding items in infancy, cocoons 
and sleeping bags, and the development of child wheeze and HDM sensitization. The two 
prospective studies, the Infant cohort study with 1995 follow-up and the 1997 CARHS have been 
analysed and the findings described in this Chapter.
The findings from the Infant Cohort Study with 1995 follow-up have been reported in a recently 
published paper (see Appendix 4):
Trevillian LF, Ponsonby AL, Dwyer T, Lim LL, Kemp A, Cochrane J, Carmichael A. A prospective 
association between cocoon use in infancy and childhood asthma. Paediatric and Perinatal 
Epidemiology 2004; 18(4):281 -189.
5.1 INTRODUCTION
HDM levels have been shown to vary within the different bedding materials, and significantly 
higher levels of dust mite allergens (9, 531-534) are found in synthetic bedding than in feather 
bedding. Der p allergen levels (in terms of geometric means) have been found to be 5 to 8 times 
greater in synthetic pillows than in feather pillows (9, 532, 534). Over a 12 month period, new 
synthetic pillows accumulated higher concentrations of Der p 1 (19.28 /yg/g; 95% Cl 9.76, 38.07) 
than new feather pillows (6.45 /vg/g; 95% Cl 2.96,14.05) (535). Also, synthetic quilts have been 
found to have 15-fold higher Der p 1 levels compared to feather quilts (ratio geometric mean Der 
p 1 ytyg/m2: 15.45; 95% Cl 4.28, 55.8) (9). ■>
Prospective studies have not previously examined the role of synthetic bedding and HDM 
sensitization. Two cross-sectional studies have reported differing results: one study finding mite 
sensitization levels were not related to the type of mattress bedding material (526) and the other,
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that foam (synthetic) mattress use was associated with an increased risk of sensitization to D. 
pteronyssinus (478) (see Section 4.1).
There have been, however, numerous studies reporting, from both developing and first world 
environments, that the use of synthetic bedding (foam mattresses, pillows, and blankets) is 
associated with a significantly increased risk of childhood wheeze. As of April 2004, seven cross- 
sectional studies (136, 197, 478, 505, 536-538) and two prospective studies (12, 13) have 
reported associations between synthetic bedding and wheeze, and in addition, two cross- 
sectional studies have reported an association between synthetic bedding and rhinitis (539, 540).
Two population-based case-control studies (136) investigated the association between childhood 
wheeze in schoolchildren 7-8 years of age and changes in the home environment between 1978 
and 1991 in Croydon, London (see Section 2.6). The study found that of the potential indoor 
environmental risk factors examined, the increasing use of non-feather pillows (from 44% in 1978 
to 67% in 1991 among control children) explained greater than half of the 20% increase in the 
population prevalence odds of current wheeze (OR 1.20; 95% Cl 1.04,1.39) in 1991 compared to 
1978. The use of non-feather pillows was positively associated with childhood wheeze (OR 1.54; 
95% Cl 1.13, 2.10). A subsequent population based case control study of schoolchildren in 
Sheffield, UK, compared secondary schoolchildren with frequent or severe wheeze with children 
with no wheeze, and found that pillows with synthetic fillings were a risk factor for severe 
childhood asthma (OR 2.78; 95% Cl 1.89, 4.17), after the exclusion of asthmatic subjects whose 
bedding had been changed because of their disease (197). This association remained evident 
when the children with severe asthma was restricted to those children whose parents denied 
making changes in the bedroom because of allergy. The results from these studies prompted 
speculation that the increase in the use of non-feather pillows contributed to the increasing 
exposure to HDM, which in turn could have been partly responsible for the increase in childhood 
wheezing (198).
In a recent cross-sectional study of children in Canberra, Australia, synthetic quilt use was 
associated with asthma (aOR 1.67; 95% Cl 1.05, 2.65) and recent wheeze (aOR 2.11; 95% Cl 
1.33, 3.34) among SPT-positive to aeroallergens, including Der p, children but not SPT-negative 
children (505). These results support the view that if the adverse respiratory effect of synthetic 
bedding, is mediated by the previously documented higher HDM allergens found in synthetic 
bedding (9, 531-534), this adverse effect would be more evident among children who were 
sensitized to aeroallergens rather than among non-sensitized children.
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The Oslo Birth Cohort (12) explored the association between early life exposure to feather versus 
non feather (synthetic and other) bedding (quilts) and found that the aOR for bronchial obstruction 
in children from 0 to 2 years of age, by exposure to feather quilt at age 6 months was 0.59 (95% 
Cl 0.41, 0.86); and for asthma at the age of 4 years was aOR 0.38 (95% Cl 0.23, 0.64). When 
parallel analyses were performed including only children with either feather or synthetic quilt 
(excluding the ‘other’ category), equal risk variation between feather and synthetic quilt as 
between feather and non-feather quilt were obtained. In addition, in children from the TIHS birth 
cohort, synthetic pillow use at one month of age has recently been reported to be associated with 
frequent wheeze (>12 epsiodes wheeze in the past year) at age 7 (aRR 2.5; 95% Cl 1.2, 5.5) 
independent of childhood exposure (13).
These studies, described above, have reported on the association between the synthetic bedding 
items of mattresses, quilts and pillows and increased risk of childhood wheeze. Thus, other 
synthetic bedding items such as cocoons or sleeping bags, might also influence asthma 
development or symptoms.
Cocoons are similar to a padded sleeping bag with a hood that comes close to the sides of the 
baby’s head, fully encasing the infant, leaving only the face exposed (see Figure 5.1). While lying 
within the cocoon, the infant is then placed on a flat surface or in the cot or pram. A pillow is 
usually not used in conjunction with a cocoon nor, unless it is exceptionally cold, would it be 
necessary to place an additional covering on top of an infant lying within a cocoon. If attached, 
straps allow the cocoon to be hand carried or tied against the mother’s chest. Infants placed in 
cocoons or baby nests may spend prolonged periods of time with their airways in closer proximity 
to the cocoon material than if placed on other thinner composite bedding, for example compared 
to cotton blankets which are washed more frequently, potentially increasing any adverse effect on 
respiratory health mediated by close proximity. There is currently no specific health advice 
available regarding the respiratory health effects of the use of cocoons or sleeping bags 
containing synthetic materials in infancy.
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Figure 5.1 Infant Cocoon
This Chapter describes the prospective relationship between an infant’s use of cocoons or 
sleeping bags and HDM sensitization and asthma in childhood. The aim of this Chapter is to test 
the hypothesis that the use of, predominantly synthetic, cocoon/baby nests or sleeping bags in 
infancy is associated with the respiratory symptoms of wheeze in childhood and/or HDM 
sensitization.
5.2 METHODS
At the home interview in the TIHS data collected as part of the infant’s sleeping environment
included the infant’s use of a cocoon or a sleeping bag as an item of bedding, not clothing. The
use of a cocoon at the time of interview or intention to use a cocoon in cold weather was
recorded, thereby avoiding the effect of current season when interviewed. In 1994, further details
regarding cocoons and sleeping bags were collected. At least 84% of cocoons were noted by the
research nurse at the one month home interview, to be either quilted or padded. In addition,
infant cocoons manufactured and sold in Southern Tasmania during the cohort study period most
commonly comprised outer coverings of cotton or polycotton with a polyester (synthetic) filling.
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Sleeping bags that were used as bedding items tended to be padded similar to the cocoons but 
with a lesser quantity of material.
For this Chapter, only prospective data using the TIHS birth cohort was analysed. The two study 
sample populations are: (i) the 863 children for whom a home interview had occurred at one 
month of age in 1988 as part of the TIHS and who also took part in the 1995 Childhood Asthma 
Survey (see Figure 3.1, Section 3.2.2); and (ii) the 499 children in the CARHS.
5.3 STATISTICAL METHODS: THE 1995 CHILDHOOD ASTHMA 
SURVEY
5.3.1 Exposure variables
The bedding exposure variables of interest were (i) cocoon use in infancy and (ii) sleeping bag 
use in infancy. Both variables were dichotomous for exposure or no exposure.
5.3.2 Outcome variables
The dichotomous outcome variables were the child’s recent wheeze or night wheeze in the past 
12 months and asthma ever. Wheeze frequency over the past year was also examined. Wheeze 
over the past year was defined as 1-3 episodes; 4-12 episodes; or greater than 12 wheeze 
episodes compared with no wheeze as the baseline group (see Section 4.3.2).
5.3.3 Generalized linear modeling
A generalized linear model with a log link function and binomial error structure was used to 
control simultaneously for multiple confounders and to obtain confidence intervals for relative risk 
(RR) estimates (452) (see Section 3.1.5.3).
To identify potential confounders, the association between a large number of factors and 
childhood wheeze was examined (see Table 5.4). More than 40 confounders were further 
examined to see how they each related separately to cocoon use and wheeze. A generalized 
linear model was then constructed as follows. Each potential confounder (330) was individually
142
added to the model as a covariate if the variable was associated with wheeze in the exposure to 
outcome analysis, or had been reported to be related to asthma in the literature. Change-in 
estimate methods (466) was used to examine the confounding effect of these factors on the 
exposure-disease association. Those factors that altered the point estimate for the exposure- 
wheeze association by 10 percent or more were included in the final model. In addition, the 
remaining variables in Table 5.4 were added as individual factors into the final model. None of 
these factors altered the adjusted risk ratios reported in Table 5.5 and were not retained in the 
final confounder set. Pearson chi-square test was used to further explore the possible 
associations between the explanatory variables.
5.3.4 Discrete-time proportional hazards modeling
The relation between infant cocoon use and age of onset of asthma symptoms was assessed 
using discrete-time proportional hazards modeling (541). Discrete-time proportional hazards 
model estimates, by maximum likelihood estimation, two discrete time (grouped duration data) 
proportional hazards regression models, and can be estimated as a regression model for a binary 
dependent variable. Discrete-time models estimate both time-varying covariates and flexible 
specifications of duration dependence, where multiple occurrences of tied failure times are also 
easily handled (542). This approach was used to model the length of time (in years) up to the 
age of onset of asthma for each child because age of onset was only recorded in complete years, 
thus the ages of 12.1 to 12.9 would have been recorded as ‘12’. This method is in contrast to the 
proportional hazard modeling used in Section 4.3.3.1 where a small time interval (At) was used in 
contrast to complete years (0, 1, 2, ..., 7) examined here. The distribution of durations until the 
age of onset of asthma is modeled via the probabilities of having asthma at each value t. There 
is a one-to-one relationship between these probabilities -  ‘hazard rates’ -  and the probabilities of 
having completed durations of different lengths until the onset of asthma -  summarized by the 
‘survivor function’. More precisely, the discrete-time hazard rate h/f is:
h/f=prob (T, = t|T/>t:X/f)
where X,y is a vector of regressor variables (covariates) which may vary with time. T,- is a discrete 
random variable representing the time at which the onset of asthma occurs. In this study, it is the 
difference in T/s distribution by cocoon exposure which is of primary interest (541).
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5.3.5 Matched cohort analysis
As the numbers of children who used a cocoon in infancy were small, a matched cohort analysis 
was also conducted to evaluate the effect of cocoon use in infancy on asthma. Matching can 
prevent confounding (see Section 3.3.4). In a cohort study with matching by exposure status, 
none of the potentially confounding variables that have been matched are likely to be 
confounding the exposure-disease association because none will be associated with the 
exposure in the study population. Potentially confounding factors are thus similarly distributed in 
those children exposed to cocoons and those children without cocoon exposure.
A matched pair stratified analysis with exposed matched to non-exposed on confounder status, 
optimizes the amount of information obtained per child (448) and addresses the difficulty in 
controlling for multiple confounders with rare exposures. The confounder status here refers not to 
a single confounder, but to a set of confounders. In a cohort study that compares risks, no 
additional action is usually required in the analysis to control confounding by the matching factors; 
the process of matching has eliminated confounding by the matching factors (448). However, 
care has to be taken to consider whether any residual confounding exists by also adjusting for the 
matched factors in the analysis stage. This is particularly an issue where the matched factor is 
broadly categorized (for example, smoking or not) and thus residual variation within each 
matched group can occur. For example, the exposed child may be matched by parental smoking 
status but some parents may smoke lightly, whereas others heavily. Matching on exposure can 
be undertaken without regard to the disease status which is unknown at the start of follow-up, 
thereby preventing selection and recall bias (448).
Fourteen strata were constructed based on 7 possible confounder combination sets. Each of the 
19 children with cocoon use was matched with non-exposed children in relation to: at-birth family 
history of asthma, any gas heating as infant, synthetic quilt use in infancy, only child at age 7, 
mother smoked during pregnancy, low maternal education at birth, and air freshener used in 
bedroom as infant. Mantel-Haenszel methods were used for the analysis of the matched-pairs 
(330). The 14 confounder sets are shown at Table 5.1.
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Table 5.1 Confounder sets by strata for the Infant cohort study with 1995 follow-up for the 
assessment of infant cocoon use and subsequent wheeze
Strata
C o n fo u n d er s tatus
Fam ily  
history  of 
asthm a at 
birth
Gas
heating
in fant
Synthetic  
as q u ilt use in 
in fancy
M o th er
O nly  child  s m o ked  
at age  7 d u rin g
p re g n a n c y
. A ir
oyN  . freshen er
m atern a l . .
used in
e d u c a tio n a l b e d ro o m a s
birth  . . .
in fant
1 0 0 0 0 V • 0
2 0 0 0 0 0 0 0
3 V 0 0 0 V V V
4 V V 0 0 V • 0
5 0 0 0 0 V V V
6 V 0 0 0 V V 0
7 0 0 V 0 V V V
8 V 0 0 0 V • 0
9 V 0 V 0 0 V 0
10 0 0 0 0 0 t V
11 0 0 0 0 V V 0
12 0 0 V 0 V • 0
13 V 0 0 0 0 t 0
U 0 0 0 0 0 • 0
Legend: V = confounder present;
0 = confounder absent; 
• = no data available.
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5.3.6 Population attributable fraction
The aetiologic fraction of asthma in childhood attributable to cocoon use in infancy was calculated 
as p(aRR-1)/aRR, where p denotes the proportion of children with cocoon use in infancy among 
those with the outcome of asthma and aRR equals the relative risk estimate for cocoon use and 
asthma, after adjustment for the confounders listed in Table 5.4 (see Section 4.3.3.4).
5.4 RESULTS: THE INFANT COHORT STUDY WITH 1995 FOLLOW­
UP
5.4.1 Characteristics of the study population
The study population is the same as that described in Section 4.6.1. Data were available for 
recent wheeze, night wheeze and asthma ever on 823, 834 and 863 children respectively (see 
Table 4.8 Section 4.6.1.1). Data on use of cocoon in infancy was available on 802 children. 
Cocoon use in infancy of 2.4% (19/802) was low. And, only 0.85% (7/823) of children used 
sleeping bags as a form of bedding in infancy. The additional study sample characteristics are 
presented at Table 5.2 (additional to Table 4.8 in Section 4.6.1.1).
Table 5.2 Additional characteristics of the study population in the Infant cohort study with 
1995 follow-up
C a teg o ric a l m easu res % n /to tal N
Bedding exposure variable
Infant cocoon 2.4 19/802
Infant sleeping bag 0.85 7/823
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5.4.2 Univariate analysis
5.4.2.1 Cocoon use and its association with childhood wheeze
Cocoon use in infancy was associated with recent wheeze in childhood (RR 2.00; 95% Cl 1.29, 
3.12). The use of a cocoon in infancy was associated with both night wheeze (RR 2.27; 95% Cl 
1.31, 3.93) and history of asthma ever (RR 1.63; 95% Cl 1.05, 2.53) in childhood. Analysis by 
frequency of wheeze episodes is presented in Table 5.3. Cocoon use in infancy was associated 
with an increased risk of more episodes of wheeze (Test for trend, p=0.015) however, the number 
of infants in each category of wheeze was very small and no further analysis was undertaken 
using the outcome measures of wheeze frequency.
Table 5.3 Cocoon use in infancy and asthma symptoms by number of wheeze episodes for 
the Infant Cohort Study with 1995 follow-up
R esp ira to ry  s y m p to m  in 
1995
N
C o co o n  use  
in in fan cy
%
U n ad ju s ted  RR (95%  Cl) fo r  
c o co o n  use  and w h eeze
p va lue
N o w heeze 559 9 1.6 1.00 (re fe rence)
1-3 ep isodes o f w heeze 117 5 4.3 2.11 (1 .0 2 ,4 .3 5 ) 0 .043
4-12  ep isodes  o f w heeze 61 4 6.6 3 .2 8 (1 .4 0 ,7 .6 8 ) 0 .006
>12 ep isodes o f w heeze 28 1 3.6 2 .1 4 (0 .3 2 ,1 4 .2 2 ) 0 .432
Test fo r tren d 0 .015
5.4.3 Confounder identification
To identify potential confounders, how each factor related separately to the use of cocoon in 
infancy and also to recent wheeze was examined. The infant factors of most relevance are 
summarized in Table 5.4. Potential confounders included: small sibling size (543), infant and 
child exposure to tobacco smoke (245) and home gas heating (245), infant synthetic pillow use 
(13), sheepskin use and season of birth.
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Table 5.4 Identification of potential confounders: unadjusted relative risk for selected 
factors and infant cocoon use and recent wheeze in the Infant cohort study with 1995 
follow-up
Cocoon use in 
infancy
Unadjusted RR 
(95%  Cl)
p value
Recent w heeze in 
1995
U nadjusted RR 
(95%  Cl)
p value
Exposure variables
Cocoon * 2 .0 0 (1 .29 ,3 .12 ) 0.002
Potential confounding variables
P a r e n ta l  f a c to r s
Mother smoked during pregnancy 2.33 (0.89, 6.07) 0.083 1.41 (1.12,1.77) 0.003
Teenage motherhood** 0.86 (0.26, 2.93) 0.814 1.19 (0.90,1.56) 0.225
Family history of asthma at child’s birth 1.31 (0.53, 3.22) 0.557 1 .50 (1 .20 ,1 .88 ) <0.001
Family history of asthma in 1995 3.55 (1 .03 ,12 .26 ) 0.045 2.27 (1.72,2.99) <0.001
Low maternal education at child’s birth 0.66 (0.14, 3.16) 0.602 1.13(0.63 , 2.03) 0.678
Low paternal education at child’s birth 0.77 (0.27, 2.18) 0.618 1.24 (1.04,1.93) 0.023
Maternal postnatal smoking at 1 month 2.66 (1.02, 6.92) 0.037 1 .38 (1 .10 ,1 .73 ) 0.006
Maternal smoking at child age 7 4 .42 (1 .45 ,13 .44 ) 0.004 1.45 (1 .15 ,1 .81 ) 0.001
Duration of second stage labour (5, 15 vs 0, 2.15 (0.88, 5.22) 0.084 1.09 (0 .85 ,1 .39) 0.497
5 mins)**
Duration of second stage labour (CS*** vs 0, 0.25 (0 .03 ,1.84) 0.136 1.00 (0.75,1.34) 0.989
5 mins)**
Season of birth (May-Jun vs Mar-Apr)** 0.62 (0.21,1.86) 0.393 1.12 (0 .8 8 ,1 .4 3 ) 0.344
Season of birth (Aug-Feb vs Mar-Apr)** 2.80 (1.07,7.29) 0.028 1.02 (0.81,1.28) 0.854
In fa n t  fa c to rs
Male sex** 0.90 (0.35, 2.33) 0.825 1.42 (1.08,1.88) 0.010
Infant first born 0.50 (0 .18 ,1.37) 0.166 1.06 (.85,1 .33) 0.604
Low birth weight** 0.64 (0.19, 2.17) 0.467 0.99 (0 .75 ,1.30) 0.916
Intention to bottle feed at birth** 1 .79(0.73, 4.40) 0.199 1 .2 6 (1 .01 ,1 .58 ) 0.045
Multiple births** 0.77 (0.18, 3.30) 0.726 0.89 (0 .62 ,1.27) 0.504
Prematurity 0.53 (0 .12 ,2.27) 0.382 1.06 (0 .80 ,1 .41) 0.673
Solid food introduced by phone interview at 1.36 (0.56, 3.31) 0.494 1 .3 0 (1 .04 ,1 .72 ) 0.024
10 weeks
Infant exclusively breast fed by phone 0.18 (0 .02 ,1.36) 0.060 0.67 (0.49, 0.92) 0.009
interview at 10 weeks
C h i ld h o o d  fa c to r s
History of eczema 1.76 (0.68, 4.56) 0.240 1.75 (1.39,2.20) <0.001
History of hay fever 2.03 (0.79, 5.26) 0.137 2.87 (2.34, 3.52) <0.001
History of bronchitis 1.46 (0.55, 3.89) 0.452 2.58 (2.08, 3.21) <0.001
148
Table 5.4 continued
C o co o n  use in 
in fan cy
U n ad ju s ted  RR  
(95 %  Cl)
p v a lu e
R ecen t w h eeze  in 
1995
U n ad justed  RR  
(95%  Cl)
p va lue
History of pneumonia ★ 1.87 (1.40, 2.50) <0.001
Child ’s fish consumption vs none 0.75 (0.22, 2.54) 0.642 0.76 (0 .57 ,1.02) 0.082
No siblings in 1995 ★ 1.68 (1.18, 2.38) 0.009
H o u s e h o ld  fa c to rs
Private health insurance at birth 0.90 (0.36, 2.27) 0.827 0.71 (0 .55 ,0.91) 0.005
Home gas appliance use in infancy 1.79 (0 .25 ,12.89) 0.559 1.25 (0 .73 ,2 .16) 0.439
No-one smoking in same room as infant 0.60 (0 .22 ,1 .65) 0.317 0.72 (0.56, 0.93) 0.009
More than six residents in household at birth 0.68 (0.16, 2.90) 0.599 0.90 (0 .65 ,1.26) 0.549
Cat as pet during infancy 0.53 (0 .18 ,1 .59) 0.249 1.09 (0.86,1.37) 0.491
Paternal full time employment at child age 7 0.77 (0 .31 ,1 .93) 0.573 0.91 (0 .72 ,1.15) 0.446
B e d r o o m  fa c to rs  - in fa n t
Infant sleeping in bedroom alone 0.44 (0 .13 ,1 .49) 0.171 0.84 (0 .65 ,1.09) 0.180
Carpet in infant’s bedroom 0.30 (0 .11 ,0 .80) 0.013 0.89 (0.62,1.28) 0.535
Humidity in infant’s bedroom>75% 0.87 (0.12, 6.35) 0.888 1.22 (0 .79 ,1 .88) 0.389
W indow in infant’s bedroom open at night 1.26 (0.52, 3.05) 0.616 1.05 (0 .83 ,1.32) 0.690
Sheepskin underbedding 0 .1 2 (0 .0 2 ,0 .9 1 ) 0.014 0.99 (0 .78 ,1.27) 0.962
Plastic mattress liner 0.88 (0 .35 ,2 .22) 0.792 0.99 (0 .79 ,1.25) 0.933
Foam mattress as infant 1.58 (0.58, 4.35) 0.367 1.05 (0 .83 ,1.33) 0.705
Use of feather quilt as infant * 0.74 (0 .21 ,2.57) 0.619
Use of synthetic quilt as infant 0.19 (0.06, 0.65) 0.003 1.05 (0.84,1.33) 0.654
Use of feather pillow as infant 3.98 (0.58, 27.28) 0.141 0.94 (0.35, 2.51) 0.894
Use of synthetic pillow as infant 1.51 (0 .51 ,4 .48) 0.455 1.29 (0 .97 ,1.72) 0.086
Use of air freshener in infant’s bedroom 4.25 (1 .47 ,12.30) 0.005 1.52 (1.04, 2.22) 0.047
B e d r o o m  fa c to r s  - c h i ld
Sleeping on bottom bunk as child — 1.11 (0 .81 ,1.52) 0.509
Use of feather quilt as child 0.51 (0 .20 ,1 .33) 0.158 0.85 (0 .68 ,1.07) 0.166
Use of synthetic quilt as child 3 .06 (1 .18 , 7.97) 0.016 1.29 (1 .03 ,1 .61 ) 0.027
Use of feather pillow as child 0.70 (0 .09 ,5 .14) 0.722 0.86 (0 .53 ,1.38) 0.516
Use of synthetic pillow as child 0.58 (0 .17 ,1 .95) 0.375 1.04 (0 .71 ,1 .54) 0.825
Carpet in child’s bedroom 0.49 (0.12, 2.06) 0.322 0.93 (0 .58 ,1.49) 0.755
‘ Indicates insufficient data for analysis.
“ The cohort entry scoring system was based on a composite score derived from these factors (437). Multiple births were 
automatically included.
*“ CS represents caesarian section.
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5.4.3.1 Cocoon use and family history
An at-birth family history of asthma was not significantly associated with cocoon use in infancy 
(RR 1.33; 95% Cl 0.53, 3.22), however, a family history of asthma in 1995 was significantly 
associated with cocoon use (RR 3.55; 95% Cl 1.03,12.26).
5.4.3.2 Cocoon use and maternal smoking
Both childhood and infant exposure to maternal smoking were associated with wheeze (see 
Table 5.4). In fact, 88% (311/354) of mothers who smoked when their infant was one month of 
age, were still smoking when their child was aged 7 years. The association between infant and 
childhood maternal tobacco smoke exposure was highly significant (Pearson’s x2 (1 df) = 470.12; 
p< 0.001). The association between cocoon use and recent wheeze remained significant after 
adjustment for maternal smoking (aRR 1.88; 95% Cl 1.21, 2.93) indicating that exposure to 
cocoons is not just a marker of the mother’s smoking but is independently associated with 
wheeze. Maternal smoking is significantly associated with recent wheeze (RR 1.38; 95% Cl 1.10, 
1.73). The association between cocoon use and recent wheeze remained significant when 
adjusted for both maternal smoking and a family history of asthma at birth (aRR 1.71; 95% Cl 
1.12, 2.62). Maternal smoking was not associated with family history of asthma at birth 
(Pearson’s x2 (1 df) = 0.31; p=0.579).
5.4.4 Univariate analysis of sleeping bag use and its association 
with childhood wheeze
There was a tendency for sleeping bag use in infancy to be associated with recent wheeze in 
childhood but the association was not statistically significant (RR 1.60; 95% Cl 0.67, 3.78). 
Similarly, the use of a sleeping bag in infancy was not significantly associated with either night 
wheeze (RR 1.50; 95% Cl 0.46,4.87) or a history of asthma ever (RR 1.32; 95% Cl 0.56,3.13).
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5.4.5 Multivariate analysis of cocoon use and its association with 
childhood wheeze
5.4.5.1 Generalized linear models
The association between cocoon use and recent wheeze remained after adjustment for the 
perinatal entry criteria as either individual factors or as a set. These results are shown at Table 
5.5. Adjustment for mattress type and mattress cover type, including sheepskin or plastic 
mattress cover, had little effect. Additional adjustment for synthetic quilt or pillow use in infancy 
further increased the association between cocoon use and childhood wheeze (aRR 4.33; 95% Cl 
2.08, 9.02). The association remained significant between the use of cocoon in infancy and night 
wheeze (aRR 3.35; 95% Cl 1.52, 7.39), and with a history of asthma (aRR 2.56; 95% Cl 1.33, 
4.92). The population attributable fraction for recent wheeze in childhood associated with cocoon 
use in infancy was 4.3%.
Table 5.5 The association between cocoon use in infancy and asthma symptoms in 
childhood in the Infant cohort study with 1995 follow-up
Respiratory 
symptom in 
1995
Cocoon use in 
infancy %
RR (95%CI) for 
cocoon use and 
respiratory 
symptom
aRR (95%C\) for 
p value cocoon use and 
respiratory symptom
p value
No wheeze* 
Recent wheeze
559
196
9
10
1.6
5.1
1.00 (reference) 
2.00(1.29,3.12) 0.002
1.00 (reference) 
4.33(2.08,9.02) <0.001*
No night wheeze* 626 
Night wheeze 148
11
8
1.8
5.4
1.00 (reference) 
2.27(1.31,3.93) 0.003
1.00 (reference) 
3.35 (1.52, 7.39) 0.003*
No asthma ever* 539
Asthma ever 262
9
10
1.7
3.8
1.00 (reference) 
1.63(1.05,2.53) 0.029
1.00 (reference) 
2.56(1.33,4.92) 0.005*
'Reference category.
“ Adjusted for at-birth family history of asthma, home gas appliance use in infancy, synthetic quilt use in infancy, synthetic pillow
use in infancy, maternal education at birth, maternal smoking at infant one month age, no other siblings in 1995.
151
The association with family and childhood history of atopic disease was examined. Further 
adjustment for at-birth family history of asthma did not alter the results in Table 5.5, and the 
positive association with cocoon use in infancy and recent wheeze remained significant after 
adjustment for the child’s history of eczema, hay fever and asthma, and also the family history of 
asthma in 1995. These positive associations persisted after adjustment for the factors listed in 
Table 5.5 and individual adjustment for over 40 possible confounders including those listed 
above. The parents of infants with an at-birth family history of asthma were not selectively using 
cocoons (42.1% use versus 35.6% non-use, p=0.556). Exposure to cocoon was positively 
associated with recent wheeze (RR 2.56; 95% Cl 1.45, 4.51) even among children without an at- 
birth family history of asthma.
5.4.5.2 Matched cohort analysis
The matched estimate was obtained using data on 383 children in 14 matched sets, based on the 
7 possible confounder combinations. The number of children, exposed and non-exposed to 
cocoon as an infant, within each confounder combination are tabulated by each outcome variable 
and presented in Table 5.6. The RR for cocoon use in infancy and subsequent recent wheeze in 
this matched analysis was 2.72 (95% Cl 1.06, 6.95). The relative risks for subsequent night 
wheeze and a history of asthma ever were 2.73 (95% Cl 1.11,6.75) and 2.44 (95% Cl 0.85, 6.97) 
respectively.
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Table 5.6 Matched cohort analysis for the Infant cohort study with 1995 follow-up
Strata Recent wheeze N ight wheeze History o f asthma
Com binations 
of 7 potential 
confounders*
Children
using
cocoons in 
infancy
Children
non-
exposed to 
cocoons in 
infancy
Children
using
cocoons in 
infancy
Children
non-
exposed to 
cocoons in 
infancy
Children
using
cocoons in 
infancy
Children
non-
exposed to 
cocoons in 
infancy
1 3 58 3 58 3 64
2 2 11 2 12 2 12
3 1 1 1 1 1 1
4** 1 2 1 2 1 2
5 1 3 1 3 1 3
6 1 10 1 10 1 10
7 1 2 1 2 1 2
8 3 33 3 34 3 35
9 1 13 1 13 1 13
10 1 3 1 2 1 3
11 1 20 1 20 1 21
12 1 57 1 57 1 61
13 1 44 1 46 1 46
14 1 89 1 89 1 91
Total 19 346
, 19
349 19 364
'Potential confounders in each set: at-birth family history of asthma, any gas heating as infant, synthetic quilt use in infancy, only 
child at age 7, mother smoked during pregnancy, low maternal education at birth, air freshener used in bedroom as infant.
“ In stratum 4, for one exposed child, synthetic quilt in childhood data was not available, so this child was matched with two non- 
exposed children with the same confounder profile who also had missing synthetic quilt data.
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5.4.5 Age of onset of wheeze
The use of cocoon in infancy did not relate to the age of onset of wheeze (aRR 0.61; 95% Cl 
0.23, 1.63). There was insufficient data to determine the association between cocoon use and 
wheeze frequency by sub-groups. Figure 5.2 shows the age of onset of asthma by cocoon use.
Figure 5.2 Age of onset or wheezy breathing by cocoon use in the Infant cohort study with 
1995 follow-up
Age of onset (years)
5.5 STATISTICAL METHODS: THE 1997 CARHS 
5.5.1 Exposure variables
The two dichotomous bedding exposure variables were the same as Section 5.3.1: cocoon use in 
infancy and sleeping bag use in infancy.
5.5.2 Outcome variables
HDM sensitization refers to a positive SPT (wheal size >3 mm diameter) (see Section 4.3.2). The 
dichotomous outcome variables for wheeze were the same as Section 5.3.2, that is, the child’s 
recent wheeze or night wheeze in the past 12 months and asthma ever. As the number of
154
children who used cocoons as infants is small, there was insufficient data to assess outcome 
variables for wheeze frequency of the number of episodes over the past year.
5.5.3 Study population and method of analysis
In this study population of 499 children, described in Section 4.4.1, only 1.22% (5/406) of these 
children used cocoons in infancy. There was only one child (1/411; 0.24%) who used a sleeping 
bag as bedding in infancy. No further analysis was undertaken on sleeping bags.
As the sample of infants with cocoon use is small (n=5), Fisher’s exact test was used. For 
dichotomous variables with an expected frequency of <5, more chance variation must be allowed 
for, and a Fisher’s exact test will calculate a significance test of the null hypothesis that the 
means are equal (544). Fisher’s exact test allows computation of the exact probability of the 
occurrence of the observed frequencies (545). Here in this study, the Fisher’s exact test 
indicates results with very small numbers for each outcome variable which are non-significant, so 
it was not appropriate to use more sophisticated methods of analysis.
5.5.4 Lung function tests 
5.5.4.1 Simple linear regression
Simple linear regression models were used to examine the effect of exposure on the continuous 
outcomes of FEVi, FVC and the ratio of FEVi to FVC. The simple linear regression equation 
(545):
y = a  + ßx
explains the change in one variable, denoted y, the outcome variable, corresponding to the 
change in the other explanatory variable, denoted x. Multiple linear regression models are 
discussed in Section 3.1.5.2.
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5.6 RESULTS: THE 1997 CARHS
5.6.1 Cocoon use, HDM sensitization and child wheeze
There was no increased risk of subsequent HDM sensitization for children who used a cocoon in 
infancy (Fisher’s exact test, t = 0.193, p=0.847). No statistically significant association was found 
between cocoon use in infancy and the respiratory symptoms in childhood of recent wheeze 
(p=0.569), night wheeze (p=0.927) or asthma ever (p=0.868). These results are presented in 
Table 5.7.
Table 5.7 Association between cocoon use in infancy and wheeze in childhood for the 
1997 CARHS
R esp ira to ry  sym p to m
%  child ren  w ith  cocoon  
w ith  w heeze
F is h e r’s e xact t fo r c o c o o n  use and  
re s p ira to ry  sym p to m
P value
Recent wheeze 40.0%  (2/5) -0.570 0.569
Night wheeze 20.0% (1/5) -0.092 0.927
Asthma ever 40.0%  (2/5) -0.167 0.868
There were no significant differences in the mean Spirometrie values between children exposed to 
cocoons in infancy compared to children who did not use cocoons in infancy. Children who used 
a cocoon in infancy did not demonstrate a greater reduction in their unadjusted difference in 
mean FEVi/FVC ratio when compared to children with recent wheeze or frequent wheeze, but 
they did have lower FEV, and FVC volumes. These results are presented in Table 5.8.
Table 5.8 Unadjusted mean difference (95% Cl) in spirometric values for children using a 
cocoon in infancy in the 1997 CARHS
U nad justed U n ad justed U n ad ju s ted
d iffe rence  in m ean d iffe re n c e  in m ean d iffe re n c e  in m ean
V ariab le
FE V i (m L ) w ith  
95%  Cl betw een
p va lue
FVC  (m L ) w ith  
9 5%  Cl b etw een
p va lue
F E V i/F V C  (% ) w ith  
9 5 %  Cl betw een
p va lue
child ren  w ith  and ch ild ren  w ith  and ch ild re n  w ith  and
w ith o u t variab le w ith o u t v a riab le w ith o u t variab le
Recent
wheeze
0.95 (-4.5, 6.4) 0.732 3.6 (-3 .2 ,10 .5 ) 0.301 -1.2 (-2.5, 0.10) 0.070
Frequent
wheeze
-19.9 (-34.2, -5.7) 0.006 -16.1 (-33 .9 ,1 .7 ) 0.077 -3.6 (-6.9, -0.38) 0.029
Cocoon -31.3 (-56 .5 ,-6 .2) 0.015 -37.8 (-68.2, -7.3) 0.015 1.1 (-4 .8 ,7 .1 ) 0.711
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5.7 DISCUSSION
In the Infant cohort study with 1995 follow-up, the use of cocoon was associated with a more than 
2-fold increased risk of recent wheeze, nocturnal wheeze and asthma ever at age 7 years. There 
was a non-significant tendency for sleeping bags to also be associated with wheeze.
For the 1997 CARHS, there was no increased risk of subsequent HDM sensitization for children 
who used a cocoon in infancy. No statistically significant association was found between cocoon 
use in infancy and the respiratory symptoms in childhood of recent wheeze, night wheeze or 
asthma ever.
The findings reported in this Chapter are based on a small number of exposed individuals to the 
use of either cocoons or sleeping bags in infancy, and the findings may have been a result of 
chance (330). The positive findings in regards to cocoon use and wheeze need to be confirmed 
in other studies. In the Infant cohort study with 1995 follow-up, the small number of children 
exposed to sleeping bag in infancy (n=7) may have contributed to the failure to detect a 
statistically significant effect in this cohort, arising in a Type II error (448). The most common 
reason for a Type II error is that the number of observations are too few and have failed to 
demonstrate a difference between the two groups (that is exposed and non-exposed to sleeping 
bags). Similarly, in the 1997 CARHS, the number of children exposed to either cocoon or 
sleeping bag in infancy may have been too small to reveal any significant association between 
subsequent wheeze, changes in lung function or HDM sensitization (see Section 3.2.4.2).
The internal validity (330) of this inference (that is, the adverse role of infant cocoon use on 
wheeze) as it pertains to the members of the source population should be considered. Internal 
validity is a study where “the index and comparison groups are selected and compared in such a 
manner that the observed differences between them on the dependent variables under study 
may, apart from sampling error, be attributed only to the hypothesized effect under investigation” 
(461). Three general types of bias can detract from internal validity: selection bias, information 
(measurement) bias, and confounding (330).
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5.7.1 Selection bias
The positive results reported in this Chapter are not likely to be influenced by differential follow-up 
as the proportion of TIHS children followed up from infancy did not differ by whether they used a 
cocoon or not. This prospective cohort study has collected standard information over time and 
has a high response rate, both factors minimizing selection bias (461). Moreover, the findings 
indicate that atopic children were not preferentially using or avoiding the use of cocoons as 
evidenced by the lack of association with eczema and rhinitis in infancy and an at-birth family 
history of asthma.
5.7.2 Measurement bias
Limitations of this study included the use of a parental questionnaire and the absence of a 
biological or physician assessment of asthma. The ISAAC questionnaire, however, is considered 
a valid instrument for the determination of current asthma symptoms in the past 12 months and 
has been previously validated (440) (see Section 3.2.2.1). As the exposure was measured 
prospectively and was independent of disease awareness, there was no recall bias. In addition, 
at the time of assessment for wheeze, the research nurse was also unaware of the infant bedding 
status, thus minimizing observer bias, another sub-type of measurement bias. Differences in 
health care utilization between cocoon users and non-users, and the potential for increased 
reporting of symptoms should not influence the findings of this study.
Cocoons manufactured and sold during the study period most commonly comprised synthetic 
materials. Reporting of the material composition of cocoons was undertaken in 1994. And, at 
that time, no cocoon was described by the research assistants as having a non-synthetic 
material. It is considered that during the study period, cocoons contained polyester/synthetic 
filling, with/without synthetic-containing outer fabric. However some infants may have been 
exposed to cocoons made of natural materials. This could lead to misclassification of the record 
of cocoon taken to indicate synthetic cocoons. This misclassification would likely be non­
differential (330). That is, the proportion of children misclassified on exposure (synthetic cocoon 
or no synthetic cocoon use) is unlikely to depend on disease status and thus the bias would be 
toward the null value (of no relation). Therefore, if this non-differential misclassification was 
present, it would reduce the study’s ability to detect the effect of cocoon use on wheeze.
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5.7.3 Confounding
The association between cocoon and wheeze was increased in magnitude after the negative 
association between cocoon and other synthetic bedding use was taken into account. It is 
noteworthy that the prospective association persisted after adjustment for many possible 
confounding factors by individual stratification and a matched cohort analysis. These 
confounders included bedding variables and other potential confounding factors operating in 
either infancy or childhood. Matching was used as a further mechanism to both control 
confounding and to improve the precision with which information was obtained regarding those 
children who as infants used cocoons, and as a means to confirm the estimates of the relative 
risks obtained from the individual stratified analysis (464). Confounding, including that due to 
infant or child exposure to maternal smoking or family history of asthma, could not explain the 
identified associations. Only one variable for maternal smoking, when infant aged one month, 
was included as a potential confounder in the final model due to the high collinearity between this 
variable and the variable for maternal smoking when child aged 7 years.
Cocoon use is not associated with an at-birth family history of asthma, however, cocoon use is 
associated with a family history of asthma in 1995. This may mean that the family is still using 
cocoons or other similar bedding, and that as cocoon use is now associated with a family history 
of asthma in 1995, perhaps it is the younger siblings also using cocoons who develop asthma 
that contribute to this positive family history in 1995, which is not evident at the index case’s birth 
as the association with asthma is not only with the index child.
It is not possible to clearly associate one particular population with use or non-use of cocoons. A 
search of the literature did not identify any other studies detailing factors associated with cocoon 
use in other populations. However, in this study the role of potential indicators of socioeconomic 
status such as private health insurance, level of maternal education, level of paternal education, 
and father’s unemployment at the time of birth were explored. None of these factors showed any 
association with cocoon use. Exposure to environmental tobacco smoke and less breastfeeding 
at 10 weeks were controlled for in the final model and their inclusion did not alter the positive 
association between cocoon use and wheeze.
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5.7.4 A causal role for cocoon and childhood wheeze
The adverse role of synthetic bedding on asthma has been demonstrated in previous studies (12, 
478, 536, 538) (see Section 5.1). And, the findings in this Chapter add to the causal inference of 
synthetic bedding causing asthma. These results meet the Bradford-Hill criteria (546) of 
consistency but as they are based on only one observational study, I am unable to report that the 
role of cocoon use in the development of child wheeze is causal. Moreover, the prospective 
findings in this study were based on a small number of exposed children and further studies are 
required to confirm these findings.
It is important to note that no study to date has shown a lower wheeze prevalence with exposure 
to synthetic bedding (12, 478, 536, 538). Moreover, it has previously been reported (13) in the 
1995 Childhood Asthma Survey that the association between synthetic upper bedding and 
frequent wheeze in childhood displayed the features of high strength of association, temporality, 
dose-response and consistency (330). These features when considered with the results from the 
previous studies (see Section 5.1) indicate that the association between infant cocoon use and 
childhood wheeze may be causal in nature. If causal, the population attributable fraction for 
recent wheeze in childhood associated with cocoon use in infancy was low, 4.3%, reflecting the 
rarity of the exposure.
5.7.5 Possible biological and physical mechanisms for the observed 
results
Cocoons provide an intimate and prolonged relationship between the cocoon material and the 
infant’s breathing zone. Thus one possibility for the effect reported in this study is that exposure 
to HDM allergen in synthetic cocoons could contribute to the increased development of wheeze in 
children (see Section 2.2.1). However, cocoon use did not appear to predict HDM sensitization. 
A full investigation of mechanisms, including whether bedding-asthma associations are mediated 
through HDM sensitization, is beyond the scope of this current thesis. There are also 
mechanisms related to bedding items, other than HDM allergen loading, that may be contributing 
to childhood wheezing. These mechanisms are discussed in Chapter 4. An increased risk of 
asthma related to the indoor emissions of VOCs has been demonstrated in children and adults 
(495, 522, 547), and VOCs released in low concentrations from synthetic materials close to the 
breathing zone might increase mucosal permeability to inhaled allergens (197) or promote
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sensitization to HDM within the household environment similar to that which has been observed 
for indoor gas heating (504) or other infant bedding materials, such as plastic mattress covers 
(548) (see Section 4.7.2).
Reduced exposure to bacterial endotoxin levels is another environmental factor that has been 
postulated to contribute to the development of child wheeze. Exposure to house dust endotoxin 
may protect against the development of atopy by enhancing Th1 responses during perinatal life 
(270) (see Section 2.3.6). A study in a community hospital in the Netherlands, found synthetic 
pillows harboured fewer bacterial products than feather pillows (549). However, a recent report 
(11) from New Zealand that endotoxin levels were not significantly different between synthetic 
and feather pillows (synthetic: feather ratio [endotoxin units per gram of dust] 0.78; 95% Cl 0.54, 
1.15) may make this a less likely mechanism of action in regards to synthetic bedding items, 
including cocoons. This study was, however, based on only eight pairs of pillows, each pair 
consisting of a synthetic and feather pillow from each bed, indicating that further studies are 
required to clarify endotoxin levels in bedding items.
The length of exposure to the bedding environment may be further increased as the infant is often 
transported from the bed to other locations while still remaining within the cocoon. In addition, 
with the close proximity of the synthetic cocoon material to the infant’s airway it is likely that 
exposure to bedding related factors such as allergens, VOCs or endotoxins may occur in a 
continuous low dose fashion.
5.7.6 Generalizability of the study findings
As previously discussed, there is no prior evidence with regard to an infant’s use of cocoons 
containing synthetic materials and adverse respiratory effects in childhood. It is important to 
determine if the results reported in this Chapter are generalizable beyond the study sample. “A 
study is externally valid or generalizable if it can produce unbiased inferences regarding a target 
population (beyond the subjects in the study)” (461). This is meaningful only with regard to a 
specific external population (461). And, a study’s results must be true for the subjects studied, 
that is internally valid, before the findings are considered for generalization to different settings 
(330). The internal validity of this cohort study has been considered above (see Section 5.7). 
The small number of infants exposed to cocoons or sleeping bags does potentially impact on the
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study’s internal validity because chance cannot be excluded as being responsible for the 
observed results.
The TIHS cohort is not representative of the general infant population of Australia. This cohort 
comprised one-fifth of live births in the defined geographical area of Tasmania, but weighting in 
selection of individual infants was given to risk factors for SIDS (436). However, the lack of 
representativeness of the cohort should not be considered as affecting external validity. In order 
for the results of an analytical cohort study to be generalized to other populations it is not 
necessary for the cohort to be representative of the community from which it was selected (330, 
550). The key concerns with regard to a study base are that the eligible participants are well 
defined, that there is good distribution of determinants, confounders and modifiers in the study 
and adequate sample size (550). The TIHS cohort fulfils the criteria that would support the 
generalization of the findings of this birth cohort. The eligible participants have been well defined, 
all satisfy the cohort-entry selection criteria and there is sufficient variability in exposure and 
potential confounders. Moreover, the potential effects of the entry scoring system components 
were taken into account in the multivariate analyses. After controlling for the factors listed in 
Table 5.5, further adjustment for these perinatal entry criteria did not alter the results. Thus, the 
TIHS cohort entry criteria are unlikely to affect the generalizability of these results. The children 
in this study should not differ from other children to any large extent with regard to the biological 
development of asthma. However, the bedding items used in Tasmania in 1988 may not be 
similar to modern cocoons in other settings thus making the applicability of these results less.
5.8 CONCLUSION
In conclusion, the results of this study add to the increasing evidence for a role for infant bedding 
items in the development of childhood asthma. This study is unique. There are no other studies, 
especially no prospective studies on infant cocoon use and child wheeze. The findings suggest 
that synthetic cocoon use in infancy is associated with an increased subsequent risk of child 
asthma. The use of cocoons in infancy is an easily modifiable environmental factor but currently 
there is no clear evidence base regarding possible health effects. No study to date, moreover, 
has shown a lower prevalence of wheeze with exposure to synthetic bedding. However, the 
number of children exposed to cocoons in this cohort study was small and further studies are now 
required to confirm these findings.
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5.9 POST-SCRIPT
Bedding items, and more specifically their material composition, are gaining recognition for their 
possible role in childhood asthma. Chapter 4 and Chapter 5 have postulated that the adverse 
effect of different types of underbedding, such as sheepskin and plastic mattress covers, and 
cocoons with subsequent HDM sensitization and child asthma may be mediated through 
mechanisms that may be enhanced by proximal airway exposure. In Chapter 6, the issue of 
proximity to airway exposure is explored as the interaction between bedding and different sleep 
positions with regard to child wheeze is examined, with specific reference to synthetic quilts.
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Chapter 6
The association between childhood sleep position, bedding 
and respiratory health
6.0 PREFACE
This Chapter examines the relationship between synthetic quilt use and sleep position in 
childhood and child asthma. The cross-sectional study, the 1995 Childhood Asthma Survey, has 
been analysed and the findings described in this Chapter.
The findings from this Chapter have been reported in a recently published paper (see Appendix 
5):
Ponsonby AL, Dwyer T, Trevillian L, Kemp A, Cochrane J, Couper D, Carmichael A. The bedding 
environment, sleep position, and frequent wheeze in childhood. Pediatrics 2004; May 
113(5):1216-22.
6.1 INTRODUCTION
Chapters 4 and 5 have reported associations between both underbedding, sheepskin and plastic 
mattress liners, and cocoon use in infancy with subsequent HDM sensitization or childhood 
wheeze. The adverse effect of these bedding items may be mediated through some mechanism 
that involved proximal airway exposure. And, as discussed, higher allergen loading near a child’s 
airway has also been proposed as one possible explanation (9, 532, 534) for the numerous 
cross-sectional and prospective associations between synthetic bedding and childhood wheeze 
(see Section 5.1). These reported associations may, however, reflect selection bias. Studies of 
bedding are potentially complicated by selection bias as children with asthma may preferentially 
use synthetic rather than feather bedding, based on the concept that they are non-allergenic (as 
opposed to feather pillows) (198). The majority of these studies reporting an association between 
synthetic bedding and childhood wheeze were based on exposure to pillows alone. It is less 
recognized that upper bedding, such as quilts, can also be a source of HDM exposure during 
sleep. Recently, synthetic quilts have been shown to have a markedly higher Der p content than 
feather quilts (9, 551): the ratio (synthetic: feather) of the geometric mean for Der p (ug/m2) was 
15.45 (95% Cl 4.28, 55.8) (9). In addition, a 10-fold reduction of airborne HDM allergen near the 
face during sleep was obtained by replacing used overlying quilts with new quilts (473). The
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authors in that study, concluded that the HDM airborne allergens near the face during sleep were 
generated from the used bedding, and not from the bedroom floor (473). Moreover, other studies 
(444, 481) have reported poor correlation between HDM allergen levels in the bed and the floor, 
supporting the view that measuring antigen levels in carpet is not a good indicator of inhaled 
antigen load (552).
Personal aeroallergen exposure may be influenced by the level of reservoir allergens, the nature 
of the allergen source, proximity of airways to the source, level of dust disturbance, level of 
ventilation and indoor humidity, the size of particles carrying the allergen and the rate of breathing 
of the individual (507, 553). Inhalation of HDM allergen is believed to occur principally through 
airborne allergen inhaled into the nose. Bedding is proximal to the human airway and will 
contribute to the airborne allergen load if physically disturbed (474). Moreover, high levels of 
airborne allergen are generated if the bedding is infested with mites as a person’s normal 
movement during sleep probably renders surface allergen airborne and available for inhalation 
(473). In addition it has been reported that uptake of a dust mite allergen particle-surrogate from 
allergen-containing surfaces, such as pillows, also occurs by direct nose transfer (554).
Specificity of association, refers to the extent to which a single well-characterized factor can be 
shown to be responsible for a single disease (9, 555) It is one of the criteria for proving causality 
between an environmental exposure and non-infectious illness defined by Bradford-Hill (9, 546). 
The validity that specificity confers on any causal inference regarding the exposure effect has 
been questioned (9, 330, 556). However, there are instances in which specificity can be used in 
support of a causal hypothesis (556, 557). According to Weiss, 2002 (557), one such 
circumstance applies to the specificity of exposure, that is, where only the exposure initially 
predicted to be associated with an outcome actually is observed to be associated with it.
The bedding environment is ideal to examine whether an expected specificity of association is in 
fact observed as one can study the influence of bedding for different sleep positions. This 
approach has previously been used to examine the interaction between bedding environment and 
sleep position in sudden infant death research (558). For example in the SIDS research study, 
an adverse effect of quilt use was observed among infants who slept supine or on the side (aOR 
6.16; 95% Cl 2.01, 18.87)) but not among prone sleeping infants (difference in effect, p=0.01) 
(559).
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This Chapter reports a novel approach to assess the role of bedding in asthma by examining the 
interaction between bedding and different sleep positions with regard to child wheeze. 
Specifically, if it could be demonstrated that synthetic quilt use, for example, conferred a different 
risk if a child slept in a different sleep position then the case for synthetic quilt use being causally 
related to asthma would be strengthened. If the adverse effect was mediated through some 
mechanism that involved the bedding being in close proximity to the airway one would postulate 
that the association between overlying synthetic quilt use and adverse respiratory outcomes 
would be specifically observed among children sleeping supine, where the face would be closer 
to overlying bedding. This aim of this Chapter is to consider specificity of exposure as it pertains 
to synthetic quilt use and its association with frequent wheeze. The hypothesis is that the 
association between synthetic quilt use and frequent wheeze is significantly stronger among 
children who slept supine compared with children who slept non-supine.
6.2 METHODS
For this Chapter, the cross-sectional data from the 1995 Childhood Asthma Survey was analysed. 
The child’s current bedding and usual sleep position were recorded by parental questionnaire for 
the 6,378 seven year children participating in the 1995 Childhood Asthma Survey (see Section 
3.2.2).
6.3 STATISTICAL METHODS
6.3.1 Exposure variables
6.3.1.1 Child bedding
Overbedding refers to any bedding items that covered the child’s body above the sheet and was 
classified into three categories: any synthetic quilt, feather quilt, and other bedding (that is, 
neither feather nor synthetic quilt) used. The most common type of bedding in the other category 
was blankets. Quilts, doonas or duvets of dacron, polyester or other synthetic composition were 
classed as synthetic quilts. A small number of children in childhood (n=23) were excluded 
because the pillow was described as “anti-allergy” but information on composition was not 
available. Synthetic pillows were those reported as foam/sponge/tontine/polyester/dacron. 
Sheepskin was any wool fleece under-bedding with either hide or material backing. Dichotomous
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exposure variables, synthetic versus feather quilt use (the main measure of bedding exposure); 
and, other overbedding versus feather quilt use were created.
6.3.1.2 Usual sleep position
Sleep position was classified as supine if the parents reported that the child usually slept on the 
back in response to the question “What position does your child usually sleep in?” Children 
usually sleeping on the side or on the stomach were termed non-supine sleepers. A dichotomous 
variable, children who slept supine versus children who slept non-supine was the main indicator 
of sleeping position.
6.3.2 Outcome variables
6.3.2.1 Respiratory wheeze and measures of iung function
Frequent wheeze was defined as children with greater than 12 wheeze episodes over the past 
year compared to children with no wheeze as the baseline group (see Section 4.3.2).
Disease misclassification within the broad spectrum of asthma has been a large problem in 
asthma epidemiology (see Section 2.2.1.6). For this bedding study, we were interested in 
identifying children who would be more likely to have HDM-triggered airway disease rather than 
those with asthma due to other mechanisms. We chose to compare children with frequent 
wheeze for the following reasons. Firstly, as a better marker of HDM-related airway disease 
revealing more bedding-wheeze patterns: (i) children with asthma who are also sensitized to 
FIDM are more likely to have severe or frequent asthma (181); (ii) feather pillow and quilt use has 
been inversely associated with severe wheeze (197); and (iii) it has been previously reported 
using the 1997 CARFIS that HDM-sensitized children are much more likely (p<0.0001) to have 
frequent wheeze than non-sensitized children in this setting (Prevalence Ratio 19.6; 95% Cl 6.9, 
55.6) (196). Secondly, in this 1995 Childhod Asthma Survey, current synthetic overbedding 
(pillow and quilt) use has been reported previously to show a strong association with frequent 
wheeze (aRR 5.2; 95% Cl 1.3-20.6, for12 episodes or more) but not with moderate wheeze (1-12 
episodes) (13).
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The continuous outcome variables of lung function were FEVi: both baseline and post-exercise 
spirometric measures were used, the latter after six minutes of free running (442). Post-exercise 
FEVi, is a lung measure previously observed to be lower in children with recent wheeze or 
asthma (442) (see Section 3.2.2.1). Exercise challenge lung function was obtained on a subset 
of children (n=414) from randomly selected schools (see Section 3.2.2).
6.4 STATISTICAL METHODS: THE 1995 CHILDHOOD ASTHMA 
SURVEY
6.4.1 Logistic regression
The Breslow Day test, a test of homogeneous association across the strata, was first used to 
examine differences in the association between synthetic versus feather quilt use and severe 
wheeze by sleep position strata (452).
Univariate odds ratios were calculated using simple logistic regression (560). The logistic 
regression equation (330) is given by:
exp (a + ßx)
p (probability) = ________________
1 + exp (a + ßx)
This logistic model is equivalent to an exponential odds model (see Section 5.5.4).
The reference group chosen for upper bedding was feather quilts because this bedding type (i) 
has lower HDM levels (532, 534), and (ii) has been previously associated with reduced wheeze 
compared to synthetic quilts (196, 198). We examined the interaction between quilt type and 
sleep position by comparing synthetic to feather quilts. Most children (88.1%) slept under these 
two overbedding types (see Table 6.1). For sleep position, children who slept supine were 
compared to non-supine sleeping children and children with no usual sleep position were 
excluded.
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6.4.2 Matched case-control analysis
A nested case-control study with each child with frequent wheeze, matched to control children 
with no wheeze over the past year, among the children who were reported to have a usual sleep 
position was utilized to increase efficiency. In total, 117 children with frequent wheeze were 
matched to 1,162 controls with up to 10 controls per case (452). Each index child was matched 
to the nearest controls by date of birth and to those who had the same status as the index child 
with regard to four characteristics: gender, foam mattress or not, electric blanket or not and 
sheepskin or not (see Section 5.3.5). More than 80% of controls were born within a month of the 
index case. Conditional logistic regression was used in the matched analysis where each 
matched set was standardized with regard to underbedding except for pillow type. As feather 
pillows and allergen-occlusive mattress covers were too uncommon to allow adequate matching, 
they were considered as additional confounders in the matched analyses.
6.4.3 Multiple logistic regression modeling
Multiple logistic regression models were used to examine the relation between quilt use, sleep 
position and reported respiratory outcomes with control for confounders (560). The difference in 
the quilt-wheeze associations by sleep position was examined by the log likelihood ratio test for 
the reduction in deviance associated with the addition of an interaction term into the logistic 
model (561). The risk estimates for each factor and the interaction term were adjusted for the 
confounding effect of the other components in the model.
The term statistical interaction denotes the interdependence between the effects of two or more 
factors within the confines of a given model of risk (562). Here, the interaction is based on a 
multiplicative model. This is using a logistic model in which the excess incidence rate of a 
disease in the population exposed to, say, two agents (measured as the difference with respect to 
the non-exposed population) is equal to the sum of the excess in the population exposed only to 
the first agent, plus the excess in the population exposed only to the second, plus a third term 
expressing the interaction effect of the two agents when both are present (563). Within this frame 
of reference, the key feature of the multiplicative model is that its interaction term is an explicit 
and easily computable function of the other two terms (the two relative rates) so that, when the 
multiplicative model holds, no independent estimation of this term is required (563). Any
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interactions observed would also be present in an additive model but negative or absent findings 
can not be taken to mean that additive interactions are not present (564).
6.4.4 Lung function tests
The lung function sample was relatively small so synthetic quilt use was examined as a 
dichotomous exposure to maximize the numbers within each category for analysis. Multiple 
linear regression models were used to examine FEVi as a continuous outcome with adjustment 
for relevant confounders (447) (see Section 3.1.5.2).
6.5 RESULTS: THE 1995 CHILDHOOD ASTHMA SURVEY 
6.5.1 Characteristics of the study population
The study population has been reported in Section 4.6.2 and comprised 6,378 children who 
turned seven years of age in 1995. Synthetic pillow or quilt use was common. Feather quilt use 
was also common but feather pillow use was not. Most parents were able to report a usual child 
sleep position with 86% of children with either frequent wheeze (117/136) or no wheeze 
(4,048/4,707) reported to have a usual position. More than a third of the children slept supine. 
Among non-supine children, the side position (n=2,564) was much more common than the prone 
sleep position (n=484). Although many children had recent wheeze (23%), only 2% (n=136) of 
children were reported to have had frequent wheeze with more than 12 episodes in the last year. 
The additional study sample characteristics (see Table 4.10) are presented below in Table 6.1.
170
Table 6.1 Distribution of sleeping environment characteristics and respiratory wheeze in 
the 1995 Childhood Asthma Survey
C h a ra c te r is t ic T o ta l N n %  w ith  v a r ia b le
Usual sleep position: 6355
Supine (on back) sleep position 2431 38.3
Non-supine (on side or prone) 3048 48.0
No usual sleep position or other 876 13.8
O verbedding type: 6345
Any synthetic quilt use 2649 41.7
Feather quilt use 2941 46.4
O ther overbedding 755 11.9
Pillow  type: 6340
Any synthetic pillow 5709 90.0
Feather pillow 231 3.6
O ther pillow 400 6.3
Sheepskin underbedding 6307 1331 21.1
Electric blanket 6307 1347 21.4
Allergen-occlusive mattress cover 54 0.86
Foam mattress 2038 32.0
Bed type: 6354
Single bed 4662 73.4
Bottom bunk bed 686 10.8
Other 1006 15.8
W heeze frequency over the past year: 6107
None (0 episodes) 4707 77.1
M oderate (1-12 episodes) 1264 20.7
Frequent (12 episodes or more) 136 2.2
Recent wheeze 1400 22.9
Asthm a ever 6307 1710 27.1
171
6.5.2 Univariate analysis
6.5.2.1 Sleeping environment and other characteristics associated 
with frequent wheeze or sleep position
The univariate analysis is shown in Table 6.2. Usual supine sleep position (versus usual side or 
prone) was not significantly associated with frequent wheeze (OR 0.90; 95% Cl 0.61, 1.33). 
Frequent wheeze was positively associated with synthetic quilt, synthetic pillow, electric blanket 
and sleeping in a bottom bunk. A supine sleep position was associated with electric blanket or 
foam mattress use but not with frequent wheeze, rhinitis or eczema. Asthma medication type and 
use over the past year did not relate to sleep position. In Australia in 1997, bedding advice to 
children with asthma included the use of an allergen-occlusive mattress cover and sheepskin 
avoidance (565). Consistent with the recommendation, children in this study with frequent 
wheeze were more likely (OR=18.39; p<0.0001) to sleep on allergen-occlusive covers but less 
likely (OR=0.54; p=0.02) to sleep on a sheepskin. There was no difference in the association 
between allergen-occlusive cover use or sheepskin use and recent wheeze by sleep position.
172
Table 6.2 The univariate association between sleeping environment, child characteristics 
and frequent wheeze or supine sleep position
C h ara c te ris tic  (re feren ce  group)
O dds R atio  (95%  C l) 
For freq u en t w h e e ze
p va lue
O d d s  R atio  (95 %  Cl) 
For s u p in e  s leep  
positio n
p va lue
S leep in g  e n v iro n m e n t
Usual supine position (usual side or prone) 0.90 (0 .61 ,1 .33) 0.585
Synthetic quilt (feather quilt) 1.74 (1.20, 2.51) 0.004 1.03 (0 .92 ,1 .16) 0.427
Other overbedding (feather quilt) 1.37 (0.78, 2.39) 0.27 0.92 (0 .77 ,1.10) 0.546
Synthetic pillow (feather pillow) 3 .24 (1 .03 ,10 .24 ) 0.045 0.98 (0 .78 ,1 .23) 0.813
Other pillow (feather pillow) 3.07 (0 .68 ,13.85) 0.145 1 .14 (0 .81 ,1 .61 ) 0.457
Sheepskin underbedding (no sheepskin) 0.54 (0.33, 0.90) 0.017 1.06 (0 .93 ,1.20) 0.400
Electric blanket (no electric blanket) 1.56(1.07, 2.29) 0.021 1 .1 7(1 .02 ,1 .33) 0.039
Foam mattress (no foam mattress) 1.35 (0 .95 ,1.92) 0.095 1.21 (1 .08 ,1.36) 0.001
Bottom bunk bed (other type of bed) 1.76 (1 .08 ,2 .88) 0.039 0.96 (0 .81 ,1.15) 0.812
Allergy occlusive cover (non-use) 18.39 (8 .10 ,41.74) <0.0001 1.37 (0.77, 2.46) 0.283
Feather pillow (no feather pillow) 0.26 (0.08, 0.82) 0.021 1.12 (0 .92 ,1.38) 0.266
C hild  ch a ra c te ris tic s
Male sex 1.31 (0 .93 ,1 .85) 0.119 1.07 (0 .96 ,1.20) 0.208
P rem a tu re  (<37 wks) b irth 2 .1 9 (1 .31 ,3 .64 ) 0.003 0 .8 3 (0 .68 ,1 .02 ) 0.078
Breastfed in infancy 0.65 (0.45, 0.95) 0.025 0.94 (0 .83 ,1.07) 0.385
No siblings 1.31 (0.66, 2.62) 0.436 0.95 (0 .75 ,1 .20) 0.650
Family history of asthma 5.43 (3.50, 8.41) <0.001 1.05 (0 .94 ,1.17) 0.386
C h ild ’s h is to ry  of:
Eczema 3.69 (2.60, 5.23) <0.001 1 .15 (1 .01 ,1 .31 ) 0.030
Hayfever 9.05 (6 .37 ,12.86) <0.001 1.14 (1 .00 ,1 .30 ) 0.057
Pneumonia 6.11 (4.00, 9.33) <0.001 1.23 (0 .99 ,1.52) 0.056
Bronchitis 6.09 (4.30, 8.62) <0.001 1.06 (0 .93 ,1 .20) 0.385
Father fu lltim e employment 0.69 (0.49, 0.98) 0.040 0.91 (0 .81 ,1.02) 0.103
Low maternal education (<12 years) 1.67 (1 .16 ,2 .42) 0.006 1.11 (1 .00 ,1.24) 0.056
Maternal smoking 1 .58 (1 .11 ,2 .25 ) 0.011 1 .12 (1 .00 ,1 .26 ) 0.055
Exposed to indoor smoking in same room 1.62(1.15, 2.29) 0.006 1.08 (0 .97 ,1 .20) 0.171
Cat as fam ily pet 0.89 (0 .63 ,1.26) 0.512 1.03 (0 .93 ,1.15) 0.562
Bedroom carpet 0.52 (0.30, 0.90) 0.019 1.22 (0 .99 ,1.52) 0.063
Exposure to gas used in cooking or 0.81 (0 .42 ,1 .56) 0.532 0.91 (0.76, 1.10) 0.330
heating
Fish consumption >/1/week 0.78 (0 .34 ,1 .79) 0.563 0.94 (0 .75 ,1.18) 0.595
Household residents >5 0.98 (0 .85 ,1.13) 0.808 1.00 (0 .96 ,1 .05) 0.974
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6.5.2.2 The relation between overbedding composition and frequent 
wheeze by usual sleep position
The association between quilt use and severe wheeze after stratification by sleep position was 
examined. These results are shown in Table 6.3. We found the association between sleep 
position and frequent wheeze varied by the type of overbedding used. Among supine sleepers, 
synthetic (versus feather) quilt use was associated with frequent wheeze (OR 3.75; 95% Cl 1.78, 
8.63). However, this apparent adverse effect was not evident among non-supine children (OR 
1.12; 95% Cl 0.65,1.93). The difference in synthetic quilt effect by sleep position was significant; 
test for interaction, p=0.007.
Table 6.3 The univariate association between overbedding composition and frequent 
wheeze by sleep position
C h a ra c te r is tic  (re fe re n c e  g ro u p ) O d d s  R a tio  (9 5 %  C l) 
F o r fre q u e n t w h ee ze
p va lue
O ve rb e d d in g  by  s le e p  position
A m ong  su p in e  s le e p e rs , syn the tic  (fea ther) quilt 3 .7 5 (1 .7 8 , 8 .63) <0.0001
A m ong  n o n -su p in e  s leepe rs , syn the tic  (fea ther) qu ilt 1 .1 2 (0 .6 5 ,1 .9 3 ) 0 .654
D iffe re n ce  in  e ffe c t b y  s le e p  p o s itio n p  =  0 .0 0 7
A m ong  su p in e  s le e p e rs , o the r o ve rbedd ing  (fea ther) qu ilt 2 .7 6  (0 .89 , 7 .90) 0 .038
A m o n g  n o n -su p in e  s leepe rs , o th e r ove rbedd ing , (fea the r) qu ilt 0 .9 9  (0 .39 , 2 .21) 0 .970
D iffe re n ce  in  e ffe c t b y  s le e p  p o s itio n p  =  0 .1 0
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6.5.3 Confounder identification
To examine the potential contribution of confounding factors, we identified factors which were 
associated with severe wheeze or sleep position. Factors significantly associated with severe 
wheeze are shown in Table 6.2. Children with hay fever, a history of eczema, bronchitis, 
pneumonia, or a family history of asthma was also significantly over-represented in the severe 
wheeze group. The following factors did not relate significantly to severe wheeze: male sex, 
family pet cat, child exposure to any active smoking in the same room, gas heater use, gas 
cooking, foam mattress use, plastic mattress liner use, recalled age of introduction of solid food, 
fish consumption >1 a week, younger, older or total sibling number, resident number, and regular 
child care at less than or one year of age. We then examined how the factors in Table 6.2 related 
to child sleep position among children with no recent wheeze. Children were more likely to sleep 
supine if they slept on a foam mattress (OR 1.21; 95% Cl 1.06,1.39), slept on an electric blanket 
(OR 1.23; 95% Cl 1.05, 1.44) or used a feather pillow (OR 1.29; 95% Cl 1.02, 1.63). The other 
factors showed little association with sleep position. Among children with frequent wheeze, type 
of medication use in the past year or frequency of use did not relate to child sleep position.
6.5.4 Multivariate analysis
6.5.4.1 The relation between overbedding composition and frequent 
wheeze by usual sleep position
We examined the nested case-control sample where each child with frequent wheeze was 
matched to controls without wheeze with regard to age, sex, foam mattress use, electric blanket 
use and sheepskin use. Again, a similar pattern was evident, with a difference in the likelihood of 
severe wheeze by overbedding apparent among supine sleeping children but not non-supine 
children. Synthetic compared to feather quilt use was associated (p=0.02) with severe wheeze 
among supine sleepers (OR 2.54; 95% Cl 1.18, 5.48) but this association was absent for children 
sleeping on the side or prone (OR 1.09; 95% Cl 0.62,1.92); test for interaction, p=0.005. Further 
adjustment for synthetic pillow use provided matched odds ratios from conditional logistic 
regression of 2.37 (95% Cl 1.08, 5.23) and 1.06 (95% Cl 0.60, 1.88) respectively; Test for 
interaction, p=0.005. Among non-supine children, the effect of synthetic versus feather quilt use 
did not vary between side and prone children (p=0.86). The significant difference in quilt effect by 
sleep position persisted after adjustment for premature (<37weeks) birth, breastfeeding history,
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sibling number, allergen-occlusive mattress cover use, overlying sheet use, home gas use or 
child exposure to tobacco smoke or the other factors listed in Table 6.2. The interaction effect 
also persisted after adjustment for child hayfever, eczema and family history of asthma (Test for 
interaction, p=0.01).
Six different sleep position-overbedding combinations with regard to frequent wheeze were 
examined. These results are shown in Table 6.4. The baseline group for each pair-wise 
comparison was sleeping supine under a feather quilt. All other sleep combinations were 
associated with a higher risk of frequent wheeze and the difference in risk for synthetic quilt use 
was significant regardless of sleep position used under a synthetic quilt. In particular, children 
sleeping under synthetic quilts were at a higher risk of severe wheeze. These findings were not 
altered by further individual adjustment for feather pillow use, premature birth, family history of 
asthma, breastfeeding history, parental smoking, sibling number or any of the factors listed in 
Table 6.2.
6.5.4.2 The relation between pillow composition and frequent 
wheeze by usual sleep position
The effect of pillow composition on frequent wheeze by sleep position was not able to be 
examined due to low numbers: there were only three children who slept supine on a non­
synthetic pillow who were reported to have frequent wheeze.
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Table 6.4 The risk of frequent wheeze for various combined sleep arrangements compared 
to sleeping supine under a feather quilt in nested case-control study.
C o m b ined  s leep ing  a rran g em en t 
S leep  p o s itio n  O verb ed d in g
C ases (% ) 
n = 1 17
M atched  
C o n tro ls  (% ) 
n = 1 144
M atch ed  O dds  
R atio * (95% C I)
p value
Supine Feather quilt 8.5 20.6 1.00 (reference)
Supine Other overbedding 6.0 4.9 2.88 (0.83 ,10.03) 0.10
Supine Synthetic quilt 26.5 17.7 2.67 (1.23, 5.80) 0.01
Non-supine Feather quilt 27.4 26.0 1.87 (0 .86 ,4 .08) 0.12
Non-supine Other overbedding 6.8 6.5 6.84 (0.82, 56.75) 0.08
Non-supine Synthetic quilt 24.8 24.4 2 .3 8 (1 .0 9 ,5 .1 8 ) 0.03
* Cases matched to controls with regard to age, sex, foam mattress use, electric blanket use and sheepskin use.
6.5.5 Lung Function
Lung function results were available on 96.7% (414/428) children. The median FEVi in this 
sample was 1.44 L (inter-quartile range; 1.30 L to 1.59L). Increasing wheeze frequency over the 
past year was associated with lower post-exercise FEVi measures, after adjustment for child age, 
sex, height, distance run, ambient humidity during exercise, family history of asthma, child 
exposure to active smoking and whether asthma medications were taken within six hours of 
testing. Children with any wheeze episodes over the past year had a lower FEVi post-exercise 
than children with no wheeze. Among children who slept non-supine, synthetic quilt use was not 
associated with a significant FEVi reduction post-exercise compared to children not using this 
item. However, among children who did sleep supine, synthetic quilt use was associated 
(p=0.05) with a lower post-exercise FEVi compared to supine sleepers under feather or other 
bedding. Synthetic quilt use was associated with lower post-exercise FEVi measures among 
supine (p=0.05) but not non-supine children (p=0.61) (see Table 6.5). An adverse effect for 
synthetic quilt use particularly among supine sleepers was observed for this measure of lung 
function, similar to the findings reported above for frequent wheeze.
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Table 6.5 Change in FEV1 post-exercise by wheeze frequency and sleep arrangement
Factor
N u m b er o f ch ild ren  w ith  
Lun g  F un ction  T es ts  
and  data  ava ilab le
A d ju s ted * FEVi 
ch a n g e  in m l p ost­
exerc is e  (95%  Cl)
p va lue
N u m b e r o f w h ee ze  ep iso d es  in the  p a s t ye a r:
None (reference) 320 0% (reference)
1-3 48 -5.5 (-8.80 to -2.2) 0.001
4-12 16 -5.5 (-11.1 to 0.05) 0.05
More than 12 2 -16.6 (-30.9 to -2.21) 0.02
Supine sleep position 349 -0.1 (-2.6 to 2.4) 0.94
Synthetic quilt use 406 -1.3 (-3.6 to 1.00) 0.27
For children with non-supine sleep position, 
synthetic quilt use
196 -1.0 (-4.7 to 2.8) 0.61
For children with supine sleep position, 
synthetic quilt use
151 -3.6 (-7.0 to 0.03) 0.05
*Lung function measures adjusted for child height, age, sex, distance run, ambient humidity during exercise, family 
history of asthma, child exposure to active smoking and whether asthma medications were taken within six hours of 
testing. Children using beta agonists on the day of testing were excluded (n=6).
6.6 DISCUSSION
In the cross-sectional and nested case-control assessment, an interaction between quilt use and 
sleep position on respiratory function was observed. There was an adverse effect associated 
with synthetic quilt use on frequent wheeze and post-exercise lung function among children who 
slept supine but not among children who did not sleep supine. Among children who slept supine, 
synthetic (versus feather) quilt use was associated with frequent wheeze. However, among non­
supine sleepers, overlying synthetic quilt use was not associated with frequent wheeze. This 
difference in quilt effect by sleep position was highly significant. Similarly, synthetic quilt use was 
associated with lower post-exercise FEVi measures among supine but not non-supine children.
The strengths of this study are a high participation rate, the availability of lung function as well as 
symptom report data and the use of frequent wheeze as a study outcome. As previously 
discussed, frequent wheeze may be a better marker of HDM allergen-related wheeze than the 
global term “asthma” because HDM atopy is strongly related to frequent wheeze (196) (see
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Section 6.3.2.1). The use of a nested case-control analysis with matching on underbedding 
reduced the likelihood that underbedding variability contributed to the observed interaction.
The cross-sectional design study does not limit the study materially because the postulated 
interaction is based on short-term, not long-term disease processes. Synthetic bedding has been 
postulated to induce adverse effects through HDM allergen loading (534), the release of VOCs 
(197), or altered endotoxin exposure (13) (see Section 5.7.5). Bronchial provocation with 
aeroallergen can produce either an immediate or late response with wheeze and FEVi reduction 
(566, 567). VOCs can induce a decline in FEVi in asthmatic subjects within 1.5 hours of 
exposure (568). Inhaled endotoxin can produce a dose-related bronchoconstriction with a 
decrease in FEV, within six hours, which is more accentuated among asthmatic subjects (569, 
570). Thus, bedding-induced bronchoconstriction could occur over a short time period.
6.6.1 Measurement bias
A potential weakness of the study is that frequent wheeze, bedding and sleep position were 
based on parental report only and therefore may introduce measurement bias. The report of 
wheeze frequency showed good agreement with measures of post-exercise lung function. 
Further, the findings for synthetic quilts and lung function were similar to those for reported 
frequent wheeze. The lung function decrement associated with synthetic quilt use among supine 
sleepers was only small but it was two-thirds the magnitude of the decrement associated with 
recent wheeze and thus may be of clinical relevance.
Previously, the parent report of infant bedding has been shown to agree well with interviewer 
observations at home interview. The validity of a parental report of usual sleep position in 
children of this age group has not been established. In addition, studies have shown that child 
sleep position is likely to change during the night (571, 572). This could lead to misclassification 
of usual sleep position. This misclassification would be likely to be non-differential and thus 
reduce the study’s ability to detect sleep position effects. However, the important issue is that the 
interaction between synthetic bedding and sleep position is unlikely to be explained by such 
misclassification. Sleep position was classified as a binary factor (supine/non-supine) and both 
differential and non-differential misclassification of a binary environmental factor will, if it has any 
effect, bias a multiplicative interaction effect toward the null value when the following conditions 
are met (573), as they are here. First, the two binary factors should be independent. The lack of
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association between synthetic quilt use and supine sleeping in Table 6.2 satisfies the criteria that 
the two binary factors should be independent (573). A second condition is that the measures 
must classify the true exposures better than random (573). Past validation work shows a high 
level of agreement between parental report and research nurse observation of infant bedding 
(13). Thus, parental report is likely to classify bedding correctly, certainly better than random.
To our knowledge, the parental report of child usual sleep position at age seven has not been 
validated. However, the study findings provide some indirect evidence that parental classification 
of usual sleep position is likely to be better than random. Children sleeping on electric blankets 
were significantly more likely to sleep supine, consistent with past thermal work on sleeping 
infants that indicates that the non-prone position assists the loss of excess body heat (574). That 
is, the sleep position data does provide a pattern of results consistent with past work on thermal 
balance (574) which would predict children with electric blankets to avoid the prone position, 
which provides a reduced capacity to lose body heat. Thus, the usual sleep position by parental 
report, although likely not to classify all true sleep positions correctly, is likely to classify sleep 
position more correctly than chance.
6.6.2 Causal inference
There is growing evidence that synthetic bedding materials are associated with increased 
childhood wheeze (198,472, 575). It is now a high priority to establish if the association is causal 
in nature. Epidemiologic research identifying an effect modification or interaction can assist in our 
understanding of the causal process of disease. Effect modification occurs when the estimate of 
the effect of one factor depends on another factor in the study base (576). The term statistical 
interaction denotes a similar phenomenon (577) but does not establish biological interaction. In 
this study, for the issue of overlying synthetic quilts and child wheeze, if the adverse effect was 
mediated through some mechanism that involved the bedding being in close proximity to the 
airway (such as, but not restricted to, HDM allergen transfer) one would postulate that the 
association between overlying synthetic quilt use and adverse respiratory outcomes would be 
specifically observed among children sleeping supine, where the face would be closer to 
overlying bedding as was observed in the present study. In contrast, the adverse effect of an 
overlying synthetic quilt would be less evident for side or prone sleeping children because other 
bedding items such as the mattress would be closer to the airway and thus relatively more
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important than any overlying items such as quilts. A diagrammatic representation of this is shown 
in Figure 6.1.
Previous studies have shown that the association between synthetic upper bedding and severe 
wheeze has a high strength of association (13,197), a dose-response relationship (13), biological 
plausibility (532) and ecological coherence (198, 472, 575). And, two recent birth cohorts have 
reported that a prospective relationship is evident (12, 13) (see Section 5.1). However, 
experimental evidence is not available and may be difficult to obtain because of the ethics of 
applying a potentially deleterious exposure (synthetic bedding) to children with asthma in a RCT.
One of the counter-arguments against a causal role for synthetic bedding with childhood wheeze 
was that the association may merely reflect selection bias even prior to wheeze development: 
that is, synthetic bedding was preferentially selected for children at risk of subsequent wheeze. 
However, the finding that the adverse effect of synthetic quilts was restricted to supine-sleeping 
children only is evidence against this because it is unlikely that this selection bias differs by sleep 
position. This is further supported by the findings of no interaction between sleep position and 
the two bedding items (sheepskin and allergen-occlusive mattress cover) that do appear to reflect 
selection according to the asthma recommendations existing at the time of the study. In 1997, 
Australian asthma recommendations were to avoid sheepskins and use impermeable mattress 
covers (565).
The interaction reported here provides further support for the causal criteria of specificity (557) 
because the adverse effect of synthetic quilts was most evident in children who would be more 
likely to be sleeping face-up near the quilt. That is, these results show specificity of exposure 
where only one type of exposure is related to a given outcome (557). In contrast, as predicted, 
the adverse effect of an overlying synthetic quilt was less evident for side or prone sleeping 
children because other bedding items such as the pillow or mattress would be closer to the face 
and thus relatively more important than overlying quilts. The exact mechanisms that underlie this 
interaction are not yet understood, but possible mechanisms in relation to synthetic bedding have 
been previously discussed in Chapter 5.
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Figure 6.1 Schematic representation of a hypothesised mechanism involving close 
proximity of bedding to the child’s airway
Overlying feather quilt in 
supine position
Overlying synthetic quilt in 
supine position
E 3  Airways closer to lower 
allergen bedding
0  Airways closer to higher 
allergen bedding
Overlying feather quilt in 
non-supine position
Overlying synthetic quilt in 
non-supine position
[ 2  Airways closer to higher risk 
underbedding, regardless of 
overlying bedding allergen
0  Airways closer to higher risk 
underbedding, regardless of 
overlying bedding allergen
I Less adverse bedding -  e.g. lower HDM allergen reservoir in bedding.
I More adverse bedding -  e.g. higher HDM allergen reservoir in bedding.
Note: The hypothesis is that the adverse effect of an overlying synthetic quilt is mediated by a mechanism involving 
close proximity to the airway. For example, inhaled HDM allergen dose into a child’s airways could be less if the 
airway is in close proximity to lower HDM allergen bedding, such as feather quilts (9,551), compared to higher HDM 
bedding such as synthetic quilts (532,534, 551,575), underbedding (551, 578) or mattress (9,556).
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6.7 CONCLUSION
This Chapter has provided further evidence of the importance of the role played by specific 
bedding items and their material composition in childhood asthma. To our knowledge, this is the 
first report on the interaction between the effect of an overlying synthetic quilt and sleep position 
on wheeze risk. We found a positive interaction between overlying synthetic quilt use and the 
supine sleep position. The interaction is consistent with an adverse effect of synthetic quilt use 
that is mediated by close physical proximity. Thus, these findings indicate that an increasing 
focus on the bedding environment immediately adjacent to the nose and mouth of children during 
sleep is required.
6.8 POST-SCRIPT
Chapters 4, 5 and 6 have considered the adverse association of individual infant bedding items 
and HDM sensitization and child wheeze. These bedding exposures, however, do not occur 
singly but in combination with other environmental factors, including additional bedding items. 
Chapter 7 examines the associations between composite bedding, bedding environmental factors 
and child asthma.
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Chapter 7
Combined bedding, allergic sensitization and respiratory health
7.0 PREFACE
This Chapter presents an additional approach to investigate the infant bedding and bedroom 
environment in asthma. This approach is based on a theoretical model of HDM loading in 
different bedding items and is used to investigate infant sleeping environment and subsequent 
childhood wheeze. Specifically, the analyses in this Chapter seeks (i) to extend bedding 
exposure measurement by considering bedding not as single items but as a composite and (ii) to 
investigate bedding-home environment interactions. The two prospective studies, the 1997 
CARHS and the Infant cohort study with 1995 follow-up, and the cross-sectional study, the 1995 
Childhood Asthma Survey, have been analysed and are described in this Chapter.
The findings from the Infant cohort study with 1995 follow-up, discussed in this Chapter, are 
reported in a paper currently ‘in press’ (see Appendix 6):
Trevillian LF, Ponsonby AL, Dwyer T, Kemp A, Cochrane J, Lim LL-Y, Carmichael A. The infant 
bedroom environment and asthma at 7 years: a prospective cohort. Am J Public Health 2005; 
95(8):(ln press).
7.1 INTRODUCTION
Difficulty in measuring indoor exposures during early life has been one of the problems that have 
hampered aetiology research in childhood asthma. Exposures such as infant sheepskins, 
discussed in Chapter 4, do not occur singly but in combination with other environmental factors, 
including additional bedding items. HDM allergen levels in bedding have been shown to be more 
important than bedroom floor HDM levels in determining (i) airway responsiveness (190) or (ii) 
asthma severity (187). A longitudinal study (190) of 30 children aged 8-12 years, demonstrated 
that the natural changes in HDM levels, as measured in the childrens’ bedding can lead to 
significant reductions in PEFR in children who are allergic to HDMs; whereas in an earlier study 
(187) mite allergen levels in the mattress were a more important determinant of asthma severity 
in children with HDM allergy, than levels in floor samples.
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The majority of previous studies that have recorded bedding HDM allergen levels have used 
composite bedding samples, for example mattress and upper bedding combined. Yet the 
appropriateness of such an approach is questioned. Marks et al., 1995 (578), found that Der p 1 
allergen concentrations in the upper bedding and mattress did not differ significantly from those in 
the whole bed (p>0.15), implying that mattress or upper bedding Der p 1 levels can be taken as 
representative of the whole bed. This was despite the concentration of Der p 1 in the pillow being 
2.78-fold lower than that in the whole bed (p=0.011); yet no distinction was made between the 
different material compositions of the individual bedding items (578). And as previously 
discussed, it is well recognized that the bedding material itself influences HDM allergen levels 
within individual items (9,14, 479, 532, 535, 556) (see Section 5.1). Furthermore, a recent study 
(9) in New Zealand has also reported a wide variation in Der p 1 levels in individual components 
of bedding. Reservoir dust samples from bedding items showed Der p 1 geometric mean levels 
were 13.4 pg/g (95% Cl 9.5, 18.9) in pillows; 29.4 (95% Cl 19.8, 43.5) in duvets; and 53.8 pg/g 
(95% Cl 39.4, 73.4) in mattresses (9). These results also suggest that the contribution of each 
individual bedding item to HDM allergen inhalation load warrants consideration.
Furthermore, dust collected from pillows and upper bedding might be an important indicator of 
HDM allergen exposure, given the more intimate, prolonged relationship between pillows and 
upper bedding, and the airway. These items are also more likely to be physically disturbed during 
sleep, generating airborne HDM. In addition, these items (pillows and upper bedding) can 
influence mattress levels, as mattress dust contains allergens that have filtered down from the 
upper bedding, and may be seen as a proxy only for the measurement of other allergen sources 
closer to the subject (527) (see Section 4.7.3). HDM allergen levels on mattresses were found to 
be significantly higher when synthetic pillows (12.22; 95% Cl 7.34, 14.63 pg/g dust) were used 
compared with feather or wool pillows (7.33; 95% Cl 3.07, 8.68 pg/g dust) (490). Thus, it is likely 
that allergen levels are influenced by the nature of the bedding, both type (for example, quilt or 
pillow) and composition (for example, wool or synthetic), by laundry routine, and by the 
environmental climate of the room (527,579).
In addition to bedding, other conditions in individual homes within the same climatic region vary 
sufficiently such that dust samples from the same site in different houses in a single locality have 
a wide distribution of HDM allergen levels (513). These variations between homes have 
prompted the identification of modifiable housing factors to create conditions less conducive to 
mite growth. Several recently published studies have reported residential and environmental
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factors that are associated with high indoor HDM allergen levels within bedroom and living room 
floor dust and mattress dust. These household factors may impact on humidity and/or 
temperature levels within the home and as a consequence affect HDM microclimate and levels 
(580). The critical humidity for HDM survival is temperature dependent, ranging from 55% to 75% 
relative humidity over the temperature range from 15-C to 359C (581). The presence and age of 
carpets, the type and age of residential buildings, the presence of damp in the home, older 
mattresses and increasing number of household residents have all been shown to influence 
indoor HDM allergen concentrations (580). Furthermore, bedroom heating increases the HDM 
levels in bedding (481, 582, 583). The Childhood Asthma Prevention Study measured HDM 
allergen levels in the homes of 616 participants in Sydney, Australia, and reported that the mean 
Der p 1 concentration (pg/g) was significantly greater in the beds of participants whose rooms 
were heated than in the beds of homes not heated (20.39; 95% Cl 14.14, 29.39 versus 14.05; 
95% Cl 12.48, 15.81) (481). As of April, 2004, there are 23 published papers (updated from 
Simpson et al., 2001) (580) that have investigated the relationship between household 
characteristics and HDM allergen levels. The findings of these studies are summarized in Table 
7.1.
Thus, with regard to childhood asthma, the environmental model for infant HDM exposure may 
not be one of single major risk factors operating independently, but rather one of environmental 
determinants operating synergistically to increase infant HDM exposure.
The aim of this Chapter is to test the hypotheses:
(i) The association between bedding items and child wheeze is of a greater magnitude for 
composite bedding than for individual bedding items; and
(ii) Other home environmental factors interact with bedding items to influence the bedding- 
wheeze association.
186
Ta
bl
e 
7.1
 R
es
ul
ts
 fr
om
 2
3 
pu
bl
is
he
d 
st
ud
ie
s 
of
 th
e 
an
al
ys
is
 o
f h
ou
se
ho
ld
 fa
ct
or
s 
as
so
ci
at
ed
 w
ith
 h
ig
he
r i
nd
oo
r 
HD
M
 a
lle
rg
en
 le
ve
l
s £  
2  « 
O E
OJ
3
co
eo
to
TJc3o
U.
O) CO
= .E
to to g.
§
>.
s §
O E
?  2
« 5
S 'S 2
I  d  J
5  c cr
2  CL
3  I
o
« a
-  3O o
S- O
to E 
O  tö
S 2
2  o
O JC
° I
co
CD>
sz
0 5
^  to  
2 $ 
2  c
j? 8.
o2
>."a
co
2
CO
Q.
ro
o
a32
o
CD>
oo
CO
sin
15
"S3
x f  £
• i  sre ^
CO
CD>-
Z
Z
CO
CD>-
CO
CD>-
CO
CD>-
O
Z
+
s
mco
m
15
"S3
*  If t
2
o
z
o
z
z
o
z
o
z
&
CD
in
CD
CD
15
ts
aco
i!2  -o
~  &
CD CD
8 £CO o
it 9.
CO
CD>
CO ^
£  J5
CO
CD>-
z
z:
z
IE
z
z
IE
z z z
IEz
a5
m
co E  «=- 
CD L Z
> - t  Z
aS
s l  ^
> - z z z z
z
co
CD> oz
co co
CD CD>- >-
.£
f
co
CD>
“8
CO
CO
2  «3
O CD 
CD > 
O 05
O
Z
o
z
o
z
o
z
co
CD>-
CO
CD>-
CO
CD>-
CO
CD>-
CO
CD>•
CO
CD>-
cb
n
co
in
s
o OJ 
^  § 
T3 Ä
Oz
eg
Z
o
CO
oz
CO
CD>-
CO
CD>-
co
CD>-
c5
_CD
o
z
CO
CD>-
o
z
CO CO
CD CD>- >-
o
CO
+
0 5
CO
CD>-
o
z
OO
CO
ID>-
Q.
O COCD
1
CO
CD
1
co
CD
CO
CD
CO
CD
0 5 >- >- Z z z > >
CO
CD
oz
z
1 -1 ®
™  15
2  -S
* i—
C CD
-S 05
CD
5  15
CO -~  
_ CD
I I
J*C
o o 
o >
CO H
c  in
5  CD
o cd
CO 
* - 
cz "S3
CD
11
CO = -
5
in
0 5
0 5
15
05
M
t  §
CD > 
CO <
eg
0 5in
15
*_ ® 
ct5 O
§>1
t Z  CD
£
CO
CO
CO
z » i £ .
CD
& _
egco
'g-
§
15
"S3
s>
00
LLI
O  CD
S 3̂
^  CO 
r CD <C _Q
No
rth
er
n 
No
rw
a'
Ta
bl
e 7
.1 
co
nt
in
ue
d
s g
2  CO
O  E
CD
a
i f )
cg
'«-oc3ou.
O) O)
%  •£
I I I
>.
o i
O E 
JE ü
f  °J2
’</>CO T-.03 .2
I  6 IE  c  IX
■a
C/5
o2
co
CD>-
I
8 .S>- ^
z
o
z
o
z
a3
8 1  O 
>  Z
oz
CO
CD>- oz
2
z
z
o
z
tos
to
j d
o
Z
o
z
CO
CD>-
co «
oa
i t
co
CD>-
O
z
o
co
CO
CD
CO
CD>
CO
CD>
CO
CD>-
f
CO
CD>
o
z
o
z
CO
CD>-
CO
CD>-
o
z
CO
CD>-
I I
CO
CD>-
o
z
sto
ICD
75
751
CM
I s
=3 co
CD 7 S
O
CM
LO
05
03
75
CD
C
JD
O
CD03
CO
E
iz
Q
2
Too
<
cd"
c
-Q
CD
.2  S '  
75
-2 2 co ^
<  75
CO 03
II<2 o 
^ O
S
LO
o 03
03fl
ZC zi
0 3
0 3
75
5  03 
Z -£
S' « 
2 S
Ü XJ 
75 Ü
•= CO .er cd 
O  In i
75
5
O
<
CO
I s
m \£ ,
2
1  75< T5
o  fc  
o « >  CD
5
CM
co"10
;2 « >  o
03 S 03 >  
CO '—'
5* *ca 
cd" 75
11
2  <
coCD
>-
jü
*  J O
8 E
>- ^
s i
>- ^
To
o
z
M
ou
ld
/
D
am
p
o
7Ö To
|  |  8  8 s COCD
CDCD COCD ToCD
Z ■£■ z  S .  >_ >. Z >- z >" z >- >-
ar
p
et
 v
s 
m
oo
th
 f
lo
or
o es es ild
er
 c
ar
pe
t)
 
es s S COCD
COCD COCD CO03
O </) Z >- >- ü  >- Z Z >- >- z >- >-
8 2 
2  o
coCD s  8 s o o O CDCD o CO03 COCD
O jz >- z  >- z Z Z z > z >- >-
N
o.
 o
f 
h
o
m
es
CM Nl- LO +IN CO CM■M" Nf t''- o 03LO
0303 o
LO 56
4
61
6
o
LO
0 3
LO
.
=> 75 
fe cS 
8 § 8.I
75
1
2 
rS
CO
75 _
S t— 
CO CO
< x
i l
T3 CM 
CO
X 3
CD
I
CO
03
E
co
CO
&
8
S'
is
03
s
CO
co
(D
h
75
E
s-
03
u
I
8
i28
s
03
is
f
§
.S2f
§
CD
■I
s1
rtr
8
>-
75
7.2 METHODS
7.2.1 Sources of data
The role of composite bedding and wheeze was examined in the three Tasmanian studies. The 
1997 CARHS provided data for assessment of HDM sensitization and lung function in childhood, 
but was too small to examine bedding-home environment interactions. The potentiation effect of 
home environmental factors on composite bedding was examined in the Infant cohort study with 
1995 follow-up and the 1995 Childhood Asthma Survey. The use of the three studies allows an 
assessment of the consistency of the findings.
7.2.2 Exposure variables
7.2.2.1 Selection and classification of bedding items
Four bedding items: synthetic pillow, synthetic quilt, cocoon and sheepskins were selected as 
exposure variables based on their capacity to contain high HDM allergen loads as reported in 
previous studies (see Section 4.1 and Section 5.1). Also, in this Tasmanian cohort, sheepskin 
use was associated with HDM sensitization (see Chapter 4) (548). And, synthetic bedding items 
such as pillow, quilt and cocoon (see Chapter 5) were associated with child wheeze (13, 196, 
598). In addition, as reported in Chapter 4, the role of infant mattress type in HDM sensitization, 
(foam mattress aRR 1.09; 95% Cl 0.72,1.67), and recent wheeze (foam mattress aRR 1.35; 95% 
Cl 0.98, 1.83) appeared less important (548) than the selected bedding items so it was not 
included here as an exposure variable. Cocoon use occurred in infancy, not in childhood, and 
thus was not in the 1995 Childhood Asthma Survey.
Sheepskins comprised the animal hide with the natural wool fibres attached. Infant cocoons 
manufactured and sold in Southern Tasmania during the study period most commonly comprised 
outer coverings of cotton/polycotton with a polyester (synthetic) filling (598). Pillows reported as 
foam/sponge/tontine/polyester/Dacron were classified as synthetic and a synthetic quilt in infancy 
was defined as the use of a synthetic quilt over the infant during cold weather. The parental 
report of infant synthetic pillow use showed high agreement with the research nurse observation 
of infant pillow used in the last night in 1995 (13).
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7.2.2.2 Composite bedding classifications
For the TIHS data, there were 16 possible combinations of an infant’s exposure to these four 
bedding items. There were 9 possible bedding exposure combinations for children exposed to 
the three bedding variables in the 1995 Childhood Asthma Survey. In all three studies, the 
composite bedding exposures were collapsed to six combinations due to sparse data in some 
exposure combination strata. This six-level composite bedding classification was ordered from 0 
to 5 based on the magnitude of previous associations with wheeze and the volume of HDM 
reservoir:
Combination 0: No synthetic quilt, pillow, sheepskin or cocoon
Combination 1: Sheepskin only
Combination 2:1 synthetic item
Combination 3: Sheepskin and 1 synthetic item
Combination 4:2 or more synthetic items
Combination 5:2 synthetic items and sheepskin
Preliminary analysis showed similar trends for the association between the six-level composite 
bedding classification and wheeze in all three data sets. Figure 7.1 shows these associations for 
recent wheeze. Test for linear trend in the 1997 CARHS, Infant cohort study with 1995 follow-up, 
and the 1995 Childhood Asthma Survey were p=0.673, p=0.068, and p<0.001, respectively. 
Similar results were found for night wheeze and asthma ever. However, due to small numbers for 
some of the exposure categories, this six-level composite bedding classification was further 
collapsed to a three-level composite bedding classification in each of the data sets.
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Figure 7.1 Graphical representation of unadjusted odds ratios for recent wheeze and the 
six-level composite bedding classification in the three Tasmanian data sets
C om bination 1 
Com bination 2 
Com bination 3 
Com bination 4 
Com bination 5
Com bination 1 
C om bination 2 
Com bination 3 
Com bination 4 
C om bination 5
Com bination 1 
Com bination 2 
C om bination 3 
Com bination 4 
C om bination 5
The three-level composite bedding classification was then made based on past work and the 
distribution of bedding exposures to the HDM allergen-rich synthetic pillows, synthetic quilts, 
cocoons or sheepskin (9, 479, 532, 556). The reference group Bedding Combination 0 (Bo) 
represented infants with no synthetic items and no sheepskin (548). Bedding Combination 1 (Bi) 
comprised either one synthetic item only (n=279) or one sheepskin only (n=121) or one synthetic 
item and one sheepskin (n=113). Bedding Combination 2 (B2) comprised two or more synthetic 
items without sheepskin (n=57) or with sheepskin (n=14). This classification put more emphasis 
on synthetic bedding items than sheepskin because of the previous reported associations with 
wheeze in this cohort (13, 196, 598) (see Section 7.2.2.1). In this Chapter, the term composite 
bedding refers to the average increase per category from Bo to B1 to B2. The B2 effect is B2 
versus Bo, and the B1 effect is B1 versus Bo.
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7.2.2.3 Classification of home environmental factors
Environmental exposure variables were coded as binary. Baby’s bedroom heated was in 
response to current use at time of interview and also intended use of any type of heating in cold 
weather. Validation of the parent’s response to the question “What heating is used in the baby’s 
bedroom?” was undertaken by the research nurse at the home interview (k=1 .00) (see Section 
7.2.2.4J. Recent painting refers to the infant’s bedroom having been painted within the previous
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12 months from the time of home interview. Absence of carpet means no wall-to-wall carpet in 
the infant’s bedroom. The research nurse also validated the type of floor covering in the baby’s 
bedroom at the time of the home interview (k=1.00). Home gas appliance use in infancy is 
defined as the positive report of gas cooking or gas heater use in the living room. A 1985-86 
survey reported that 86% of the gas-heated Tasmanian homes used bottled gas for heaters of 
portable or fixed type (599). Infant exposure to tobacco smoke refers to people smoking in the 
same room as the infant. Biological validation of questionnaire data on infant exposure to 
tobacco smoke was provided by a 1995 sub-study using infant urinary cotinine levels (600). The 
absence of bedroom carpet, home gas use during childhood and child exposed to indoor tobacco 
smoke are the environmental exposure variables I examined for the cross-sectional 1995 
Childhood Asthma Survey study.
7.2.2A Validation of exposure variables
Inter-observer (rater or interviewer) agreement may be an important source of measurement 
error. The kappa coefficient (k) measures pairwise agreement among a set of raters making 
category judgements, correcting for expected chance agreement. In assessing the amount of 
agreement among raters of category distinctions, the kappa statistic normalizes for the amount of 
expected chance agreement and allows a single measure to be calculated over multiple coders 
(601). Cohen’s kappa (602) is also a measure of validity for binary outcomes (603). And, for two 
raters, the formula is the same (604) for Cohen’s kappa (602) and for Fleiss’s kappa (605). 
Measurement validity is defined as “the degree to which a measurement measures what it 
purports to measure” (461). In this study, the kappa coefficient is used to determine the level of 
assessment of the dichotomous response to the presence of an infant variable, for example 
baby’s bedroom heating or infant pillow use, between the parental questionnaire and the research 
nurse’s observation at the home interview. The latter is considered the gold standard. The 
principal weakness of kappa stems from it being a measure of the frequency of exact agreement 
rather than a measure of the degree of approximate agreement. This is not, however, a 
weakness with dichotomous data as in this Chapter, since observations then either agree exactly 
or they totally disagree (604).
k has a maximum of 1.00 when agreement is perfect, and a value of zero indicates no agreement 
better than chance. The thresholds for evaluation of inter-rater agreement can be interpreted 
using the following guidelines (606).
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Table 7.2 Guidelines for interpretation of kappa
Value of K
Strength of agreement 
(606)
<0.00 Poor
0.00 - 0.20 Slight
0.21 -0.40 Fair
0.41 -0.60 Moderate
0.61 -0.80 Substantial
0.81-1.00 Almost perfect
k is defined as (602,605):
(Po-Pe)
K= (1 -  Pe)
where P0 is an observational probability of agreement, and Pe is a hypothetical expected 
probability of agreement under an appropriate set of baseline constraints such as total 
independence of observer classifications (606).
In a typical experimental design of two raters making dichotomous decisions on the same 
population of subjects, the distribution of data can be displayed in a 2 x 2 contingency table (607). 
The respective cell proportions are given by
P ( x ) = -  
v '  N
Where the cell count, x = a, b, c, or d and N = a + b + c + d is the total number of observations. 
The proportion of agreements is given by
p _ (a + d)
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The expected agreement, Pe, is calculated from the marginals by the equation
Pe =
c
a + —
V N ,
+
(
p
- v
b + — 
N
*P
f dYl
c + —l N JJ
From the observed P0 and the derived Pe:
K =
( p - p  ^M)_ |_e
1 -P .
=  1 - (1 -P q)
(1-Pe).
Here, kappa is used to assess the validity of parental report of exposures compared to the 
research nurse observations.
7.2.3 Outcome variables
The outcome variables HDM sensitization, recent wheeze, night wheeze, asthma ever and 
wheeze frequency were coded as previously described in Section 4.3.2. The validity of these 
measures is discussed in Section 3.2.2.1.
7.3 STATISTICAL METHODS
Pair-wise correlations were obtained by Spearman’s rank order correlation. Univariate ORs and 
95% confidence intervals were logit-based and calculated by logistic regression. To assess the 
role of the composite bedding combination exposures in infancy as risk factors for asthma at the 
age of 7 years, multivariate logistic regression models were calculated to control for multiple 
confounders simultaneously, providing adjusted ORs (503) for the categorical outcome variables 
recent wheeze, asthma ever and night wheeze. Those factors found in univariate analysis, or a 
priori, to be associated with wheeze were examined as potential confounders. Using a change- 
in-estimate methods (466) those factors that altered the point estimate for the exposure-wheeze 
association by 10 percent or more, were included in the final model. I examined the confounding 
effect of a large number of factors including sibling number, in utero exposure to maternal 
smoking, air freshener use in infant’s bedroom, cat or dog as a family pet during infancy, visible 
indoor mould and plastic mattress liner use in infancy, which were eliminated according to the 
10% rule during modeling. The cohort entry criteria, either separately or as a set did not alter any
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of the reported associations. Factors that could operate on the causal pathway between bedding 
and asthma or could modify the association were not included as routine confounders. Those 
potential confounders selected were not considered to physically influence bedding or host 
response to bedding and thus modify the bedding effect. I used the Wald test (608) for linear 
trend of the categorical bedding variables (B i vs Bo or B2 vs Bo) by replacing the binary predictors 
with a single predictor, taking category rank scores.
To assess whether an association between a composite bedding combination and a respiratory 
outcome differed by environmental factor status after controlling for confounders, a model was 
first built with terms for composite bedding and each confounder and the dependent variable was 
one of the respiratory outcomes examined. A second model was then built in the same way as 
the first but also with a term for the environmental factor and an interaction term between 
composite bedding and environmental factor. The resulting deduction in deviance obtained by 
using the second model compared to the first was then assessed using the p value associated 
with the log likelihood ratio test (503). Tesis for interaction ofien use a higher significance than 
p=0.05 (560). Here, interaction terms that improve the model by p<0.1 are considered important. 
Stratified multivariate logistic regression was used to explore the potentiation of more than one 
environmental factor on the bedding-wheeze effect. Stratification was made on the number of 
environmental factors present (0, 1, 2 or 3). Discrete proportional hazard modeling (541) was 
used to examine age of onset of asthma or wheezy breathing by bedding. The potentiation of 
age of onset by environmental factors was determined by a stratified log rank test (467).
Multiple linear regression models were used to examine the effect of exposure on continuous 
outcomes, such as the lung function measures of FEV1, FVC and the ratio of FEV1 to FVC with 
adjustment for relevant covariates (see Section 3.1.5.2).
7.4 RESULTS: THE INFANT COHORT STUDY WITH 1995 FOLLOW­
UP
7.4.1. Characteristics of the study population
The characteristics of the study population, including wheeze prevalence, are shown in Table 7.3.
Infant bedding data for all bedding combinations was available on 800 children. The percentage
of infants exposed to each composite bedding category was 27.0%, 64.1% and 8.9% for Bo, B1
and B2 respectively. The majority of infant’s bedrooms were carpeted (90.6%) whereas less
195
infants were exposed to the two other environmental factors: infant bedroom heated (34.3%) or 
bedroom recently painted within the previous 12 months (33.5%).
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Table 7.3 Characteristics of the study population in the Infant cohort study with 1995 
follow-up
% n/total N*
M ean age (years) 6.9 (standard deviation=0.3)
Respiratory symptoms
R ecent w heeze over past year 27.0 222/823
N ight w heeze over past year 19.2 160/834
A sthm a ever 32.4 280/863
Infant bedding
S ynthe tic  p illowcase use at 1 m onth age 14.8 127/857
S ynthe tic  qu ilt use at 1 m onth age 44.9 396/802
C ocoon use at 1 m onth age 2.4 19/802
S heepskin  use at 1 m onth age 29.8 256/859
S ix -le ve ! co m p o s ite  b e d d in g  c lass ifica tion
C om bination 0: No synthetic quilt, pillow or cocoon, or sheepskin 27.0 216/800
C om bination 1: Sheepskin only 15.1 121/800
C om bination 2 :1  synthetic item 34.9 279/800
C om bination 3: Sheepskin and 1 synthetic item 14.1 113/800
C om bination  4 :2  or m ore synthetic items 7.1 57/800
C om bination 5 :2  synthetic items and sheepskin 1.8 14/800
T hre e -le ve l co m p o s ite  b e d d in g  c lass ifica tion
C om bination 0: No synthetic quilt, pillow or cocoon, or sheepskin 27.0 216/800
C om bination 1 :1  S ynthetic and/or 1 sheepskin item 64.1 513/800
C om bination 2 :2  or more synthetic items 8.9 71/800
Environment
H eating in in fan t’s bedroom 34.3 294/857
C arpet in in fant’s bedroom 90.6 767/847
In fan t’s bedroom  painted w ith in previous 12 months 33.5 287/856
A ny gas appliance use in in fan t’s house 3.3 28/856
Infant exposed to tobacco sm oke in house 65.6 558/851
*Small N for some characteristics: bedding items (N=800).
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7.4.2 Risk of childhood wheeze associated with increasing numbers 
of bedding items in infancy
Infants exposed to a composite bedding arrangement of two or more synthetic items in infancy, 
had a more than two-fold risk of subsequent wheeze by age 7 years compared with children who 
had none of these bedding items in infancy aOR 2.10 (95% Cl 1.15, 3.82) (Table 7.4). There was 
a dose-response relationship between exposure to increasing number of bedding items in infancy 
and the risk of recent wheeze in childhood (Test for linear trend, p=0.053) (Table 7.4). This trend 
for a higher number of HDM allergen-rich bedding items and increasing risk of subsequent 
wheeze was also found for asthma ever (Test for linear trend, p=0.072) and night wheeze (Test 
for linear trend, p=0.034).
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7.4.3 Bedding and home environmental factors
No associations were found between the composite bedding classifications, Bi versus Bo or B2 
versus Bo, and any of the three home environmental factors. There was no relationship between 
bedroom heating and bedroom carpet (Spearman r = 0.052); bedroom heating and recent 
painting (Spearman r = 0.078); bedroom carpet and recent painting (Spearman r = -0.029). Nor 
were these factors associated with the composite bedding combinations (Spearman r = -0.015; - 
0.002 and -0.083 for bedroom heating, recent bedroom painting or bedroom carpet respectively). 
Bedroom heating, recent bedroom painting and the absence of bedroom carpet did not 
significantly predict wheeze with: OR 1.08 (95% Cl 0.85,1.37); OR 0.82 (95% Cl 0.63,1.05); and 
OR 1.12 (95% Cl 0.78, 1.61) respectively. However, Figure 7.2 shows that each of these three 
environmental factors did potentiate the composite bedding effect on wheeze.
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Figure 7.2 Difference of potentiation of composite bedding effects on recent wheeze by 
environmental factors in the Infant cohort study with 1995 follow-up.
(A) Bedroom Heating
Composite Bedding Combinations
(B) Bedroom Recently Painted
Composite Bedding Combinations
— ♦—  With Painting
Without Painting
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Figure 7.2 continued
(C) Bedroom Carpet
0 -i-------------------------- 1-------------------------- T-- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
BO B1 B2
Composite Bedding Combinations
In (A) the p value is for the difference in the potentiation of the composite bedding effect on recent wheeze by room heating; (B) 
the p value is for the difference in the potentiation of the composite bedding effect on recent wheeze by recent bedroom painting; 
and, (C) the p value is for the difference in the potentiation of the composite bedding effect on recent wheeze by absence of 
carpet. The analysis was adjusted for male sex, at-birth family history of asthma, foam mattress use in infancy, exposure as infant 
to maternal cigarette smoking. Further adjustment for cohort entry criteria did not alter the results.
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7.4.3.1 Risk potentiation of composite bedding effect by room 
heating
The dose-response relationship of composite infant bedding on the risk of subsequent wheeze 
was particularly evident when the infant slept in a heated room (Test for trend, p=0.004) than in a 
non-heated room (Test for trend, p=0.653). These results are shown in Table 7.5. In particular, a 
high number of HDM allergen-rich bedding items in infancy (B2) was strongly associated with 
recent wheeze in childhood (aOR 7.87; 95% Cl 2.17,28.51) when the infant’s bedroom had been 
heated; but, this association was not found in a non-heated room. The difference in the 
potentiation of the composite bedding effect by room heating was significant (Likelihood ratio test, 
p=0.051) (see Figure 7.2(A)). This potentiation of the composite bedding effect by room heating 
was also evident for asthma ever or night wheeze (see Table 7.5).
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7A.3.2 Risk potentiation of composite bedding by bedroom painting
The greater increase on risk of subsequent wheeze by composite bedding for infants sleeping in 
a recently painted bedroom (Test for trend, p=0.013) was not shown in children who as infants 
slept in a bedroom that had not been recently painted (Test for trend, p=0.383). These results 
are shown in Table 7.6. Among infants in recently painted rooms, those infants exposed to a 
composite bedding arrangement of two or more high HDM allergen-rich items (B2), had a more 
than five-fold increase in risk of recent wheeze by age 7 years (aOR 5.39; 95% Cl 1.44, 20.25) 
than those infants not exposed to this bedding combination (see Table 7.6). There was a greater 
adverse effect for bedding in a room recently painted than in a non-painted room (Likelihood ratio 
test, p=0.095) (see Figure 7.2(B)). Thus, recent bedroom painting appears to potentiate the 
adverse effect of bedding. This potentiation of the composite bedding effect by recent bedroom 
painting was also evident for asthma ever or night wheeze (see Table 7.6).
7.4.3.3 Risk potentiation of composite bedding in the absence of 
bedroom carpet
The effect of infant HDM-rich composite bedding on wheeze was particularly evident when there 
was no floor carpet in the infant’s bedroom (Test for linear trend, p=0.032) rather than when the 
bedroom was carpeted (Test for linear trend, p=0.200). These results are shown in Table 7.7. 
The potentiation of composite bedding effect on subsequent wheeze was significant when 
bedroom carpet was absent in an infant’s bedroom compared with the presence of carpet 
(Likelihood ratio test, p=0.003) (see Figure 7.2 (C)). This potentiation of the composite bedding 
effect by the absence of bedroom carpet was also evident for asthma ever or night wheeze (see 
Table 7.7).
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7.4.3.4 Risk potentiation of composite bedding in the presence of 
environmental tobacco smoke or home gas appliance use
The use of home gas appliances was not found to potentiate the bedding effect on wheeze for 
either Bi or B2 (Likelihood ratio test, p=0.124). Exposure to environmental tobacco smoke was 
also not found to potentiate the bedding effect (Likelihood ratio test, p=0.285). As the increase in 
risk per bedding classification was not altered if there was either smoking or gas appliance use in 
the home environment, both these exposure variables were then considered as potential 
confounders in the process of determining the final models.
7.4.3.5 Risk potentiation of composite bedding in the presence of 
one or more environmental factors
The effect modification patterns reported above for bedroom heating, recent bedroom painting 
and the absence of carpet, each remained following further adjustment for the other two 
environmental factors, either individually or together, plus the confounders listed at the bottom of 
Table 7.4. Thus, bedroom heating, recent bedroom painting and the absence of carpet appeared 
to potentiate the risk of the composite bedding classification on wheeze independently of these 
confounders and each other. Next, I considered concomitant infant exposure to one or more of 
these environmental factors. Figure 7.3 shows when any two or more of these environmental 
bedding-wheeze enhancers were present the Bi-wheeze association was increased (OR 3.45; 
95% Cl 1.01, 11.83). The B2-wheeze association was even stronger (OR 14.94; 95% Cl 1.94, 
115.1). The difference for potentiation of the bedding classification B2-wheeze effect by 
environmental factor number was significant (p=0.012) (see Figure 7.3).
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Figure 7.3 Relationship between the number of environmental factors (bedroom heating, 
recent bedroom painting, absence of bedroom carpet) and potentiation of composite 
bedding- wheeze effect by bedding combination* B0, B1 and B2 in the Infant cohorts with 
1995 follow-up
None One T w o  or more
Environmental Factors
‘ The reference group is Bo. The difference in effect for potentiation of the bedding combination Bi-wheeze effect, from none to 
two or more of the environmental factors is p=0-017. The difference in effect for potentiation of the bedding combination B2- 
wheeze effect, from none to two or more of the environmental factors is p=0012.
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7.4.4 Composite bedding and age of onset of asthma
Overall, there was a shift to earlier onset of asthma symptoms with an increase in the amount of 
infant composite bedding items (Log-rank test, p=0.002) (see Figure 7.4). Among infants with 
childhood asthma, increasing the number of high HDM allergen-rich bedding items was 
associated with an increased risk of subsequent earlier onset of asthma symptoms by age 7 
years compared with infants without these bedding items (see Table 7.8). Infants with bedding 
combinations 0, 1 and 2 had a mean age of onset of 3.7, 3.2 and 2.1 years respectively. The 
adjusted Hazard Ratio for bedding combinations 0,1 and 2 were 1.00 (reference); 1.20; (95% Cl 
0.89, 1.61); and, 1.73 (95% Cl 1.10, 2.73) respectively. Thus, an earlier onset of asthma 
symptoms was associated with children who as infants had the highest HDM allergen-rich 
composite bedding, after adjustment for at-birth family history of asthma, male sex, mother 
smoking during infancy, and foam mattress use in infancy.
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Figure 7.4 Age of onset of wheezy breathing*  by composite bedding use at 1 month of age 
in the Infant cohort study with 1995 follow-up
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7.4.5 Role of home environmental factors on composite bedding and 
age of onset of asthma
Figure 7.5 shows that the presence of environmental factors identified as bedding-wheeze 
enhancers in infancy (bedroom heating, recent bedroom painting, and absence of bedroom 
carpet), also potentiated the shift by the bedding combinations to an earlier age of onset of 
asthma. Infants sleeping in a heated bedroom had an earlier onset of asthma than infants with 
bedrooms not heated (Stratified logrank test, p=0.002). With heated bedroom, infants with 
bedding combinations 0,1 and 2 had a mean age of onset for asthma of 3.8, 3.3 and 1.6 years 
respectively, and 3.7, 3.2 and 2.2 years respectively for infants with no bedroom heating.
This potentiation of shift to earlier age of onset of asthma by bedding combinations was also 
found for infants sleeping in a recently painted bedroom compared with infants in a non-painted 
room (Stratified logrank test, p=0.002). For infants in a recently painted bedroom, with bedding 
combinations 0, 1 and 2 the mean age of onset for asthma was 3.6, 3.6 and 1.5 years 
respectively, compared with 3.8, 2.9 and 2.3 years respectively for infants sleeping in a bedroom 
that had not been recently painted.
The absence of carpet in an infant’s bedroom was associated with an earlier onset of wheeze for 
the bedding combinations than if the infant’s bedroom was carpeted (Stratified logrank test, 
p=0.004). If the infant’s bedroom was un-carpeted, the mean age for asthma onset for bedding 
combinations 0, 1 and 2 was 3.1, 3.3 and 1.1 years respectively, whereas for infants with a 
carpeted bedroom it was 3.8, 3.2 and 2.2 years respectively.
The environmental factors, bedroom heating, recent bedroom painting or absence of bedroom 
carpet, as individual factors did not influence the age of onset of asthma.
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Figure 7.5 Mean age of onset of asthma or wheezy breathing by bedding 
combinations and environmental factors in the Infant cohort study with 1995 
follow-up
(A ) Bedroom heating No bedroom heating
□  BO
□  B1 
■  B2
2 3 4 5 6
(B) Recent painting No recent painting
□  BO
□  B 1 
■  B2
2 3 5 6
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p = 0.004
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(A) The p value is for the difference between mean age of onset of asthma when infants’ bedroom heated versus non-heated 
bedroom; (B) The p value is for the difference between mean age of onset of asthma when infants’ bedroom recently painted 
versus non-painted bedroom; and, (C) The p value is for the difference between mean age of onset of asthma when infants’ 
bedroom not carpeted versus infants’ bedroom carpeted.
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7.4.6 Summary of findings from the Infant cohort study with 1995 
follow-up
Composite infant bedding was associated with subsequent recent wheeze. This composite 
bedding effect was further enhanced by the home environmental factors of bedroom heating, 
recent bedroom painting and the absence of bedroom carpet. When two or more of these home 
environmental bedding-wheeze enhancers were present, a dose-response was evident. Among 
infants with childhood asthma, composite bedding was associated with subsequent earlier onset 
of asthma, an effect which was again potentiated by indoor environmental factors.
7.5 RESULTS: THE 1997 CARHS
7.5.1. Characteristics of the study population
The characteristics of the study population are shown in Table 7.9. Infant bedding data for all 
bedding combinations was available on 408 children. The percentage of infants exposed to each 
composite bedding classification was 32.8%, 62.3% and 4.9% for Bo, Bi and B2 respectively. The 
majority of infant’s bedrooms were carpeted (89.9%) and had also been recently painted within 
the previous 12 months (67.9%) whereas less infants were exposed to bedroom heating (30.5%).
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Table 7.9 Characteristics of the study population in the 1997 CARHS
% n /to ta l N *
M ean age (years) 8.7 (standard deviation=0.6)
R e s p ira to ry  sym p to m s
R ecent wheeze over past year 30.8 153/497
N ight w heeze over past year 20.7 101/487
A sthm a ever 37.8 188/497
HDM  sensitization* 23.3 116/498
Lung function tests undertaken 99.2 495/499
In fa n t bed d in g
Synthetic  pillowcase use at 1 month age 8.7 40/458
Synthetic  quilt use at 1 month age 51.1 210/411
C ocoon use at 1 month age 1.2 5/411
Sheepskin  use at 1 month age 23.2 107/461
S ix-leve l com posite bedding classification
C om bination 0: No synthetic quilt, p illow  or cocoon, o r sheepskin 32.8 134/408
C om bination 1: Sheepskin only 12.0 49/408
C om bination 2 :1  synthetic item 39.0 159/408
C om bination 3: Sheepskin and 1 synthetic item 11.3 46/408
C om bination 4 :2  or more synthetic item s 3.7 15/408
C om bination 5 :2  synthetic items and sheepskin 1.2 5/408
Three-leve l com posite bedding classification
C om bination 0: No synthetic quilt, p illow  or cocoon, or sheepskin 32.8 134/408
C om bination 1:1 Synthetic and/or 1 sheepskin item 62.3 254/408
C om bination 2 :2  or more synthetic items 4.9 20/408
E n v iro n m e n t
H eating in infant’s bedroom 30.5 140/459
C arpet in infant’s bedroom 89.9 408/454
In fant’s bedroom painted w ithin previous 12 months 67.9 311/458
A ny gas appliance use in infant’s house 3.9 18/457
Infant exposed to tobacco sm oke in house 64.7 295/456
‘ Any skin prick reaction of greater than or equal to 3mm to mite allergens D. pteronyssinus or D. farinae.
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7.5.2 Risk of HDM sensitization associated with increasing numbers 
of bedding items in infancy
No association was found between infants exposed to Bi and B2 and subsequent HDM 
sensitization when compared with children who had none of these bedding items in infancy (see 
Table 7.10). The absence of any association remained when SPT positivity was taken as equal 
or greater than a 2 mm HDM allergen wheal diameter.
Table 7.10 Prospective association between infant composite bedding combinations and 
HDM sensitization in childhood in the 1997 CARHS
B ed d in g
c o m b in a tio n s
%  C h ild ren  w ith  in fan t b ed d in g  
c o m b in a tio n  w ith  H D M  sen s itiza tio n *
U n ad ju s ted  o d d s  ratio
% n /to ta l N O dds ratio 95%  Cl p va lue
C om bination  0 32.6 31/95 1.00 (reference)
C om bination  1 63.2 60/95 1.03 0 .6 3 ,1 .6 9 0.898
C om bination  2 4.2 4/95 0.83 0.26, 2.67 0.755
Linear Trend p=0.933
‘ Any skin prick reaction of greater than or equal to 3mm to mite allergens D. pteronyssinus or D. farinae.
7.5.3 Risk of childhood wheeze associated with increasing numbers 
of bedding items in infancy
Infants exposed to B2 showed a non-significant increase in risk of asthma ever at age 9 years 
when compared with children who had none of these bedding items in infancy (Test for linear 
trend, p=0.072). This trend was less evident for recent wheeze and night wheeze (see Table 
7.11).
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7.5.4 The effect of composite bedding classification in infancy and 
changes in lung function
Composite bedding was not associated with FEVi or FVC measures in childhood. The mean 
difference in the FEVi/FVC ratio among children exposed to Bi or B2 in infancy was not 
significantly different from children who had not been exposed to these bedding items in infancy 
after adjustment for other determinants of lung function as shown in Table 7.12 and Table 7.13. 
The adjusted mean difference in the FEVi/FVC ratio among children exposed to composite 
bedding category B2 in infancy was reduced -1.8% (95% Cl -5.0,1.4). As a measure of airways 
obstruction (196, 504), this reduction for children exposed to B2 in infancy was slightly greater 
than the reduction of the FEVi/FVC ratio for children with recent wheeze,( -1.8% vs -1.1 % 
respectively). The adjusted difference in mean FEVi/FVC ratio for children with frequent wheeze 
(>12 episodes) was more substantial, that is, -3.8 % (95% Cl —7.1, -0.57). Even though small, 
this margin of difference may be important as a measure of airways obstruction (196, 504) in 
those children exposed to B2 . However, the sub-set, limited by those children with the three 
bedding categories, has small numbers across the strata, making it difficult to examine fully and 
possibly reducing the relative importance of these findings.
7.5.5 Bedding and home environmental factors
The very small numbers in some of the strata of each composite bedding classification and 
individual environmental factors did not allow investigation of any possible associations between 
these variables in the 1997 CARHS.
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7.6 RESULTS: THE 1995 CHILDHOOD ASTHMA SURVEY
7.6.1. Characteristics of the study population
The characteristics of the study population are shown in Table 7.14. Data for all bedding 
combinations was available on 6,265 children. The percentage of children exposed to each 
composite bedding classification was: Bo 5.6%; Bi 55.3%; and B2 39.1%. The majority of 
children’s bedrooms were carpeted (93.4%).
7.6.2 Risk of childhood wheeze associated with increasing numbers 
of bedding items in childhood
Children currently exposed to B2 versus Bo had an increased likelihood of wheeze (aOR 1.44; 
95% Cl 1.07, 1.92). There was a dose-response relationship between the current exposure to 
increasing number of bedding items and the risk of recent wheeze (Test for linear trend, p < 
0.001) This trend for a higher number of bedding items and increasing risk of recent wheeze was 
also found for asthma ever (Test for linear trend, p<0.001) and night wheeze (Test for linear 
trend, p=0.001). These results are shown in Table 7.15.
7.6.3 Bedding and home environmental factors
Children who currently slept with bedding combination B2 had a more than 3-fold risk of recent 
wheeze if their bedroom floor was un-carpeted (aOR 3.87; 95% Cl 1.26,11.87) when compared 
to children with Bo who were also sleeping in un-carpeted bedrooms. The potentiation of 
composite bedding effect on recent wheeze was significant when bedroom carpet was absent in 
a child’s bedroom compared with the presence of carpet (Likelihood ratio test, p=0.001). 
However, the slightly stronger composite bedding effects for both asthma ever and night wheeze 
found in uncarpeted compared to carpeted rooms were not statistically significant. For children 
with the same bedding combination B2, the presence of bedroom carpet did not significantly 
increase their risk of recent wheeze. These results are shown in Table 7.16. As the increase in 
risk per bedding category was not modified by either smoking or gas appliance use in the home
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environment, both these exposure variables were considered as potential confounders in the final 
models.
Table 7.14 Characteristics of the study population in the 1995 Childhood Asthma Survey
% n /to ta l N *
Mean age (years) 6.9 (standard devia tion=0.3)
Male sex 50.5 3220/6378
R esp ira to ry  sym p to m s
Recent w heeze over past year 22.9 1400/6107
N ight wheeze over past year 14.4 889/6172
A sthm a ever 27.1 1710/6307
C hild  b ed d in g
Synthetic pillowcase use at age 7 years 90.1 5709/6340
Synthetic quilt use at age 7 years 41.6 2649/6364
Sheepskin use at age 7 years 21.1 1331/6307
S ix -le ve l co m p o s ite  bed d ing  c lass ifica tion
C om bination 0: No synthetic quilt, p illow  or sheepskin 5.6 350/6265
Com bination 1: Sheepskin only 1.9 119/6265
Com bination 2 :1  synthetic item 41.2 2582/6265
C om bination 3: Sheepskin and 1 synthetic item 12.2 766/6265
Com bination 4 :2  or more synthetic items 32.0 2007/6265
C om bination 5 :2  synthetic items and sheepskin 7.0 441/6265
T hre e -le ve l co m p o s ite  b e d d ing  c lass ifica tion
Com bination 0: No synthetic quilt, pillow or sheepskin 5.6 350/6265
C om bination 1 :1  synthetic and/or 1 sheepskin item 55.3 3467/6265
Com bination 2 :2  or m ore synthetic items 39.1 2448/6265
E n v iro n m en t
Carpet in ch ild ’s bedroom 93.4 5952/6370
Hom e gas appliance use during childhood 9.1 581/6361
Child exposed to indoor tobacco smoke 41.7 2632/6320
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7.7 DISCUSSION
7.7.1 Overview of results
7.7.1.1 The Infant cohort study with 1995 follow-up and the 1997 
CARHS
This is the first report to investigate composite infant bedding and subsequent wheeze taking into 
consideration modification by the home environment. Wheeze risk in childhood at age 7 years 
increased linearly with increasing numbers of potentially high HDM allergen-rich bedding items at 
one month of age, with a two-fold overall increase between the highest compared to lowest 
bedding classification. This composite bedding effect was further modified by the indoor 
environmental factors of bedroom heating, recent bedroom painting and absence of bedroom 
carpet. When two or more of these environmental factors were present the bedding-wheeze 
effect was markedly exacerbated with increasing composite bedding in infancy (OR 14.94; 95% 
Cl 1.94,115.1 for B2 versus Bo). The findings in this study, of a dose-response for the number of 
synthetic items and frequent wheeze (p=0.004), or earlier age of onset among children with 
asthma (p=0.03), indicates the importance of now considering bedding items not in isolation but 
part of a composite bedding environment. For children aged 9 years, there was also a linear 
increase in wheeze risk, for asthma ever and night wheeze, with increasing number of composite 
bedding items, but this was not statistically significant, possibly reflecting the inadequate 
statistical power due to small sample size.
The strengths and potential weaknesses of these prospective studies have been discussed 
earlier (see Section 4.7 and Section 5.7). An additional strength of this particular study was the 
use of a composite bedding classification and the interaction with home environmental factors 
that has allowed for a more realistic assessment of the actual infant bedding environment. It is 
recognized, however, that bedding items may change over time, so the one measure of use in 
this study may not be a reliable measure regarding the long term use, for example of sheepskin 
over the first five years of a child’s life. In addition, no data was available on the biological 
mechanisms underlying the findings in these studies.
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7.7.1.2 The 1995 Childhood Asthma Survey
The 1995 Childhood Asthma Survey cross-sectional data also showed a linear increase in the 
risk of recent wheeze with increasing numbers of the selected bedding items. The strengths and 
potential weaknesses of this cross-sectional study have been discussed in Section 6.5. Here, 
these results support an earlier report using the same study population where current synthetic 
pillow and quilt use was strongly associated with frequent wheeze (aRR 5.2; 95% Cl 1.3, 20.6) 
(13). In addition, children with wheeze may have removed their sheepskins as an allergy- 
reducing measure. This would tend to work against the patterns found here, but these patterns 
have been found despite the preferential removal of any HDM-loaded bedding items. The 
composite bedding effect on recent wheeze found here was also further modified by the indoor 
home environmental factor of the absence of carpet in the child’s bedroom.
7.7.2 Reported findings from the Infant cohort study with 1995 
follow-up that support causality
The issue of internal validity for the prospective study population has been discussed in detail in 
Chapter 5. Specifically for this Chapter, the research nurse validation of baby’s bedroom heating 
and floor covering has minimized measurement error for these environmental factors. Any 
misclassification of the other dichotomous exposures, both bedding type and environmental 
factors, if present, would likely be non-differential and distort the results toward the null value. 
Also, past literature supports the proposal that the bedding items in this study are likely to reflect 
high HDM exposure (9,14, 479, 535) (see Section 8.2.2.1). Again, the prospective associations 
have remained after adjustment for a large number of possible confounding factors. This study 
has demonstrated several criteria indicative of a causal relationship (330) between composite 
bedding and wheeze: consistency in the bedding-wheeze effect and the findings from other 
studies (see Section 5.1), a high strength of association with an OR greater than 14 which 
remained after adjusting for confounding factors, and a marked dose-response effect for wheeze 
(see Table 2). Furthermore, the prospective measurement of infant bedding before asthma 
development and the earlier shift in age of onset of asthma with the use of bedding combination 
B2, establishes the causal feature of temporality. In addition, the environment-enhancers not only 
increased the magnitude of the bedding-wheeze associations but also shifted to earlier age of 
asthma onset. The specificity of an association as it relates to the bedding-wheeze effect has
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been discussed in Section 6.5.2. I will now discuss another criterion of causality, biological 
plausibility. A diagrammatic model of the possible biological mechanisms underlying the bedding- 
wheeze effects is presented in Figure 7.6.
7.7.2.1 Possible biological mechanisms for the bedding-wheeze 
effects
The three-level composite bedding classification used in this study is based on the distribution of 
bedding exposures to the HDM allergen-rich synthetic pillows, synthetic quilts, cocoons or 
sheepskin (see Section S.2.2.2). Thus, if these findings are causal, one possible mechanism 
might be that the use of synthetic or sheepskin bedding items results in increased HDM allergen 
exposure (9, 14, 479, 535) in early childhood, increasing the risk of atopic disease by placing a 
higher allergen load near the infant’s airway compared with either fewer or none of these items 
(13). These results are also consistent with past work. In this Tasmanian study sensitization to 
HDM is increased in children exposed to sheepskin (548) (see Chapter 4) or to synthetic bedding 
(as compared to those using feather bedding) in infancy (196). In addition, although carpet was 
associated with higher floor dust Der p1 levels than the infant’s bed (2.25 versus 0.91 pg per gm), 
carpet was not associated with subsequent asthma (aRR 0.92; 95% Cl 0.70, 1.21) (245)) in a 
small sub-study within the TIHS (444). As of April 2004, seven cross-sectional studies and two 
prospective studies have reported associations between synthetic bedding and wheeze (see 
Section 5.1). The results from these previous studies prompted speculation that the increase in 
the use of non-feather (synthetic) pillows contributed to the increasing exposure to HDMs (198), 
which in turn has been partly responsible for the increase in childhood wheezing (198).
With the exception of a small sub-study (444), HDM allergen levels are not available in these 
Tasmanian studies. However, a single allergen measure of, for example, bedroom carpet (178), 
which may not have consistent patterns of allergen distribution (609), would not have 
encompassed the bedding and home environmental determinants leading to personal allergen 
exposure studied here. There is great variation of Der p 1 levels between areas within a room, 
and no consistent pattern of distribution of mite allergen within carpeted rooms has been found 
(610, 611). A prospective association between infant bedroom floor HDM levels and asthma has 
been found in only one (170) of three studies (178,209). Moreover, the concept of a putative role 
for proximity to the airways of HDM allergen-rich bedding items is further reinforced by the 
findings reported in Chapter 6 which show that the adverse effect of synthetic quilts on wheeze
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varies by sleeping position (612). Thus, exposure models that take into account the multiple 
determinants of personal allergen exposure are required. The inhalational HDM allergen dose 
will reflect HDM allergen from multiple sources. Clearly, prospective allergen measurement of 
only one component of this complex system is not likely to adequately reflect the infant’s 
inhalational HDM allergen dose over time in early life. The composite bedding model was based 
on HDM allergen loading, but it is also recognized that other possible biological mechanisms 
include the release of VOCs from synthetic materials (see Section 4.7.2) and/or the role of 
endotoxins in the synthetic bedding (see Section 5.7.5).
7.7.2.2 Possible biological mechanisms for the bedding-wheeze 
effects and home environment interactions
Induction of asthmatic symptoms are influenced by various environmental adjuvant factors (613, 
614). For atopic infants, the presence of other environmental exposures, in addition to 
aeroallergens, has been hypothesized to be synergistic and increase the risk of asthma. A recent 
study reported that the animal (pet) sensitization-wheeze association in children during their first 
two years of life was significantly modified by exposure to an increasing number of home 
environmental factors, with a multiplicative interaction in the presence of three risk environmental 
factors (Test for trend, p<0.001) (615).
Synergy is the causal counterpart of statistical interaction (616), and, in this study I have reported 
that the potentiation of the composite bedding-wheeze effect is greatest in the presence of two or 
more of the environmental factors, bedroom heating, recent painting or absence of carpet. 
Possible synergistic mechanisms could include increased HDM exposure, increased allergen 
sensitization, increased organic compound-induced inflammation in vulnerable early life airways, 
or reduced exposure to endotoxin. The potentiation of the composite bedding on wheeze by 
room heating may be due to an enrichment of the allergen content of bedding and is consistent 
with previous studies that reported room heating increased HDM load in bedding (481,582, 583). 
Many residential characteristics are interrelated such as temperature, age and structure of the 
house, central heating, type of carpets and bedding, which are, in turn, also related to other 
residential characteristics, potentially influencing the HDM allergen levels (579). Thus, differing 
room conditions may impact directly on the bedding microclimate and enhance HDM proliferation 
and levels. A warm, humid bedroom may not operate independently of bedding HDM allergen 
levels to increase asthma risk.
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The potentiation of the HDM allergen-rich bedding effect on wheeze by recent painting operates 
possibly through a different mechanism that may influence an infant’s vulnerability to HDM 
allergen. Pollutant-allergen interactions within the home environment may be important (617). 
Exposure to certain air pollutants has been shown to enhance the airway response to inhaled 
allergens in susceptible individuals (237) (see Section 4.7.2). Recently painted walls release 
VOCs (618, 619) and their presence in the infant’s bedroom may enhance sensitization to HDM 
by airway inflammation resulting in increased permeability and enhanced allergen presentation to 
the immune system (492, 519), and / or by VOC-induced Th2 deviation (496). Other birth cohort 
studies in addition to this Tasmanian study, have also found an exposure-response relationship 
between recent home redecoration, including wall painting, and an increase risk of bronchial 
obstruction (618,620) or asthma (621, 622).
The potentiating effect of having no carpet raises the possibility that carpet exposure in infancy is 
the source of a protective influence. The promoting effect of no carpet did not operate 
independently of composite bedding exposure. A reason for the apparent bedding-potentiation 
effect of no carpet may be that the absence of bedroom carpet as a habitat for HDM (609), has 
increased the relative importance of the bedding as a HDM allergen reservoir (510). One further 
possibility to be considered is that in infancy the bedroom carpet is a significant reservoir of 
endotoxin (334, 623, 624). And, endotoxin exposure at a critical time in infancy has been 
postulated to be protective for the development of atopic asthma (625) (see Section 2.3.6). 
Bedroom carpets contain significantly more endotoxin than bedding (624) and thus may be a 
major reservoir for infantile endotoxin exposure. In addition, measures associated with carpet 
cleaning such as vacuuming (626) and steam cleaning (623) may significantly increase airborne 
levels of carpet contaminants, and the re-use of vacuum dust collection bags, possibly because 
of the dispersal of dust back into the room during dust disposal, also significantly increases 
bedroom endotoxin levels (623). As synthetic bedding may contain less endotoxin as compared 
to other bedding (549), this could be counterbalanced by increased levels in the bedroom carpet.
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7.8 CONCLUSION
In conclusion, composite HDM allergen-rich bedding exposure as an infant at one month of age 
predicts subsequent childhood wheeze, particularly if exacerbating home environmental factors 
are present. Asthma epidemiology has been hampered by problems in exposure and disease 
classification and the absence of detailed bedding information in a prospective infant cohort. In 
this study, improvements in defining exposure by composite bedding combinations has revealed 
stronger associations than previously demonstrated for most home environmental factors. This 
study has demonstrated that the sleeping environment should not be based on a single bedding 
item. Composite bedding arrangements in infancy have been shown to increase the risk of 
subsequent wheeze. Furthermore, my results indicate that the home environment appears to 
modify the bedding effect on subsequent asthma development. There may be interaction of more 
than one environmental factor. Few studies have compared the increase in asthma prevalence 
over time with changes in the identified potential risk factors for asthma and atopy development 
(see Section 2.6). However, Butland et al., 1997 (136), reported that home environmental risk 
factors appeared to explain 52% of the increase in the population prevalence odds of wheeze. 
Bedding items, specifically the type of pillow, was one home environmental factor for which trends 
in exposure were conducive to an increase in prevalence. The results in this Chapter support the 
findings of that study where there is not just one, but various, home environmental factors 
impacting on the level of child asthma.
Furthermore, the inter-relation of environmental factors is important. Mihrshahi et al., 2002 (481), 
reported that when only the significant factors associated with HDM allergen level (such as 
synthetic quilts) were absent from the bed, the mean Der p 1 allergen concentration in the bed 
was reduced from 14.30 pg/g to 8.55 pg/g (95% Cl 6.54,11.16). However, analysis of houses 
with characteristics shown in univariate and other studies to be related to lower HDM levels, had 
an even lower level of bed HDM allergen (Derp 1 of 3.19 pg/g (95% Cl 1.21,8.39) (481).
Infants spend a significant proportion of their time in bed with consequent opportunity for 
prolonged exposure to adverse environmental influences. Bedding is a readily modifiable 
environmental factor but these results suggest that greater attention and further study should also 
be given to other environmental factors relating to the bedding environment that may potentiate 
any adverse bedding effect. These findings indicate that a greater public health effort to promote 
optimal infant sleeping environments for primary prevention of asthma is required. RCTs of infant
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bedding interventions which target not only the components of, but also, the combined sleep 
environment to reduce childhood wheeze are now required.
7.9 POST-SCRIPT
The findings here further emphasize the likely important role of the infant sleeping environment 
on asthma development. Chapter 8 discusses the key findings of this thesis, the relevance of 
these findings to current knowledge and the implications for future research.
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Chapter 8
Key findings and implications for public health policy and 
future research directions
8.0 INTRODUCTION
The aim of this thesis was to extend knowledge on home environmental risk factors for HDM 
sensitization and child asthma, focusing on infant and child bedding and the bedding 
environment. The key findings of this thesis emphasize the likely dominant role of the infant 
sleeping environment on both asthma development and the provocation of symptoms. Most 
importantly, Chapter 7 shows that composite bedding, not single bedding items, may more validly 
reflect the true bedding environment and its relationship to allergic sensitization and adverse 
respiratory associations. In addition, the bedding and home environment interactions were found 
to influence the relationships between bedding items and respiratory health.
The level of evidence provided by the results reported in this thesis for the two prospective 
Tasmanian studies can be considered as Type 111-2 and future studies, such as RCTs, are 
needed to provide a higher level of evidence (627). There were limitations from using the 
Tasmanian studies, and these have been discussed in detail in the preceding Chapters. 
Notwithstanding, there remains a strong effect with the identified associations. The infant cohort, 
TIHS, was a study designed, not for asthma, but to explore SIDS. However, the study is unique, 
providing a wealth of information regarding an infant’s early home and bedding environment. The 
TIHS cohort was restricted to Tasmania and thus is not representative of the general infant 
population of Australia, yet the study base fulfils the criteria that would support the generalization 
of the findings of this birth cohort (550). The number of children participating in the prospective 
asthma studies was not large: limiting, at times, the exposure to individual bedding items and 
environmental factors, and impacting on the ability to identify consistency in the results between 
each study. The identification of these limitations serves to inform future studies. And, ideally, 
future studies, designed to specifically examine the role of bedding in child asthma, will be of RCT 
design.
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8.1 KEY FINDINGS OF THIS THESIS AND THEIR IMPLICATIONS
8.1.1 Underbedding, mattress and bed type
This thesis reports the first prospective association between the use of sheepskin or the use of 
plastic mattress covers in infancy with an increased risk of HDM sensitization in childhood. The 
adverse association of bedding items with HDM sensitization and/or wheeze may be influenced 
by the HDM-loading of the individual item. Furthermore, this adverse association may also be 
influenced by the material composition of the bedding item, such that HDM or endotoxin loading 
in bedding items may not be the only biological mechanisms accounting for the associations. The 
emission of VOCs from individual bedding items may provide another plausible biological 
mechanism.
8.1.1.1 Sheepskin
It is well recognized that infant sheepskins harbour high levels of HDM, indicating likelihood of a 
high infant exposure to HDM allergen when in the bed. The prospective association between 
sheepskin use and subsequent HDM sensitization, is consistent with this concept that sheepskins 
have high HDM. Moreover, these results support current recommendations that the use of 
sheepskins as infant bedding in atopic families is inappropriate. A novel finding in this thesis was 
that exposure to sheepskin in infancy tended to be positively associated with HDM sensitization 
even among the sub-group of those with no at-birth family history of asthma. This finding 
supports earlier reports that many children who develop atopic diseases during the first years of 
life come from families without an atopic heredity (628,629).
8.1.1.2 Plastic mattress covers
The novel finding of an association between plastic mattress cover use and HDM sensitization
adds to the evidence that greater attention and further study should be given to other potentially
adverse environmental factors, such as VOCs, related to the bedding environment. Plastic
mattress covers have previously been considered a priori to protect from sensitization to HDM.
This has not been proven and the findings in this thesis are also inconsistent with this
assumption. Moreover, there is conflicting evidence regarding the efficacy of using mattress
covers in the prevention of asthma symptoms despite a reduction in HDM levels (488). The
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influence of VOCs is one explanation that may also be considered in attempting to explain these 
findings and there is some support from other work to make this suggestion worthy of 
consideration (496). In addition, there is also a body of work to support the proposition that 
organic or other components affecting infant air quality may induce sensitization to allergens 
(504). Previous studies have measured HDM and endotoxin levels in bedding; it would now be 
appropriate for future studies to consider other potential factors, such as the emission of chemical 
compounds from bedding materials, that may initiate and/or trigger asthma in those individuals 
exposed to plastic mattress covers.
8.1.1.3 Implications of the sheepskin and plastic mattress cover 
associations: the current public health recommendations for 
bedding and asthma
These findings, described above, have implications for the current public health 
recommendations regarding sheepskin use in infancy. The reported associations suggest that 
further consideration of the current preventive measures for infants at high-risk of atopic disease 
and sheepskin use, now be given to the whole population. That is, future guidelines may 
consider that all infants, and not only those infants at high-risk of acquiring asthma, should avoid 
the use of sheepskins in infancy if laundering techniques are unable to maintain low mite 
populations (479).
In addition, plastic (PVC) or vinyl mattress covers, commonly used to prevent bedwetting, may 
also form part of a HDM reduction program by acting as an occlusive cover to the underlying 
mattress. Plastic mattress covers, however, but should not be considered beneficial for infants at 
high-risk of atopic disease without a careful evaluation of other potential adverse health effects 
that may arise from the barrier method that is being used to reduce HDM bedding levels.
8.1.1.4 Bunk beds and electric blanket
In Chapter 4, those children sleeping in the bottom bunk-bed were found to have an increased 
risk of frequent wheeze compared with children sleeping in the top bunk-bed. Also, in this same 
study population, a positive association was found between the current use of electric blanket and 
wheeze. As these associations have been found in a cross-sectional study issues related to
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measurement bias, disease-related changes in behaviour and bedding, and confounding may 
have contributed to the observed association. However, there are no previous reports of an 
association between the current use of electric blanket and wheeze. The proposed role, 
presented in this thesis, of HDMs contributing to the increased association of frequent wheeze 
and the use of electric blankets or sleeping on a bottom bunk-bed is speculative. At this time, 
there are no recommendations regarding the use of electric blankets for children at risk of, or 
suffering from, atopic diseases. Thus, these findings suggest new areas which might be the 
subject of further consideration and study, for example, further studies to explore the associations 
between electric blanket and bunk-bed use and HDM sensitization and wheeze.
8.1.1.5 Allergen-specific determinants of atopy
Close proximity of a bedding item to the infant’s airways may play an important role in the 
reported associations and is supported by the finding in Chapter 4 of the absence of interaction 
when both sheepskin and plastic mattress cover were used together. It may be appropriate for 
future work to consider allergen-specific outcomes when searching for determinants of atopy as 
the exposure effect, from sheepskin or plastic mattress cover use, was acting principally on 
inhalant allergens present in the bedding environment. This was demonstrated by the lack of any 
association between an infant’s exposure to these types of underbedding and outdoor 
aeroallergens such as rye grass.
8.1.1.6 The use of frequent wheeze as marker of allergen-induced 
airway disease and disease misclassification
There is strong evidence that children with asthma who are also sensitized to HDM, are more 
likely to have severe or frequent asthma (Sections 6.3.2.1 and 2.2.1.6). The findings in this thesis 
provide further support to this concept and suggest consideration of asthma phenotypes in the 
assessment of allergen-induced airway disease through the use of wheeze frequency as an 
outcome measure. The positive associations between either sleeping in the bottom bunk-bed or 
current use of an electric blanket, compared to children who were not exposed to these bedding 
items, were stronger for children with frequent wheeze in the past year. These findings may be 
related to HDM sensitization. The reporting of the frequencies of wheeze episodes as outcome 
measures should reduce the level of disease misclassification for atopic asthma by identifying
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sub-groups of children with more frequent episodes of wheeze in the past year that are more 
likely to reflect allergen-induced airway disease rather than airway disturbance due to viral 
infection or other non-atopic factors.
8.1.2 Synthetic bedding exposure, sleep position and increased risk 
of asthma
8.1.2.1 Infant cocoons
A prospective association of predominantly synthetic cocoon use in infancy with an increased risk 
of wheeze at age 7 years has been reported in this thesis. Cocoon use in infancy was also 
associated with an increased wheeze frequency. Furthermore, these results are consistent with, 
and support, the growing evidence that synthetic bedding materials are associated with increased 
childhood wheeze (Section 5.1). Cocoons are an easily modifiable environmental factor that is 
currently used in child care. The association between infant cocoon use and childhood wheeze 
may be causal in nature, but further work is required to confirm these results, particularly as the 
number of children using cocoons was small, thus the role of chance must be considered.
8.1.2.2 Synthetic quilts and sleep position
In Chapter 6, the interaction between quilt use and sleep position on respiratory function was 
assessed among seven year old children. There was an adverse effect associated with synthetic 
quilt use on frequent wheeze and post-exercise lung function among children who slept supine 
but not among children who did not sleep supine. The interaction is consistent with an adverse 
effect of synthetic quilt use that is mediated by close proximity. These results are also consistent 
with two recent birth cohorts (12, 13) reporting an association between synthetic material and 
frequent wheeze. Selection bias due to bedding choice by parents whose children are at higher 
risk of asthma has been one possible explanation for these findings (12, 13), however, the 
findings in Chapter 6 are unlikely to reflect selection bias. Moreover, these findings have added 
support to the causal inference between synthetic bedding and wheeze by predicting specificity of 
association as the adverse effect of synthetic quilts was most evident in children who would be 
more likely to sleep face-up near the quilt.
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8.1.3 Composite bedding and environmental interactions
The reported findings of this thesis are the first to investigate composite infant bedding and 
subsequent wheeze taking into consideration modification by the home environment, utilizing a 
new conceptual approach. Wheeze risk in childhood at age 7 years increased linearly with 
increasing numbers of potentially high HDM allergen-rich bedding items at one month of age. 
This composite bedding effect was further potentiated by the indoor environmental factors of 
bedroom heating, recent bedroom painting and absence of bedroom carpet. When two or more 
of these environmental factors were present the bedding-wheeze effect was markedly 
exacerbated with increasing composite bedding in infancy. The findings in this thesis, of a dose- 
response for the number of bedding items and frequent wheeze, or earlier age of onset among 
children with asthma, indicates the importance of considering bedding items not in isolation but as 
part of a composite bedding environment.
8.2 FUTURE RESEARCH IN CHILD ASTHMA: A FOCUS ON BEDDING
This thesis raises issues pertaining to bedding and the sleep environment that will contribute to 
the further evaluation and identification of factors involved in both child asthma development and 
symptom exacerbation. For infants at high-risk of developing asthma and for children with the 
disease, the bed may be considered the most important site of allergen exposure because of the 
high level of mite allergen exposure experienced during sleep (473, 475), the proximity of the 
subject to the source, the high proportion of indoor time spent at this one site (14, 15), and the 
large amounts of dust present in the bed (14).
It has been argued that there is strong evidence for allergen exposure as an important factor in 
the aetiology of asthma and in determining the severity of the disease. Existing data and the 
findings from this thesis support the role of allergen avoidance as a component of both asthma 
prevention and management strategies (630). The findings from this thesis also suggest that 
other factors in the bedding environment may be operating to potentiate the effect of HDM- 
allergen exposure in a susceptible individual. Multiple components, not single items, and their 
relationship to the proximal sleeping microenvironment, may all play a role in child asthma.
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8.2.1 Personal allergen measures
Personal allergen measures during sleep should take into account bedding, proximity and ideally, 
individual inhaled dose. To date, there is poor understanding of what constitutes the true level of 
personal allergen exposure (630). Current indices used to measure HDM allergen level in dust 
reservoirs vary spatially (611) and temporally (578) and, as allergens are taken up by inhalation, 
dust mite allergen concentrations in reservoir dust cannot directly reflect personal exposure (631). 
There is a key role for direct measures of inhaled allergens to avoid the misclassification of 
inhalational exposure that occurs when proxy measures such as the floor are used to indicate 
bedding exposure levels. Airborne allergens during sleep have been shown to be generated from 
used (HDM-loaded) bedding and not from the floor (473). And, moreover, measurement of 
mattress mite levels at a particular moment does not necessarily reflect the dynamics of exposure 
during sleep, as movement will disturb HDMs in the individual bedding items, such as quilts. 
Furthermore, Chapter 6 indicates the importance of proximity to bedding items.
I had the opportunity to assess the feasibility of using a new technology, the intra nasal air 
sampler, to measure the amount of personal HDM allergen inhaled associated with different 
sleeping positions and proximity of bedding items 2. The intra nasal air sampler provides a 
measure of directly inspired allergen-bearing particles (507). Future research studies should also 
consider HDM allergen levels in bedding, in addition to the bedroom floor, as well as the proximity 
of the HDM reservoir to the airways. The intra nasal air sampler offers the potential to compare 
the personal mite aeroallergen exposure of children using beds fitted with pillows and duvets 
made from differing materials such as synthetic or feather. Quantitative measures of personal 
inhaled allergen exposure will assist in the understanding of additional factors that may be 
involved in the bedding environment.
8.2.2 Bedding changes over time
Bedding changes over time should be considered as a possible contributing factor to temporal 
changes in asthma prevalence. It is, therefore, appropriate to consider recent reports of either a 
decline (3, 4,150-152) or a plateauing (5,154-156) of child asthma prevalence in the context of 
the findings in this thesis. Evidence is not readily available indicating a temporal change in
2 The nasal air samplers were provided for the feasibility study by Inhalix, Institute of Respiratory 
Medicine, University of Sydney, Sydney, Australia.
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factors, both environment and genetic influences, previously considered responsible for the 
increase in the burden of asthma. Some authors have suggested that the lack of a further 
increase in asthma prevalence is a result of the environmental factors that promote or trigger 
asthma, having reached their maximum effect on a susceptible genetic background (152, 154). 
Whereas others have cited as possible factors, the increase in the number of nursery places 
since 1996 in Britain (156) or the increased attendance at DCCs (3). Two Australian studies have 
recently reported a decrease in the prevalence of child asthma (3, 4). Robertson et al., 2003, 
reported a 26% reduction in current wheeze prevalence from 1993 to 2002 in Melbourne 
schoolchildren (3). Whereas, Toelle et al., 2004 (4), found the prevalence of recent wheeze 
decreased significantly (-4.9%; 95% Cl -9.1%, -0.7%) between 1992 and 2002 in schoolchildren 
from Belmont, Australia.
The studies discussed in Chapter 2 (see Section 2.1.3) indicate that these reported decreases in 
child asthma prevalence are, however, likely to reflect disease changes, not changes in 
diagnostic criteria. Moreover, a child’s bedroom environment may have changed over that 
period. In addition, epidemiological associations between the home environment and asthma 
may be underestimated by the greater tendency of cases and their families to avoid potential 
causes of asthma in the home. Strachan & Carey, 1995 (197), in a population based case- 
control study in 1991 in Sheffield UK found that the bedroom environmental factors, including 
bedding pillows and quilts, of 25% of teenagers with troublesome asthma had been altered 
because of the child’s allergy or asthma (197).
Thus, the results of this thesis support the case that the role of a change in infant bedding and the 
bedroom environment to these childhood asthma trends should be considered in future research 
directions. This is particularly important in view of changes in infant bedding during the 1990’s, 
the same time period for the reported decrease in asthma prevalence, principally as a result of 
campaigns conducted to reduce the risk of SIDS (632-634). Hiley & Morley, 1994, reviewed the 
change in duvet (quilt) use at one year (634) and two years (633) after the UK’s Department of 
Health’s 1991 “Back to Sleep” campaign in three East Anglian health districts. One year after the 
campaign, mothers having their first baby were less likely to use a duvet than were mothers with 
other children (for infants three months of age: 34% versus 66%, p<0.001). Compared with 1992, 
quilts or duvets were used less frequently two years after the campaign (for infants three months 
of age: rate difference -8; 95% Cl -1, -13). Dwyer et al., 1995 (632), compared the prevalence of 
infant, parental and environmental risk factors before and after the 1991 Australian “Reducing the 
Risks of Cot Death” campaign in the TIHS. Infant use of sheepskins was found to be less in the
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18-month period after the intervention (aOR 0.79; 95% Cl 0.70, 0.90 for prevalence after versus 
before the campaign). The ISAAC Phase 3 (146) may offer the opportunity to compare 
prevalence changes in asthma with bedding changes in the period from ISAAC Phase 1 to ISAAC 
Phase 3.
8.2.3 Composite bedding measurements
Composite bedding, not single bedding items, as an exposure measure may more validly reflect 
the true bedding environment and its relationship to allergic sensitization and adverse respiratory 
associations. Bedding and home environmental interactions should be considered when 
exploring relationships between bedding items and respiratory health. The role of bedding 
manipulation, including the sleep environment, in primary prevention of atopy and wheeze may 
not yet have been fully assessed. Future studies addressing the concepts raised in this thesis 
could prove worthwhile in regards to prevention activities and are needed to determine the 
relevance of these findings. Identification of modifiable factors contributing to the burden of 
asthmatic disease would have considerable public health benefit. Many environmental factors 
have been proposed as risk factors for the development of childhood asthma and atopy, but the 
relevant causes are as yet not fully determined. More information that may be provided through 
appropriate RCTs is required about the relative contribution of individual sites to personal 
exposure in order to target prevention and intervention strategies. Thus, multifaceted approaches 
are necessary to determine the combinations of factors which influence HDM allergen exposure.
8.3 CONCLUSION
In conclusion, this thesis has contributed to the current knowledge regarding the possible 
aetiology of child asthma with a focus on the home and bedding environment. It has presented 
new findings in regards to a composite bedding effect. Moreover, the contribution of this thesis to 
public health is evidenced by three published papers, one paper provisionally accepted for 
publication, and two further papers in progress (including a Review of bedding and asthma). 
Further research is required in both the identification of risk factors and also the understanding of 
the underlying mechanisms through which the identified risk factors are responsible for child 
asthma
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Appendix 1
1995 Childhood Asthma Survey Questionnaire.
How  To A nsw er The Q uestionnaire A bout Your Child W ho T urns Seven In 1995
lease read the information letter first. Please make sure that all questions have an answer. In most cases, uni 
therwise indicated, you are asked to answer by putting a tick (vQ in the appropriate box;
(e.g. if you want to answer'yes', mark Yes £3 No[~])
If you wish to add more information please write in the space provided at the end of the questionnaire. 
Thank you for participating in childhood asthma research.
(PLEASE PRINT ALL NAMES IN BLOCK LETTERS) 
hi Id's name
(Surname) (Given names)
hild's full name as registered at birth
r the same as above, please write ‘ns above').
(Surname) (Given names)
urrent Address
P/C
lother's name
(Surname) (Given name)
lother's name when the child was bom (if the same as above 
please write 'as above').
(Surname) (Given name)
ate questionnaire filled out
RTH AND OTHER DETAILS
Mother's Date of Birth
Child's date of birth
Sex Boy ..............CD
School ________________
/.../...
Girl
/  . . .  /  . . .  
/  . . .  /  . . .
Where was this child bom?
Tasmania ........................
Other Australian State 
Other Country (Please specify)
□
□
Place/hospital of birth?
Queen Alexandra Division, RHH, Hobart ........ Cl
Queen Victoria Hospital, Launceston ................ CD
......  CD
. □ 
□
7.
8 .
9.
Calvary Hospital, Hobart ..............
NW Regional Hospital, Burnie ........
Mersey Women's Division, Devonport 
Other Hospital (Please specify below)
Other circumstances (Please specify below)
Was this child premature? (i.e, more than 3 ivks early).
Yes Cl No CD
Complete child's birthweight, if known
_____  lbs. ______ oz. OR _____
Is this child from:- 
A single birth
First of a twin birth 
Second of a twin birth 
Triplet birth ..........
□
□
□
□
10. Do you recall this child taking part in the 
Tasmanian Infant Health Survey conducted by the 
Menzies Centre when he/she was a baby? (You may 
remember a sister visited your heme with a thermometer).
Yes CD No CD
11. What are the ages of the brothers or sisters of this 
child? (List ages from eldest down eg. 11, 9, 9, 3)
CHILDHOOD ILLNESS
12. Has he/she ever had eczema in the creases (bends) o 
elbows, wrists, or knees?
Yes CD No CD
13. Has he/she at any time in his/her life suffered from 
attacks of asthma or of wheezy breathing?
(SB. Please regard asthma" .m.i " vhei’VJ rrrathtry " is barg •auch the
L At w hat age did these attacks begin?
__________Y ea rs
Not applicable O
5. Does he/she get attacks of "hay fever" (that is, sneezing, 
running or blocked nose, sometimes with itchy eyes or nose)?
Yes d  No d
j . Has your child had wheezing or whistling in the 
chest in the last 12 months?
Yes □  No □
7. H ow  many attacks of w heezing has your child had
in the last 12 months?
None.................. d
1 to 3 ..................  □
4 to 12..................  □
More than 12 ..................  d
In the last 12 months, how often, on average, has 
your child's sleep been disturbed due to wheezing?
Never woken with wheezing ...................... d
Less than one night per week ...................... d
One or more nights per week ...................... d
26. In the last 12 months how often on average has you; 
child taken asthma medicine?
Not at all ............................................................  d
Less than once a month .................................  d
More than once a month .................................  d
Every day ........................................................  d
27. In the last 12 months has your child taken any of th 
following medicines for asthma?
Ventolin, Bricanyl, Berotec ..;r......    d
Intal ........    d
Becotide, Becloforte, Pulmicort ......................  d
None of the above .............................................  d
28. Did this child attend regular child care* w ith  more 
than two other children at the following ages:-
Less than 1 year of age Yes d N o d
1 year of age Yes d N o d
2 years of age Yes d N o d
3 years of age Yes d N o d
4 years of age Yes d N o d
(’ please consider regular child care as being at least once a week for 3 
hours or more)
3. In the last 12 months, has wheezing ever been severe 
enough to limit your child's speech to only one or two 
words at a time between breaths?
Yes d  No d
3. Has your child ever had asthma?
Yes d  No d
1. In the last 12 months, has your child's chest sounded 
w heezy  during or after exercise?
Yes d  No d
29. Has child had any of the following?
(please tick applicable box/boxes)
Bronchitis ....................................
Cough lasting for more than 3 weeks
Pneumonia ....................................
Pleurisy ....................................
Frequent ear infections (more than 2/year) 
None of the above .....................
d  
d  
d  ‘ 
d  ‘ 
d  i 
d
FAMILY HISTORY
In the last 12 m onths, has your child had a dry cough 
at n ight,  apart from a cough associated w ith  a cold 
or chest infection?
Yes d  No d
Since birth has this child attended hospital for any 
reason?
(If yes tick all applicable boxes) Yes d  No d
In Southern Tasmania (002) 
cv In Northern Tasmania (003)
^  In North Western Tasmania (004)
) Outside Tasmania (Please specify)
a
d
d
d
------------------------------------------------------
/  *
'[ Since birth has this child attended hospital for:
, "'f — 'A^thma Yes d  No d
b Other breathing problems Yes O' N o d  •
< Please specify)__________________________ 2___________ •
Has your child ever taken any medicine for asthma? ,
(Medicine includes inhalers, liquids, tablets, riehulisers).
Yes d  No d
Do any of the child's brothers or sisters, parents or 
grandparents, have any history of the following?
(please tick applicable box/boxes).
Febrile convulsions ..........................
Asthma .................................................
Heart disease, dying before age of 60 years
Epilepsy or fits .................................
Diabetes (requiring insulin injections) .......
d  
d  
d  < 
□  * 
d  <
Diabetes (not requiring insulin injections,
often called 'late onset’ or 'sugar' diabetes) ..............
Eczema ............................................................
Hayfever ........................................................
None of the above illnesses .................................
Please indicate your re lationship to the child:
□  \ 
d
d *
Qj
r̂ i m m
Mother Father
Other (please state)/_
- Step-parent/ 
adopted parent/ 
Tguaraian
d
CHILD’S PARENTS 41. The father's current occupation is (please print):
32. Has child's natural mother ever had asthma or 
attacks of wheezing like asthma?
Yes CD No d  
Medical details of mother unknown......  CD SMOKING
33.
34.
35.
36.
37.
38.
Has she ever suffered from "hay fever"
Yes □  No □
Medical details of mother unknown....... d
Please indicate the highest level of school education
the child's mother has completed:
Primary school (eg. left before end of year 10) ..........  d
High school completed to end of year 10 ........... d
Completed secondary education to end yr. 12 ... O
University, TAFE or other institution ..........  d
Unknown ........................................................... d
Which one of the following best describes the 
mother's current employment status?
Unemployed ....................................................... d
Home duties ....................................................... d
Employed part-time ...............................................  d
Employed full-time ...........................................  d
Student ..........   d
Sole parent pension ....................... I—1-;
Other (please state)
_____________________________________  d  .
The mother's current occupation is (pleaseprint):
Has child's natural father ever had asthma or 
attacks of wheezing like asthma?
Yes d  No Q
Medical details of father unknow n....................... d
Has he ever suffered from "hay fever"
Yes d  No d
Medical details of father unknow n...... d
42. How many cigarettes does child's mother smoke j
day?
N il.........................    C
1 - 10/day...........................................  C
11 - 20/day................................   C
21 - 4 0 /d a y .......................................  C
41 + /d ay  ..................................  d
43. How often does child's mother smoke in the same 
room as the child?
Usually .................................................... d
Sometimes ...................................................  d
Never ...................................................................  d
44. How many other adults excluding child's mother 
smoke in the house?
_________ Other
45.
46.
How many cigarettes do other adults (excluding mothei 
your household smoke, in total, per day?
Nil .......................................................................  □
I - 10/day ..................... , ...................................  d
I I  - 20/day ................................................ ’. ..............................  d
21 - 40/day ......................................................  d
41+ /dav   d
I—
Don't know ..........................................................  I—
How often do other adults (excluding mother) smoke in 
same room as the child?
Usually
Sometimes
Never.
d
d
d
INFANT & CHILD FEEDING
39. Please indicate the highest level of school education
completed by the child's father:
Primary school (eg. left before end of year 10) ....... d
High school completed to end of year 10 ..........  d
Completed secondary education to end yr. 12 ... d
University, TAFE or other institution ......  d
Unknown ........................................................... d
47.
48.
Was your child breastfed?
Yes d  No d
Age of child when breastfeeding ceased? (completed 
months).
Not applicable
Month
.... d
Which of the following best describes the father's
current employment status?
Unemployed ....................................................... d
Home duties ....................................................... f~1
Employed part-time ............................................... d  L
Employed full-time ........................................... d
Student .............................................................  Q  •"
Permanently unable to work or ill ......................  1 1 <
Other 'olease state'
49.
50.
At what age were solids introduced?
Month
How often does your child eat fish?
Never ............................................ .
Once a week or less ................
More than once a week ............
d
d
d
Which of the following fats does your child usually 
have on bread or toast:
Butter ................................
Canola, soy, olive margarine 
Other margarines (eg. sunflower,
safflower, m ixed vegetable)
None of the above .............
□
□
□
□
57.
Has your family had a cat for a pet during this 
child's life?
58.
Yes CD
(p lease tic k  a ll the ages of your ch ild  w hen  a cat
No-CD 9
w a s a p e t)
59.
□  1 □ □  *
A
□ □  j 60.
0-6 mths 6-12 mths ly r 2vrs 3yrs
of age of age of age of age of age
□  '
a
□ □  1 □
4vrs 5yrs 6yrs 7yrs 61.
o f age of age of age of age
DME ENVIRONMENT
What is your home made from?
Weatherboard ...............
Brick veneer ...................
Double brick ...................
Other (please specify)
□
□
□
□ 62.
What main type of floor does your house have? (tick 
one box).
Wooden ..............
Concrete slab on ground
Raised concrete slab 
? Other (please specify)
□
m□
□
63.
Do you have wall to wall carpet or large rugs 
(occupying more than half the floor area in total) in your living 
room?
Yes □  No □
64.
What is the main heating used in your living room?
(Tick one box)
No heating   0
Open fire   CD
Wood heater (freestanding or in fireplace) ....... GD
Oil heater with fan   CD
Oil heater without fan   CD
Gas heater with flue (chimney) ..................  CD
Gas heater without flue   CD
Kerosene heater   CD
Off-peak electricity    CD
Electric radiators or fan heaters .................. CD
Electric Central heating .............................  1—J
Gas Central heating ......................................... CD
Other (please specify)
□
66 .
What power source do you use for cooking? (Tick one bo.
Electricity .........................................................  CD
Gas    CD
Wood stove   CD
Other (please specify) □
How many rooms does your house have?
(Excluding bathroom and toilet)
___________ Rooms
How many people live in your home?
People
Have you noticed mould inside your house? {
(Excluding bathroom)
Yes □
What is the floor covering in the child's bedroom?
(Tick one box).
Wood   ED
Lino   CD
Concrete .........................................................  CD
Carpet .............................................................  ED
Tiles   Ep
Other (Please specify) □
Is there also a rug or rugs on the floor of your child's 
room which occupy more than half the floor area?
Yes □  No CD
At night, is/are window(s) in room where child 
sleeps:- (Tick one box).
Partly open in cold weather only ..................
Partly open in warm weather only ..................
Partly open all year round ..............................
Closed all year round .....................................
□
□
□
□
What type of bed does your child use?
Child's small bed .................................
Single bed .........................................
Double bed .........................................
Top bunk ............................. ..........
Bottom bunk ....................................
Other (Please specify)
□
□
□
□
□
□
Is child’s bed -
On the floor ........
Supported by legs/frame
□
□
What type of mattress is now on child's bed?
Foam ............................................................
Innerspring .................................................
Other (Please specify)
□
□
□
67. In the last month have you used the following 
products - (tick nil applicable boxes)
In t h e In c h i l d ' s
h o m e b e d r o o m
A i r f r e s h e n e r  s p r a y □ □
I n s e c t  k i l l i n g  s t r i p s □ □
I n s e c t  k i l l i n g  s p r a y □ □
68. Which of the following are between the child and 
the mattress? (Tick all applicable boxes).
No covering ........................................................ D
Cotton covered quilted mattress protectors ... D
Plastic/PVC ....................................................... □
4̂s Wool fleece with hide/material backing ......  U
Electric Blanket ......................................    D
Allergy cover (eg. 'Allersearch')   C
Other (Please specify)
_____________________ □
69. What type of pillow does your child have?
No pillow ............................................................ D
Foam/Sponge/Tontine/Polyester/Dacron ... D
Rubber ...........................................................  t—i
Feather ............................................................  D
Material ............................................................ d
Other {please specify) □
70. Which of the following is usually over your chi]
during sleep? (Tick all applicable boxes).
Sheet(s)   (
Feather doona/duvet/quilt(s) ..........................  [
Dacron/polyester doona/duvet/quilt(s) ..........  [
Woollen doona(s) .................................................  [
Woollen blanket(s) .........................................  [
Cotton blanket(s) .............................................  L
Synthetic blanket(s) (eg. acrylic) ..........................  C
Other covering(s) (Pleasespecify)
______________________________________  [
71. What position does child usually sleep in?
On side ............................................................. C
On stomach, face down .................................. C
On stomach, face to the side .............................. C
On back, face up .............................................  L
On back face to the side .................................. C
Child doesn't have usual sleeping position ... L
Not known ..................................................... C
Other (Please specify) c
C o m m e n ts :
I have  read  a n d  u n d e r s t a n d  the in f o r m a t io n  le tter .  I ag ree  t h a t  
i n fo r m a t io n  on m y  child from this survey, from the  T asm an ian  In fan t  H e a l th  
S u rv ey  (if applicable) and  from my child's hospita l  of b i r th  m ay  be used  for the 
p u r p o s e  of as thm a research.  I agree that research data  ga thered  for the s tu d y  
m ay  be  p u b l i sh e d  prov ided  that  my child cannot be identi fied  as a subject.
PLEASE SIGN HERE
Signature of parent7guardian
ih i s  is the end of the questionnaire.
©  Thank  You for your time,
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□□□□□□□□□
f* R e,
A
□□□□□□□□c
H ow  To A nsw er  The Questionnaire A bout  Your Child
Please read the information letter first. Please make sure that all questions have an answer. In most cases, unle 
otherwise indicated, you are asked to answer by putting a tick (✓ ) in the appropriate box;
(e.g. if you want to answer 'yes', mark Yes 0  No □)
If you wish to add more information please write in the space provided at the end of the questionnaire. 
Thank you for participating in childhood asthma research
(PLEASE PRINT ALL NAMES IN BLOCK LETTERS) 
Child's name
(Surname) (Given names)
Child's full name as registered at birth
(If the same as above, please write 'as above').
(Surname) (Given names)
Current Address _____________________________
____________________________  P/C
Mother's name
(Surname) (Given name)
Mother's name when the child was bom  (if the same as 
above p lease w rite  'ns above').
(Surname) 
(Given name)
Date questionnaire filled out ... /  ... / ...
6. Place/hospital of birth?
Queen Alexandra Division, RHH, Hobart 
Queen Victoria Hospital, Launceston
Calvary Hospital, Hobart ......................
NW Regional Hospital, Burnie ..............
Mersey Women's Division, Devonport ... 
Other Hospital (Please specify below)
Other circumstances (Please specify below)
7. Was this child premature? (i.e, more than  3 wks
early).
Yes n  No I—I
8. Complete child's birthweight, if known
_____ lbs. _______oz. OR __________ g;
9. Is this child from:-
A single birth .................................................
First of a twin birth .....................................
Second of a twin birth ..............................
Triplet birth .................................................
10. Do you recall this child taking part in the 
Tasmanian Infant Health Survey conducted by 
the Menzies Centre when he/she was a baby?
(You may remember a sister visited your home with a thermometer
Yes □  No □
BIRTH AND OTHER DETAILS
1. Mother's Date of Birth
2. Child's date of birth .. /  ... /  ...
3. Sex B ov.............. HH Girl .. □
4. School
5. Where was this child born?
Tasmania ............................... □
Other Australian State ........ □
Other Country (Please specify)
□
11. What are the ages of the brothers or sisters of th 
child? (List ages ‘font eldest down eg. 11, 9, 9, 3)
CHILDHOOD ILLNESS
12. Has he/she ever had eczema in the creases (bend 
of elbows, wrists, or knees?
Yes n  No n
13. Has he/she at any time in his/her life suffered 
from attacks of asthma or of wheezy breathing?
iNB. Please regard 'asthma " and "wheezy breathing" as being much th 
same thing for this auestion: we do not ask i/ou to try to tell the different
Yes □  No □
4.
5.
6 .
.7.
18.
19.
20.
21.
23.
24.
25.
At w h a t  age d id  these  attacks begin?
______Years Not applicable d
Does he /she  get a ttacks of "hay fever" (Unit is, 
<neezing, running or blocked nose, sometimes with itchy eyes or 
nose)?
Yes □  No □
Has y o u r  ch ild  h ad  w h eez in g  or w h is t l in g  in the 
chest in the last 12 m onths?
Yes d  No d
H ow  m an y  attacks of w h eez in g  has your child
had in  the last 12 m o n th s?  N o n e ................... d
1 to 3 ................... □
4 to 1 2 ................... □
More than 1 2 ..................  I—1
In the  last 12 m o n th s ,  h o w  often, on  average, has 
you r  ch ild 's  s leep  b een  d is tu rb ed  d u e  to 
w h eez in g ?
Never woken with wheezing ........................  d
Less than one night per week ....................... d
One or more nights per week ....................... d
In the last 12 m o n th s ,  has  w h eez in g  ever been  
severe  e n o u g h  to l im it  you r  ch ild 's  speech  to 
only  o n e  or tw o w o rd s  at a time b e tw een  
b rea th s?
Yes d  No d
Has y o u r  ch ild  ever  h a d  asthm a?
Yes d  No d
In the  last 12 m o n th s ,  has you r  ch ild 's  chest 
s o u n d e d  w h eezy  d u r in g  or after exercise?
Yes □  No □
In the  last 12 m o n th s ,  has  your  ch ild  had a dry 
cough  at n igh t,  apa r t  from  a cough  associated 
w i th  a cold or chest infection?
Yes d  No d
Since b i r th  has  th is  ch ild  a t ten d ed  hosp ita l  for 
any reason?
Yes d  N o d  (If yes tick all applicable boxes)
In Southern Tasmania (002) ...............................  d
In Northern Tasmania (003) ...............................  d
In North Western Tasmania (004) ...................  d
Outside Tasmania (Please specify) 
__________________________;___________________□
Since b i r th  has th is  child  a t tended  hosp ita l  for:
Asthma Yes d  No d
Other breathing problems Yes d  No d
Please specify)______________________________________
Has y o u r  child  eve r  taken  any m edic ine  for 
a s th m a ?  cMedicine includes inhalers, liquids, tablets, nebulisers). 
\  es d  No d
26. In the  last 12 m o n th s  how  o ften  on  average  has  
y o u r  ch ild  taken  a s thm a  m ed ic in e?
Not at all ................................................................
Less than once a month ....................................
More than once a month ....................................
Everv dav ............................................................
c
c
c
c
27. In the  last 12 m o n th s  has y o u r  c h i ld  taken  an y  of 
the fo l low ing  m ed ic in es  for a s th m a ?
Ventolin, Bricanyl, Berotec
Intal ....................................
Becotide, Becloforte, Pulmicort 
Other asthma medication
c
c
c
(please state) _________
No athma medication
c
c
28. D id  th is  child  a t te n d  regu la r  c h i ld  care* w ith  
m o re  than  two o th e r  ch i ld ren  at the  fo l lo w in g  
ages:-
Less than 1 year of age Yes d  N o d
1 year of age Yes d  N o d
2 years of age Yes d  N o d
3 years of age Yes d  No d
4 years of age Yes d  N o d
f" please consider regular child care as being at least once a week for . 
hours or more)
29. H as ch ild  had  any  of the fo l lo w in g ?
(please tick applicable box/boxes)
Bronchitis ......................................
Cough lasting for more than 3 weeks
Pneumonia ......................................
Pleurisy ......................................
Frequent ear infections <more than 2/year) 
None of the above ......................
c
L
C
c
:
c
FAMILY HISTORY
30. D o a n y  of the ch i ld 's  b ro th e rs  o r  s is ters , pa ren ts  
or g ra n d p a re n ts ,  have  any h is to ry  of the 
fo l lo w in g ?  'please tick applicable box/boxes).
Febrile convulsions   ^
Asthma ................................................................
Heart disease, dving before age of 60 years ... C
Epilepsv or fits    f-
r
Diabetes <requiring insulin injections) ................... L
Diabetes inot requiring insulin injections,
often called 'late onset ' er sugar' diabetes) ............... ^
Eczema ................................................................ ^
Havfever ...........................................................  ^
None of the above illnesses ...................   *-
31. P lease  indicate  y o u r  re la t io n sh ip  to the child:
d
Mother
d
Father
d
Step-parent/' 
adopted parent/ 
guardian
Other '■please state) .
CHILD'S PARENTS
32. Has child's natural mother ever had asthma or 
attacks of wheezing like asthma?
Yes □  No □
Medical details of mother unknown...... D
53.
34.
Has she ever suffered from "hay fever"
Yes □  No □
Medical details of mother unknown...... D
Please indicate the highest level of school 
education the child's mother has completed:
Primary school fey. left before end of year 10) ......... CJ
High school completed to end of year 10 ......... D
Completed secondary education to end yr. 12 ...D
University, TAFE or other institution ......... t—1
Unknown .................................................... D
Which one of the following best describes the 
mother's current employment status?
Unemployed 
Home duties 
Employed part-time 
Employed full-time 
Student
Sole parent pension
Other (please state)________________________
□
□
□
□
□
□
□
36. The mother's current occupation is (please print):
37. Has child's natural father ever had asthma or 
attacks of wheezing like asthma?
Yes □  No □
Medical details of father unknown....... O
38. Has he ever suffered from "hay fever"
Yes I—1 No D
Medical details of father unknown......  t—1
39. Please indicate the highest level of school 
education completed by the child's father:
Primary school (eg. left before end of year 10) ......  C
High school completed to end of year 10 ............ D
Completed secondary education to end yr. 12 ... O
University, TAFE or other institution ........ D
Unknown ..........................................................  tZl
40. Which of the following best describes the 
father's current employment status?
Unemployed ......................................................  d
Home duties ......................................................  CH
Employed part-time .............................................  t—J
Employed full-time .........................................  L 1
Student ..............................................................  d
Permanently unable to work or ill .......................  1—1
Other {please state).................................................... -..D
41. The father's current occupation is (pleaseprint):
SMOKING
42. How many cigarettes does child's mother smoke 
per day?
N il......................................  C
1 - 10/dav.......................................  £~
11 - 20/day.......................................  t-
21 - 40/day...................................  t-
41 + /d a y ...................................
43. How often does child's mother smoke in the 
same room as the child?
Usually .........................................................  t-
Sometimes   U
Never .............................................................
44. How many other adults excluding child's mother 
smoke in the house?
________ Othe
45. How many cigarettes do other adults (excluding 
mother) in your household smoke, in total, per day
Nil ................................................................. C
I - 10/dav ...................................................... t-
II - 20/day ...................................................... E
21 - 40/day ..................................................
41+/day   ^
Don't know ...................................................... L
46. How often do other adults (excluding mother) smoke 
in the same room as the child?
Usually .........................................................  E
Sometimes ...................................................... ^
Never ....................................................................
INFANT & CHILD FEEDING
47. Was your child breastfed?
Yes Ü  No D
48. Age of child when breastfeeding ceased?
(completed mon
____ _ _  Mont
[Not applicable..............
At what age were solids introduced?
Mont
How often does your child eat fish?
Never ............................................................. ^
Once a week or less .................................... ^
More than once a week ...............................  ^
51. Which of the following fats does your child 
usually have on bread or toast:
Butter ................................................................... ED
Canola, soy, olive margarine ........................... ED
Other margarines (eg. sunflower,
safflower, mixed vegetable) ..........................................  ED
None of the above ............................................... ED
52. Has your family had a cat for a pet during this 
child's life?
Yes □  No □
(please lick all the ages of your child when a cat was a pet)
57. What power source do you use for cooking? (Tick
one box)
Electricity ............................................................  ED
Gas   ED
Wood stove   ED
Other (please specif/)__________________    ED
58. How many rooms does your house have?
(Excluding bathroom and toilet)
____________ Rooms
59. How many people live in your home?
____________ People
□ □ □ □ □
0-6 mths 6-12 mths lyr 2yrs 3yrs
of age of age of age of age of age
□ □ □ □ □ □
4yrs 5yrs 6yrs 7yrs 8 yrs 9 yrs
of age of age of age of age of age of age
TOME ENVIRONMENT
53. What is your home made from?
Weatherboard ..............................    ED
Brick veneer ................................................... ED
Double brick ................................................... ED
Other (please specify)____________________________ED
>4. What main type of floor does your house have?
(tick one box).
Wooden ...........................................................  ED
Concrete slab on ground ...............................  ED
Raised concrete slab ....................................... [Z
O ther (please specify)__________________________  ED
55. Do you have wall to wall carpet or large rugs
(occupying more than half the floor area in total) in your 
living room?
Yes ED No ED
56. What is the main heating used in your living
room ? (Tick one box)
No heating . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  ED
Open fire ....................................................... ED
Wood heater (freestanding »or in fireplace) .......  ED
Oil heater with fan . . . . . . . . . . . . . . . . . . . . . . . .  ED
Oil heater without fan ...............................  Ed
Gas heater with flue (chimnev) ...................  ED
Gas heater without flue   ED
Kerosene heater   ED
Off-peak electricity .......................................  ED
Electric radiators or fan heaters ...................  ED
Electric Central heating ...............................  ED
Gas Central heating ...........................................  ED
Other (please specif/)
-------------------------------------------------------------□
60. Have you noticed mould inside your house?
(Excluding bathroom)
Yes □  No □
61. What is the floor covering in the child's 
bedroom? (Tick one box).
Wood   ED
Lino ................................................................  ED
Concrete ............................................................  ED
Carpet ................................................................  ED
Tiles ................................................................  ED
Other (Please specify)
_______________________________________ □
62. Is there also a rug or rugs on the floor of your 
child's room which occupy more than half the 
floor area?
Yes □  No □
63. At night, is/are window(s) in room where child 
sleeps:- (Tick one box).
Partly open in cold weather only ................... ED
Partly open in warm weather only ...................  ED
Partly open all year round ...............................  ED
Closed all vear round .......................................  ED
64. What type of bed does your child use?
Child's small bed ....................................
Single bed ............................................
Double bed ............................................
Top bunk ............................................
Bottom bunk ........................................
Other (Please specify)_______________________
□
□
□
□
□
□
65. Is child's bed -
On the floor ..........
Supported by legs/frame
□
□
66. What type of mattress is now on child's bed?
Foam .................................................................
Innerspring ....................... :............................
Other (Please specify)______________________________
□
□
□
>7. In the last m onth  have you used the following 
products - (tick nil applicable boxes)
Airfreshener spray 
Insect killing strips 
Insect killing spray
In the In child's
home bedroom
□ □
□ □
□ □
)8, Which of the following are between the child 
and the mattress? (Tick all applicable boxes).
No covering ...................................................
Cotton covered quilted mattress protectors
Plastic/PVC .................................................  □
Wool fleece with hide/material backing ......  CI
Electric Blanket ..........................................  O
Allergy cover (eg. 'Allersearch') ....................  t—1
Other (Please specify)
________________________________________ □
What type of pillow does your child have?
No pillow .................................................
Foam/Sponge/Tontine/Polyester/Dacron
Rubber .................................................
Feather .................................................
Material .................................................
Other (please specify)____________________
□
□
□
□
□
□
70. W hich of the following is usually over your child 
d u r in g  sleep? (Tick all applicable boxes).
Sheet(s)   1
Feather doona/duvet/quilt(s) ........................  1
Dacron/polyester doona/duvet/quilt(s) .......... O
Woollen doona(s) .............................................  F-*
Woollen blanket(s) ......................................  O
Cotton blanket(s) ..........................................  Q
Synthetic blanket(s) (eg. acn/lic) ........................ D
Other covering(s) (Please specify) 
______________________ :________________ □
71. What position does child usually sleep in?
On side ...................................................
On stomach, face down ........................
On stomach, face to the side .....................
On back, face up ...................................
On back face to the side ........................
Child doesn't have usual sleeping position
Not known ..........................................
Other (Please specif/)
_____________:__________________________ □
72. What is this child 's place in the family?
(mothers children only):........................... child
(Please state, 1st child, 2nd child, etc.)
73. W hat is the baby 's  natural parents ' present
marital relationship?
Unmarried, living together.................. O
Unmarried, not living together.............Q
Married, living together....................... I—I
Married, separated............................... d
Divorced...............................................Q
Other........................................................I
(If 'Other', please specify)____
One or both parents deceased
74. Have you moved residence since the birth  of this 
child?
Yes I I If yes, please fill out table below 
No □
74b. Yes, we have moved residence since the birth of this child, please find details below.
C hild 's  age
(in completed years) Suburb, State and Post Code
•
□ □□□□□□
omments:
I have read and understand the information letter. I agree that inform ation 
on my child from this survey, from the Tasmanian Infant Health Survey 
(if applicable) and from my child's hospital of birth may be used for the 
purpose of asthma and allergy research. I agree that research data gathered 
for the study may be published provided that my child cannot be identified 
as a subject.
PLEASE SIGN HERE
Signature of parent/guardian 
I would like a copy of my child's allergy results to be sent to: 
n  our address
Q  our family doctor Dr_________________________________________ _
SUBURB ___________________________________ PC
This is the end of this questionnaire . 
T hank  You for your time.
Appendix 3
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An association between plastic mattress covers and sheepskin underbedding use in 
infancy and house dust mite sensitization in childhood: a prospective study
L. F. Trevillian*, A.-L. Ponsonby*f, T. Dwyerf, L. L.-Y. Lim*, A. Kemp§, J. Cochranet and A. Carmichael^
*National Centre for Epidemiology and Population Health, The Australian National University, Canberra, |Menzies Centre for Population Health, University of 
Tasmania, Hobart, §Department o f Immunology, Royal Children’s Hospital, University o f Melbourne, Melbourne and \Department o f Paediatrics and Child 
Health, University o f Tasmania, Hobart, Australia
Summary
Background Higher house dust mite (HDM) allergen exposure during infancy has been associated 
with increased HDM sensitization. Infant bedding has been associated with the accumulation of 
varying levels of HDM. Prospective data on the relationship between infant bedding and the 
development of HDM sensitization has not been previously examined.
Objectives To determine if particular types of bedding used in infancy are associated with increased 
risk of house dust mite sensitization in childhood.
Methods A population-based sample (« = 498) of children born in 1988 or 1989, and who were 
resident in Northern Tasmania in 1997, participated in this study. These children were part of a birth 
cohort study (1988-95), the Tasmanian Infant Health Survey. Data on infant underbedding and 
mattresses was available on 460 and 457 children, respectively. The main outcome measure was 
HDM sensitization defined as a skin prick test (SPT) reaction of 3 mm or more to the allergens of 
Dermalophagoides pleronyssinus and/or Dermatophagoides farinae.
Results The use of either sheepskin underbedding or plastic mattress covers in infancy was 
associated with an increased risk of sensitization to HDM allergens at age 8 years. The adjusted 
risk ratio (RR) for sensitization to HDM with sheepskin in infancy was 2.27 (95% Cl: 1.14,4.55), 
P = 0.020. The adjusted RR for sensitization to HDM with the use of plastic mattress covers in 
infancy was 2.06 (95% Cl; 1.22,3.51), P — 0.007. The use of a foam mattress in infancy was not 
related to subsequent HDM sensitization.
Conclusion Infant’s bedding plays a role in the development of HDM sensitization in childhood. 
Intervention studies to examine mite allergen levels and the role of underbedding on the development 
of HDM sensitization are required.
Keywords aeroallergen sensitization, house dust mite, infant bedding, mattress covers, prospect­
ive cohort, volatile organic compounds
Submitted 5 August 2002; revised 18 November 2002; accepted 25 November 2002
Introduction
Inhalant allergen sensitization is an important determinant of 
childhood asthma [1-3], Early infancy has been identified as a 
critical period for primary sensitization [4, 5] to indoor inhalant 
allergens such as house dust mite (HDM). The bedding environ­
ment during infancy may play an important role in increasing 
an infant’s likelihood of HDM sensitization [3,6], Infants spend 
prolonged periods in bed with close proximity to bedding items, 
enhanced further by their sleep position. Moreover, mattress 
and bedding are two of the main reservoirs of HDM [7,8] and 
also a potential source of pulmonary irritants in the form of 
volatile organic compounds [9,10].
Correspondence: L. F. Trevillian, National Centre for Epidemiology and 
Population Health, The Australian National University, Canberra ACT 
0200, Australia. E-mail: leigh.trevillian@anu.edu.au
Both prospective [5,11,12] and cross-sectional [2,13,14] 
studies have now shown a dose-response relationship between 
the level of exposure to HDM allergens and allergic sensitiza­
tion. In a cohort of 1314 newborns followed for 3 years, Wahn 
and co-workers [5], using mixed floor dust from the child’s 
bedroom, parent’s bedroom and living room, found that in 
homes with low (<  25th percentile) dust concentrations, the 
risk of sensitization to HDM for these children was substan­
tially lower, 1.6% compared to 6.5%, with domestic exposure to 
the HDM allergen than if dust concentrations were above the 
75th percentile. A similar result, with increasing HDM sensi­
tization occurring at increasing HDM levels to the infant’s 
bedroom and living room dust, was reported during the first 
5 years of life from a smaller study in Sweden [11]. An earlier 
study examined the incidence of sensitization to Dermatopha­
goides pteronyssinus (D. pteronyssinus) in 1812 children with a 
mean initial age of 7.3 years over a two-year period [12], It 
identified an increased risk for initial sensitization for increasing 
levels of Der p 1 in the child’s mattress dust.
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Prospective data, however, on infant underbedding and sub­
sequent HDM sensitization are not available. This is likely to be 
an important area because different bedding items differ with 
regard to HDM allergen levels. For example infant sheepskins, 
because of their frequent use, dampness, and warmth, can 
contain very high populations of mites [6,15], In addition, 
mattress type has been the determinant for differing Der p 1 
levels in some studies, with higher allergen levels found on 
innerspring and kapok compared with foam rubber mattresses 
[16]. Kapok is a natural cotton-like fibre which surrounds the 
seeds of the kapok tree. Both sheepskins and mattresses have 
been shown to accumulate allergen rapidly [17,18], whereas, 
mattress covers have been shown to be effective in reducing the 
amount of house dust mite allergen [19,20], Secondly, several 
cross-sectional studies have shown that later sensitization to 
mites is strongly associated with HDM mattress level in child­
hood [13, 14,21], An effect of bedding type on allergen sensitiza­
tion may not only be due to allergen levels [22], Waterproof 
infant cot mattress covers release volatile organic compounds 
(VOC) that can be associated with airway inflammation (either 
atopic or non-atopic) in humans [9,23] and animals [10], and 
the promotion of sensitization to allergens [24],
In this report we examine the relationship between types of 
underbedding (sheepskins and plastic mattress covers), and 
mattress type used in infancy and the subsequent development 
of HDM sensitization in childhood.
Methods
The Tasmanian Infant Health Survey (TIHS)
TheTIHS was a cohort study of infants born from 1988 to 1995 
in Tasmania, Australia. This study operated from hospitals, 
where approximately 93% of births in Tasmania occurred. 
Infants born were scored to assess the risk of sudden infant 
death syndrome (SIDS) using a perinatal score model based 
on maternal age, birth weight, gender, breastfeeding, season of 
birth and duration of second stage of labour [25]. Infants 
exceeding a scoring cut-off were eligible for inclusion together 
with all multiple births. The eligibility criteria and study 
methods are discussed in more detail elsewhere [26]. Data 
were obtained on three occasions. The first interview was con­
ducted in hospital on the fourth day of the infant’s life. A home 
interview was conducted during the fifth postnatal week, and a 
telephone interview at approximately 10 weeks postnatally. At 
the home interview, data were collected on a number of paren­
tal, infant, environmental and childcare factors. Data were 
collected on the type of underbedding used, including under­
sheet, mattress coverings and mattress types. Use of sheepskin 
as underbedding at time of interview or intention to use sheep­
skin in cold weather was recorded in order to avoid the effect of 
current season when questioned. Responses of plastic to the 
type of mattress lining used were classified as having plastic 
mattress covers. In addition, the usual sleeping position of the 
infant was also recorded.
The 1997 Childhood Allergy and Respiratory Health Study 
(CARHS)
In 1997, a follow-up study of TIHS participants born in 1988 or 
1989 was conducted in Northern Tasmania through school
records. Eligible children and their parents were invited to 
attend the Launceston General Hospital for a parental inter­
view and child assessment. The parental questionnaire included 
childhood questions on asthma, wheeze, hayfever and eczema 
from the International Study of Asthma and Allergy in Child­
hood (ISAAC) [27] and also questions on the home environ­
ment and other factors. Skin prick test (SPT) was used to assess 
the cutaneous reaction to exposure to the allergens of house 
dust mites D. pteronyssinus and Dermatophagoides farinae 
{D. farinae), cat, dog, alternaria, ryegrass, cow’s milk, egg, 
and peanut (Hollister-Stier purified allergen extracts supplied 
by Bayer, Sydney, Australia) and positive (histamine lOmg/mL 
and 1 mg/mL) and negative (glycerine) controls. Weal size was 
determined at 15 min. To examine the influence of bedding on 
HDM sensitization we examined weal sizes of both greater than 
and equal to 2 mm. In addition, we further examined any rela­
tionship using a weal size of greater than or equal to 3 mm [28]. 
Children with a positive SPT were classified as atopic. Children 
with a positive SPT to either D. pteronyssinus or D. farinae were 
classified as sensitized to house dust mite [28].
Statistical methods
The main bedding exposure variables of interest were the use in 
infancy of sheepskin underbedding, plastic mattress cover and 
foam mattress. Sheepskin is a common form of underbedding 
for infants in Australia and comprises the animal hide with the 
natural wool fibres attached. Infants are typically placed dir­
ectly on the sheepskin. A plastic mattress cover is used mostly as 
a mattress protector from wetting. All three variables were 
dichotomous for exposure or no exposure to the bedding vari­
able. The dichotomous outcome variable was HDM sensitiza­
tion which refers to a positive skin test to either D. pteronyssinus 
or D. farinae.
The Cox proportional hazard model [29] was applied as the 
main method of analysis. The risk ratio (RR) was used as the 
measure of effect to report any risk associations, firstly for 
exposure to outcome associations without any potential con- 
founders, and secondly, for the multivariate analysis that in­
cluded potential confounders. ‘Time to event’ was defined as the 
period in days from birth to the date of assessment. Children not 
HDM sensitized at the time of follow-up assessment were con­
sidered censored.
To identify potential confounders, we examined the associ­
ation between a large number of factors and HDM sensitization 
(Table 1). We further examined how these factors related to the 
bedding exposures of interest. We examined more than 80 
potential confounders to see how they each related separately 
to use of the individual exposure variables and HDM sensitiza­
tion. Several factors, early introduction of solid food, home gas 
heating and private health insurance at birth, are associated 
with sensitization to HDM and have been previously reported 
[30]. Moreover, we have previously shown in this population 
that feather bedding is inversely associated with HDM sensi­
tization [31],
A proportional hazards model was then constructed as 
follows. For each exposure, potential confounders [32] were 
added to the model as covariates if the variables were associated 
with HDM sensitization in the exposure to outcome analysis, or 
were reported to be related to HDM sensitization or asthma in 
the literature. We examined the confounding effect of these
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Table 1. Unadjusted risk ratio for infant underbedding, mattress and potential predictors of HDM sensitization*
HDM sensitization 
Unadjusted RR (95% Cl) P-value
Exposure variables
Underbedding
Neither sheepskin nor plastic cover 1.00 (reference) -
Only sheepskin 2.12 (1.12,4.04) 0.022
Only plastic mattress cover 1.96 (1.18, 3.25) 0.009
Both sheepskin and plastic cover 2.97 (1.51,5.86) 0.022
Mattress type
No foam mattress 1.00 (reference) -
Foam mattress 1.01 (0.69,1.48) 0.945
Potential confounding infant variables
Maternal factors
Mother smoking during pregnancy 0.89 (0.62,1.30) 0.566
Teenage motherhood 0.75 (0.43,1.32) 0.323
Family history of asthma 1.30 (0.90,1.89) 0.168
Infant factors
Infant only child 0.29(0.07,1.19) 0.087
Infant first born 0.78 (0.54,1.14) 0.203
Low birth weight 1.15(0.73,1.82) 0.550
Infant bottle fed at one month 1.03 (0.69,1.54) 0.883
Solid food introduced by phone interview at 10 weeks 1.26 (0.85,1.85) 0.247
Infant exclusively breastfed by phone interview at 10 weeks 0.74 (0.48,1.15) 0.183
Infant sleep position
Usual sleep position in infancy: supine 1.00 (reference) -
Usual sleep position in infancy: prone 1.33 (0.47,3.73) 0.591
Usual sleep position in infancy: side 1.33 (0.48,3.71) 0.582
Household factors
Private health insurance at birth 1.86 (1.29,2.70) 0.001
Home gas appliance use 1.83 (0.89,3.77) 0.101
No-one smoking in same room as infant 1.18 (0.80,1.72) 0.402
More than six residents in household at birth 1.23 (0.76, 2.00) 0.404
Cat as pet during infancy 1.42 (0.97,2.08) 0.069
Bedroom factors
Use of foam pillow at one month age 0.62 (0.27,1.41) 0.251
Infant sleeping in bedroom alone 0.75 (0.50,1.13) 0.176
Carpet in infant's bedroom 1.13 (0.59,2.17) 0.716
Humidity in infant’s bedroom > 75% 1.44 (0.70, 2.98) 0.321
Window in infant’s bedroom open at night 1.06 (0.70,1.60) 0.774
Use of feather quilt as child 0.65 (0.45,0.95) 0.025
*Skin prick reaction of greater than or equal to 3 mm to either mite allergen, D. pteronyssinus or D. iarinae.
factors on each exposure-disease association using change-in 
estimate methods [33]. Those factors that altered the point 
estimate for the exposure-HDM association by 10% or more 
were included. To confirm that the final confounder sets used 
were the most appropriate, we then added in the remaining 
variables in Table 1 as individual factors into the final model. 
None o f these factors substantially altered the adjusted risk 
ratios reported in Table 2. Family history was defined as asthma 
in any o f the infant’s siblings, parents or grandparents. 
A positive family history at birth may result from shared bed­
ding practices within the family [34], thus the possible contribu­
tion o f family history o f asthma to the association between 
bedding and HDM sensitization was explored. The proximity 
o f bedding to the infant’s airway may be affected by sleep 
position. Thus, the infant’s usual sleep position and its associ­
ation with subsequent H D M  sensitization were also examined.
The aetiologic fraction of H D M  sensitization in childhood 
attributable to either plastic mattress cover or sheepskin use in 
infancy we calculated as p (aRR-l)/aRR, where p =  the propor­
tion of children with either plastic mattress cover or sheepskin 
use in infancy among those with the outcome of H D M  sensitiza­
tion and aRR =  the relative risk estimate for either plastic mat­
tress cover or sheepskin use and HDM  sensitization, after 
adjustment for the confounders listed in Table 2 [32], We con­
ducted the analysis using STATA 7 [35],
Results
In Northern Tasmania in 1997,499 (84%) o f the 596 children 
identified as participants in the 1988-89 TIHS at birth agreed to 
participate in the CARHS study. The mean age at follow-up
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Table 2. The prospective association between sheepskin, plastic mattress cover, toam mattress use in infancy and child sensitization to house dust mite
Underbedding
% HDM sensitized* 
among exposed
A djusted" RR (95% Cl) for 
underbedding vs. none P-value
Neither sheepskin nor plastic cover 15.8% (22/139) 1.00 (reference) -
Only plastic m attress cover 25.6% (55/215) 2.06 (1.22,3.51) 0.007
Only sheepskin 25.4% (17/67) 2.27 (1.14,4.55) 0.020
Both sheepskin and plastic cover 35.9% (14/39) 2.25 (1.05,4.83) 0.038
No foam m attress 23.2% (51/220) 1.00 (reference) -
Foam mattress 23.6% (56/237) 1.09 (0.72,1.67) 0.676
‘Skin prick reaction of greater than or equal to 3 mm to either mite allergen, D. pteronyssinus or D.farinae. ** The risk ratio has been adjusted for 
parent's with private health insurance at time of child’s birth, at-birth family history of asthma, being an only child, whether child was exclusively 
breastfed by 10 weeks of age, home gas heater use in infancy, and use of a feather quilt as a child.
was 8.7 (standard deviation =  0.6) years. SPT data were avail­
able on 498. One autistic child did not undergo the SPT. Data 
on use of underbedding was available on 460, and for mattresses 
on 457 children. The characteristics of the study sample are 
shown in Table 3. Overall, 31.5% of the children were sensitized 
to at least one HDM species.
Plastic mattress covers (55%, 254/460) were used more com­
monly than sheepskin underbedding (23%, 106/460) in early 
infancy. Other types of mattress covers used included cotton, 
wool or synthetic. The use of foam mattresses (52%, 237/457) 
was also common. Non-foam mattresses were predominantly 
ti-tree (40%) or other (8%). Ti-tree is native to Australasia and 
the bark is used for mattress filling. The time-period of use for 
each particular bedding item was not available.
In Table 1, the unadjusted RR showed that use of sheepskin 
only, without a plastic mattress cover, in infancy was signifi­
cantly associated with sensitization to HDM in childhood (un­
adjusted RR 2.12 (1.12,4.04) P =  0.022). The use of only plastic 
mattress covers was associated with a significant increase in the 
risk ratio of HDM sensitization (unadjusted RR 1.96 
(1.18, 3.25) P =  0.009). The use of both a sheepskin and a plastic 
mattress cover remained significantly associated with HDM 
sensitization (unadjusted RR 2.97 (1.51,5.86) P — 0.022). 
Foam mattress use in infancy was not significantly more likely 
to be associated with HDM sensitization in childhood (un­
adjusted RR 1.01 (0.69,1.48) P =  0.945).
An at-birth family history of asthma was not significantly 
associated with subsequent HDM sensitization (unadjusted 
RR 1.30 (0.90,1.89)). HDM sensitization was significantly as­
sociated with childhood asthma, but there was no relation 
between the use of either sheepskin or plastic mattress covers 
in infancy and childhood asthma. Individual adjustment for the 
factors, listed in Table 1, considered as potential predictors of 
subsequent HDM sensitization did not alter the point estimate 
for the exposure-HDM association by 10% or more.
Table 2 reports the association between underbedding and 
mattress type and HDM sensitization after adjustment for con- 
founders using a weal size of 3 mm as SPT positivity. The 
adjusted risk ratios for subsequent HDM sensitization 
remained significant when the different bedding combinations 
of sheepskin use and/or plastic mattress cover use were com­
pared against a reference variable of neither sheepskin nor 
plastic mattress cover use. The use of a plastic mattress cover 
in infancy alone was significantly associated with subsequent 
HDM sensitization (Table 2). Similarly, the use of sheepskin 
alone was significantly related to HDM sensitization in
Table 3. Characteristics of the study sample
Categorical m easures % n/total n
D. pteronyssinus sensitization* 22.5 112/498
D.larinae sensitization* 11.9 59/498
HDM sensitization* 23.3 116/498
Ryegrass sensitization" 17.1 85/498
Other indoor aeroallergen sensitization*** 7.0 35/498
Cat sensitization 2.8 14/498
Alternaria sensitization 4.0 20/498
Dog sensitization 0.2 1/498
Underbedding
Neither sheepskin nor plastic cover use 30.2 139/460
Only sheepskin use in infancy 14.6 67/460
Only plastic m attress cover 46.7 215/460
Both sheepskin and plastic cover 8.5 39/460
Mattress type
No foam m attress 48.1 220/457
Foam mattress 51.9 237/457
‘Any skin prick reaction of greater than or equal to 3 mm to mite 
allergen, D. pteronyssinus or D. farinae. "Any skin prick reaction of 
greater than or equal to 3 mm to ryegrass. ***Any skin prick reaction 
of greater than or equal to 3 mm to alternaria, cat or dog.
childhood (Table 2). There was very little additional effect 
with exposure to both sheepskin and plastic mattress cover in 
infancy. Both sheepskin use and plastic mattress cover use in 
combination were significantly associated with HDM sensitiza­
tion (Table 2). The population attributable fractions for HDM 
sensitization associated with sheepskin or plastic mattress cover 
use in infancy, if causal, were as follows: 8.8% for sheepskin; 
and 26.2% for plastic mattress cover. The use of a foam mattress 
in infancy was not prospectively associated with an increased 
risk of sensitization to HDM. The results in Table 2 were not 
altered when the SPT cut-off was 2 mm.
Among children exposed only to plastic mattress covers in 
infancy, there was no significant association with childhood 
sensitization to the other primarily indoor aeroallergens, cat 
(unadjusted RR 0.60 (0.18,1.97)) or alternaria (unadjusted 
RR 1.46 (0.55, 3.90)). Moreover, there was no association with 
exposure to sheepskin and/or plastic mattress cover as an infant 
and subsequent ryegrass sensitization. A childhood history of 
asthma or hayfever was significantly associated with HDM 
sensitization. Hayfever in childhood was also significantly asso­
ciated with use in infancy of sheepskin alone (adjusted RR 2.26
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(1.19,4.32) P =  0.013). The use of plastic mattress covers alone 
in infancy was associated with hayfever in childhood (adjusted 
RR 1.78 (1.09,2.90) P = 0.022).
Further adjustment for at-birth family history of asthma did 
not alter the results in Table 2. There was no evidence that 
parents of infants with an at-birth family history of asthma 
were selectively avoiding sheepskins (37.1% use vs. 37.0% non­
use, jP = 0.953) as part of a bed allergen reduction strategy, nor 
were they selectively using a plastic mattress cover (38.8% use 
vs. 34.8% non-use, P = 0.376). Exposures to sheepskin (un­
adjusted RR 2.12 (0.94,4.80)) or plastic mattress cover (un­
adjusted RR 1.89 (1.01,3.55)) tended to be positively 
associated with HDM sensitization even among the subgroup 
of those with no at-birth family history of asthma. The positive 
association with either sheepskin use or plastic mattress cover 
use in infancy and subsequent HDM sensitization remained 
significant after adjustment for the child’s history of eczema, 
hayfever and asthma, and also the family history of asthma in 
1997.
We found that usual infant sleep position was not signifi­
cantly associated with HDM sensitization. The association be­
tween sheepskin and HDM sensitization or plastic cover and 
HDM sensitization did not vary by whether child slept prone 
or not. Similar patterns to Table 2 were also found using 
D. pteronyssinus or D. fartnae as individual species-specific 
outcomes.
Discussion
In this birth cohort, the use of sheepskin or the use of plastic 
mattress covers in infancy were associated with an increased 
risk of HDM sensitization in childhood. The lack of an associ­
ation with ryegrass sensitization is consistent with an exposure 
effect acting principally on inhalant allergens present in the 
bedding environment. No association was found between 
either foam mattress use or infant sleep position and HDM 
sensitization.
The strengths of this study include prospective infant bedding 
measures, the ability to examine many potential confounders 
and the availability of a biological parameter to HDM sensitiza­
tion among the child sample. The study sample was not repre­
sentative of all live births in the geographical area, it consisted 
of infants born at higher risk of SIDS [26], However, none of the 
cohort entry criteria predicted HDM sensitization. After con­
trolling for the factors listed in Table 2, additional individual 
adjustment for any scoring system components did not alter the 
results. The results are not likely to be influenced by differential 
follow-up as the proportion of TIHS children followed up from 
infancy did not differ by the type of bedding to which they were 
exposed. In addition, we were able to control for other bedding 
variables that are associated with underbedding plus a large 
number of potential confounding factors operating in either 
infancy or childhood. There was a good follow-up rate and 
the children in this study should not differ from other children 
to any large extent with regard to the development of allergic 
sensitization. Furthermore, there was no recall bias as the ex­
posure was measured prospectively and was independent of 
disease awareness. At the time of assessment for HDM sensi­
tization, the nurse was also unaware of the infant bedding 
status.
Personal exposure measures to HDM allergen levels were not 
available. Furthermore, there is uncertainty concerning the 
most appropriate measures of personal exposure thus, further 
studies which measure (i) inhaled HDM dose [36], (ii) HDM 
allergen levels both on the mattress surface [13] and in the 
bedding [2], and (iii) bedding composition arrangements during 
early infancy, are needed to assess to what extent the positive 
association between sheepskin and HDM sensitization is medi­
ated by higher exposure to inhaled HDM allergens.
Confounding, including that due to family history of asthma, 
could not explain the identified associations. In fact, the risk 
ratio increased after adjustment for significant confounders, 
showing the importance of being able to take these into account. 
Previous work indicates that underbedding may increase the 
risk of HDM sensitization by allergen loading and/or a poten­
tiation of bedding allergenicity [34], Infant sheepskins may 
harbour very high levels of mites and potentially serve as an 
important source of exposure for infants. Moreover, it has been 
shown that the high levels of airborne HDM allergens experi­
enced during sleep are generated from the bedding and not from 
the floor [37].
The increased risk of sensitization to HDM in those children 
exposed to plastic mattress covers in infancy demonstrated in 
this study is unexpected as previous studies have shown mat­
tress covers to be effective in reducing the amount of house dust 
mite allergen in the bed [38,39], Occlusive bedding covers are 
advocated as an important avoidance measure to mite allergens 
[19,20]. Far fewer mites have been collected from cot mattresses 
which were either vinyl topped or covered with a plastic cover- 
slip than were collected from a cot mattress with a cotton top 
alone [15]. Yet, despite allergen levels being dramatically re­
duced in the weeks after the introduction of such covers [38], 
long-term effectiveness is unknown. A meta-analysis [40] found 
that bedding changes aimed at reducing exposure to allergens 
from house dust mites seem to be ineffective, even among the 
subgroup on whom effective allergen reduction was docu­
mented. This could be because, even though beneficial in rela­
tion to HDM allergen reduction, there may be other adverse 
effects from the barrier method used. The finding that exposure 
to plastic mattress covers is not associated with other indoor 
allergen sensitization does not mean that HDM loading is the 
only mechanism. Plastic mattress covers release VOC which in 
animal models produce airway inflammation and airflow limi­
tation after a brief 1-h exposure [10]. Furthermore the presence 
of these compounds in the bedroom has been associated with 
Th2 deviation and increased allergen sensitization in children 
[24], This could specifically affect house dust mites. One possi­
bility is that VOC and HDM interaction at the bedding site is 
greater than at other locations. Sleeping infants whose airway is 
in close proximity to the covers may be exposed to high concen­
trations of these compounds for considerable periods of time 
[10]. Sensitization to inhaled allergens such as house dust mite 
could thus be enhanced either by airway inflammation resulting 
in increased airway permeability and enhanced allergen presen­
tation to the immune system [9,10,41-44], by volatile organic 
compound induced Th2 deviation [24,45,46] or a combination 
of both.
In conclusion, this study has shown that an infant’s under­
bedding in the form of sheepskins and the use of plastic mattress 
covers are associated with the development of HDM sensitiza­
tion in childhood. Infants spend a significant proportion of their
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time in bed with consequent opportunity for prolonged expos­
ure to adverse environmental influences. Furthermore bedding 
is a readily modifiable environmental factor. Sheepskins are 
commonly used in infant bedding in New Zealand and 
Australia. Although they may have a more restricted use 
world-wide, due to their high content of HDM allergen [15,17], 
they indicate a likelihood of a high infant exposure to HDM 
allergen when in the bed. Plastic mattress covers are used 
throughout the world as part of infant bedding. Our results 
support current recommendations [47] that the use of sheepskins 
as infant bedding in atopic families is inappropriate because they 
are responsible for significantly greater exposures to HDM aller­
gens and also suggest that greater attention and further study 
should be given to other potentially adverse environmental 
factors related to the bedding environment such as VOC.
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There is increasing evidence for a role for bedding items in the development of asthma. 
The use of some forms of synthetic bedding, such as foam mattresses and pillows, is 
associated with a significantly increased risk of childhood wheeze. Our aim was to 
examine prospectively whether the use of synthetic cocoon/baby nests in infancy is 
associated with the subsequent development of wheeze in childhood. Data collected 
in 1988 as part of the Tasmanian Infant Health Survey were linked to the cross-sectional 
Childhood Asthma Survey conducted in 1995 in Tasmania, Australia.
We were able to match 863 records out of the 1111 in the 1988 survey. Information 
including parental, child-care, and the infant's sleeping environment was collected at 
home interview in 1988 when the infant was 1 month of age. Data including sleep 
environment and asthma symptoms were available for each child at age 7 years. A 
generalised linear model was used to calculate the adjusted relative risk (RR) estimates 
for symptoms of wheeze and infant cocoon use. For children who were placed in a 
cocoon in infancy, there was an increased risk of recent wheeze (adjusted RR = 4.33 
[95% Cl 2.08, 9.02]) and night wheeze (adjusted RR = 3.35 [95% Cl 1.52, 7.39]) at age 
7 years.
In view of the increasing prevalence of childhood asthma, the identification of 
potentially modifiable environmental factors which might operate in infancy is of 
importance. The present findings implicate infant bedding choice as a significant factor 
and further studies on the infant sleeping environment are indicated.
Introduction
Bedding items, and more specifically their material 
composition, are gaining recognition for their possible 
role in childhood asthma. The use of synthetic bedding 
(foam mattresses, pillows, blankets) is associated with 
a significantly increased risk of childhood wheeze in 
children from varying world environments.1̂ 1
Indoor environmental factors, notably inhalant aller­
gens such as house dust mite (HDM), are well recog­
nised as contributing to childhood asthma.5,6 Bedding 
is a major source of HDM7,8 and HDM levels have been 
shown to vary within different composite bedding 
materials. Significantly higher levels of dust mite 
allergens9“11 are found in synthetic bedding than in 
feather bedding. Dermatophagoides pteronyssinus (Der
p) allergen levels (recorded as geometric means) have 
been found to be 5-8 times greater in synthetic pillows 
than in feather pillows.10,12
In addition to mattresses, pillows and doonas or 
quilts, there are other infant synthetic bedding items 
such as cocoons/baby nests that might influence 
asthma development or symptoms. Cocoons are simi­
lar to a padded sleeping bag with a hood that comes 
close to the sides of the baby's head, fully encasing the 
infant, leaving only the face exposed (Fig. 1). While 
lying within the cocoon, the infant is then placed on a 
flat surface or in the cot or pram. A pillow is usually 
not used in conjunction with a cocoon nor, unless it is 
exceptionally cold, would it be necessary to place an 
additional covering on top of an infant lying within a
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Figure 1. Infant cocoon.
cocoon. If attached, straps allow the cocoon to be hand 
carried or tied against the mother's chest. Infants 
placed in cocoons or baby nests may spend prolonged 
periods of time with their airways in closer proximity 
to the cocoon material than if placed on a pillow and/ 
or covered with a quilt, potentially increasing any 
adverse effect on health mediated by close proximity. 
There is currently no specific advice with regard to 
asthma prevention and the use of cocoons containing 
synthetic materials in infancy.
In this prospective study, we examine the relation­
ship between the use of cocoons/baby nests in infancy 
and the subsequent development of wheeze in 
childhood.
Methods
The Tasmanian Infant Health Survey (TIHS)
The TIHS was a cohort study of infants born over 
an 8-year period 1988-95 in Tasmania, Australia. This 
study operated from hospitals where approximately 
93% of births in Tasmania occurred. Newborn infants 
were scored to assess the risk of sudden infant death 
syndrome (SIDS) using perinatal entry criteria based 
on maternal age, birthweight, gender, breast feeding, 
season of birth and duration of second stage of 
labour.13 Infants exceeding a scoring cut-off were eligi­
ble for inclusion together with all multiple births. The 
eligibility criteria and study methods are discussed in 
more detail elsewhere.14 From 1988 to 1995, a total of 
9826 (89%) of eligible infants participated in hospital 
and home interviews.
Data were obtained on three occasions. The first 
interview was conducted in hospital on the fourth day 
of the infant's life. A home interview was conducted 
during the fifth postnatal week, and a telephone inter­
view at approximately 10 weeks postnatally. At the 
home interview, data were collected on a number of 
parental, infant, environmental and child-care factors. 
Data were collected on the infant's sleeping environ­
ment, including type of pillow, mattress coverings, 
mattress types and bed. Use of a cocoon at time of 
interview or intention to use a cocoon in cold weather 
was recorded, thereby avoiding the effect of current 
season when interviewed. In 1994, further details 
regarding cocoons and sleeping bags were collected. 
At least 84% of cocoons were noted to be either quilted 
or padded by the research nurse at the 1 month home 
interview. In addition, infant cocoons manufactured 
and sold in Southern Tasmania during the study 
period most commonly comprised outer coverings 
of cotton or polycotton with a polyester (synthetic) 
filling.
The 1995 Childhood Asthma Survey
In 1995, a cross-sectional survey was conducted on all 
children who turned 7 years of age in Tasmania. This 
survey included 863 (78%) of the 1111 children who 
were born in 1988 and participated in the TIHS home 
interview. Children were identified through primary 
schools, home learning and distance education organ­
isations. Data included sleeping environment and 
asthma symptoms, using questions from the Interna­
tional Study of Asthma and Allergies in Childhood.15 
The child's age (in completed years) at onset of wheezy 
breathing or asthma was obtained. We linked the 1995 
asthma data of the 863 children for whom a home 
interview had occurred at 1 month of age in 1988 as 
part of the TIHS (Fig. 2).
Definitions
Recent wheeze refers to one or more wheeze episodes 
over the past 12 months. Nocturnal wheeze is defined as 
the child's sleep being disturbed one or more nights 
per week in the past 12 months due to wheezing. In 
accordance with ISAAC terminology, a history of asthma 
refers to a positive response to the question, 'Has your 
child ever had asthma?'15 A family history of asthma was 
defined as asthma in any of the infant's siblings, par­
ents or grandparents.
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THE 1995 CHILDHOOD ASTHMA 
SURVEY
Full cross-sectional sample
N= 6378 (92% of eligible) with parental 
questionnaires
1995 TIHS follow-up sample
N= 863* TIHS children bom in 1988 with 1988 
home interview data and 1995 asthma data 
available and parental consent for record linkage
*86% of 1988 TIHS infants identified in 1995 
*78% of 1988 TIHS children with home interview 
in 1988
THE 1988 TO 1995 TASMANIAN INFANT 
HEALTH SURVEY (TIHS)
1995 N= 9826 (89% of eligible) infants with hospital 
and home interview data
1988 Afcll 11 (81% of eligible) surviving infants 
participated in home interview
Figure 2. The relation between the Tasmanian Infant Health Survey and the 1995 Childhood Asthma Survey.
Statistical methods
The bedding exposure variable of interest was cocoon 
use in infancy and was dichotomous for exposure or 
no exposure. The dichotomous outcome variables 
were the child's recent wheeze, night wheeze or 
asthma ever. A generalised linear model with a log link 
function and binomial error structure was used to con­
trol simultaneously for multiple confounders and to 
obtain confidence intervals for relative risk (RR) 
estimates.16
To identify potential confounders, we examined the 
association between a large number of factors and 
childhood wheeze (Table 1). We further examined how 
these factors related to cocoon bedding. We examined 
more than 40 confounders to see how they each related 
separately to cocoon use and wheeze. A generalised 
linear model was then constructed as follows. Each 
potential confounder17 was individually added to the 
model as a covariate if the variable was associated with 
wheeze in the exposure to outcome analysis, or had 
been reported to be related to asthma in the literature. 
We examined the confounding effect of these factors 
on the exposure-disease association using change-in 
estimate methods.18 Those factors that altered the point 
estimate for the exposure-wheeze association by 10% 
or more were included in the final model. In addition, 
we then added in the remaining variables in Table 1 as 
individual factors into the final model. None of these 
factors altered the adjusted risk ratios reported in
Table 2 and were not retained in the final confounder 
set.
Pearson chi-square test was used to explore further 
the possible associations between the explanatory vari­
ables. Logistic regression was not used because in 
asthma epidemiological studies, where the proportion 
of the children with the disease is large, odds ratios 
will not approximate RRs well.'9 We assessed the rela­
tion between infant cocoon use and age of onset of 
asthma symptoms using discrete proportional hazard 
modelling.20 The aetiological fraction of asthma in 
childhood attributable to cocoon use in infancy we 
calculated as p(aRR -  l)/aRR, where p denotes the 
proportion of children with cocoon use in infancy 
among those with the outcome of asthma and aRR 
equals the RR estimate for cocoon use and asthma, 
after adjustment for the confounders listed in Table 2. 
We conducted the analysis using statistical software, 
STATA 7.O.21
Results
The 863 subjects (78%) of the TIHS cohort who had a 
home interview agreed to participate. In 1995 their 
mean age was 6.9 years (standard deviation = 0.6). 
Data were available for recent wheeze, night wheeze 
and asthma ever on 823, 834 and 863 children, respec­
tively. Data on use of cocoon in infancy was available 
on 802 children. The prevalences of asthma ever and 
recent wheeze were high, 32.4% (280/863) and 27.0%
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Table 1. Identification of potential confounders: unadjusted relative risk (RR) for infant cocoon use and childhood wheeze
Recent wheeze in 1995 
Unadjusted RR [95% Cl] P-value
Cocoon use in infancy 
Unadjusted RR [95% Cl] P-value
Exposure variables
Cocoon 2.00 [1.29, 3.12] 0.002 -
Potential confounding variables
Parental factors
Mother smoked during pregnancy 1.41 [1.12, 1.77] 0.003 2.33 [0.89, 6.07] 0.083
Teenage motherhood3 1.19 [0.90, 1.56] 0.225 0.86 [0.26, 2.93] 0.814
Family history of asthma at child's birth 1.50 [1.20, 1.88] <0.001 1.31 [0.53, 3.22] 0.557
Family history of asthma in 1995 2.27 [1.72, 2.99] <0.001 3.55 [1.03, 12.26] 0.045
Low maternal education at child's birth 1.13 [0.63, 2.03] 0.678 0.66 [0.14, 3.16] 0.602
Low paternal education at child's birth 1.24 [1.04, 1.93] 0.023 0.77 [0.27, 2.18] 0.618
Maternal postnatal smoking at 1 month 1.38 [1.10,1.73] 0.006 2.66 [1.02, 6.92] 0.037
Maternal smoking at child age 7 1.45 [1.15, 1.81] 0.001 4.42 [1.45, 13.44] 0.004
Duration of second stage labour (5,15 vs. 1.09 [0.85, 1.39] 0.497 2.15 [0.88, 5.22] 0.084
0, 5 min)3
Duration of second stage labour (CS vs. 1.00 [0.75, 1.34] 0.989 0.25 [0.03, 1.84] 0.136
0, 5 min)3
Season of birth (May-Jun vs. Mar-Apr)3 1.12 [0.88, 1.43] 0.344 0.62 [0.21, 1.86] 0.393
Season of birth (Aug-Feb vs. Mar-Apr)3 1.02 [0.81, 1.28] 0.854 2.80 [1.07, 7.29] 0.028
Infant factors
Male sex3 1.42 [1.08, 1.88] 0.010 0.90 [0.35, 2.33] 0.825
Infant first born 1.06 [0.85, 1.33] 0.604 0.50 [0.18, 1.37] 0.166
Low birthweight3 0.99 [0.75, 1.30] 0.916 0.64 [0.19, 2.17] 0.467
Intention to bottle feed at birth3 1.26 [1.01, 1.58] 0.045 1.79 [0.73, 4.40] 0.199
Multiple births3 0.89 [0.62, 1.27] 0.504 0.77[0.18, 3.30] 0.726
Prematurity 1.06 [0.80, 1.41] 0.673 0.53 [0.12, 2.27] 0.382
Solid food introduced, by phone interview 1.30 [1.04, 1.72] 0.024 1.36 [0.56, 3.31] 0.494
at 10 weeks
Infant exclusively breast fed, by phone 0.67 10.49, 0.92] 0.009 0.18 10.02, 1.36] 0.060
interview at 10 weeks
Childhood factors
History of eczema 1.75 [1.39, 2.20] <0.001 1.76 [0.68, 4.56] 0.240
History of hay fever 2.87 [2.34, 3.52] <0.001 2.03 [0.79, 5.26] 0.137
History of bronchitis 2.58 [2.08, 3.21] <0.001 1.46 [0.55, 3.89] 0.452
History of pneumonia 1.87 11.40, 2.50] <0.001 -
Child's fish consumption vs. none 0.76 [0.57, 1.02] 0.082 0.75 [0.22, 2.54] 0.642
No siblings in 1995 1.68 [1.18, 2.38] 0.009 -
Household factors
Private health insurance at birth 0.71 [0.55, 0.91] 0.005 0.90 [0.36, 2.27] 0.827
Home gas appliance use in infancy 1.25 [0.73,2.16] 0.439 1.79 [0.25, 12.89] 0.559
No-one smoking in same room as infant 0.72 [0.56, 0.93] 0.009 0.60 [0.22, 1.65] 0.317
More than six residents in household at birth 0.90 [0.65, 1.26] 0.549 0.68 [0.16, 2.90] 0.599
Cat as pet during infancy 1.09 [0.86, 1.37] 0.491 0.53 [0.18, 1.59] 0.249
Paternal full-time employment at child age 7 0.91 [0.72, 1.15] 0.446 0.77 [0.31, 1.93] 0.573
Bedroom factors -  infant
Use of foam pillow at age 1 month 1.27 [0.92, 1.75] 0.159 2.19 [0.74, 6.44] 0.149
Infant sleeping in bedroom alone 0.84 [0.65, 1.09] 0.180 0.44 [0.13, 1.49] 0.171
Carpet in infant's bedroom 0.89 [0.62, 1.28] 0.535 0.30 [0.11, 0.80] 0.013
Humidity in infant's bedroom >75% 1.22 [0.79, 1.88] 0.389 0.87 [0.12, 6.35] 0.888
Window in infant's bedroom open at night 1.05 [0.83, 1.32] 0.690 1.26 [0.52, 3.05] 0.616
Sheepskin underbedding 0.99 [0.78, 1.27] 0.962 0.12 [0.02, 0.91] 0.014
Plastic mattress liner 0.99 [0.79, 1.25] 0.933 0.88 [0.35, 2.22] 0.792
Foam mattress as infant 1.05 [0.83, 1.33] 0.705 1.58 [0.58, 4.35] 0.367
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Table 1. Continued
Recent wheeze in 1995 
Unadjusted RR [95% Cl] P-value
Cocoon use in infancy 
Unadjusted RR [95% Cl] P-value
Use of feather quilt 0.74 [0.21, 2.57] 0.619 -
Use of synthetic quilt 1.05 [0.84,1.33] 0.654 0.19 [0.06, 0.65] 0.003
Use of feather pillow 0.94 [0.35, 2.51] 0.894 3.98 [0.58, 27.28] 0.141
Use of synthetic pillow 1.29 [0.97,1.72] 0.086 1.51 [0.51, 4.48] 0.455
Use of air freshener in infant7s bedroom 1.52 [1.04, 2.22] ' 0.047 4.25 [1.47, 12.30] 0.005
Bedroom factors -  child
Sleeping on bottom bunk as child 1.11 [0.81, 1.52] 0.509 -
Use of feather quilt 0.85 [0.68, 1.07] 0.166 0.51 [0.20, 1.33] 0.158
Use of synthetic quilt 1.29 [1.03, 1.61] 0.027 3.06 [1.18, 7.97] 0.016
Use of feather pillow 0.86 [0.53, 1.38] 0.516 0.70 [0.09, 5.14] 0.722
Use of synthetic pillow 1.04 [0.71, 1.54] 0.825 0.58 [0.17, 1.95] 0.375
Carpet in child's bedroom 0.93 [0.58, 1.49] 0.755 0.49 [0.12, 2.06] 0.322
aThe cohort entry scoring system was based on a composite score derived from these factors.13 M ultiple births were automatically 
included.
(222/823), respectively. The prevalence of night 
wheeze was 19.2% (160/843) and cocoon use in 
infancy 2.4% (19/802).
Table 1 shows that cocoon use in infancy was asso­
ciated with recent wheeze in childhood (RR = 2.00 
[95% Cl 1.29,3.12]). The use of a cocoon in infancy was 
associated with both night wheeze (RR = 2.27 [95% Cl 
1.31, 3.93]) and history of asthma ever (RR = 1.63 [95% 
Cl 1.05, 2.53]) in childhood.
To identify potential confounders, we examined 
how each factor related separately to the use of cocoon 
in infancy and also to recent wheeze. The infant factors 
of most relevance are summarised in Table 1. Potential 
confounders included: small sibling size,22 infant and 
child exposure to tobacco smoke23 and home gas heat­
ing,23 infant synthetic pillow use,24 sheepskin use and
season of birth. An at-birth family history of asthma 
was not significantly associated with cocoon use in 
infancy; however, it was related to subsequent devel­
opment of recent wheeze (RR = 1.50 [95% Cl 1.20, 
1.88]). Both childhood and infant exposure to maternal 
smoking were associated with wheeze. In fact, 88% of 
mothers who smoked when their infant was 1 month 
of age, were still smoking when their child was aged 
7 years. The association between infant and childhood 
maternal tobacco smoke exposure was highly signifi­
cant (P = 0.0001).
The association between cocoon use and recent 
wheeze remained after adjustment for the perinatal 
entry criteria as either individual factors or as a set. 
Adjustment for mattress type and mattress cover type, 
including sheepskin or plastic mattress cover, had lit-
Table 2. The association between cocoon use in infancy and asthma symptoms in childhood
Respiratory 
symptom in 1995 n
Cocoon use 
in infancy %
RR [95% Cl] for cocoon use 
and respiratory symptom P-value
aRR [95% Cl] for cocoon 
use and respiratory symptom P-value
No wheeze 559 9 1.6 1.00 [Reference] 1.00 [Reference]
Recent wheeze 196 10 5.1 2.00 [1.29, 3.12] 0.002 4.33 [2.08, 9.02] <0.001a
No night wheeze 626 11 1.8 1.00 [Reference] 1.00 [Reference]
Night wheeze 148 8 5.4 2.27 [1.31, 3.93] 0.003 3.35 [1.52, 7.39] 0.003b
No asthma ever 539 9 1.7 1.00 [Reference] 1.00 [Reference]
Asthma ever 262 10 3.8 1.63 [1.05, 2.53] 0.029 2.56 [1.33, 4.92] 0.005c
a,bcAdjusted for family history of asthma at birth, home gas appliance use in infancy, synthetic quilt use in infancy, synthetic pillow use 
in infancy, maternal education at birth, m aternal smoking at infant 1 month age, no other siblings in 1995.
Cl, confidence interval.
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tie effect but additional adjustment for synthetic quilt 
or pillow use in infancy further increased the associa­
tion between cocoon use and childhood wheeze 
(adjusted RR [aRR] = 4.33 [95% Cl 2.08, 9.02]) 
(Table 2). Similarly, the association remained signifi­
cant between the use of cocoon in infancy and night 
wheeze (aRR = 3.35 [95% Cl 1.52, 7.39]), and with a 
history of asthma (aRR = 2.56 [95% Cl 1.33, 4.92]) 
(Table 2). The population attributable fraction for 
recent wheeze in childhood associated with cocoon 
use in infancy was 4.3%.
We examined the association with family and child­
hood history of atopic disease. Further adjustment for 
at-birth family history of asthma did not alter the 
results in Table 2, and the positive association with 
cocoon use in infancy and recent wheeze remained 
significant after adjustment for the child's history of 
eczema and asthma, and also the family history of 
asthma in 1995. These positive associations persisted 
after adjustment for the factors listed in Table 2 and 
individual adjustment for over 40 possible confound- 
ers including those listed above. The parents of infants 
with an at-birth family history of asthma were not 
selectively using cocoons (42.1% use vs. 35.6% non­
use, P = 0.56). Exposure to cocoon was positively asso­
ciated with recent wheeze (RR = 2.56 [95% Cl 1.45, 
4.51] P = 0.001) even among children without an at- 
birth family history of asthma. The use of cocoon in 
infancy did not relate to age of onset of wheeze 
(aRR = 0.83 [95% Cl 0.30, 2.31]) overall nor to wheeze 
frequency subgroups of moderate (4-12) or frequent 
(>12) episodes of wheeze.
Discussion
In this birth cohort, the use of cocoon/baby nests in 
infancy was associated with an increased risk of recent 
wheeze and nocturnal wheeze in childhood. Close 
proximity to the airways combined with the infant's 
prolonged exposure to the cocoon material may have 
contributed to this finding. The prospective association 
remained after adjustment for other synthetic bedding 
items in infancy. Our findings indicate that atopic chil­
dren were not preferentially using or avoiding the use 
of cocoons as evidenced by the lack of association with 
eczema and rhinitis in infancy and an at-birth family 
history of asthma. The adverse role of synthetic bed­
ding on asthma has been demonstrated in previous 
studies; however, currently there is no evidence with
regard to the use of cocoons containing synthetic mate­
rials in infancy.
The strengths of this study include the availability 
of prospective infant data, a high participation rate and 
the ability to control for multiple confounders, includ­
ing bedding variables and other potential confounding 
factors operating in either infancy or childhood. The 
study sample was not representative of all live births 
in the geographical area; it consisted of infants born at 
higher risk of SIDS.14 The eligibility criteria were well 
defined and the potential effects of the entry scoring 
system components were taken into account in the 
multivariate analyses. After controlling for the factors 
listed in Table 2, further adjustment for these perinatal 
entry criteria did not alter the results. Thus the TIHS 
cohort entry criteria are unlikely to affect the general- 
isability of these results. The children in this study 
should not differ from other children to any large 
extent with regard to the biological development of 
asthma.
As the exposure was measured prospectively and 
was independent of disease awareness, there was no 
recall bias. At the time of assessment for wheeze, the 
nurse was also unaware of the infant bedding status. 
The results are not likely to be influenced by differen­
tial follow-up as the proportion of TIHS children fol­
lowed up from infancy did not differ by whether they 
used a cocoon or not. Cocoons manufactured and sold 
during the study period most commonly comprised 
synthetic materials. However some infants may have 
been exposed to cocoons made of natural materials. 
This could lead to misclassification of the dichotomous 
exposure. This misclassification would be likely to be 
non-differential17 and therefore, if present, it would 
reduce the study's ability to detect the effect of cocoon 
use on wheeze.
Confounding, including that due to infant or child 
exposure to maternal smoking or family history of 
asthma, could not explain the identified associations. 
We included only one variable for maternal smoking, 
when infant was aged 1 month, as a potential con- 
founder in the final model due to the high collinearity 
between this variable and the variable for maternal 
smoking when child was aged 7 years. Limitations of 
this study included the use of a parental questionnaire 
and the absence of a biological or physician assessment 
of asthma. The ISAAC questionnaire, however, is con­
sidered a valid instrument for the determination of 
current asthma symptoms in the past 12 months; the 
report of 'wheeze' over the past 12 months has a sen-
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sitivity of 0.85 and a specificity of 0.81 for the physician 
diagnosis of asthma in childhood.25 The prospective 
findings in this study were, however, based on a small 
number of exposed children and further studies are 
required to confirm these findings. It is important to 
note that no study to date has shown a lower wheeze 
prevalence with exposure to synthetic bedding.1-4 
Moreover, we have previously reported24 that the asso­
ciation between synthetic upper bedding and frequent 
wheeze in childhood displayed the features of high 
strength of association, temporality, dose-response and 
consistency.17
Cocoons provide an intimate and prolonged rela­
tionship between the cocoon material and the infant's 
breathing zone. Thus one possibility for the effect 
noted in this study is that exposure to dust mite aller­
gen in synthetic cocoons could contribute to the 
increased development of wheeze in children. Bedding 
items may be particularly relevant to the development 
or triggering of asthma symptoms due to their prox­
imity to the airway and their prolonged periods of 
exposure in addition to bedding allergen levels. Air 
sampling has identified that the bed is a major site of 
exposure to HDM allergens with airborne HDM aller­
gen levels shown to be 10-fold higher during sleep 
than in the living room during the day.26 Exposure 
to HDM allergen is a factor in triggering attacks of 
asthma in asthmatic subjects,27 with a clear dose- 
response relation demonstrated between levels of Der 
p 1 in the home and current asthma symptoms.28-29
Two population-based case-control studies30 investi­
gated the association between childhood wheeze in 
schoolchildren 7-8 years of age and changes in the 
home environment between 1978 and 1991 in Croy­
don, London. The study found that of the potential 
indoor environmental risk factors examined, the 
increasing use of non-feather pillows (from 44% in 
1978 to 67% in 1991) explained greater than half of the 
20% increase in the population prevalence odds of cur­
rent wheeze (OR = 1.20 [95% Cl 1.04,1.39]). The use of 
non-feather pillows was positively associated with 
childhood wheeze (OR =1.54 [95% Cl 1.13, 2.10). A 
case-control study of children in Sheffield, UK,31 found 
that pillows with synthetic fillings were a risk factor 
for severe childhood asthma (OR = 2.78 [95% CI 1.89, 
4.17]), after the exclusion of asthmatic subjects whose 
bedding had been changed because of their disease. 
These results prompted speculation that the increase 
in the use of non-feather pillows contributed to the 
increasing exposure to HDMs, which in turn could
have been partly responsible for the increase in child­
hood wheezing.32 In a cross-sectional study of children 
in Canberra, Australia, synthetic quilt use was associ­
ated with asthma (AOR = 1.67 [95% Cl 1.05, 2.65]) and 
recent wheeze (AOR = 2.11 [95% Cl 1.33, 3.34]) among 
SPT-positive to aeroallergens, including Der p, chil­
dren but not SPT-negative children.33
These results support the view that if the adverse 
respiratory effect of synthetic bedding such as cocoons, 
is mediated by the previously documented higher 
HDM allergens found in synthetic bedding,10-12 this 
adverse effect would be more evident among children 
who were sensitised to aeroallergens rather than non- 
sensitised children.
Other mechanisms, related to bedding items, may be 
contributing to childhood wheezing. An increased risk 
of asthma related to the indoor emissions of volatile 
organic compounds (VOCs) has been demonstrated in 
children and adults,34-36 and VOCs released in low con­
centrations close to the breathing zone might increase 
mucosal permeability to inhaled allergens31 or promote 
sensitisation to HDM within the household environ­
ment similar to that which has been observed for 
indoor gas heating37 or other infant bedding materi­
als.38 Exposure to house dust endotoxin may protect 
against the development of atopy by enhancing Thl 
responses.37 A study40 of 61 infants with a high risk 
for developing asthma in Colorado, USA, showed 
that allergen sensitised infants had significantly lower 
house dust endotoxin levels than non-sensitised 
infants. However recent reports41 that endotoxin levels 
were not significantly different between synthetic and 
feather pillows makes this a less likely mechanism of 
action. The exposure to the bedding environment may 
be further increased as the infant is often transported 
from the bed to other locations while still remaining 
within the cocoon. In addition, with the close proxim­
ity of the synthetic cocoon material to the infant's air­
way it is likely that exposure to bedding-related factors 
such as allergens, VOCs or endotoxins occurs in a con­
tinuous low dose fashion.
In conclusion, this study adds to the increasing evi­
dence for a role for bedding items in the development 
of childhood asthma. Our findings suggest that syn­
thetic cocoon use in infancy is associated with an 
increased subsequent risk of child asthma. However, 
the number of children exposed to cocoons in this 
cohort study was small and further studies are now 
required to confirm these findings. The contribution of 
infant bedding to the increasing problem of childhood
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asthma must be more clearly determined in view of the 
implications of bedding modification for both primary 
and secondary preventative measures for childhood 
asthma.
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The Bedding Environment, Sleep Position, and 
Frequent Wheeze in Childhood
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ABSTRACT. Objective. Synthetic q u ilt  use has been 
associated w ith  increased childhood wheeze in previous 
studies. O ur aim was to examine whether the adverse 
effect of synthetic q u ilt  use on frequent wheeze d iffe red 
by usual sleep position.
Design, Setting, ami Participants. A population-based 
cross-sectional study o f 6378 (92% of those e lig ib le) 
7-year-olds in  Tasmania, Austra lia , was conducted in 
1995. Exercise-challenge lung  function was obtained on a 
subset o f 414 children from  random ly selected schools.
Exposure Measures. C h ild  bedding in c lud in g  p illo w  
and overbedding com position and usual sleep position 
by parental questionnaire.
Outcome Measures. Frequent wheeze (>  12 wheeze 
episodes over the past year), using the International 
Study o f Asthma and A llerg ies in C h ildhood parental 
questionnaire, and baseline and postexercise forced ex­
p ira tory volum e in 1 second lung -function  measures.
Results. Frequent wheeze (n =  117) was positive ly  
associated w ith  synthetic qu ilts , synthetic p illow s, elec­
tric blankets, and sleeping in a bottom  bu nk  bed but d id  
not vary by sleep position. In a nested case-control anal­
ysis, the association between synthetic q u ilt  use and 
frequent wheeze d iffe red  by sleep position. Am ong ch il­
dren who slept supine, synthetic (versus feather) q u ilt  
use was associated w ith  frequent wheeze (adjusted odds 
ratio: 2.37 11.08, 5.23]). However, among nonsupine sleep­
ers, ove rly ing  synthetic q u ilt  use was not associated w ith  
frequent wheeze (adjusted odds ratio: 1.06 [0.60, 1.88]). 
This difference in q u ilt  effect by sleep position was 
h igh ly  s ign ificant. S im ila rly , synthetic q u ilt  use was as­
sociated w ith  low er postexercise forced expira tory vo l­
ume in  1 second measures among supine bu t not nonsu­
pine sleeping children.
Conclusion. An increasing focus on the bedding en­
v ironm ent im m edia te ly adjacent to the nose and m outh 
is required fo r respiratory disorders provoked by bed­
ding, such as ch ild  asthma characterized by frequent 
wheeze. Pediatrics 2004;113:1216-1222; bedding, sleep po­
s ition , interaction, asthma, wheeze.
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ABBREVIATIONS. HDM, house dust mite; Der P, Dermntoplin- 
gnides pteriDn/ssinus; Cl, confidence interval; IT.V,, forced expira­
tory volume in 1 second; OR, odds ratio.
I  'y  edding can trigger child wheeze, particularly 
wheeze caused by house dust mite (HDIM)- 
JL-/re lated airway obstruction. Bedding HDM 
(such as Dermatophagoides pteroin/ssinus [Der pj) lev­
els predict respiratory symptoms and lung func­
tion.1'2 Mattresses and underbedding are significant 
FiDM allergen reservoirs.1-1 It is less recognized that 
upperbedding such as quilts also can be a source of 
HDM exposure during sleep. A 10-fold reduction of
a irb o rn e  I ID M  allergen  n ear the face d u rin g  sleep  
was obtained by replacing used overlying quilts with 
new quilts.5 Recently, synthetic quilts have been 
shown to have a markedly higher Der p content than 
feather quilts6; the ratio (synthctic/feathcr) of the 
geometric mean for Der p (jug/in2) was 15.45 (95% 
confidence interval [Cl]: 4.28-55.8).6 Higher HDM 
allergen levels have been found also in synthetic as 
compared with feather pillows.7-* The higher aller­
gen loading near a child's airway has been proposed 
as one possible explanation7-* for the numerous 
cross-sectional9 "  and prospective associations12-11 
between synthetic bedding and childhood wheeze. 
However, the association may reflect selection bias 
associated w ith the preferential choice of synthetic 
bedding for children at risk of later allergic asthma." 
Although randomized, controlled trials are con­
strained by the ethics of applying potentially delete­
rious synthetic bedding to children with severe 
wheeze, additional confirmatory evidence is needed 
from observational studies.
One novel approach to assess the role of bedding 
in asthma could be to look at the interaction between 
bedding and different sleep positions with regard to 
child wheeze. Specifically, if it could be demon­
strated that synthetic quilt use, for example, con­
ferred a different risk if a child slept in a different 
sleep position, then the case for synthetic quilt use 
being causally related to asthma would be strength­
ened. If the adverse effect was mediated through 
some mechanism that involved the bedding being in 
close proximity to the airway, one would postulate 
that the association between overlying synthetic quilt 
use and adverse respiratory outcomes would be ob­
served specifically among children sleeping supine,
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during which the face would be closer to overlying 
bedding.
In the Tasmanian Asthma Survey, synthetic bed­
ding was strongly associated with frequent wheeze. 13 
The aim of this report is to examine whether the 
association between synthetic quilt use and frequent 
wheeze is significantly stronger among children who 
slept supine compared with children who slept non­
supine.
M E T H O D S
The 1995 Tasm anian A sthm a Survey
We conducted a cross-sectional survey on nil children who 
turned 7 years old in Tasmania, Australia, identified through 
primary schools and home-learning and distance-education orga­
nizations. By December 31, 1995, questionnaires had been com­
pleted for 92% (6378 of 6911) of eligible children.1'  The question­
naire included questions from the International Study of Asthma 
and Allergies in C hildhood." Previous validation work has 
shown that the report of wheeze over the past 12 months has a 
sensitivity of 0.81 and a specificity of 0.85 for the physician diag­
nosis of asthma in childhood.18
Sleep position was classified as supine if the parents reported 
that the child usually slept on the back in response to the question: 
"What position does your child usually sleep in?" Children usu­
ally sleeping on their sides or stomachs were termed nonsupine 
sleepers. Synthetic pillows were those reported as foam/sponge/ 
tontine/polyesler/Dacron. Quilts, doonas, or duvets of Dacron, 
polyester, or other synthetic composition were classed as synthetic 
quilts. Overlying bedding was categorized into 3 categories: any 
synthetic quilt, feather quilt, and other bedding (ie, neither feather 
nor synthetic quilt). Sheepskin was any wool fleece underbedding 
with either hide or material backing.
In addition, we conducted full exercise-challenge lung-function 
testing on 414 children at 23 randomly selected schools in South­
ern Tasmania; the method is described in detail elsewhere.1*’ It 
included baseline and postexercise spirometric measures of forced 
expiratory volume in I second (FEV,), the latter after 6 minutes of 
free running.1*’ These studies were approved by the University of 
Tasmania Ethics Committee (Human Experimentation), and par­
ents provided informed, written consent.
O utcom e M easurem ent
Disease misclassification within the broad spectrum of asthma 
has been a large problem in asthma epidemiology. For this bed­
ding study, we were interested in identifying children who would
be more likely to have HDM-triggered airway disease rather than 
those w ith asthma caused by other mechanisms. We chose to 
compare children w ith frequent wheeze (>12 episodes in the past 
year compared w ith children w ith no wheeze) for the following 
reasons: 1) children w ith  asthma who are also sensitized to HDM 
are more likely to have severe or frequent asthma17; 2) feather 
pillow and qu ilt use has been inversely associated w ith severe 
wheeze18; and 3) in our setting, we have reported previously that 
HDM-sensitized children are much more likely (P <  .0001) to have 
frequent wheeze than nonsensitized children in our setting (prev­
alence ratio 19.6 [95% Cl: 6.9, 55.6]).1,1 In addition, we examined 
postexercise FEV,, a lung measure previously observed to be 
lower in children w ith recent wheeze or asthma.16
S ta tis tica l M e thods
First, univariate odds ratios (ORs) were calculated by using 
lo g is t ic  regression.-0 The reference group chosen for upperbed­
ding was feather quilts, because this bedding type has 1) lower 
HDM levels7'8 and 2) has been associated previously with reduced 
wheeze, compared with synthetic quilts.10 We examined the in­
teraction between quilt type and sleep position by comparing 
synthetic and feather quilts. Most children (88.17u) slept under 
these 2 overbedding types (Table 1). For sleep position, children 
who slept supine were compared w ith nonsupine children, and 
children w ith no usual sleep position were excluded. The Brcslow- 
Day test was used to examine differences in the association be­
tween synthetic versus feather quilt use and severe wheeze by 
sleep-position strata.21 We then conducted a nested case-control 
study among the children who were reported to have a usual sleep 
position. Each child w ith  frequent wheeze matched to control 
children w ith no wheeze over the past year. Each index child was 
matched to the nearest controls by date of birth who had the same 
status as the index child w ith  regard to 4 characteristics: gender, 
foam mattress or not, electric blanket or not, and sheepskin or not. 
Thus, in the matched analysis, each matched set was standardized 
w ith regard to underbedding except for p illow  type. Feather p il­
lows and allergen-occlusive mattress covers were too uncommon 
to allow adequate matching and thus were considered as addi­
tional confounders in the matched analyses. In total, 117 children 
w ith frequent wheeze were matched to 1162 controls, w ith up to 
10 controls per case. More than 80% of controls were born w ith in 
a month of the index case. Conditional logistic regression models 
then were used to examine the relation between quilt use, sleep 
position, and reported respiratory outcomes, w ith  control for con- 
founders.20 The difference in the quilt-wheeze associations by 
sleep position was examined by the log likelihood ratio test for the 
reduction in deviance associated with the addition of an interac­
tion term into the logistic model.22 Thus, the interaction is based 
on a multiplicative model. Any interactions observed would be
TABLE 1. Distribution of Sleeping Environment Characteristics and Respiratory Wheeze in the 
1995 Cross-Sectional Study
Characteristic Total, n ii % W illi Variable
Usual sleep position 
Supine (on back) sleep position
6355
2431 38.3
Nonsupine (on side or tummy) 3048 48.0
No usual sleep position or other 876 13.8
Overbedd ing
Any synthetic qu ilt use
6345
2649 41.7
Feather quilt use 2941 46.4
Other overbedding 755 11.9
Pillow
Any synthetic p illow
6340
5709 90.0
Feather pillow 231 3.6
Other pillow 400 6.3
Sheepskin underbedding 6307 1331 21.1
Electric blanket 6307 1347 21.4
Allergen-occlusive mattress cover 6307 54 0.9
Foam mattress 6363 2038 32.0
Bed type
Bottom bunk bed
6354
686 10.8
Wheeze frequency over the past year 
None (0 episodes)
6107
4707 77.1
Moderate (1—12 episodes) 1264 20.7
Frequent (>12 episodes) 136 2.2
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present also in an additive model, but negative or absent findings 
cannot be taken to mean that additive interactions are not 
present.2-1 The lung-function sample was relatively small, and thus 
synthetic quilt use was examined as a dichotomous exposure to 
maximize the sample size for analysis. Multiple linear regression 
models were used to examine FF,V, as a continuous outcome, with 
adjustment for relevant confounders.7-'1
RESULTS
G eneral Features
The mean age of the participants was 6.9 years 
(SD: 0.3), and 50.5% were male. Synthetic pillow or 
quilt use was common (Table 1). Feather quilt use 
was also common, but feather pillow use was not. 
Most parents were able to report a usual child sleep 
position, with 86°/) of children with frequent wheeze 
(117 of 136) or no wheeze (4048 of 4707) reported to 
have a usual position. More than one third of the 
children slept supine (Table 1). Among nonsupine 
children, the side position (n = 2564) was much more 
common than the prone sleep position {n = 484). 
Although many children had recent wheeze (23%), 
only 2% (n = 136) of the children were reported to 
have had frequent wheeze with >12 episodes in the 
last year (Table 1).
S leep in g  E nvironm ent and Other Characteristics 
A ssociated  W ith Frequent W heeze or Sleep Position
Frequent wheeze was positively associated with 
the use of a synthetic quilt, synthetic pillow, or elec­
tric blanket and sleeping in a bottom bunk (Table 2). 
A supine sleep position was associated with electric 
blanket or foam mattress use but not with frequent 
wheeze, rhinitis, or eczema (Table 2). Asthma medi­
cation type and use over the past year did not relate 
to sleep position, in Australia in 1997, bedding ad­
vice to children with asthma included the use of an
allergen-occlusive mattress cover and sheepskin 
avoidance.25 Consistent with this, children with fre­
quent wheeze were more likely (OR: 18.39; P < .0001) 
to sleep on allergen-occlusive covers but less likely 
(OR: 0.54; P = .02) to sleep on a sheepskin.
The R elation  Betw een O verbedd ing  C om position and 
Frequent W heeze by U sual S leep  Position
First, we examined the association between quilt 
use and severe wheeze after stratification by sleep 
position (Table 2). Among supine sleepers, synthetic 
(versus feather) quilt use was associated with fre­
quent wheeze (OR: 3.75 [95% Cl: 1.78, 8.63]). How­
ever, this apparent adverse effect was not evident 
among nonsupine children (OR: 1.12 |95% Cl: 0.65, 
1.93]). The difference in synthetic quilt effect by sleep 
position was significant (test for interaction: P =-- 
.007). There was no difference in the association be­
tween allergen-occlusive cover use or sheepskin use 
and recent wheeze by sleep position.
Second, we examined the data, taking possible 
confounding factors into account. We examined the 
nested case-control sample in which each child with 
frequent wheeze was matched to controls without 
wheeze with regard to age, gender, foam mattress 
use, electric blanket use, and sheepskin use. Again, 
synthetic compared with feather quilt use was asso­
ciated (P = .02) with severe wheeze among supine 
sleepers (OR: 2.54 [95% Cl: 1.18, 5.48]), but this asso­
ciation was absent for children sleeping on their 
sides or prone (OR: 1.09 [95% Cl: 0.62, 1.92]; test for 
interaction: P = .005). Additional adjustment for syn­
thetic pillow use provided matched ORs of 2.37 (95% 
Cl: 1.08, 5.23) and 1.06 (95% Cl: 0.60, 1.88), respec­
tively (test for interaction: P — .005). Among nonsu­
pine children, the effect of synthetic versus feather
TABLE 2. The Association Between Sleeping Environment, Child Characteristics, and Frequent Wheeze or Supine Sleep Position in 
the Tasmanian Asthma Survey
Characteristic (Reference Group) OR (95% Cl) 
for Frequent 
Wheeze
OR (95% Cl) 
for Supine 
Sleep Position
Sleep i ng en v iron men t
Usual supine position (usual side or prone) 0.90 (0.61,1.33)
Synthetic quilt (feather quilt) 1.74 (1.20, 2.51) 1.03(0.92, 1.16)
Other overbedding (feather quilt) 1.37 (0.78, 2.39) 0.92 (0.77, 1.10)
Synthetic pillow (feather pillow) 3.24(1.03, 10.24) 0.98 (0.78, 1.23)
Other pillow (feather pillow) 2.59 (0.57, 11.73) 1.26 (0.88, 1.81)
Sheepskin underbedding (no sheepskin) 0.54 (0.33, 0.90) 1.06 (0.93, 1.20)
Electric blanket (no electric blanket) 1.56(1.07, 2.29) 1.17(1.02, 1.33)
Foam mattress (no foam mattress) 1.35 (0.95, 1.92) 1.21 (1.08, 1.36)
Bottom bunk bed (other type of bed) 1.76(1.08, 2.88) 0.96(0.81, 1.15)
Overbedding by sleep position
Among supine sleepers, synthetic (feather) quilt 3.75 (1.78, 8.63)* —
Among nonsupine sleepers, synthetic (feather) quilt 1.12 (0.65, 1.93)* —
Among supine sleepers, other overbedding (feather) quilt 2.76 (0.89, 7.90)+ —
Among nonsupine sleepers, other overbedding (feather) quilt 0.99(0.39, 2.21)4 —
Chi Id cha racterislics
Male .sex 1.31 (0.93,1.85) 1.07(0.96, 1.20)
Premature (<37 wk gestation) birth 2.19(1.31, 3.64) 0.86(0.70, 1.06)
Breastfed in infancy 0.61 (0.41, 0.92) 0.93(0.81, 1.06)
No siblings 1.31 (0.66, 2.62) 0.95(0.75, 1.21)
Family history of asthma 5.43 (3.50, 8.41) 1.03(0.92, 1.15)
Eczema 3.69 (2.60, 5.23) 1.12(0.98, 1.28)
Hay fever 9.05(6.37, 12.86) 1.11(0.97, 1.27)
* Difference in effect by sleep position; P .007. 
+ Difference in effect by sleep position; P ■■ .10.
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quilt use did not vary between side- and prone- 
sleeping children (P = .86). The significant difference 
in quilt effect by sleep position persisted after adjust­
ment for premature (<37 weeks' gestation) birth, 
breastfeeding history, sibling number, allergen-oc­
clusive mattress cover use, overlying sheet use, home 
gas use, child exposure to tobacco smoke, or expo­
sure to the other factors listed in Table 2. The inter­
action effect also persisted after adjustment for child 
hay fever, eczema, and family history of asthma (test 
for interaction: P = .01). Third, we examined 6 dif­
ferent sleep-position-overbedding combinations 
with regard to frequent wheeze (Table 3). The base­
line group for each pairwise comparison was sleep­
ing supine under a feather quilt. All other sleep 
combinations were associated with a higher risk of 
frequent wheeze, and the difference in risk for syn­
thetic quilt use was significant regardless of sleep 
position used under a synthetic quilt. Fourth, we 
attempted to examine the effect of pillow composi­
tion on frequent wheeze by sleep position. However, 
this was not possible because of low numbers: only 3 
children who slept supine on a nonsynthetic pillow 
were reported to have frequent wheeze.
Lung Function
The median FKV, in this sample was 1.44 L (inter­
quartile range: 1.30-1.59 L). The results in Table 4 
have been adjusted for child age, gender, height, 
distance run, ambient humidity during exercise, 
family history of asthma, child exposure to active 
smoking, and whether asthma medications were 
taken within 6 hours of testing. Increasing wheeze 
frequency over the past year was clearly associated 
with lower postexercise FEV, measures. Children 
with any wheeze episodes over the past year had a 
lower FEV, postexercise than children with no 
wheeze. Among children who slept nonsupine, syn­
thetic quilt use was not associated with a significant 
FEV, reduction postexercise, compared with chil­
dren not using this item. However, among children 
who did sleep supine, synthetic quilt use was asso­
ciated (P = .05) with a lower postexercise FEV, com­
pared with supine sleepers under feather or other 
bedding (Table 4). Thus, an adverse effect for syn­
thetic quilt use, particularly among supine sleepers, 
was observed for this measure of lung function, sim­
ilar to the findings reported above for frequent 
wheeze.
D ISC U SSIO N
An interaction between quilt use and sleep posi­
tion on respiratory function was observed. There was 
an adverse effect associated with synthetic quilt use 
on frequent wheeze and postexercise lung function 
among children who slept supine but not among 
children who did not sleep supine. It is of relevance 
to study the interaction between bedding and differ­
ent sleep positions, an approach we have used pre­
viously in sudden infant death research.26 For the 
issue of overlying synthetic quilts and child wheeze, 
if the adverse effect was mediated through some 
mechanism that involved the bedding being in close 
proximity to the a irw ay  (such as, but not restricted 
to, HDM allergen transfer), one would postulate that 
the association between overlying synthetic quilt use 
and adverse respiratory outcomes would be ob­
served specifically among children sleeping supine, 
during which the face would be closer to overlying 
bedding, as was observed in the present study. In 
contrast, the adverse effect of an overlying synthetic 
quilt would be less evident for side- or prone-sleep­
ing children, because other bedding items such as the 
mattress would be closer to the airway and thus 
relatively more important than any overlying items 
such as quilts. A diagrammatic representation of this 
is shown in Fig I.
The strengths of this study are a high participation 
rate, the availability of lung-function and symptom- 
report data, and the use of frequent wheeze as a 
study outcome. Frequent wheeze is a better marker 
of HDM allergen-related wheeze than the global 
term "asthma," because HDM atopy is strongly re­
lated to frequent wheeze.19 The use of a nested case- 
control analysis with matching on underbedding re­
duced the likelihood that underbedding variability 
contributed to the observed interaction. The cross- 
sectional design study does not limit the study ma­
terially, because the postulated interaction is based 
on short-term disease processes. Synthetic bedding 
has been postulated to induce adverse effects 
through HDM allergen loading,7 the release of vola­
tile organic compounds,18 or altered endotoxin expo­
sure.13 Bronchial provocation with aeroallergen can 
produce either an immediate or late response with 
wheeze and FEV, reduction.27,28 Volatile organic 
compounds can induce a decline in FEV, in asth­
matic subjects within 1.5 hours of exposure.29 In­
haled endotoxin can produce a dose-related bron- 
choconstriction within 6 hours.30 Thus, bedding-
TABLE 3. The Risk of Frequent Wheeze for Various Combined Sleep Arrangements Compared With Sleeping Supine Under a Feather 
Quilt
Combined Sleeping Arrangement 
Sleep Position Overbedding
Cases, % 
(u = 117)
Matched 
Controls, % 
(n =  1144)
Matched OR* 
(95% Cl)
P  Value
Supine Feather quilt 8.5 20.6 1.00 (reference) —
Supine Other overbedd ing 6.0 4.9 2.88 (0.83, 10.03) .10
Supine Synthetic quilt 26.5 17.7 2.67 (1.23, 5.80) .01
Nonsupine Feather quilt 27.4 26.0 1.87 (0.86, 4.08) .12
Nonsupine Other overbedd ing 6.8 6.5 6.84 (0.82, 56.75) .08
Nonsupine Synthetic quilt 24.8 24.4 2.38(1.09, 5.18) .03
* Cases matched to controls with regard to age, gender, foam mattress use, electric blanket use, and sheepskin use.
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TABLE 4. Change in FEV, Postexercise bv Wheeze Frequency and Sleep Arrangement
Factor No. of Children FEV, Change in m l P Value
With Lung-Function Postexercise
Tests and Data Available (95% Cl)
Number of wheeze episodes in the past year
None (reference) 320 0% (reference) —
1-3 48 -5.5 (-8.80 to - 2.2) .001
4-12 16 -5.5 ( 11.1 to 0.05) .05
>12 2 16.6 ( 30.9 to 2.21) .02
Supine sleep position 349 -0.1 (-2.6 to 2.4) .94
Synthetic quill use 406 -1.3 (-3.6 to LOO) .27
For children with nonsupine sleep position, synthetic quilt use 196 -1.0 (-4.7 to 2.8) .61
For children with supine sleep position, synthetic quilt use 151 -3.6 (-7.0 to 0.03) .05
Lung-function measures were adjusted for child height, age, gender, distance run, ambient humidity during exercise, family history of 
asthma, child exposure to active smoking, and whether asthma medications were taken within 6 hours of testing. Children with no usual 
sleep position were excluded. Children using ß-agonists on the day of testing were excluded (n ~ 6).
Fig. 1. Schematic representation of a hy­
pothesized mechanism involving close 
proximity of bedding to the child's air­
way. The hypothesis is that the adverse 
effect of an overlying synthetic quilt is 
mediated by a mechanism involving 
close proximity to the airway. For exam­
ple, the inhaled HDM allergen dose into 
a child's airways could be less if the air­
way is in close proximity to lower HDM 
allergen bedding such as feather quilts,6 
compared with higher HDM allergen 
bedding such as synthetic quilts,6 under- 
bedding,'* or mattresses.4
Overlying feather quilt in supine Overlying synthetic quilt in supine position
position
Increased wheeze risk
1 3  Airways closer to 
higher allergen beddine
IXJ Airways closer to 
lower allergen bedding
Overlying feather quilt in nonsupine 
position
Overlying synthetic quilt in nonsupine 
position
No change in wheeze 
risk
1 3  Airways closer to higher risk 
underbedding. regardless of 
overlying bedding allergen
1 3  Airways closer to 
higher risk underbedding, 
regardless of overlying 
bedding allergen
I I Less adverse bedding -  e.g. lower HDM allergen reservoir in bedding.
1 1 More adverse bedding -  e.g. higher HDM allergen reservoir in bedding.
induced bronchoconstriction could occur over a 
short time period. A potential weakness of the study 
is that frequent wheeze, bedding, and sleep position 
were based on parental report only. The report of 
wheeze frequency showed good agreement with 
measures of postexercise lung function. Addition­
ally, the findings for synthetic quilts and lung func­
tion were similar to those for frequent wheeze. The 
king-function decrement associated with synthetic 
quilt use among supine sleepers was small, but it 
was two thirds the magnitude of the decrement as­
sociated with recent wheeze and thus may be of
clinical relevance. Previously, the parent report of 
infant bedding has been shown to agree well with 
interviewer observations at home interview. The va­
lidity of a parental report of usual sleep position in 
children of this age group has not been established. 
Child sleep position is likely to change during the 
night,31 which could lead to m^classification of 
usual sleep position. This misclassification would be 
likely to be nondifferential and thus reduce the 
study's ability to detect sleep-position effects.
However, the important issue is that the interac­
tion between synthetic bedding and sleep position
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cannot be explained by such misclassification. Sleep 
position was classified as a binary factor (supine/ 
nonsupinc), and both differential and nondifferential 
misclassification of a binary environmental factor 
will, if it has any effect, bias a multiplicative interac­
tion effect toward the null value when the following 
conditions are met.32 First, the 2 binary factors 
should be independent. The lack of association be­
tween synthetic quilt use and supine sleeping in 
Table 2 satisfies the criteria that the 2 binary factors 
should be independent.32 A second condition is that 
the measures must classify the true exposures better 
than random.32 Past validation work shows a high 
level of agreement between parental report and 
nurse observation of infant bedding.13 Thus, parental 
report is likely to classify bedding correctly, certainly 
better than random. To our knowledge, the parental 
report of child usual sleep position at age 7 has not 
been validated. However, findings in this study re­
lated to sleep position and electric blanket use indi­
cate that parental classification of usual sleep posi­
tion is not random. Children sleeping on electric 
blankets were classified by parents as significantly 
more likely to sleep supine, consistent with past 
thermal work on sleeping infants.33 That is, the sleep- 
position data do provide a pattern of results consis­
tent with past work on thermal balance,33 which 
would predict that children with electric blankets 
would avoid the prone position, which provides a 
reduced capacity to lose body heat. Thus, parental 
report, although it may not classify all sleep positions 
correctly, is likely to reflect the actual predominant 
sleeping position.
There is growing evidence that synthetic bedding 
materials are associated with increased childhood 
wheeze/1-11 It is now a high priority to establish 
whether the association is causal in nature. Previous 
studies have shown that the association between 
synthetic upperbedding and severe wheeze has a 
high strength of association,13'18 a dose-response re­
lationship,13 biological plausibility,7 and ecological 
coherence/1-11 Two recent birth cohorts have re­
ported that a prospective relationship is evident.12'13 
However, experimental evidence is not available and 
may be difficult to obtain because of the ethics of 
applying a potentially deleterious exposure (syn­
thetic bedding) to children with asthma. One of the 
counterarguments against a causal role for synthetic 
bedding with childhood wheeze was that the associ­
ation may merely reflect selection bias even before 
wheeze development (ie, synthetic bedding was 
preferentially selected for children at risk of subse­
quent wheeze). However, the finding that the ad­
verse effect of synthetic quilts was restricted to su­
pine-sleeping children only is evidence against this, 
because it is unlikely that this selection bias differs by 
sleep position. This is supported by the findings of 
no interaction between sleep position and the 2 bed­
ding items (sheepskin and allergen-occlusive mat­
tress cover) that do seem to reflect selection accord­
ing to the asthma recommendations existing at the 
time of the study. In 1997, Australian asthma recom­
mendations were to avoid sheepskins and use im­
permeable mattress covers.23 The interaction re­
ported here provides additional support for a causal 
interpretation,34 because the adverse effect of syn­
thetic quilts was most evident in children who would 
be more likely to be sleeping face-up near the quilt. 
In contrast, as predicted, the adverse effect of an 
overlying synthetic quilt was less evident for side- or 
supine-sleeping children, because other bedding 
items such as the pillow or mattress would be closer 
to the face and thus relatively more important than 
overlying quilts. The exact mechanisms that underlie 
this interaction are not understood yet. An increasing 
focus on the bedding environment immediately ad­
jacent to the nose and mouth of children during sleep 
is required.
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Abstract
Objective To investigate the role of infant bedding items, not in isolation, but as part of a 
composite bedding environment with the development of wheeze in childhood.
Methods Prospective cohort study of 863 children who participated in an infant survey in 
1988 and asthma study in 1995 (78% follow-up) in Tasmania, Australia. The three composite 
infant bedding categories (Bo, Bi and B2) corresponded to increasing numbers of the bedding 
items of synthetic pillow, quilt, cocoon and sheepskin. 1995 outcome measures included 
recent wheeze.
Findings Infant bedding was associated with subsequent recent wheeze (AOR Bo 1.00 
[reference]; B, AOR 1.07 [95%CI 0.72, 1.57]; B2 AOR 2.10[95%CI 1.15, 3.82]; p for trend = 
0.05). This composite bedding effect was further enhanced by the home environment factors 
of bedroom heating, recent bedroom painting and absence of bedroom carpet. When any two 
or more of these environmental bedding-wheeze enhancers were present a strong dose- 
response was evident (p for trend = 0.01).
Conclusion Bedding exposure in infancy is prospectively associated with childhood wheeze 
and home environmental conditions may modify this association.
2
Introduction
Reasons for the changing incidence of childhood asthma over time are unclear. The indoor 
environment, in particular house-dust mite (HDM) allergen exposure, is an area of concern.1 
High exposure to HDM allergens is associated with an increased risk of subsequent HDM 
sensitization but the role of HDM exposure in asthma is less clear.2 Bedding is a significant 
source of HDM allergens with infant bedding such as synthetic pillows and quilts,3 and 
sheepskins4 harboring high HDM levels. Replacing used with new bed quilts reduced more 
than 10-fold airborne Dermatophagoides HDM allergen levels near the face during sleep.5 
HDM allergen levels in bedding have been shown to be more important than bedroom floor 
HDM levels in determining airway responsiveness6 or asthma severity.7 This may explain 
why a prospective association between infant bedroom floor HDM levels and asthma has been 
found in only one of three studies.810 Furthermore, increased environmental exposure to 
endotoxins, found in the bedroom, has been postulated to influence the risk of asthma and 
allergic sensitization.11,12
Difficulty in measuring indoor exposures during infancy has been one problem hampering 
research into early life influences on childhood asthma. Detailed information on the infant 
sleep environment has not been readily available. The Tasmanian infant cohort provides such 
information. Previous studies on this cohort demonstrated infant exposure to synthetic 
bedding items such as pillow, quilt and cocoon was associated with child wheeze.13'15 
Sheepskin use was associated with HDM sensitization.16 In contrast, bedroom carpet17 and 
infant mattress type appeared less important.16
Moreover, with regard to childhood asthma, the environmental model for infant HDM 
exposure may not be one of single major independent risk factors but rather one of 
environmental determinants synergistically increasing infant HDM exposure. For example,
3
bedroom heating increases the HDM levels in bedding. 18 In addition to allergen exposure, 
environmental air quality may also be important with substances such as volatile organic 
compounds (VOCs) possibly potentiating allergen sensitization, whereas, endotoxin presence 
may affect HDM sensitization. 11
An additional approach investigating the role of infant bedding and bedroom environment in 
asthma development is to (i) further quantitate bedding exposure measurement by considering 
bedding not as single items but as a composite and, (ii) investigate bedding-environment 
interactions. We utilize this approach, based on a theoretical model of HDM-loading in 
bedding, to investigate infant sleeping environment and subsequent childhood.
4
Methods
Study Design
The Tasmanian Infant Health Survey (TIHS) was a cohort study of infants bom from 1988 
through 1995 in Tasmania, Australia that operated from hospitals where approximately 93% 
of births occurred. Infants bom were scored to assess the risk of sudden infant death 
syndrome (SIDS) using perinatal entry criteria.19 Infants exceeding a scoring cutoff were 
eligible for inclusion together with all multiple births. The eligibility criteria and study 
methods are discussed elsewhere.19 Data were obtained on three occasions, including a home 
interview during the fifth postnatal week. Data included parental, infant, home environmental, 
child-care factors and the infant’s sleeping environment at age one-month.
In 1995, the cross-sectional Childhood Asthma Survey was conducted on all children who 
turned seven years of age in Tasmania.17 We linked the 1995 asthma data of the 863 children 
who had an at-home interview at one-month of age in 1988 as part of the TTHS. Data included 
sleeping environment and asthma symptoms, using International Study of Asthma and 
Allergies in Childhood (ISAAC) questions.20 The child’s age (in completed years) at onset of 
wheezy breathing or asthma was obtained.
Definitions
Recent wheeze refers to one or more wheeze episodes over the past 12 months. Asthma ever 
refers to a positive response to the ISAAC question, “Has your child ever had asthma?”.20 
Bronchial hyperresponsiveness after exercise is related to these outcomes.14 Night wheeze is 
the child’s sleep being disturbed one or more nights per week in the past 12 months due to 
wheezing. Frequent wheeze refers to 12 episodes or more of wheeze over the past 12 months. 
A family history o f asthma was defined as asthma in any of the infant’s siblings, parents or 
grandparents at the time of the infant’s birth.
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Classification of Bedding Items
Sheepskins comprised the animal hide with natural wool fibres attached. Infant cocoons 
manufactured and sold in Southern Tasmania during the study period most commonly 
comprised outer coverings of cotton/polycotton with a synthetic filling.15 Pillows reported as 
foam/sponge/tontine/polyester/Dacron were classified as synthetic and a synthetic quilt in 
infancy was defined as the use of a synthetic quilt over the infant during cold weather. Use of 
sheepskin and/or cocoon at time of interview or intention to use either of these items in cold 
weather was recorded, thereby avoiding the effect of current season when interviewed.
A three-level composite bedding classification was made based on past work and the 
distribution of bedding exposures to HDM-rich synthetic pillows, quilts and cocoons, or 
sheepskin.3,4 The reference group Bedding Combination 0 (B0) represented infants with no 
synthetic items and no sheepskin.16 Bedding Combination 1 (Bi) comprised either one 
synthetic item only (n=279) or one sheepskin only (n=12I) or one synthetic item and one 
sheepskin (n= 113). Bedding Combination 2 (TU) comprised two or more synthetic items 
without sheepskin (n=57) or with sheepskin (n=14). More emphasis was on synthetic bedding 
items than sheepskin because of the previous reported associations with wheeze in this 
cohort.13"15 Here, the term composite bedding refers to the increase from B0 to Bi to B2 . The 
B2 effect is B2 versus Bo, and the Bi effect is Bi versus B0.
Classification o f Indoor Environmental Factors
We coded possible effect modifiers as binary. Baby’s bedroom heated was in response to 
current use at time of interview and also intended use of heating in cold weather. Recent 
painting refers to the infant’s bedroom having been painted within the previous 12 months 
from the time of home interview. Absence of carpet means no wall-to-wall carpet in the 
infant’s bedroom.
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Statistical Methods
Pair-wise correlations were obtained by Spearman’s rank order correlation. Logit-based 
univariate odds ratios and 95 percent confidence intervals were calculated by logistic 
regression. To assess the role of the composite bedding exposures in infancy as a risk factor 
for asthma at the age of 7 years, multivariate logistic regression models controlled for 
multiple confounders simultaneously, providing adjusted odds ratios21 for the categorical 
outcome variables “recent wheeze” and “asthma ever”. We also examined “frequent wheeze” 
as a measure of asthma severity and “night wheeze” because bedding was the exposure of 
interest. Those factors found in univariate analysis, or a priori, to be associated with wheeze 
were examined as potential confounders. Using change-in-estimate methods, factors altering 
the exposure-wheeze association point estimate by 10 percent or more were included in the 
final model. We examined the confounding effect of a large number of factors including 
sibling number, in utero exposure to maternal smoking, air freshener use in infant’s bedroom, 
cat or dog as a family pet during infancy, visible indoor mould and plastic mattress cover use 
in infancy, and low maternal education or paternal unemployment at child’s birth. We 
explored the contribution of family asthma history to the association between bedding and 
wheeze as either a confounder or an intervening variable using stratification. Factors that 
altered the exposure-wheeze association by 10 percent or more were an at-birth family history 
of asthma, male sex, foam mattress use in infancy and maternal cigarette smoking during 
infancy. The cohort entry criteria, either separately or as a set did not alter any of the reported 
associations. We used the Wald test for linear trend of the categorical bedding variables by 
replacing the binary predictors with a single predictor, taking category rank scores.
A model was built with terms for composite bedding and each confounder to assess whether 
an association between a composite bedding classification and a respiratory outcome differed
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by environmental factor status after controlling for confounders. The dependent variable was 
one of the respiratory outcomes examined. A second model, was built similar to the first but 
also with a term for the environmental factor and an interaction term between composite 
bedding and environmental factor. The resulting deduction in deviance obtained using the 
second model compared to the first was then assessed using the p-value associated with the 
log likelihood ratio test.21 Tests for interaction often use a higher significance than p=0.05.22 
Here, interaction terms improving the model by p<0.1 are considered important. Stratified 
multivariate logistic regression explored the potentiation of more than one environmental 
factor on the bedding-wheeze effect. Discrete proportional hazard modeling21 examined age 
of asthma onset or wheezy breathing by bedding. The potentiation of age of onset by 
environmental factors was determined by a stratified log rank test.21 We conducted the 
analysis using statistical software, STATA 7.0.23
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Results
The characteristics of the study sample are shown in Table 1. Infants exposed to composite 
bedding B2, had a more than two-fold risk of recent wheeze and night wheeze by age 7 years 
compared with children who had none of these bedding items in infancy (Table 2). There was 
a dose-response relationship between exposure to increasing number of composite bedding 
items in infancy and the risk of recent wheeze and asthma ever in childhood. This trend for a 
higher number of composite bedding items and increasing risk of subsequent wheeze was also 
found with night wheeze and frequent wheeze. A parental history of asthma was not 
associated with selection of composite bedding combinations. Even among children without 
an at-birth family history of asthma, the risk of wheeze increased with more composite 
bedding items (Test for trend, p=0.03).
We examined the influence of bedroom heating, bedroom carpet and recent bedroom painting 
on wheeze and the interactions of these factors with the use of composite bedding. There was 
no relationship between bedroom heating and bedroom carpet (Spearman r=0.052); bedroom 
heating and recent painting (Spearman r=0.078); bedroom carpet and recent painting 
(Spearman r=-0.029). Nor were these factors associated with the composite bedding 
(Spearman r =-0.015; -0.002 and -0.083 for bedroom heating, recent bedroom painting and 
bedroom carpet respectively). Bedroom heating, recent bedroom painting and the absence of 
bedroom carpet did not significantly predict wheeze with ORs of 1.08, 0.82, and 1.12 
respectively. Carpet may be removed as part of an allergy-reduction measure in families with 
a history of asthma. In this cohort, there was no difference in the proportion of children with a 
family history of asthma (9.1%) that had no carpet in their bedrooms compared to children 
who did not have a family history of asthma without carpet in their bedroom (10.1%) 
(p=0.576).
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These three environmental factors altered the bedding-wheeze associations. The dose- 
response relationship of infant composite bedding on the risk of subsequent recent wheeze 
was particularly evident when the infant slept in a heated room (Table 3). In particular, B2 
was strongly associated with recent wheeze in childhood (adjusted OR 7.87; 95% Cl 2.17, 
28.51) when the infant’s bedroom had been heated. The difference in the potentiation of the 
composite bedding effect by room heating was significant (Likelihood ratio test, p=0.051). 
Similarly, children with asthma ever demonstrated this potentiation of the composite bedding 
effect by room heating. No significant associations were found between each of the different 
types of heating used in the infant’s bedroom and recent wheeze. The bedding-wheeze effect 
was potentiated by room heating irrespective of the heating type.
There was a greater increase on risk of subsequent wheeze by composite bedding for infants 
sleeping in a recently painted bedroom (Table 3). Among infants in recently painted rooms, 
infants exposed to a composite bedding arrangement of B2 , had a more than five-fold increase 
in risk of recent wheeze by age 7 years than infants with B0 bedding. We next examined 
whether the relative importance of composite bedding on wheeze would be greater in 
uncarpeted or carpeted rooms. Stronger composite bedding effects on wheeze were found in 
uncarpeted compared to carpeted bedrooms (Table 3). The potentiation of the composite 
bedding effect by these three environmental factors was also evident for night and frequent 
wheeze.
The effect modification patterns reported above for bedroom heating, recent bedroom painting 
and the absence of carpet, remained after adjustment for the other two environmental factors, 
either individually or together, plus the confounders listed at the bottom of Table 2. These 
three environmental factors appeared to independently potentiate the risk of composite 
bedding categories on wheeze. Moreover, Figure 1 shows when any two or more of these
10
environmental bedding-wheeze enhancers were present, the OR for the Bpwheeze association 
was 3.45; 95%CI 1.01, 11.83, and the OR for the B2-wheeze association was 14.94; 95%CI 
1.94, 115.1. The difference for potentiation of the bedding classification B2-wheeze effect in 
the presence of from none to two or more environmental factors was significant (p=0.012).
Among infants with childhood asthma, increasing the number of composite bedding items 
was associated with an increased risk of subsequent earlier onset of asthma symptoms by age 
7 years. Infants with Bo, Bi and B2 had a mean age of onset of 3.7, 3.2 and 2.1 years 
respectively (Log-rank test for equality of survivor functions, p=0.002). The presence of the 
three environmental factors, identified as bedding-wheeze enhancers in infancy, also 
potentiated the shift by the bedding combinations to an earlier age of onset of asthma among 
children with a history of asthma ever.
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Discussion
This is the first report investigating composite infant bedding and subsequent wheeze to 
consider modification by the home environment. Wheeze risk in childhood increased linearly 
with increasing numbers of potentially high HDM-rich bedding items at one-month of age.
This composite bedding effect was further modified by the indoor environment factors of 
bedroom heating, recent bedroom painting and absence of bedroom carpet. When two or more 
of these environmental factors were present the bedding-wheeze association was markedly 
exacerbated.
Strengths of this study include prospective sleeping environment data, minimizing recall bias, 
and the use of a composite bedding classification. At the time of assessment of wheeze, the 
research nurse was unaware of the infant bedding status. The results are not likely to be 
influenced by differential follow-up as the proportion of TIHS children followed-up from 
infancy did not differ by use of particular bedding items. The study sample was not 
representative of all live births in the geographical area as it consisted of infants bom at a 
higher risk of SIDS, however, the TIHS cohort entry criteria are unlikely to affect the 
generalizability of these results. The eligibility criteria were well defined 24 and the potential 
effects of the entry scoring system components were considered in the multivariate analyses. 
Thus, the children in this study should not differ from other children to any large extent with 
regard to the biological development of asthma. Importantly, the bedding-wheeze associations 
were evident even among children without an at-birth family history of asthma. A potential 
weakness is the absence of a biological or physician assessment of asthma. The ISAAC 
questionnaire, however, is considered a valid instrument for the determination of current 
asthma symptoms; the report of ‘wheeze’ over the past 12 months has a sensitivity of 0.85 
and a specificity of 0.81 for the physician diagnosis of asthma in childhood.25
12
Our findings emphasise the important role of infant sleeping environment on asthma 
development. Moreover, this study demonstrates features suggestive of a causal relationship26 
between composite bedding and wheeze: a high strength of association, a marked dose- 
response effect for wheeze, consistency in the bedding-wheeze effect and the significant 
earlier shift in age of onset of asthma by composite bedding. Further, the environment 
enhancers not only increased the magnitude of bedding-wheeze associations but also shifted 
to earlier age of asthma onset. These results are also consistent with past work. In the 
Tasmanian study, sensitization to HDM is increased in children exposed to sheepskin16 or to 
synthetic bedding as compared to those using featherbedding in infancy. 13 Moreover, several 
cross-sectional27,28 and prospective14' 15 studies have reported an association between 
synthetic bedding and childhood wheeze.
Several mechanisms provide biological plausibility for the increase risk of wheeze reported 
here. An increased exposure to HDM allergen levels, the model on which this report is based, 
has been reported with the use of synthetic or sheepskin bedding items 3' 4 in early childhood. 
Thus high HDM-rich bedding items may increase the risk of HDM sensitization and airways 
inflammation by placing a higher allergen load near the infant’s airway. 14 This is further 
reinforced by new work which shows that the adverse effect of synthetic quilts on wheeze 
varies by sleeping position.29
Atopic individuals are over-represented at the severe end of the asthma spectrum, with earlier 
studies suggesting frequent wheeze may be a better marker of HDM-allergen-related airway 
disease than a history of asthma or milder symptoms. 13’ 28- 30’ 31 HDM allergen exposure is 
associated with increasing wheeze frequency. 32 Here, the risk of frequent wheeze in 
childhood also increased linearly with increasing numbers of potentially high HDM-rich
13
bedding items at age one-month. This is consistent with a bedding effect on HDM-allergen- 
related airway disease but is not definitive as child HDM-atopy status was not available.
Conflicting results regarding associations between mattress and respiratory symptoms or 
HDM sensitization have been reported. 32,33 Mattress HDM allergen levels may be a proxy for 
the measurement of other allergen sources closer to the subject. 34 A recent Cochrane meta­
analysis found bedding changes aimed at reducing exposure to HDM allergens seem 
ineffective in improving the symptoms of asthma in HDM-sensitive asthmatics. Overall, no 
statistically significant difference in improvement of asthma was found even among the sub­
group for whom effective allergen reduction was documented. 35 The findings reported 
indicate the lack of effect may relate to the effective allergen reduction for mattress only, but 
not other allergen sources. Multiple components, not single items, and their relationship to the 
proximal sleeping microenvironment may all play a role in child asthma.
We did not determine HDM allergen levels. However, a single allergen measure of, for 
example, bedroom carpet9, which may not have consistent patterns of allergen distribution36, 
would not have encompassed the bedding and indoor environmental determinants leading to 
personal allergen exposure studied here. Thus, exposure models that take into account the 
multiple determinants of personal allergen exposure are now required to identify the 
mechanisms involved.
Various environmental factors influence asthmatic symptom development.37 For atopic 
infants, the presence of other environmental exposures, in addition to aeroallergens has been 
hypothesised to be synergistic and increase the risk of asthma.38 Here, the potentiation of the 
composite bedding-wheeze effect by indoor environmental factors could reflect various 
synergistic mechanisms. These include increased HDM exposure, increased allergen
14
sensitization, increased VOC-induced inflammation in vulnerable infant airways, or reduced 
exposure to endotoxin. The potentiation of the composite bedding effect on wheeze by room 
heating may be due to an enrichment of the allergen content of bedding, consistent with 
previous studies that reported room heating increased HDM load in bedding.18 The finding 
here that bedroom heating potentiation did not vary by heating type is consistent with the 
effect being that of increased heat in the bedroom environment and not due to characteristics 
associated with the type of heating. The potentiation of the composite bedding effect on 
wheeze by recent painting may reflect that recently painted walls release VOCs39 and their 
presence in the infant’s bedroom may enhance sensitization to HDM by airway inflammation 
resulting in increased permeability and enhanced allergen presentation to the immune 
system40, and/or by VOC-induced Th2 deviation.41 Several birth cohort studies have also 
found an exposure-response relationship between recent home redecoration, including wall 
painting, and an increased risk of wheeze39 or asthma.42
The potentiating effect of having no bedroom carpet is intriguing. The promoting effect of no 
carpet did not operate independently but was seen in association with composite bedding 
exposure. Possibly the absence of bedroom carpet has reduced one habitat for HDM36, 
potentially increasing the relative importance of the bedding as a HDM allergen reservoir. 
Other possible mechanisms include that bedroom carpets, containing significantly more 
endotoxin than bedding43, may be a major reservoir for infantile endotoxin exposure 44,45. As 
synthetic bedding may contain less endotoxin as compared to other bedding46, this could be 
counterbalanced by increased levels in the bedroom carpet. Although, the role of 
environmental endotoxin exposure in asthma development is unclear, several studies have 
postulated that endotoxin exposure in infancy may be protective.12,47.
15
In conclusion, composite bedding exposure as an infant at age one-month predicts subsequent 
childhood wheeze, particularly if exacerbating home environment factors are present. Infants 
spend a significant proportion of their time in bed with consequent opportunity for prolonged 
exposure to adverse environmental influences. These findings indicate that a greater public 
health effort to achieve optimal infant sleeping environments for asthma prevention is 
required.
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Table 1: 1995 Study Sample Characteristics (N=863) at age 7 years
% N*
Mean age (years) 6-9 (SD= 0-3)
Male sex 71.3 615/863
At birth family history of asthma 35.0 301/859
No siblings in 1995 5.8 48/823
Recent wheeze over past year 27-0 222/823
Night wheeze over past year 19-2 160/834
Asthma ever 324 280/863
Frequent wheeze over past year 4.8 30/631
Bedroom  factors in infancy
Synthetic pillowcase use at 1 month age 14-8 127/857
Synthetic quilt use at 1 month age 44-9 396/802
Cocoon use at 1 month age 24 19/802
Sheepskin use at 1 month age 29-8 256/859
Foam mattress use in infancy 62.2 531/854
Plastic mattress cover use in infancy 41.0 352/859
Three-level Composite Bedding Classification
Combination B0 27-0 216/800
Combination Bi 64-1 513/800
Combination B2 8-9 71/800
Environm ental factors in infancy
Heating in infant’s bedroom 34-3 294/857
Carpet in infant’s bedroom 90-6 767/847
Infant’s bedroom painted within previous 12 33-5 287/856
months
Maternal cigarette smoking during infancy 44.7 382/855
Use of home gas appliances (cooking and/or 3.3 28/856
living room heating) in infancy
Presence of mould in home (excluding 4.7 ■40/855
bathroom) in infancy
Cat as pet during infancy 34.3 294/857
Dog as pet during infancy 35.9 308/857
Parental factors
Low maternal education at child’s birth 22.2 191/859
Paternal unemployment at child’s birth 17.4 146/837
* Small N for some characteristics: bedding items (N=800)
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Figure 1. Relationship between the Number of Environmental Factors (Bedroom 
Heating, Recent Bedroom Painting, Absence Of Bedroom Carpet) and Potentiation 
of Composite Bedding- Wheeze Effect by Bedding Combination B0, Bi And B2
The reference group is B0. The difference in effect for potentiation of the bedding 
combination Br  wheeze effect, from none to two or more of the environmental factors is 
p=0017. The difference in effect for potentiation of the bedding combination B2- 
wheeze effect, from none to two or more of the environmental factors is p=0012.
OR = 14.94 
(1.94, 115.10)
OR = 3.73 
(1.36, 10.22)
OR = 3.45 
(1.01, 11.83)
OR = 1.28 OR = 1.26 
(0.66, 2.42)
OR = 1 
(reference)
OR = 1 
(reference)
OR = 1 
(reference)
OR = 0.73 (0.48,3.42) 
(0.41. 1 . 2 9 ) g ^ ^ ^ M
None Two or more
Environmental Factors
Note: The reference group Bedding Combination 0 ( B o )  represented infants with no 
synthetic items and no sheepskin. Bedding Combination 1 (Bj) comprised either one 
synthetic item only (n=279) or one sheepskin only (n=121) or one synthetic item and one 
sheepskin (n=l 13). Bedding Combination 2 (B2) comprised two or more synthetic items 
without sheepskin (n=57) or with sheepskin (n=14).
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